[
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_FORM_5500",
    "schedule_type": "FORM_5500",
    "page_range": "1-3",
    "page_count": 3,
    "raw_text": "Form5500 Annual Return/Report of Employee Benefit Plan OMB Nos. 1210-0110\n1210-0089\nThis form is required to be filed for employee benefit plans under sections 104\nand 4065 of the Employee Retirement Income Security Act of 1974 (ERISA) and\nDepartment of the Treasury\nInternal Revenue Service sections 6057(b) and 6058(a) of the Internal Revenue Code (the Code). 2024\nDepartment of Labor \uf034 Complete all entries in accordance with\nEmployee Benefits Security the instructions to the Form 5500.\nAdministration\nPension Benefit Guaranty Corporation This Form is Open to Public\nInspection\nPart I Annual Report Identification Information\nFor calendar plan year 2024 or fiscal plan year beginning 01/01/2024 and ending 12/31/2024\nA This return/report is for: X a multiemployer plan X a multiple-employer plan (Filers checking this box must provide participating\nemployer information in accordance with the form instructions.)\nXX a single-employer plan X a DFE (specify) _C_\nB This return/report is: X the first return/report X the final return/report\nX an amended return/report X a short plan year return/report (less than 12 months)\nC If the plan is a collectively-bargained plan, check here. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..\uf034 X\nD Check box if filing under: XX Form 5558 X automatic extension X the DFVC program\nX special extension (enter description) ABCDEFGHI ABCDE\nE If this is a retroactively adopted plan permitted by SECURE Act section 201, check here. . . . . . . . . . . . . . . . . . . . . . . . . ..\uf034 X\nPart II Basic Plan Information\u2014enter all requested information\n1a Name of plan 1b Three-digit plan\nAGBLCADXEOFSGMHITIH KALBINCED CEAFSGHH BIA LAABNCCDEE PFEGNHSIIO NA PBLCADNEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI number (PN) \uf034 000031\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 1c Effective date of plan\nY0Y1/Y01Y/1-9M8M0-DD\n2a Plan sponsor\u2019s name (employer, if for a single-employer plan) 2b Employer Identification\nMailing address (include room, apt., suite no. and street, or P.O. Box) Number (EIN)\nCity or town, state or province, country, and ZIP or foreign postal code (if foreign, see instructions) 0213-21039495056078\nAGBLCADXOEFSMGHITIH KALIBNCED LELCFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 2c Plan Sponsor\u2019s telephone\nD/B/A ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI number\nABCDEFGHI 01223145-576517-48990 8\ncF/MoC TAOBWCEDRE FAGT HCIIR AA CBECNDTERFEG SHOIU TAHB CDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 2d Business code (see\n12293294 W56A7LN8U9T SATBRCEDEETF, SGUHIITE A17B0C0D EFGHI ABCDE instructions)\n1\nP\n2\nH\n3\nIL\n4\nA\n5\nD\n6\nE\n7\nL\n8\nPH\n9\nI A\nA\n, P\nB\nA\nC D\n19\nE\n1\nF\n04\nGHI ABCDEFGHI ABCDE\n031252431045\nCITYEFGHI ABCDEFGHI AB, ST 012345678901\nUK\nCaution: A penalty for the late or incomplete filing of this return/report will be assessed unless reasonable cause is established.\nUnder penalties of perjury and other penalties set forth in the instructions, I declare that I have examined this return/report, including accompanying schedules,\nstatements and attachments, as well as the electronic version of this return/report, and to the best of my knowledge and belief, it is true, correct, and complete.\nSIGN Filed with authorized/valid electronic signature. Y0Y9/Y25Y/-20M2M5-DD AMBACUDREEEFNG HEIPS TAEBINCDEFGHI ABCDEFGHI ABCDE\nHERE\nSignature of plan administrator Date Enter name of individual signing as plan administrator\nSIGN YYYY-MM-DD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nHERE\nSignature of employer/plan sponsor Date Enter name of individual signing as employer or plan sponsor\nSIGN YYYY-MM-DD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nHERE\nSignature of DFE Date Enter name of individual signing as DFE\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Form 5500 (2024)\nv.240311\n\nForm 5500 (2024) Page 2\n3a Plan administrator\u2019s name and address X Same as Plan Sponsor 3b Administrator\u2019s EIN\n012233-415096970580\nABGCLADXEOFSGMHIITH KALBINCED ELLFCG HI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 3c Administrator\u2019s telephone\nc/o ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI number\n410 BLACKWELL STREET\n12D3UR4H5A6M7,8 N9C 2A7B7C01DEFGHI ABCDEFGHI ABCDE 01223145-575617-48990 8\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITYEFGHI ABCDEFGHI AB, ST 012345678901\nUK\n4 If the name and/or EIN of the plan sponsor or the plan name has changed since the last return/report filed for this plan, 4b EIN012345678\nenter the plan sponsor\u2019s name, EIN, the plan name and the plan number from the last return/report:\na Sponsor\u2019s name 4d PN\nc Plan Name 012\n5 Total number of participants at the beginning of the plan year 5 12345678397071572\n6 Number of participants as of the end of the plan year unless otherwise stated (welfare plans complete only lines 6a(1),\n6a(2), 6b, 6c, and 6d).\na(1) Total number of active participants at the beginning of the plan year ............................................................................ 6a(1) 7770\na(2) Total number of active participants at the end of the plan year ..................................................................................... 6a(2) 7110\nb Retired or separated participants receiving benefits ....................................................................................................... 6b 12345678192011082\nc Other retired or separated participants entitled to future benefits ................................................................................... 6c 12345678194061862\nd Subtotal. Add lines 6a(2), 6b, and 6c. ............................................................................................................................ 6d 12345678393091042\ne Deceased participants whose beneficiaries are receiving or are entitled to receive benefits. ......................................... 6e 1234567891071972\nf Total. Add lines 6d and 6e. ........................................................................................................................................... 6f 12345678395071012\ng(1) Number of participants with account balances as of the beginning of the plan year (only defined contribution plans 6g(1)\ncomplete this item) .........................................................................................................................................................\ng(2) N\nco\nu\nm\nm\np\nb\nl\ne\net\nr\ne\no\nt\nf\nh\np\nis\na r\nit\nti\ne\nc\nm\nip\n)\na\n.\nn\n..\nt\n.\ns\n. .\nw\n...\ni\n.\nt\n.\nh\n.. .\na\n..\nc\n.\nc\n..\no\n..\nu\n..\nn\n..\nt\n. .\nb\n..\na\n..\nl\n.\na\n..\nn\n.\nc\n..\ne\n..\ns\n.. .\na\n..\ns\n.. .\no\n..\nf\n.\nt\n.\nh\n..\ne\n.. .\ne\n..\nn\n..\nd\n.. .\no\n..\nf\n. .\nt\n.\nh\n..\ne\n.. .\np\n..\nl\n.\na\n..\nn\n. .\ny\n..\ne\n..\na\n..\nr\n. .\n(\n.\no\n..\nn\n..\nl\n.\ny\n.. .\nd\n..\ne\n..\nf\n.\ni\n.\nn\n.\ne\n..\nd\n.. .\nc\n..\no\n..\nn\n..\nt\n.\nr\n.\ni\n.\nb\n..\nu\n..\nt\n.\ni\n.\no\n..\nn\n. .\np\n..\nl\n.\na\n..\nn\n..\ns\n.. . ............... 6g(2) 123456789012\nh N le u s m s t b h e a r n o 1 f 0 p 0 a % rti c v ip es a t n e t d s . w ... h .. o .. . t . e .. r . m ... i . n .. a .. t . e . d .. . e .. m ... p .. l . o .. y .. m ... e .. n . t . . d .. u .. r .. in .. g .. . t . h .. e .. . p .. l . a .. n .. . y . e .. a .. r . . w ... i . t . h .. . a .. c . c .. r . u .. e .. d .. . b .. e .. n .. e .. f . i . t . s . . t . h .. a .. t . . w ... e .. r . e .. . .................... 6h 1234567890102\n7 Enter the total number of employers obligated to contribute to the plan (only multiemployer plans complete this item) ........ 7\n8a If the plan provides pension benefits, enter the applicable pension feature codes from the List of Plan Characteristics Codes in the instructions:\n1A 1C 1I 3F 3H 3J\nb If the plan provides welfare benefits, enter the applicable welfare feature codes from the List of Plan Characteristics Codes in the instructions:\n9a Plan funding arrangement (check all that apply) 9b Plan benefit arrangement (check all that apply)\n(1) XX Insurance (1) XX Insurance\n(2) X Code section 412(e)(3) insurance contracts (2) X Code section 412(e)(3) insurance contracts\n(3) XX Trust (3) XX Trust\n(4) X General assets of the sponsor (4) X General assets of the sponsor\n10 Check all applicable boxes in 10a and 10b to indicate which schedules are attached, and, where indicated, enter the number attached. (See instructions)\na Pension Schedules b General Schedules\n(1) XX R (Retirement Plan Information) (1) XX H (Financial Information)\n(2) X I (Financial Information \u2013 Small Plan)\n(2) X MB (Multiemployer Defined Benefit Plan and Certain Money\nPurchase Plan Actuarial Information) - signed by the plan (3) XX A (Insurance Information) \u2013 Number Attached ___ 2 ___\nactuary (4) XX C (Service Provider Information)\n(3) XX SB (Single-Employer Defined Benefit Plan Actuarial (5) XX D (DFE/Participating Plan Information)\nInformation) - signed by the plan actuary\n(4) X DCG (Individual Plan Information) \u2013 Number Attached ______ (6) X G (Financial Transaction Schedules)\n(5) X MEP (Multiple-Employer Retirement Plan Information)\n\nForm 5500 (2024) Page 3\nPart III Form M-1 Compliance Information (to be completed by welfare benefit plans)\n11a If the plan provides welfare benefits, was the plan subject to the Form M-1 filing requirements during the plan year? (See instructions and 29 CFR\n2520.101-2.) ........................\u2026\u2026\u2026..\u2026. X Yes X No\nIf \u201cYes\u201d is checked, complete lines 11b and 11c.\n11b Is the plan currently in compliance with the Form M-1 filing requirements? (See instructions and 29 CFR 2520.101-2.) \u2026\u2026..... X Yes X No\n11c Enter the Receipt Confirmation Code for the 2024 Form M-1 annual report. If the plan was not required to file the 2024 Form M-1 annual report, enter the\nReceipt Confirmation Code for the most recent Form M-1 that was required to be filed under the Form M-1 filing requirements. (Failure to enter a valid\nReceipt Confirmation Code will subject the Form 5500 filing to rejection as incomplete.)\nReceipt Confirmation Code______________________",
    "char_count": 9901
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SCHEDULE_A",
    "schedule_type": "SCHEDULE_A",
    "page_range": "4-11",
    "page_count": 8,
    "raw_text": "SCHEDULE A Insurance Information\nOMB No. 1210-0110\n(Form 5500)\nDepartment of the Treasury This schedule is required to be filed under section 104 of the\nInternal Revenue Service Employee Retirement Income Security Act of 1974 (ERISA). 2024\nDepartment of Labor \uf034 File as an attachment to Form 5500.\nEmployee Benefits Security Administration\nPension Benefit Guaranty Corporation \uf034 Insurance companies are required to provide the information This Form is Open to Public\npursuant to ERISA section 103(a)(2). Inspection\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAGBLCADXEOFSGMHITIH KALBINCED CEAFSGHH BIA LAABNCCDEE PFEGNHSIIO NA PBLCADNEFGHI ABCDEFGHI ABCDE\nplan number (PN)\n\uf034 003 001\nFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE 012345678\nGLAXOSMITHKLINE LLC 23-1099050\nFGHI ABCDEFGHI\nPart I Information Concerning Insurance Contract Coverage, Fees, and Commissions Provide information for each contract\non a separate Schedule A. Individual contracts grouped as a unit in Parts II and III can be reported on a single Schedule A.\n1 Coverage Information:\n(a) Name of insurance carrier\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nMETROPOLITAN LIFE INSURANCE COMPANY\n(e) Approximate number of Policy or contract year\n(c) NAIC (d) Contract or\n(b) EIN persons covered at end of\ncode identification number (f) From (g) To\npolicy or contract year\n13-5581829 65978 0154373 974 01/01/2024 12/31/2024\n012345678 ABCDE ABCDE0123456789 1234567 YYYY-MM-DD YYYY-MM-DD\n2 Insurance fee and commission information. Enter the total fees and total commissions paid. List in line 3 the agents, brokers, and other persons in\ndescending order of the amount paid.\n(a) Total amount of commissions paid (b) Total amount of fees paid\n1234560789012345 15273744756789012345\n3 Persons receiving commissions and fees. (Complete as many entries as needed to report all persons).\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nMERCER HEALTH & BENEFITS LLC 4565 PAYSPHERE CIR\n123456789 ABCDEFGHI ABCDEFGHI ABCDE CHICAGO, IL 60674-0001\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\n(b) Amount of sales and base Fees and other commissions paid\ncommissions paid (c) Amount (d) Purpose (e) Organization code\n-123456789012345\n0\n-1234567890123\n57\n4\n7\n5\n4 7 S\nA\nU\nB\nP\nC\nP\nD\nL\nE\nEM\nFG\nEN\nH\nT\nI\nA L\nA\nC\nB\nO\nC\nM\nD\nP\nE\nE\nF\nN\nG\nS\nH\nA\nI\nT IO\nA\nN\nBCDEFGHI\n3\n1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid\n(b) Amount of sales and base\ncommissions paid (c) Amount (d) Purpose (e) Organization code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule A (Form 5500) 2024\nv. 240311\n\nSchedule A (Form 5500) 2024 Page 2 \u2013 1 1 x\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n\nSchedule A (Form 5500) 2024 Page 3\nPart II Investment and Annuity Contract Information\nWhere individual contracts are provided, the entire group of such individual contracts with each carrier may be treated as a unit for purposes of\nthis report.\n4 Current value of plan\u2019s interest under this contract in the general account at year end ............................................... 4 123456789012345\n5 Current value of plan\u2019s interest under this contract in separate accounts at year end .................................................. 5 123456789012345\n6 Contracts With Allocated Funds:\na State the basis of premium rates \uf034\nb Premiums paid to carrier .................................................................................................................................... 6b -123456789012345\nc Premiums due but unpaid at the end of the year ................................................................................................ 6c -123456789012345\nd If the carrier, service, or other organization incurred any specific costs in connection with the acquisition or 6d -123456789012345\nretention of the contract or policy, enter amount. ................................................................................................\nSpecify nature of costs\n\uf034\ne Type of contract: (1) X individual policies (2) X group deferred annuity\n(3) X other (specify) \uf034\nf If contract purchased, in whole or in part, to distribute benefits from a terminating plan, check here \uf034 X X\n7 Contracts With Unallocated Funds (Do not include portions of these contracts maintained in separate accounts)\na Type of contract: (1) X deposit administration (2) X immediate participation guarantee\n(3) X guaranteed investment (4) X other \uf034\nb Balance at the end of the previous year ............................................................................................................. 7b 1234567890123450\nc Additions: (1) Contributions deposited during the year ............................... 7c(1) -123456789012345\n(2) Dividends and credits ............................................................................. 7c(2) -123456789012345\n(3) Interest credited during the year ............................................................. 7c(3) -123456789012345\n(4) Transferred from separate account ........................................................ 7c(4) -123456789012345\n(5) Other (specify below) ............................................................................. 7c(5) -123456789012345\n\uf034\n(6)Total additions ............................................................................................................................................... 7c(6) 1234567890123450\nd Total of balance and additions (add lines 7b and 7c(6)). ..................................................................................... 7d 1234567890123450\ne Deductions:\n(1) Disbursed from fund to pay benefits or purchase annuities during year 7e(1) -123456789012345\n(2) Administration charge made by carrier .................................................... 7e(2) -123456789012345\n(3) Transferred to separate account ............................................................. 7e(3) -123456789012345\n(4) Other (specify below) .............................................................................. 7e(4) -123456789012345\n\uf034\n(5) Total deductions ............................................................................................................................................ 7e(5) 1234567890123450\nf Balance at the end of the current year (subtract line 7e(5) from line 7d) ............................................................. 7f 1234567890123450\n\nSchedule A (Form 5500) 2024 Page 4\nPart III Welfare Benefit Contract Information\nIf more than one contract covers the same group of employees of the same employer(s) or members of the same employee organizations(s),\nthe information may be combined for reporting purposes if such contracts are experience-rated as a unit. Where contracts cover individual\nemployees, the entire group of such individual contracts with each carrier may be treated as a unit for purposes of this report.\n8 Benefit and contract type (check all applicable boxes)\na X Health (other than dental or vision) b X Dental c X Vision d XX Life insurance\ne X Temporary disability (accident and sickness) f X Long-term disability g X Supplemental unemployment h X Prescription drug\ni X Stop loss (large deductible) j X HMO contract k X PPO contract l X Indemnity contract\nm X Other (specify) \uf034 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCKEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n9 Experience-rated contracts:\na Premiums: (1) Amount received ................................................................ 9a(1) -123456789012345\n(2) Increase (decrease) in amount due but unpaid ................................... 9a(2) -123456789012345\n(3) Increase (decrease) in unearned premium reserve ............................. 9a(3) -123456789012345\n(4) Earned ((1) + (2) - (3)) ........................................................................................................................................9..a..(.4..) 1234567890123450\nb Benefit charges (1) Claims paid ............................................................... 9b(1) -123456789012345\n(2) Increase (decrease) in claim reserves ................................................. 9b(2) -123456789012345\n(3) Incurred claims (add (1) and (2)) ................................................................................................................ 9b(3) 1234567890123450\n(4) Claims charged .......................................................................................................................................... 9b(4) 123456789012345\nc Remainder of premium: (1) Retention charges (on an accrual basis) -- -123456789012345\n(A) Commissions ............................................................................... 9c(1)(A) -123456789012345\n(B) Administrative service or other fees ............................................. 9c(1)(B) -123456789012345\n(C) Other specific acquisition costs ....................................................\n9c(1)(C) -123456789012345\n(D) Other expenses ........................................................................... 9c(1)(D) -123456789012345\n(E) Taxes ...........................................................................................\n9c(1)(E) -123456789012345\n(F) Charges for risks or other contingencies ...................................... 9c(1)(F) -123456789012345\n(G) Other retention charges ...............................................................\n9c(1)(G) -123456789012345\n(H) Total retention..................................................................................................................................... 9c(1)(H) 1234567890123450\n(2) Dividends or retroactive rate refunds. (These amounts were X paid in cash, or X credited.).................. 9c(2) 123456789012345\nd Status of policyholder reserves at end of year: (1) Amount held to provide benefits after retirement ............... 9d(1) 123456789012345\n(2) Claim reserves .......................................................................................................................................... 9d(2) 123456789012345\n(3) Other reserves .......................................................................................................................................... 9d(3) 123456789012345\ne Dividends or retroactive rate refunds due. (Do not include amount entered in line 9c(2).) .............................. 9e 123456789012345\n10 Nonexperience-rated contracts:\na Total premiums or subscription charges paid to carrier ................................................................................... 10a 1234567890132634241579\n-\nb If the carrier, service, or other organization incurred any specific costs in connection with the acquisition or\nretention of the contract or policy, other than reported in Part I, line 2 above, report amount. ......................... 10b 123456789012345\nSpecify nature of costs.\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nPart IV Provision of Information\n11 Did the insurance company fail to provide any information necessary to complete Schedule A? ............. X Yes XX No\n12 If the answer to line 11 is \u201cYes,\u201d specify the information not provided. \uf034\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDE\n\nSCHEDULE A Insurance Information\nOMB No. 1210-0110\n(Form 5500)\nDepartment of the Treasury This schedule is required to be filed under section 104 of the\nInternal Revenue Service Employee Retirement Income Security Act of 1974 (ERISA). 2024\nDepartment of Labor \uf034 File as an attachment to Form 5500.\nEmployee Benefits Security Administration\nPension Benefit Guaranty Corporation \uf034 Insurance companies are required to provide the information This Form is Open to Public\npursuant to ERISA section 103(a)(2). Inspection\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAGBLCADXEOFSGMHITIH KALBINCED CEAFSGHH BIA LAABNCCDEE PFEGNHSIIO NA PBLCADNEFGHI ABCDEFGHI ABCDE\nplan number (PN)\n\uf034 003 001\nFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE 012345678\nGLAXOSMITHKLINE LLC 23-1099050\nFGHI ABCDEFGHI\nPart I Information Concerning Insurance Contract Coverage, Fees, and Commissions Provide information for each contract\non a separate Schedule A. Individual contracts grouped as a unit in Parts II and III can be reported on a single Schedule A.\n1 Coverage Information:\n(a) Name of insurance carrier\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nJOHN HANCOCK LIFE INSURANCE COMPANY\n(e) Approximate number of Policy or contract year\n(c) NAIC (d) Contract or\n(b) EIN persons covered at end of\ncode identification number (f) From (g) To\npolicy or contract year\n01-0233346 65838 GAC 299 ASSN 1 86 01/01/2024 12/31/2024\n012345678 ABCDE ABCDE0123456789 1234567 YYYY-MM-DD YYYY-MM-DD\n2 Insurance fee and commission information. Enter the total fees and total commissions paid. List in line 3 the agents, brokers, and other persons in\ndescending order of the amount paid.\n(a) Total amount of commissions paid (b) Total amount of fees paid\n1234560789012345 1234056789012345\n3 Persons receiving commissions and fees. (Complete as many entries as needed to report all persons).\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\n(b) Amount of sales and base Fees and other commissions paid\ncommissions paid (c) Amount (d) Purpose (e) Organization code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid\n(b) Amount of sales and base\ncommissions paid (c) Amount (d) Purpose (e) Organization code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule A (Form 5500) 2024\nv. 240311\n\nSchedule A (Form 5500) 2024 Page 2 \u2013 1 1 x\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Name and address of the agent, broker, or other person to whom commissions or fees were paid\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITY56789 ABCDEFGHI AB, ST 021345678901\nFees and other commissions paid (e)\n(b) Amount of sales and base Organization\ncommissions paid (c) Amount (d) Purpose code\n-123456789012345 -123456789012345 ABCDEFGHI ABCDEFGHI ABCDEFGHI 1\nABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n\nSchedule A (Form 5500) 2024 Page 3\nPart II Investment and Annuity Contract Information\nWhere individual contracts are provided, the entire group of such individual contracts with each carrier may be treated as a unit for purposes of\nthis report.\n4 Current value of plan\u2019s interest under this contract in the general account at year end ............................................... 4 1234567890110263594551 4\n5 Current value of plan\u2019s interest under this contract in separate accounts at year end .................................................. 5 123456789012345\n6 Contracts With Allocated Funds:\na State the basis of premium rates \uf034\nb Premiums paid to carrier .................................................................................................................................... 6b -123456789012345\nc Premiums due but unpaid at the end of the year ................................................................................................ 6c -123456789012345\nd If the carrier, service, or other organization incurred any specific costs in connection with the acquisition or 6d -123456789012345\nretention of the contract or policy, enter amount. ................................................................................................\nSpecify nature of costs\n\uf034\ne Type of contract: (1) X individual policies (2) X group deferred annuity\n(3) X other (specify) \uf034\nf If contract purchased, in whole or in part, to distribute benefits from a terminating plan, check here \uf034 X X\n7 Contracts With Unallocated Funds (Do not include portions of these contracts maintained in separate accounts)\na Type of contract: (1) X deposit administration (2) XX immediate participation guarantee\n(3) X guaranteed investment (4) X other \uf034\nb Balance at the end of the previous year ............................................................................................................. 7b 12345678901102537442599\nc Additions: (1) Contributions deposited during the year ............................... 7c(1) -123456789012345\n(2) Dividends and credits ............................................................................. 7c(2) -1234567890123450\n(3) Interest credited during the year ............................................................. 7c(3) -123456789011243045552\n(4) Transferred from separate account ........................................................ 7c(4) -123456789012345\n(5) Other (specify below) ............................................................................. 7c(5) -123456789012345\n\uf034\n(6)Total additions ............................................................................................................................................... 7c(6) 123456789012134045552\nd Total of balance and additions (add lines 7b and 7c(6)). ..................................................................................... 7d 12345678901102731448551\ne Deductions:\n(1) Disbursed from fund to pay benefits or purchase annuities during year 7e(1) -12345678901223244652\n(2) Administration charge made by carrier .................................................... 7e(2) -12345678901223449959\n(3) Transferred to separate account ............................................................. 7e(3) -123456789012345\n(4) Other (specify below) .............................................................................. 7e(4) -1234567890123748756\n\uf034 ANNUAL ADJUSTMENTS\n(5) Total deductions ............................................................................................................................................ 7e(5) 12345678901235543537\nf Balance at the end of the current year (subtract line 7e(5) from line 7d) ............................................................. 7f 12345678901102635945514\n\nSchedule A (Form 5500) 2024 Page 4\nPart III Welfare Benefit Contract Information\nIf more than one contract covers the same group of employees of the same employer(s) or members of the same employee organizations(s),\nthe information may be combined for reporting purposes if such contracts are experience-rated as a unit. Where contracts cover individual\nemployees, the entire group of such individual contracts with each carrier may be treated as a unit for purposes of this report.\n8 Benefit and contract type (check all applicable boxes)\na X Health (other than dental or vision) b X Dental c X Vision d X Life insurance\ne X Temporary disability (accident and sickness) f X Long-term disability g X Supplemental unemployment h X Prescription drug\ni X Stop loss (large deductible) j X HMO contract k X PPO contract l X Indemnity contract\nm X Other (specify) \uf034 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCKEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n9 Experience-rated contracts:\na Premiums: (1) Amount received ................................................................ 9a(1) -123456789012345\n(2) Increase (decrease) in amount due but unpaid ................................... 9a(2) -123456789012345\n(3) Increase (decrease) in unearned premium reserve ............................. 9a(3) -123456789012345\n(4) Earned ((1) + (2) - (3)) ........................................................................................................................................9..a..(.4..) 1234567890123450\nb Benefit charges (1) Claims paid ............................................................... 9b(1) -123456789012345\n(2) Increase (decrease) in claim reserves ................................................. 9b(2) -123456789012345\n(3) Incurred claims (add (1) and (2)) ................................................................................................................ 9b(3) 1234567890123450\n(4) Claims charged .......................................................................................................................................... 9b(4) 123456789012345\nc Remainder of premium: (1) Retention charges (on an accrual basis) -- -123456789012345\n(A) Commissions ............................................................................... 9c(1)(A) -123456789012345\n(B) Administrative service or other fees ............................................. 9c(1)(B) -123456789012345\n(C) Other specific acquisition costs ....................................................\n9c(1)(C) -123456789012345\n(D) Other expenses ........................................................................... 9c(1)(D) -123456789012345\n(E) Taxes ...........................................................................................\n9c(1)(E) -123456789012345\n(F) Charges for risks or other contingencies ...................................... 9c(1)(F) -123456789012345\n(G) Other retention charges ...............................................................\n9c(1)(G) -123456789012345\n(H) Total retention..................................................................................................................................... 9c(1)(H) 1234567890123450\n(2) Dividends or retroactive rate refunds. (These amounts were X paid in cash, or X credited.).................. 9c(2) 123456789012345\nd Status of policyholder reserves at end of year: (1) Amount held to provide benefits after retirement ............... 9d(1) 123456789012345\n(2) Claim reserves .......................................................................................................................................... 9d(2) 123456789012345\n(3) Other reserves .......................................................................................................................................... 9d(3) 123456789012345\ne Dividends or retroactive rate refunds due. (Do not include amount entered in line 9c(2).) .............................. 9e 123456789012345\n10 Nonexperience-rated contracts:\na Total premiums or subscription charges paid to carrier ................................................................................... 10a 123456789012345\n-\nb If the carrier, service, or other organization incurred any specific costs in connection with the acquisition or\nretention of the contract or policy, other than reported in Part I, line 2 above, report amount. ......................... 10b 123456789012345\nSpecify nature of costs.\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nPart IV Provision of Information\n11 Did the insurance company fail to provide any information necessary to complete Schedule A? ............. X Yes XX No\n12 If the answer to line 11 is \u201cYes,\u201d specify the information not provided. \uf034\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDE",
    "char_count": 30915
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SCHEDULE_SB",
    "schedule_type": "SCHEDULE_SB",
    "page_range": "12-14",
    "page_count": 3,
    "raw_text": "SCHEDULE SB Single-Employer Defined Benefit Plan OMB No. 1210-0110\n(Form 5500) Actuarial Information\n2024\nDepartment of the Treasury\nInternal Revenue Service\nThis schedule is required to be filed under section 104 of the Employee\nDepartment of Labor Retirement Income Security Act of 1974 (ERISA) and section 6059 of the This Form is Open to Public\nEmployee Benefits Security Administration\nInternal Revenue Code (the Code). Inspection\nPension Benefit Guaranty Corporation\n\uf034 File as an attachment to Form 5500 or 5500-SF.\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\n\uf034\nRound off amounts to nearest dollar.\n\uf034\nCaution: A penalty of $1,000 will be assessed for late filing of this report unless reasonable cause is established.\nA Name of plan B Three-digit\nABC G D L E A F XO GH SM I IT A H B K C LI D N E E F C G A H S I H B A A B LA C N D C E E F G PE H N I S I A O B N C P D L E AN FGHI ABCDEFGHI plan number (PN) \uf034 003 001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 or 5500-SF D Employer Identification Number (EIN)\nG\nA\nL\nB\nA\nC\nXO\nDE\nSM\nFG\nIT\nH\nH\nI\nK LI\nA\nN\nB\nE\nC\nL\nD\nLC\nEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0123456\n2\n7\n3\n8\n-1 099050\nABCDEFGHI ABCDEFGHI\nE Type of plan: XX Single X Multiple-A X Multiple-B F Prior year plan size: X 100 or fewer X 101-500 XX More than 500\nPart I Basic Information\n1 Enter the valuation date: Month ___0_1_____ Day __0_1______ Year _2_0_2_4_____\n2 Assets:\na Market value ..................................................................................................................................................... 2a -1234562798296800172293045\nb Actuarial value .................................................................................................................................................. 2b -1234563708190407192353245\n3 Funding target/participant count breakdown (1) Number of (2) Vested Funding (3) Total Funding\nparticipants Target Target\na For retired participants and beneficiaries receiving payment .................................... . 14266 1279666385 1279666385\nb For terminated vested participants............................................................................ 16393 1044093394 1044093394\nc For active participants .............................................................................................. 7488 717046485 717046485\nd Total ......................................................................................................................... 38147 3040806264 3040806264\n4 If the plan is in at-risk status, check the box and complete lines (a) and (b)............................. X\na Funding target disregarding prescribed at-risk assumptions ............................................................................... 4a -123456789012345\nb Funding target reflecting at-risk assumptions, but disregarding transition rule for plans that have been in\n4b -123456789012345\nat-risk status for fewer than five consecutive years and disregarding loading factor ............................................\n5 Effective interest rate ............................................................................................................................................. 5 1234..9162%\n6 Target normal cost\na Present value of current plan year accruals ........................................................................................................ 6a 0\nb Expected plan-related expenses ........................................................................................................................ 6b 13100000\nc Target normal cost.............................................................................................................................................. 6c 13100000\nStatement by Enrolled Actuary\nTo the best of my knowledge, the information supplied in this schedule and accompanying schedules, statements and attachments, if any, is complete and accurate. Each prescribed assumption was applied in\naccordance with applicable law and regulations. In my opinion, each other assumption is reasonable (taking into account the experience of the plan and reasonable expectations) and such other assumptions, in\ncombination, offer my best estimate of anticipated experience under the plan.\nSIGN\nHERE 09/09/2025\nSignature of actuary Date\nABCSDHEERFIG XH DIE CARBICSTDOEFFAGRHOI,F SAAB, CEDAEFGHI ABCDE 23-06629 YYYY-MM-DD\nType or print name of actuary Most recent enrollment number\nABCWDILELFISG THOIW AERBSC DWEAFTGSHOIN UASB LCLDCEFGHI ABCDE 215-246-6000 1234567\nFirm name Telephone number (including area code)\n121390405 M6A7RK8E9T SATBRECEDTE FGHI ABCDEFGHI ABCDE 1234567890\n12F3LO4O5R6 87 89 ABCDEFGHI ABCDEFGHI ABCDE\nPHILADELPHIA, PA 19103-3527\nUK\nAddress of the firm\nIf the actuary has not fully reflected any regulation or ruling promulgated under the statute in completing this schedule, check the box and see instructions X\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500 or 5500-SF. Schedule SB (Form 5500) 2024\nv. 240311\n\nSchedule SB (Form 5500) 2024 Page 2 - 1-1 x\nPart II Beginning of Year Carryover and Prefunding Balances\n(a) Carryover balance (b) Prefunding balance\n7 Balance at beginning of prior year after applicable adjustments (line 13 from prior -123456789012345 -123456789012345\nyear) ............................................................................................................................ 271884328 0\n8 Portion elected for use to offset prior year\u2019s funding requirement (line 35 from prior\nyear) ..........................................................................................................................\n-1234567890120345 -1234567890123045\n9 Amount remaining (line 7 minus line 8) ........................................................................ -123456277188984031228345 -1234567890123045\n10 Interest on line 9 using prior year\u2019s actual return of 9 . 7 3 % ................................. -12345627684954031425345 -1234567890123045\n11 Prior year\u2019s excess contributions to be added to prefunding balance:\na Present value of excess contributions (line 38a from prior year) ............................... -123456715899406417253645\nb(1) Interest on the excess, if any, of line 38a over line 38b from prior year\nSchedule SB, using prior year's effective interest rate of 5 . 0 9 % .............\n-1234567889101617253645\nb(2) Interest on line 38b from prior year Schedule SB, using prior year's actual\nreturn ................................................................................................................. 0\nc Total available at beginning of current plan year to add to prefunding balance ................ 167581512\nd Portion of (c) to be added to prefunding balance ...................................................... -1234567 16 8 7 9 5 0 81 1 5 2 1 3 2 45\n-123456789012345\n12 Other reductions in balances due to elections or deemed elections ............................. -1234567890120345 -1234567890123045\n13 Balance at beginning of current year (line 9 + line 10 + line 11d \u2013 line 12) ................... -123456297883938061723345 -123456716879508115213245\nPart III Funding Percentages\n14 Funding target attainment percentage ..................................................................................................................................................................... 14 12383..1682%\n15 Adjusted funding target attainment percentage ...................................................................................................................................... 15 12383..1682%\n16 Prior year\u2019s funding percentage for purposes of determining whether carryover/prefunding balances may be used to reduce current\nyear\u2019s funding requirement .....................................................................................................................................................................\n16 121302..1512%\n17 If the current value of the assets of the plan is less than 70 percent of the funding target, enter such percentage. ................................. 17 123.12%\nPart IV Contributions and Liquidity Shortfalls\n18 Contributions made to the plan for the plan year by employer(s) and employees:\n(a) Date (b) Amount paid by (c) Amount paid by (a) Date (b) Amount paid by (c) Amount paid by\n(MM-DD-YYYY) employer(s) employees (MM-DD-YYYY) employer(s) employees\n08/12/2 025 131000000 0\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\n5 5 5- 123456789012345\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\nYYYY-MM-DD 1234567\n5\n8 901234 1234567\n5\n8 901234 YYYY- MM-DD\n1\n1\n2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n54\n4\n5\n- -\n-\n1\n1\n1\n1\n2\n2\n2\n2\n3\n3\n3\n3\n4\n4\n4\n4\n5\n5\n5\n5\n6\n6\n6\n6\n7\n7\n7\n7\n8\n8\n8\n8\n9\n9\n9\n9\n0\n0\n0\n0\n1\n1\n1\n1\n2\n2\n2\n2\n3\n3\n3\n3\n4\n4\n4\n4\n5\n5\n5\n5\n-\nYYYY-MM-DD 1234567\n5\n8 901234 1234567\n5\n8 901234 YYYY- MM-DD\n1\n1\n2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n54\n4-5\n-\n-\n-\n- 11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n66\n6\n6\n6\n77\n7\n7\n7\n88\n8\n8\n8\n99\n9\n9\n9\n00\n0\n0\n0\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n-\nYYYY-MM-DD 1234567 5 8 901234 1234567 5 8 901234 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 0 0 1 1 2 2 3 354 4 -5 - - - - - 1 1 1 1 12 2 2 2 23 3 3 3 34 4 4 4 45 5 5 5 56 6 6 6 67 7 7 7 7 8 8 8 8 89 9 9 9 90 0 0 0 01 1 1 1 12 2 2 2 23 3 3 3 34 4 4 4 45 5 5 5 5\n5 5\nTotals \u25ba 18(b)\n1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8\n1\n9 9\n3\n0 0\n10\n1 1\n0\n2 2\n0\n3 3\n00\n4 45\n-5 -5 0\n1--\n-\n- -8(11\n1\n1 1c22\n2\n2\n2)\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n66\n6\n6\n6\n77\n7\n7\n7\n88\n8\n8\n8\n99\n9\n9\n9\n00\n0\n0\n0\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n50\n19 Discounted employer contributio ns \u2013 see instructions for small plan with a valuation date after the be1\n1\ng2\n2\nin3\n3\nn4\n4\nin5\n5\ng 6\n6\nof7\n7\nt8\n8\nhe9\n9\ny0\n0\ne1\n1\na2\n2\nr: 3\n3\n4\n4\n-5 -\n-- -11 122 233 344 455 566\n6\n77 788 899 900 011 122 233 344 455\n5\na\nb\nC\nC\no\no\nn\nn\nt\nt\nr\nr\ni\ni\nb\nb\nu\nu\nt\nt\ni\ni\no\no\nn\nn\ns\ns\na\nm\nll\na\no\nd\nc\ne\na t\nt\ne\no\nd\na\nt\nv\no\no\nw\nid\na r\nr\nd\ne s\nu\nt\nn\nri\np\nc\na\nti\ni\no\nd\nn\nm\ns\ni\na\nn\nd\nim\nju\nu\ns\nm\nte d\nre\nt\nq\no\nu\nv\nir\na\ne\nlu\nd\na\nc\nti\no\no\nn\nn\nt r\nd\nib\na\nu\nte\nti\n.\no\n.\nn\n..\ns\n.. .\nf\n.\nr\n.\no\n..\nm\n... .\np\n..\nr\n.\ni\n.\no\n..\nr\n. .\ny\n..\ne\n..\na\n.\nr\n..\ns\n.\n.\n. .\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n1\n1\n1\n1\n.\n.\n.\n.\n2\n2\n2\n2\n.\n.\n.\n.\n.\n.\n3\n3\n3\n3\n.\n.\n.\n.\n.\n.\n4\n4\n4\n4\n.\n.\n.\n.\n5\n5\n5\n5\n.\n.\n.\n.\n.\n.\n6\n6\n6\n6\n.\n.\n.\n.\n.\n.\n7\n7\n7\n7 .\n..\n.\n8\n8\n8\n8\n.\n.\n.\n.\n.\n.\n9\n9\n9\n9\n.\n.\n0\n0\n0\n0\n1\n1\n9 1\n1\n1\n1 9\nb\na\n2\n2\n2\n2\n3\n3\n3\n3\n4\n4\n4\n45\n- 5\n-5\n-\n--\n-\n-\n-\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n66\n6\n6\n6\n77\n7\n7\n7\n88\n8\n8\n8\n99\n9\n9\n9\n00\n0\n0\n0\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n0\n0\n44\n4\n4\n4\n55\n5\n5\n5\n-\nc Contributions allocated toward minimum required contribution for current year adjusted to valuation date\n1\n1.\n2\n2...\n3\n3...\n4\n4..\n5\n5...\n6\n6...\n7\n7..\n8\n8...\n9\n9.\n0\n01\n1\n19c\n2\n2\n3\n3\n4\n45 5 -123456718291105142953645\n-\n20 Quarterly contributions and liquidity shortfalls: 12345678901234 - 5 5\na Did the plan have a \u201cfunding shortfall\u201d for the prior year? ............................................................... 1 1 .. 2 2 ... 3 3 ... 4 4 .. 5 5 ... 6 6 ... 7 7 .. 8 8 ... 9 9 ... 0 0 .. 1 1 ... 2 2 .. 3 3 ... 4 45 - 5 - ... ...................... XX Yes X No\nb If line 20a is \u201cYes,\u201d were required quarterly installments for the current year made in a timely man 1 ne 2 r 3 ?. 4 .. 5 ... 6 ... 7 .. 8 ... 9 ... 0 .. 1 ... 2 .. 3 ... 4 -\n5\n- 5... ...................... XX Yes X No\nc If line 20a is \u201cYes,\u201d see instructions and complete the following table as applicable: 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 0 0 1 1 2 2 3 3 4 4 - -\n5\nLiquidity shortfall as of end of quarter of this plan ye1\n1\nar2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n4\n45\n-\n5\n(1) 1st (2) 2nd (3) 3r1d 2345678901234 5 - (4) 4th\n0 -1234567890012345 -1234567890012345 5 -1234567890012345\n12345678901234\n5\n-123456789012345\n\nSchedule SB (Form 5500) 2024 Page 3\nPart V Assumptions Used to Determine Funding Target and Target Normal Cost\n21 Discount rate:\na Segment rates: 1 1s 2 t 3 s . eg 41 m .27 e 5_ n % t: 1 2n 2 d 3 s . e 41 g . m 287 e _ n % t: 1 3r 2 d 3 s . e 5 g 1. m 529 e n % t: X N/A, full yield curve used\nb Applicable month (enter code) ........................................................................................................................ 21b 4 1\n22 Weighted average retirement age ......................................................................................................................... 22 58 12\n23 Mortality table(s) (see instructions) _ Prescribed - combined _ X Prescribed - separate _ Substitute\nPart VI Miscellaneous Items\n24 Has a change been made in the non-prescribed actuarial assumptions for the current plan year? If \u201cYes,\u201d see instructions regarding required\nattachment. ................................................................................................................................................................................................... XX Yes X No\n25 Has a method change been made for the current plan year? If \u201cYes,\u201d see instructions regarding required attachment. ................................ X Yes XX No\n26 Demographic and benefit information\na Is the plan required to provide a Schedule of Active Participants? If \u201cYes,\u201d see instructions regarding required attachment. ............... XX Yes X No\nb Is the plan required to provide a projection of expected benefit payments? If \u201cYes,\u201d see instructions regarding required attachment ... XX Yes X No\n27 If the plan is subject to alternative funding rules, enter applicable code and see instructions regarding\n27\nattachment ..........................................................................................................................................................\nPart VII Reconciliation of Unpaid Minimum Required Contributions For Prior Years\n28 Unpaid minimum required contributions for all prior years ................................................................................... 28 -1234567890120345\n29 Discounted employer contributions allocated toward unpaid minimum required contributions from prior years\n29 -1234567890120345\n(line 19a) .............................................................................................................................................................\n30 Remaining amount of unpaid minimum required contributions (line 28 minus line 29) ........................................... 30 -1234567890120345\nPart VIII Minimum Required Contribution For Current Year\n31 Target normal cost and excess assets (see instructions):\na Target normal cost (line 6c) ............................................................................................................................. 31a -12345671839100010200345\nb Excess assets, if applicable, but not greater than line 31a ................................................................................ 31b 0\n32 Amortization installments: Outstanding Balance Installment\na Net shortfall amortization installment ............................................................................ -123456784996021427039475 -12345674859140817212345\nb Waiver amortization installment .................................................................................... -1234567890123405 -1234567890120345\n33 If a waiver has been approved for this plan year, enter the date of the ruling letter granting the approval\n33\n(Month _________ Day _________ Year _________ )_and the waived amount ............................................ -123456789012345\n34 Total funding requirement before reflecting carryover/prefunding balances (lines 31a - 31b + 32a + 32b - 33)..... 34 -12345675889240817212345\nCarryover balance Prefunding balance Total balance\n35 Balances elected for use to offset funding\n20000000 0 20000000\nrequirement .............................................................. -123456789012345 -123456789012345 -123456789012345\n36 Additional cash requirement (line 34 minus line 35) ............................................................................................ 36 -12345673889240817212345\n37 Contributions allocated toward minimum required contribution for current year adjusted to valuation date (line 37 -123456172819150419256345\n19c) ......................................................................................................................................................................\n38 Present value of excess contributions for current year (see instructions)\na Total (excess, if any, of line 37 over line 36) 38a\n-1234567\n8\n8\n2\n9\n90\n0\n6\n1\n2\n2\n44\n345\nb Portion included in line 38a attributable to use of prefunding and funding standard carryover balances ............. 38b 20000000\n39 Unpaid minimum required contribution for current year (excess, if any, of line 36 over line 37) ........................... 39 -1234567890120345\n40 Unpaid minimum required contributions for all years ............................................................................................. 40 -1234567890120345\nPart IX Pension Funding Relief Under the American Rescue Plan Act of 2021 (See Instructions)\n41 If an election was made to use the extended amortization rule for a plan year beginning on or before December 31, 2021, check the box to indicate the first\nplan year for which the rule applies. X 2019 X 2020 XX 2021",
    "char_count": 17446
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SCHEDULE_C",
    "schedule_type": "SCHEDULE_C",
    "page_range": "15-24",
    "page_count": 10,
    "raw_text": "SCHEDULE C Service Provider Information OMB No. 1210-0110\n(Form 5500)\n2024\nDepartment of the Treasury This schedule is required to be filed under section 104 of the Employee\nInternal Revenue Service Retirement Income Security Act of 1974 (ERISA).\nEmployee B D e e n p e a f r it t s m S en e t c u o r f it L y a A bo d r m inistration \uf034 File as an attachment to Form 5500. This Form is Open to Public\nInspection.\nPension Benefit Guaranty Corporation\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nA G B L C A D X E O F S G M H IT I H K LINE CASH BALANCE PENSION PLAN plan number (PN) \uf034 000013\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nABCDEFGHI 012345678\nGLAXOSMITHKLINE LLC 23-1099050\nPart I Service Provider Information (see instructions)\nYou must complete this Part, in accordance with the instructions, to report the information required for each person who received, directly or indirectly,\n$5,000 or more in total compensation (i.e., money or anything else of monetary value) in connection with services rendered to the plan or the person's\nposition with the plan during the plan year. If a person received only eligible indirect compensation for which the plan received the required disclosures,\nyou are required to answer line 1 but are not required to include that person when completing the remainder of this Part.\n1 Information on Persons Receiving Only Eligible Indirect Compensation\na Check \"Yes\" or \"No\" to indicate whether you are excluding a person from the remainder of this Part because they received only eligible\nindirect compensation for which the plan received the required disclosures (see instructions for definitions and conditions).. . . . . . . . . . . . . . . XX Yes X\nNo\nb If you answered line 1a \u201cYes,\u201d enter the name and EIN or address of each person providing the required disclosures for the service providers who\nreceived only eligible indirect compensation. Complete as many entries as needed (see instructions).\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\nBLACKROCK ADVISORS, LLC\n23-2784752\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\nJENNISON ASSOCIATES LLC\n22-2540245\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\nSTATE STREET GLOBAL ADVISORS\n81-4017137\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule C (Form 5500) 2024\nv. 240311\n\nSchedule C (Form 5500) 2024 Page 2- 1 1 x\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n\nSchedule C (Form 5500) 2024 Page 3 - 1 1 x\n2. Information on Other Service Providers Receiving Direct or Indirect Compensation. Except for those persons for whom you\nanswered \u201cYes\u201d to line 1a above, complete as many entries as needed to list each person receiving, directly or indirectly, $5,000 or more in total compensation\n(i.e., money or anything else of value) in connection with services rendered to the plan or their position with the plan during the plan year. (See instructions).\n(a) Enter name and EIN or address (see instructions)\nALIGHT SOLUTIONS\n36-2235791\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n13 15 99 ARBECCDOERFDGKHEIE PER 1234567280975071427 123456789012345 0\nABCDEFGHI 345 Yes XX No X Yes XX No X Yes X No XX\nABCD\n(a) Enter name and EIN or address (see instructions)\nLEGAL & GENERAL INVSTMT MGMT AMER\n20-8058531\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n28 51 ANBOCNDEEFGHI 1234567185994091123 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nJENNISON ASSOCIATES LLC\n22-2540245\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n28 51 6 8 ANBOCNDEEFGHI 123456786294021922\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n\nSchedule C (Form 5500) 2024 Page 3 - 1 2 x\n2. Information on Other Service Providers Receiving Direct or Indirect Compensation. Except for those persons for whom you\nanswered \u201cYes\u201d to line 1a above, complete as many entries as needed to list each person receiving, directly or indirectly, $5,000 or more in total compensation\n(i.e., money or anything else of value) in connection with services rendered to the plan or their position with the plan during the plan year. (See instructions).\n(a) Enter name and EIN or address (see instructions)\nINCOME RESEARCH & MANAGEMENT\n04-2955404\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n28 51 ANBOCNDEEFGHI 123456785909031122 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nTHE BANK OF NEW YORK MELLON\n13-5160382\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n19 25 52 ACBUCSDTEOFDGIAHNI & 123456784982071223 123456789012345 0\nATBRCUDSETFEGEHI 345 Yes XX No X Yes XX No X Yes X No XX\nABCD\n(a) Enter name and EIN or address (see instructions)\nWALTER SCOTT & PARTNERS LTD\n98-0465834\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n28 51 ANBOCNDEEFGHI 123456784298031812\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n\nSchedule C (Form 5500) 2024 Page 3 - 1 3 x\n2. Information on Other Service Providers Receiving Direct or Indirect Compensation. Except for those persons for whom you\nanswered \u201cYes\u201d to line 1a above, complete as many entries as needed to list each person receiving, directly or indirectly, $5,000 or more in total compensation\n(i.e., money or anything else of value) in connection with services rendered to the plan or their position with the plan during the plan year. (See instructions).\n(a) Enter name and EIN or address (see instructions)\nTOWERS WATSON DELAWARE INC\n53-0181291\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n11 50 70 ANBOCNDEEFGHI 123456783911051127 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nROCATON INVESTMENT ADVISORS\n04-3638035\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n28 51 56 ANBOCNDEEFGHI 123456781938091328 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nSTATE STREET GLOBAL ADVISORS\n81-4017137\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n18 51 1 9 ANBOCNDEEFGHI 123456781199051352 0\n28 ABCDEFGHI 345 Yes XX No X Yes XX No X Yes X No XX\nABCD\n\nSchedule C (Form 5500) 2024 Page 3 - 1 4 x\n2. Information on Other Service Providers Receiving Direct or Indirect Compensation. Except for those persons for whom you\nanswered \u201cYes\u201d to line 1a above, complete as many entries as needed to list each person receiving, directly or indirectly, $5,000 or more in total compensation\n(i.e., money or anything else of value) in connection with services rendered to the plan or their position with the plan during the plan year. (See instructions).\n(a) Enter name and EIN or address (see instructions)\nDELOITTE & TOUCHE LLP\n13-3891517\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n10 ANBOCNDEEFGHI 12345678987071625 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nMARATHON ASSET MANAGEMENT LIMITED\n98-1669899\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n28 51 68 ANBOCNDEEFGHI 12345678941051327 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nJOHN HANCOCK LIFE INSURANCE COMPANY\n01-0233346\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n13 ANBOCNDEEFGHI 12345678390031382\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n\nSchedule C (Form 5500) 2024 Page 3 - 1 5 x\n2. Information on Other Service Providers Receiving Direct or Indirect Compensation. Except for those persons for whom you\nanswered \u201cYes\u201d to line 1a above, complete as many entries as needed to list each person receiving, directly or indirectly, $5,000 or more in total compensation\n(i.e., money or anything else of value) in connection with services rendered to the plan or their position with the plan during the plan year. (See instructions).\n(a) Enter name and EIN or address (see instructions)\nPRICEWATERHOUSECOOPERS LLP\n13-4008324\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n10 50 ANBOCNDEEFGHI 12345678914091120 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nAPEX FINTECH SOLUTIONS 350 NORTH ST. PAUL, SUITE 300\nDALLAS, TX 75201\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n13 19 ANBOCNDEEFGHI 12345678912081424 123456789012345\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\nMSCI 7 WORLD TRADE CENTER, 250 GREENWICH\nNEW Y ORK, NY 10007\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\n13 ANBOCNDEEFGHI 1234567895041002\nABCDEFGHI 345 Yes X No XX Yes X No X Yes X No X\nABCD\n\nSchedule C (Form 5500) 2024 Page 4 - 1 1 x\nPart I Service Provider Information (continued)\n3. If you reported on line 2 receipt of indirect compensation, other than eligible indirect compensation, by a service provider, and the service provider is a fiduciary\nor provides contract administrator, consulting, custodial, investment advisory, investment management, broker, or recordkeeping services, answer the following\nquestions for (a) each source from whom the service provider received $1,000 or more in indirect compensation and (b) each source for whom the service\nprovider gave you a formula used to determine the indirect compensation instead of an amount or estimated amount of the indirect compensation. Complete as\nmany entries as needed to report the required information for each source.\n(a) Enter service provider name as it appears on line 2 (b) Service Codes (c) Enter amount of indirect\n(see instructions) compensation\n(d) Enter name and EIN (address) of source of indirect compensation (e) Describe the indirect compensation, including any\nformula used to determine the service provider\u2019s eligibility\nfor or the amount of the indirect compensation.\n(a) Enter service provider name as it appears on line 2 (b) Service Codes (c) Enter amount of indirect\n(see instructions) compensation\n(d) Enter name and EIN (address) of source of indirect compensation (e) Describe the indirect compensation, including any\nformula used to determine the service provider\u2019s eligibility\nfor or the amount of the indirect compensation.\n(a) Enter service provider name as it appears on line 2 (b) Service Codes (c) Enter amount of indirect\n(see instructions) compensation\n(d) Enter name and EIN (address) of source of indirect compensation (e) Describe the indirect compensation, including any\nformula used to determine the service provider\u2019s eligibility\nfor or the amount of the indirect compensation.\n\nSchedule C (Form 5500) 2024 Page 5 - 1 1 x\nPart II Service Providers Who Fail or Refuse to Provide Information\n4 Provide, to the extent possible, the following information for each service provider who failed or refused to provide the information necessary to complete\nthis Schedule.\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 12 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 12 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 12 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 12 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 12 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n\nSchedule C (Form 5500) 2024 Page 6 - 1 1 x\nPart III Termination Information on Accountants and Enrolled Actuaries (see instructions)\n(complete as many entries as needed)\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI",
    "char_count": 27751
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SCHEDULE_D",
    "schedule_type": "SCHEDULE_D",
    "page_range": "25-27",
    "page_count": 3,
    "raw_text": "SCHEDULE D DFE/Participating Plan Information\nOMB No. 1210-0110\n(Form 5500)\nThis schedule is required to be filed under section 104 of the Employee\nDepartment of the Treasury 2024\nInternal Revenue Service Retirement Income Security Act of 1974 (ERISA).\nDepartment of Labor \uf034 File as an attachment to Form 5500.\nEmployee Benefits Security Administration\nThis Form is Open to Public\nInspection.\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAGBLCADXEOFSGMHITIH KALBINCED CEAFSGHH BIA LAABNCCDE EPFEGNHSIIO NA PBLCADNEFGHI ABCDEFGHI ABCDEFGHI plan number (PN) \uf034 003 001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI\nC Plan or DFE sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nAGBLCADXEOFSGMHITIH KALBINCED LELFCGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 02132-1304995065078\nABCDEFGHI\nPart I Information on interests in MTIAs, CCTs, PSAs, and 103-12 IEs (to be completed by plans and DFEs)\n(Complete as many entries as needed to report all interests in DFEs)\na Name of MTIA, CCT, PSA, or 103-12 IE: MARATAHOBCN-DLEOFNGDHOIN INATBECRDNEAFTGIOHNIA LA FBUCNDDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): MARAT A H B O C N D A E S F S G E H T I M ANAGEMENT LIMITED\nc EIN-PN 1621-3645056687928-900-1123 d E\nc\nn\no\nt\nd\nit\ne\ny 1C e D\n1\no\n0\nl\n3\nla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\ni\n,\nn s\nC\nt\nC\nru\nT\nc\n,\nt i\nP\non\nS\ns\nA\n)\n, or -1234567890012345\na Name of MTIA, CCT, PSA, or 103-12 IE: STATE ASTBRCEDEETF MGSHCII EAABFEC DINEDFXG NHLI F UANBDCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): STATE A S B TR C E D E E T F B G A H N I K AND TRUST COMPANY\nc EIN-PN 1024-3040255607818-924-1123 d E\nc\nn\no\nt\nd\nit\ne\ny 1C e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -12349536077789909012345\na Name of MTIA, CCT, PSA, or 103-12 IE: SS DAILAYB MCSDCEIF EGMHEIR GA MBKCTDSE IFNGDH NIL FADBCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): STATE A S B TR C E D E E T F B G A H N I K AND TRUST COMPANY\nc EIN-PN 1024-3040255607818-919-2123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 C e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -1234 6 5 2 6 56 7 5 8 6 9 17 012345\na Name of MTIA, CCT, PSA, or 103-12 IE: THE GEANBECSDISE GFRGOHUIP ATRBTC DFOERF GEHE IB EANB PCNDEFGHI ABCD\nGENESAISB ACSDSEEFTG MHAIN AAGBECRDSE, FLPGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 1 2 2 2- 3 3 4 16 5 3 6 8 7 72 8 - 9 00 - 1 123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 C e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789 0 012345\na Name of MTIA, CCT, PSA, or 103-12 IE: SSGA RAUBSCSDEELLF 3G0H0I0 INADBECXD NELF FGUHNID ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nSTATE STREET GLOBAL ADVISORS TRUST COMPANY\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 1 0 2 4- 3 0 4 02 5 5 6 0 7 81 8 - 9 04 - 2 123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 C e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123 3 4 8 5 5 6 33 7 8 8 4 9 74 012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule D (Form 5500) 2024\nv. 240311\n\nSchedule D (Form 5500) 2024 Page 2 - 11 x\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\n\nSchedule D (Form 5500) 2024 Page 3 - 11 x\n6\nPart II Information on Participating Plans (to be completed by DFEs, other than DCGs)\n(Complete as many entries as needed to report all participating plans. DCGs must report each participating plan using Schedule DCG.)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123",
    "char_count": 11895
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SCHEDULE_H",
    "schedule_type": "SCHEDULE_H",
    "page_range": "28-32",
    "page_count": 5,
    "raw_text": "SCHEDULE H Financial Information OMB No. 1210-0110\n(Form 5500)\nDepartment of the Treasury This schedule is required to be filed under section 104 of the Employee 2024\nDepartment of the Treasury\nInternal Revenue Service\nRetirement Income Security Act of 1974 (ERISA), and section 6058(a) of the\nInternal Revenue Code (the Code).\nDepartment of Labor\nEmployee Benefits Security Administration \uf034 File as an attachment to Form 5500. This Form is Open to Public\nPension Benefit Guaranty Corporation Inspection\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nABGCLDAXEOFSGMHIIT HAKLBICNED ECFAGSHH IB AALABNCCDEE PFEGNHSIIO NA BPCLADNEFGHI ABCDEFGHI ABCDEFGHI\nplan number (PN)\n\uf034 003001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nABGCLDAEXOFSGMHIIT HAKLBICNDE ELFLCGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0123243-516097980 50\nABCDEFGHI\nPart I Asset and Liability Statement\n1 Current value of plan assets and liabilities at the beginning and end of the plan year. Combine the value of plan assets held in more than one trust. Report\nthe value of the plan\u2019s interest in a commingled fund containing the assets of more than one plan on a line-by-line basis unless the value is reportable on\nlines 1c(9) through 1c(14). Do not enter the value of that portion of an insurance contract which guarantees, during this plan year, to pay a specific dollar\nbenefit at a future date. Round off amounts to the nearest dollar. MTIAs, CCTs, PSAs, and 103-12 IEs do not complete lines 1b(1), 1b(2), 1c(8), 1g, 1h,\nand 1i. CCTs, PSAs, and 103-12 IEs also do not complete lines 1d and 1e. See instructions.\nAssets (a) Beginning of Year (b) End of Year\na Total noninterest-bearing cash ....................................................................... 1a -12345678913031624233425 -1234567891081902631445\nb Receivables (less allowance for doubtful accounts):\n(1) Employer contributions ......................................................................... 1b(1) -123456781990501020300405 -123456781931001020030405\n(2) Participant contributions ........................................................................ 1b(2) -123456789012345 -123456789012345\n(3) Other .................................................................................................... 1b(3) -12345678920531124315455 -12345678925031523835495\nc General investments:\n(1) Interest-bearing cash (include money market accounts & certificates\n1c(1) -123456789012345 -123456789012345\nof deposit) ...........................................................................................\n(2) U.S. Government securities .................................................................. 1c(2) -123456788980761424317405 -123456789966091124736495\n(3) Corporate debt instruments (other than employer securities):\n(A) Preferred ........................................................................................ 1c(3)(A) -123456785920941426352415 -123456785969001323631405\n(B) All other .......................................................................................... 1c(3)(B) -123456784950481925376495 -123456783956061421035455\n(4) Corporate stocks (other than employer securities):\n(A) Preferred ........................................................................................ 1c(4)(A) -123456789012345 -123456789012345\n(B) Common ........................................................................................ 1c(4)(B) -12345678950821229306495 -12345678950091425632465\n(5) Partnership/joint venture interests ......................................................... 1c(5) -123456781940451521378405 -123456781923061721930455\n(6) Real estate (other than employer real property) .................................... 1c(6) -123456789012345 -123456789012345\n(7) Loans (other than to participants) .......................................................... 1c(7) -123456789012345 -123456789012345\n(8) Participant loans ................................................................................... 1c(8) -123456789012345 -123456789012345\n(9) Value of interest in common/collective trusts ......................................... 1c(9) -123456785910141128359415 -123456785940091822030405\n(10) Value of interest in pooled separate accounts ....................................... 1c(10) -123456789012345 -123456789012345\n(11) Value of interest in master trust investment accounts ............................ 1c(11) -123456789012345 -123456789012345\n(12) Value of interest in 103-12 investment entities ...................................... 1c(12) -123456789012345 -123456789012345\n(13) Value of interest in registered investment companies (e.g., mutual\n1c(13)\n-123456781900181821315465 -123456781921071629731435\nfunds) ...................................................................................\n(14) Value of funds held in insurance company general account (unallocated\n1c(14)\n-12345678910051724329495 -12345678910061529531445\ncontracts)..............................................................................................\n(15) Other ..................................................................................................... 1c(15) -1234567890411328335435 -1234567892091125334485\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule H (Form 5500) 2024\nv. 240311\n\nSchedule H (Form 5500) 2024 Page 2\n1d Employer-related investments: (a) Beginning of Year (b) End of Year\n(1) Employer securities ............................................................................... 1d(1) -123456789012345 -123456789012345\n(2) Employer real property .......................................................................... 1d(2) -123456789012345 -123456789012345\n1e Buildings and other property used in plan operation .................................... 1e -123456789012345 -123456789012345\n1f Total assets (add all amounts in lines 1a through 1e) .................................. 1f -1234562793869405810293545 -1234562970819770810213345\nLiabilities\n1g Benefit claims payable ................................................................................ 1g -123456789012345 -123456789012345\n1h Operating payables ..................................................................................... 1h -123456789800714263845 -123456789190712275345\n1i Acquisition indebtedness ............................................................................. 1i -123456789012345 -123456789012345\n1j Other liabilities ............................................................................................. 1j -1234567819104517203645 -123456789690814293345\n1k Total liabilities (add all amounts in lines 1g through1j) ................................. 1k -1234567819905311273445 -123456789890517268345\nNet Assets\n1l Net assets (subtract line 1k from line 1f) ...................................................... 1l -1234562793849500419223145 -1234562970809880212245345\nPart II Income and Expense Statement\n2 Plan income, expenses, and changes in net assets for the year. Include all income and expenses of the plan, including any trust(s) or separately maintained\nfund(s) and any payments/receipts to/from insurance carriers. Round off amounts to the nearest dollar. MTIAs, CCTs, PSAs, and 103-12 IEs do not\ncomplete lines 2a, 2b(1)(E), 2e, 2f, and 2g.\nIncome (a) Amount (b) Total\na Contributions:\n(1) Received or receivable in cash from: (A) Employers ............................. 2a(1)(A) -123456173819000010200345\n(B) Participants ................................................................................... 2a(1)(B) -123456789012345\n(C) Others (including rollovers) ............................................................ 2a(1)(C) -123456789012345\n(2) Noncash contributions ........................................................................... 2a(2) -123456789012345\n(3) Total contributions. Add lines 2a(1)(A), (B), (C), and line 2a(2) ............. 2a(3) -123456173810900010020345\nb Earnings on investments:\n(1) Interest:\n(A) Interest-bearing cash (including money market accounts and -123456789012345\n2b(1)(A)\ncertificates of deposit) ....................................................................\n(B) U.S. Government securities ........................................................... 2b(1)(B) -12345672889010913229345\n(C) Corporate debt instruments ........................................................... 2b(1)(C) -12345674879310113213345\n(D) Loans (other than to participants) .................................................. 2b(1)(D) -123456789012345\n(E) Participant loans ............................................................................ 2b(1)(E) -123456789012345\n(F) Other ............................................................................................. 2b(1)(F) -123456789140015252345\n(G) Total interest. Add lines 2b(1)(A) through (F) ................................. 2b(1)(G) -12345677854970111924345\n(2) Dividends: (A) Preferred stock ............................................................... 2b(2)(A) -123456789012345\n(B) Common stock .............................................................................. 2b(2)(B) -123456789980913237345\n(C) Registered investment company shares (e.g. mutual funds) .......... 2b(2)(C) 6381425\n(D) Total dividends. Add lines 2b(2)(A), (B), and (C) 2b(2)(D) -1234567873970017622345\n(3) Rents .................................................................................................... 2b(3) -123456789012345\n(4) Net gain (loss) on sale of assets: (A) Aggregate proceeds ................... 2b(4)(A) -1234561677839780010215345\n(B) Aggregate carrying amount (see instructions) ................................ 2b(4)(B) -1234561275889590210299345\n(C) Subtract line 2b(4)(B) from line 2b(4)(A) and enter result .............. 2b(4)(C) -123456471851980719126345\n(5) Unrealized appreciation (depreciation) of assets: (A) Real estate .................... 2b(5)(A)\n(B) Other ............................................................................................. 2b(5)(B) -528628092\n(C) Total unrealized appreciation of assets.\n2b(5)(C) -528628092\nAdd lines 2b(5)(A) and (B) .............................................................\n\nSchedule H (Form 5500) 2024 Page 3\n(a) Amount (b) Total\n(6) Net investment gain (loss) from common/collective trusts ...................... 2b(6) 123456179889480611226345\n(7) Net investment gain (loss) from pooled separate accounts .................... 2b(7)\n-123456789012345-\n(8) Net investment gain (loss) from master trust investment accounts ......... 2b(8)\n-112233445566778899001122334455-\n(9) Net investment gain (loss) from 103-12 investment entities ................... 2b(9)\n-112233445566778899001122334455-\n-112233445566778899001122334455-\n(10) N\nco\ne\nm\nt i\np\nn\na\nv\nn\ne\ni\ns\ne\nt\ns\nm\n(\ne\ne\nn\n.g\nt\n.\ng\n,\na\nm\nin\nu t\n(\nu\nlo\na\ns\nl\ns\nfu\n)\nn\nfr\nd\no\ns\nm\n) .\nr\n.\ne\n..\ng\n..\ni\n.\ns\n..\nt\n.\ne\n..\nr\n.\ne\n..\nd\n.. .\nin\n..\nv\n..\ne\n..\ns\n..\nt\n.\nm\n...\ne\n..\nn\n..\nt\n. . .........................\n2b(10) 1234567-1839130214201345\nc Other income .............................................................................................. 2c -1234567859450917269345\nd Total income. Add all income amounts in column (b) and enter total .................. 2d 291215274\nExpenses\ne Benefit payment and payments to provide benefits:\n(1) Directly to participants or beneficiaries, including direct rollovers ........... 2e(1) -123456738069602114253645\n(2) To insurance carriers for the provision of benefits ................................. 2e(2) -1234567839604121273945\n(3) Other ..................................................................................................... 2e(3) -123456789012345\n(4) Total benefit payments. Add lines 2e(1) through (3) .............................. 2e(4) 310263635\nf Corrective distributions (see instructions) .................................................... 2f\ng Certain deemed distributions of participant loans (see instructions) ............. 2g\nh Interest expense .......................................................................................... 2h\ni Administrative expenses:\n(1) Salaries and allowances ........................................................................ 2i(1)\n(2) Contract administrator fees ................................................................... 2i(2) -1234567829601106253245\n(3) Recordkeeping fees .............................................................................. 2i(3)\n(4) IQPA audit fees ..................................................................................... 2i(4) 87765\n(5) Investment advisory and investment management fees ........................ 2i(5) 2881721\n(6) Bank or trust company trustee/custodial fees ........................................ 2i(6) 500216\n(7) Actuarial fees ........................................................................................ 2i(7) 311517\n(8) Legal fees ............................................................................................. 2i(8)\n(9) Valuation/appraisal fees ........................................................................ 2i(9)\n(10) Other trustee fees and expenses ......................................................... 2i(10)\n(11) Other expenses.................................................................................... 2i(11) 8182444\n(12) Total administrative expenses. Add lines 2i(1) through (11) ................. 2i(12) 14574315\nj Total expenses. Add all expense amounts in column (b) and enter total ..... 2j -123456372849830719250345\nNet Income and Reconciliation\nk Net income (loss). Subtract line 2j from line 2d ........................................................ 2k -33622676\nl Transfers of assets:\n(1) To this plan............................................................................................ 2l(1) -123456789012345\n(2) From this plan ....................................................................................... 2l(2) -123456789012345\n\nSchedule H (Form 5500) 2024 Page 4\nPart III Accountant\u2019s Opinion\n3 Complete lines 3a through 3c if the opinion of an independent qualified public accountant is attached to this Form 5500. Complete line 3d if an opinion is not\nattached.\na The attached opinion of an independent qualified public accountant for this plan is (see instructions):\n(1) XX Unmodified (2) X Qualified (3) X Disclaimer (4) X Adverse\nb Check the appropriate box(es) to indicate whether the IQPA performed an ERISA section 103(a)(3)(C) audit. Check both boxes (1) and (2) if the audit was\nperformed pursuant to both 29 CFR 2520.103-8 and 29 CFR 2520.103-12(d). Check box (3) if pursuant to neither.\n(1) X DOL Regulation 2520.103-8 (2) X DOL Regulation 2520.103-12(d) (3) XX neither DOL Regulation 2520.103-8 nor DOL Regulation 2520.103-12(d).\nc Enter the name and EIN of the accountant (or accounting firm) below:\n(1) Name: ADBELCODIETTFEG H& IT OAUBCCHDE ELFLPGHI ABCDEFGHI ABCD (2) EIN: 11233-3485916571879\nd The opinion of an independent qualified public accountant is not attached as part of Schedule H because:\n(1) X This form is filed for a CCT, PSA, DCG or MTIA. (2) X It will be attached to the next Form 5500 pursuant to 29 CFR 2520.104-50.\nPart IV Compliance Questions\n4 CCTs and PSAs do not complete Part IV. MTIAs, 103-12 IEs, and GIAs do not complete lines 4a, 4e, 4f, 4g, 4h, 4k, 4m, 4n, or 5.\n103-12 IEs also do not complete lines 4j and 4l. MTIAs also do not complete line 4l. DCGs do not complete lines 4e, 4f, 4k, 4l, and 5, and DCGs generally\ncomplete the rest of Part IV collectively for all plans in the DCG, except as otherwise provided (see instructions).\nDuring the plan year: Yes No Amount\na Was there a failure to transmit to the plan any participant contributions within the time\nperiod described in 29 CFR 2510.3-102? Continue to answer \u201cYes\u201d for any prior year failures until\nfully corrected. (See instructions and DOL\u2019s Voluntary Fiduciary Correction Program.) .................. 4a\nX\nb Were any loans by the plan or fixed income obligations due the plan in default as of the\nclose of the plan year or classified during the year as uncollectible? Disregard participant loans\nsecured by participant\u2019s account balance. (Attach Schedule G (Form 5500) Part I if \u201cYes\u201d is\nX\nchecked.) ........................................................................................................................................ 4b\nc Were any leases to which the plan was a party in default or classified during the year as\nuncollectible? (Attach Schedule G (Form 5500) Part II if \u201cYes\u201d is checked.) ................................... 4c X -123456789012345\nd Were there any nonexempt transactions with any party-in-interest? (Do not include transactions\nreported on line 4a. Attach Schedule G (Form 5500) Part III if \u201cYes\u201d is\nchecked.) ........................................................................................................................................ 4d X -123456789012345\ne Was this plan covered by a fidelity bond? ....................................................................................... 4e X -123456758090000102345\nf Did the plan have a loss, whether or not reimbursed by the plan\u2019s fidelity bond, that was caused\nby fraud or dishonesty? ................................................................................................................. 4f X -123456789012345\ng Did the plan hold any assets whose current value was neither readily determinable on an\nestablished market nor set by an independent third party appraiser? .............................................. 4g X -123456789012345\nh Did the plan receive any noncash contributions whose value was neither readily\ndeterminable on an established market nor set by an independent third party appraiser? ............... 4h X -123456789012345\ni Did the plan have assets held for investment? (Attach schedule(s) of assets if \u201cYes\u201d is checked,\nand see instructions for format requirements.) ................................................................................ 4i X\nj Were any plan transactions or series of transactions in excess of 5% of the current\nvalue of plan assets? (Attach schedule of transactions if \u201cYes\u201d is checked and\nsee instructions for format requirements.) ....................................................................................... 4j X\nk Were all the plan assets either distributed to participants or beneficiaries, transferred to another\nplan, or brought under the control of the PBGC? ............................................................................ 4k X\nl Has the plan failed to provide any benefit when due under the plan? .............................................. 4l X -123456789012345\nm If this is an individual account plan, was there a blackout period? (See instructions and 29 CFR\n2520.101-3.) ................................................................................................................................... 4m\nn If 4m was answered \u201cYes,\u201d check the \u201cYes\u201d box if you either provided the required notice or one\nof the exceptions to providing the notice applied under 29 CFR 2520.101-3. .................................. 4n\n5a Has a resolution to terminate the plan been adopted during the plan year or any prior plan year?........ X Yes XX No\nIf \u201cYes,\u201d enter the amount of any plan assets that reverted to the employer this year ____________________________________.\n\nSchedule H (Form 5500) 2024 Page 5- 1 1\n5b If, during this plan year, any assets or liabilities were transferred from this plan to another plan(s), identify the plan(s) to which assets or liabilities were\ntransferred. (See instructions.)\n5b(1) Name of plan(s) 5b(2) EIN(s) 5b(3) PN(s)\n123456789 123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 123456789 123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 123456789 123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHII 123456789 123\nABCDEFHI\n5c Was the plan a defined benefit plan covered under the PBGC insurance program at any time during this plan year? (See ERISA section 4021 and\ninstructions.) \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. XX Yes X No X Not determined\nIf \u201cYes\u201d is checked, enter the My PAA confirmation number from the PBGC premium filing for this plan year _5_5_2_6_9_4______________.",
    "char_count": 20679
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SCHEDULE_R",
    "schedule_type": "SCHEDULE_R",
    "page_range": "33-35",
    "page_count": 3,
    "raw_text": "SCHEDULE R Retirement Plan Information OMB No. 1210-0110\n(Form 5500)\n2024\nThis schedule is required to be filed under sections 104 and 4065 of the\nD\nI\ne\nn\np\nte\na\nr\nr\nn\ntm\nal\ne\nR\nn\ne\nt\nv\no\ne\nf\nn\nth\nu\ne\ne\nT\nS\nr\ne\ne\nr\na\nv\ns\nic\nu\ne\nr y\nEmployee Retirement Income Security Act of 1974 (ERISA) and section\n6058(a) of the Internal Revenue Code (the Code).\nDepartment of Labor This Form is Open to Public\nEmployee Benefits Security Administration \uf034 File as an attachment to Form 5500. Inspection.\nPension Benefit Guaranty Corporation\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAGBLCADXEOFSGMHITIH KALBINCED CEAFSGHH BIA LAABNCCDEE PFEGNHSIIO NA PBLCADNEFGHI ABCDEFGHI ABCDEFGHI plan number\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI (PN) \uf034 003 001\nABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nAGBLCADXEOFSGMHITIH KALBINCED LELFCGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0\n2\n1\n3-\n2\n1\n3\n09\n4\n9\n5\n05\n6\n0\n78\nABCDEFGHI\nPart I Distributions\nAll references to distributions relate only to payments of benefits during the plan year.\n1 Total value of distributions paid in property other than in cash or the forms of property specified in the 1 0\ninstructions\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...... -123456789012345\n2 Enter the EIN(s) of payor(s) who paid benefits on behalf of the plan to participants or beneficiaries during the year (if more than two, enter EINs of the\ntwo payors who paid the greatest dollar amounts of benefits):\n25-1897231\nEIN(s): _______________________________ ________________________________\nProfit-sharing plans, ESOPs, and stock bonus plans, skip line 3.\n3 Number of participants (living or deceased) whose benefits were distributed in a single sum, during the plan 3 1576\nyear ..................................................................................................................................................................\n12345678\nPart II Funding Information (If the plan is not subject to the minimum funding requirements of section 412 of the Internal Revenue Code or\nERISA section 302, skip this Part.)\n4 Is the plan administrator making an election under Code section 412(d)(2) or ERISA section 302(d)(2)? ....................... X Yes X No XX N/A\nIf the plan is a defined benefit plan, go to line 8.\n5 If a waiver of the minimum funding standard for a prior year is being amortized in this\nplan year, see instructions and enter the date of the ruling letter granting the waiver. Date: Month _________ Day _________ Year _________\nIf you completed line 5, complete lines 3, 9, and 10 of Schedule MB and do not complete the remainder of this schedule.\n6 a Enter the minimum required contribution for this plan year (include any prior year accumulated funding\n6a -123456789012345\n)\ndeficiency not waived ................................................................................................................................\nb Enter the amount contributed by the employer to the plan for this plan year ................................................ 6b -123456789012345\nc Subtract the amount in line 6b from the amount in line 6a. Enter the result\n(enter a minus sign to the left of a negative amount) .................................................................................... 6c\n-123456789012345\nIf you completed line 6c, skip lines 8 and 9.\n7 Will the minimum funding amount reported on line 6c be met by the funding deadline? ........................................ X Yes X No X N/A\n8 If a change in actuarial cost method was made for this plan year pursuant to a revenue procedure or other\nauthority providing automatic approval for the change or a class ruling letter, does the plan sponsor or plan X Yes X No XX N/A\nadministrator agree with the change? .................................................................................................................\nPart III Amendments\n9 If this is a defined benefit pension plan, were any amendments adopted during this plan\nyear that increased or decreased the value of benefits? If yes, check the appropriate\nbox. If no, check the \u201cNo\u201d box. .........................................................................................\nX Increase X Decrease X Both XX No\nPart IV ESOPs (see instructions). If this is not a plan described under section 409(a) or 4975(e)(7) of the Internal Revenue Code, skip this Part.\n10 Were unallocated employer securities or proceeds from the sale of unallocated securities used to repay any exempt loan? ............. X Yes X No\n11 a Does the ESOP hold any preferred stock? ................................................................................................................................. X Yes X No\nb If the ESOP has an outstanding exempt loan with the employer as lender, is such loan part of a \u201cback-to-back\u201d loan? X Yes X No\n(See instructions for definition of \u201cback-to-back\u201d loan.) ...............................................................................................................\n12 Does the ESOP hold any stock that is not readily tradable on an established securities market? ....................................................... X Yes X No\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule R (Form 5500) 2024\nv. 240311\n\nSchedule R (Form 5500) 2024 Page 2 - 1-1 x\nPart V Additional Information for Multiemployer Defined Benefit Pension Plans\n13 Enter the following information for each employer that (1) contributed more than 5% of total contributions to the plan during the plan year or (2) was one of\nthe top-ten highest contributors (measured in dollars). See instructions. Complete as many entries as needed to report all applicable employers.\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify):\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\n\nSchedule R (Form 5500) 2024 Page 3\n14 Enter the number of deferred vested and retired participants (inactive participants), as of the beginning of the\n123456789012345\nplan year, whose contributing employer is no longer making contributions to the plan for:\na The current plan year. Check the box to indicate the counting method used to determine the number of\ninactive participants: X last contributing employer X alternative X reasonable approximation (see 14a\ninstructions for required attachment).....................................................................................................................\nb The plan year immediately preceding the current plan year. X Check the box if the number reported is a 14b\nchange from what was previously reported (see instructions for required attachment)..........................................\n123456789012345\nc The second preceding plan year. X Check the box if the number reported is a change from what was 14c\npreviously reported (see instructions for required attachment) ..............................................................................\n123456789012345\n15 Enter the ratio of the number of participants under the plan on whose behalf no employer had an obligation to make an\nemployer contribution during the current plan year to:\na The corresponding number for the plan year immediately preceding the current plan year ............................. 15a 123456789012345\nb The corresponding number for the second preceding plan year ..................................................................... 15b 123456789012345\n16 Information with respect to any employers who withdrew from the plan during the preceding plan year:\na Enter the number of employers who withdrew during the preceding plan year ............................................. 16a 123456789012345\nb If line 16a is greater than 0, enter the aggregate amount of withdrawal liability assessed or estimated to be 16b\nassessed against such withdrawn employers .................................................................................................\n123456789012345\n17 If assets and liabilities from another plan have been transferred to or merged with this plan during the plan year, check box and see instructions regarding\nsupplemental information to be included as an attachment ................................................................................................................................................ X\nPart VI Additional Information for Single-Employer and Multiemployer Defined Benefit Pension Plans\n18 If any liabilities to participants or their beneficiaries under the plan as of the end of the plan year consist (in whole or in part) of liabilities to such\nparticipants and beneficiaries under two or more pension plans as of immediately before such plan year, check box and see instructions regarding\nsupplemental information to be included as an attachment ................................................................................................................................................ X\n19 If the total number of participants is 1,000 or more, complete lines (a) and (b):\na Enter the percentage of plan assets held as:\nPublic Equity: __21_.0__% Private Equity: _____% Investment-Grade Debt and Interest Rate Hedging Assets: __70_._0_%\nHigh-Yield Debt: _____% Real Assets: __5_.0__% Cash or Cash Equivalents: __4_.0__% Other: _____%\nb Provide the average duration of the Investment-Grade Debt and Interest Rate Hedging Assets:\nXX 0-5 years X 5-10 years X 10-15 years X 15 years or more\n20 PBGC missed contribution reporting requirements. If this is a multiemployer plan or a single-employer plan that is not covered by PBGC, skip line 20.\na Is the amount of unpaid minimum required contributions for all years from Schedule SB (Form 5500) line 40 greater than zero? Yes No\nb If line 20a is \u201cYes,\u201d has PBGC been notified as required by ERISA sections 4043(c)(5) and/or 303(k)(4)? Check the applicable box:\nYes.\n_ No. Reporting was waived under 29 CFR 4043.25(c)(2) because contributions equal to or exceeding the unpaid minimum required contribution\nwere made by the 30th day after the due date.\n_ No. The 30-day period referenced in 29 CFR 4043.25(c)(2) has not yet ended, and the sponsor intends to make a contribution equal to or\nexceeding the unpaid minimum required contribution by the 30th day after the due date.\n_ No. Other. Provide explanation.__________________________________________________________________________________________\nPart VII IRS Compliance Questions\n21a Does the plan satisfy the coverage and nondiscrimination tests of Code sections 410(b) and 401(a)(4) by combining this plan with any other plans under\nthe permissive aggregation rules? Yes X No\n21b If this is a Code section 401(k) plan, check all boxes that apply to indicate how the plan is intended to satisfy the nondiscrimination requirements for\nemployee deferrals and employer matching contributions (as applicable) under Code sections 401(k)(3) and 401(m)(2).\n_ Design-based safe harbor method\n_ \u201cPrior year\u201d ADP test\n_ \u201cCurrent year\u201d ADP test\n_X N/A\n22 If the plan sponsor is an adopter of a pre-approved plan that received a favorable IRS Opinion Letter, enter the date of the Opinion Letter ___/___/_____\n(MM/DD/YYYY) and the Opinion Letter serial number__________.",
    "char_count": 15353
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_FINANCIAL_STATEMENTS",
    "schedule_type": "FINANCIAL_STATEMENTS",
    "page_range": "36-90",
    "page_count": 55,
    "raw_text": "GlaxoSmithKline\nCash Balance Pension Plan\nFinancial Statements as of and for the Years\nEnded December 31, 2024 and 2023 and\nSupplemental Schedules as of and for the Year Ended\nDecember 31, 2024 and Independent Auditor\u2019s Report\nEmployer Identification Number (EIN) : 23-1099050\nPlan Number (PN) : 003\n\nGlaxoSmithKline Cash Balance Pension Plan\nIndex\nPage(s)\nIndependent Auditor\u2019s Report\u2026..............................................................................................................1-3\nFinancial Statements\nStatements of Net Assets Available for Benefits\nAs of December 31, 2024 and 2023.............................................................................................................4\nStatements of Changes in Net Assets Available for Benefits\nYears Ended December 31, 2024 and 2023 ................................................................................................5\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023 ..................................................................6\u201318\nSupplemental Schedules*\nForm 5500 Schedule H, Line 4(i) - Schedule of Assets (Held at End of Year)\nAs of December 31, 2024 .......................................................................................................................19\u201352\nForm 5500 Schedule H, Line 4(j) \u2013 Schedule of Reportable Transactions\nFor the Year Ended December 31, 2024 .... .................................................................................................53\n* Other schedules required by section 2520.103-10 of the Department of Labor Rules and\nRegulations for Reporting and Disclosure under the Employee Retirement Income Security\nAct of 1974 have been omitted, because they are not applicable.\n\nDeloitte & Touche LLP\n1700 Market Street\nPhiladelphia, PA 19103\nUSA\nTel: +1 215 246 2300\nwww.deloitte.com\nINDEPENDENT AUDITOR\u2019S REPORT\nTo the Plan Administrator of\nGlaxoSmithKline Cash Balance Pension Plan\nWe have audited the financial statements of GlaxoSmithKline Cash Balance Pension Plan (the \u201cPlan\u201d), an\nemployee benefit plan subject to the Employee Retirement Income Security Act of 1974 (ERISA), which\ncomprise the statements of net assets available for benefits as of December 31, 2024 and 2023, and the\nrelated statements of changes in net assets available for benefits for the years then ended, and the related\nnotes to the financial statements.\nIn our opinion, the accompanying financial statements present fairly, in all material respects, the net assets\navailable for benefits of the Plan as of December 31, 2024 and 2023, and the changes in its net assets\navailable for benefits for the years then ended, in accordance with accounting principles generally accepted\nin the United States of America.\nBasis for Opinion\nWe conducted our audits in accordance with auditing standards generally accepted in the United States of\nAmerica (GAAS). Our responsibilities under those standards are further described in the Auditor\u2019s\nResponsibilities for the Audit of the Financial Statements section of our report. We are required to be\nindependent of the Plan and to meet our other ethical responsibilities, in accordance with the relevant\nethical requirements relating to our audits. We believe that the audit evidence we have obtained is\nsufficient and appropriate to provide a basis for our audit opinion.\nResponsibilities of Management for the Financial Statements\nManagement is responsible for the preparation and fair presentation of the financial statements in\naccordance with accounting principles generally accepted in the United States of America, and for the\ndesign, implementation, and maintenance of internal control relevant to the preparation and fair\npresentation of financial statements that are free from material misstatement, whether due to fraud or\nerror.\nIn preparing the financial statements, management is required to evaluate whether there are conditions\nor events, considered in the aggregate, that raise substantial doubt about the Plan\u2019s ability to continue as\na going concern for one year after the date that the financial statements are available to be issued.\nManagement is also responsible for maintaining a current plan instrument, including all plan amendments,\nadministering the Plan, and determining that the Plan\u2019s transactions that are presented and disclosed in\nthe financial statements are in conformity with the Plan\u2019s provisions, including maintaining sufficient\nrecords with respect to each of the participants, to determine the benefits due or which may become due\nto such participants.\n\nAuditor\u2019s Responsibilities for the Audit of the Financial Statements\nOur objectives are to obtain reasonable assurance about whether the financial statements as a whole are\nfree from material misstatement, whether due to fraud or error, and to issue an auditor\u2019s report that\nincludes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and\ntherefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material\nmisstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher\nthan for one resulting from error, as fraud may involve collusion, forgery, intentional omissions,\nmisrepresentations, or the override of internal control. Misstatements are considered material if there is a\nsubstantial likelihood that, individually or in the aggregate, they would influence the judgment made by a\nreasonable user based on the financial statements.\nIn performing an audit in accordance with GAAS, we:\n\u2022 Exercise professional judgment and maintain professional skepticism throughout the audit.\n\u2022 Identify and assess the risks of material misstatement of the financial statements, whether due to fraud\nor error, and design and perform audit procedures responsive to those risks. Such procedures include\nexamining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.\n\u2022 Obtain an understanding of internal control relevant to the audit in order to design audit procedures\nthat are appropriate in the circumstances, but not for the purpose of expressing an opinion on the\neffectiveness of the Plan\u2019s internal control. Accordingly, no such opinion is expressed.\n\u2022 Evaluate the appropriateness of accounting policies used and the reasonableness of significant\naccounting estimates made by management, as well as evaluate the overall presentation of the\nfinancial statements.\n\u2022 Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that\nraise substantial doubt about the Plan\u2019s ability to continue as a going concern for a reasonable period\nof time.\nWe are required to communicate with those charged with governance regarding, among other matters,\nthe planned scope and timing of the audit, significant audit findings, and certain internal control-related\nmatters that we identified during the audit.\nSupplemental Schedules Required by ERISA\nOur audits were conducted for the purpose of forming an opinion on the financial statements as a whole.\nThe supplemental schedule of assets (held at end of year) as of December 31, 2024, and schedule of\nreportable transactions for the year ended December 31, 2024 are presented for purposes of additional\nanalysis and are not a required part of the financial statements but are supplementary information required\nby the Department of Labor\u2019s Rules and Regulations for Reporting and Disclosure under ERISA. Such\ninformation is the responsibility of management and was derived from and relates directly to the underlying\naccounting and other records used to prepare the financial statements. The information has been\nsubjected to the auditing procedures applied in the audits of the financial statements and certain additional\nprocedures, including comparing and reconciling such information directly to the underlying accounting\nand other records used to prepare the financial statements or to the financial statements themselves, and\nother additional procedures in accordance with GAAS.\n\nIn forming our opinion on the supplemental schedules, we evaluated whether the supplemental schedules,\nincluding their form and content, are presented in conformity with the Department of Labor\u2019s Rules and\nRegulations for Reporting and Disclosure under ERISA.\nIn our opinion, the information in the accompanying schedules are fairly stated, in all material respects, in\nrelation to the financial statements as a whole, and the form and content are presented in conformity with\nthe Department of Labor\u2019s Rules and Regulations for Reporting and Disclosure under ERISA.\nSeptember 19, 2025\n\nGlaxoSmithKline\nCash Balance Pension Plan\nStatements of Net Assets Available for Benefits\nAs of December 31, 2024 and 2023\n2024 2023\nAssets\nInvestments, at fair value\nForeign currency $ 80 $ 1 05,750\nCommon stocks 2,993,127 2,596,542\nInternational common stocks 47,952,499 55,632,527\nCommon collective trust funds 540,982,000 511,418,591\nManaged real estate funds 123,671,905 144,551,780\nU.S. government securities 966,914,769 887,644,170\nCorporate bonds 925,674,665 984,342,290\nMunicipal bonds 2,915,348 4,138,353\nRegistered investment company 121,769,713 101,881,156\nInvestments, at contract value\nUnallocated insurance contract 10,659,514 10,574,299\nTotal investments 2,743,533,620 2,702,885,458\nCash 1,890,534 13,258,482\nReceivables\nAccrued interest and dividends 22,667,032 19,823,642\nVariation margin on futures contracts 2,686,827 5,232,313\nReceivables for securities sold - 258,200\nContributions receivable 131,000,000 195,000,000\nTotal receivables 156,353,859 220,314,155\nTotal assets 2,901,778,013 2,936,458,095\nLiabilities\nAccrued expenses 197,275 807,468\nPayables for securities purchased 698,493 1,145,104\nVariation margin on swaps contracts - 602\nTotal liabilities 895,768 1,953,174\nNet assets available for benefits $ 2 ,900,882,245 $ 2 ,934,504,921\nThe accompanying notes are an integral part of these financial statements\n4\n\nGlaxoSmithKline\nCash Balance Pension Plan\nStatements of Changes in Net Assets Available for Benefits\nYears Ended December 31, 2024 and 2023\n2024 2023\nAdditions to net assets attributed to\nNet Investment income\nInterest $ 81,852,619 $ 94,009,530\nDividends 6,449,106 7,287,379\nNet appreciation in the fair value of investments 71,913,549 175,991,565\n160,215,274 277,288,474\nContributions\nEmployer 131,000,000 195,000,000\nTotal additions 291,215,274 472,288,474\nDeductions from net assets attributed to\nBenefits paid to participants 306,621,456 335,530,046\nAdministrative expenses 18,216,494 41,982,283\nTotal deductions 324,837,950 377,512,329\nNet increase/(decrease) (33,622,676) 94,776,145\nNet assets available for benefits\nBeginning of year 2,934,504,921 2,839,728,776\nEnd of year $ 2,900,882,245 $ 2,934,504,921\nThe accompanying notes are an integral part of these financial statements\n5\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\n1. Description of the Plan\nThe following brief description of the GlaxoSmithKline Cash Balance Pension Plan (the \u201cPlan\u201d) is\nprovided for general information purposes only. Participants should refer to the Plan Document for\na more complete description of the plan provisions.\nThe Plan is a defined benefit plan, sponsored by GlaxoSmithKline LLC (the \u201cCompany\u201d) and covers\nfull-time and part-time U.S. and Puerto Rico-based employees who were eligible prior to January 1,\n2021. It is subject to the provisions of the Employee Retirement Income Security Act of 1974\n(\u201cERISA\u201d).\nPlan Freeze of Eligibility and Company Credits\nEffective January 1, 2021, the Plan was closed to new entrants and there are no future Company credits\nmade to participants\u2019 accounts. Participants with account balances as of December 31, 2020 will have\ntheir balances remain in the Plan and will continue to receive interest credits. Participants who are\nreceiving long-term disability (LTD) benefits from the GSK LTD Plan as of December 31, 2020, will\ncontinue to accumulate Company credits during their disability until the earlier of (i) the date they elect to\nreceive their pension distribution from the Plan; (ii) the date LTD benefits end; or (iii) date of death, as\ndefined in the Plan Document. There have been no other changes to the terms of the Plan.\nVesting\nParticipants\u2019 account balances are 100% vested.\nPayment of Benefits\nUpon termination of employment, retirement, or death, a participant with an account balance not\nexceeding $5,000, receives a lump-sum payment. Participants with account balances in excess of\n$5,000 have the choice of payment in the form of a lump-sum or an annuity.\nParticipants Accounts\nEach eligible participant has a hypothetical account, which was credited with Company credits\nbased on the participant\u2019s eligible pay prior to January 1, 2021 and will continue to be credited with\ninterest credits based on the account balance at the beginning of each pay period.\nDeath Benefits\nIf an active employee dies, the account value of the employee\u2019s pension benefit is paid to the\nemployee\u2019s beneficiary.\nCash Balance Plan Formula for Company Credits prior to January 1, 2021\nThe Company allocated Company credits to participants\u2019 accounts equal to 5% of eligible pay up to the\nInternal Revenue Code (\u201cIRC\u201d) limit on eligible pay. Eligible pay includes base earnings, regularly\nscheduled bonuses or incentive compensation, overtime, and shift differential. Interest is credited each\npay period. The interest rate is set each year for the Plan year and is based on the 24-month average\nof 30-year Treasury Bond rates ending each June 30 of the prior year (rounded to the next higher \u00bc\npercent), not to exceed the 3rd segment rate for funding valuations published in September of the prior\nyear by the Internal Revenue Service (\u201cIRS\u201d).\nCrediting interest rates and provision\nThe interest rate was 3.00% and 2.25% during 2024 and 2023, respectively.\n6\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\nBenefits change\nEffective January 1, 2020, the actuarial 417(e) table for lump sums and social security level income\noptions was changed to use the applicable interest rate for August of the preceding calendar year to\nwhen the distribution is made.\nRequired Minimum Distribution\nAs permissible under the SECURE 2.0 Act (Setting Every Community Up for Retirement Enhancement\nAct of 2022), the Required Minimum Distribution for the Plan was increased from age 72 to 73 effective\nJanuary 1, 2023.\n2. Summary of Significant Accounting Policies\nBasis of Accounting\nThe accompanying financial statements have been prepared on the accrual basis of accounting in\nconformity with accounting principles generally accepted in the United States of America.\nUse of Estimates\nThe preparation of financial statements in conformity with accounting principles generally accepted in\nthe United States of America requires management to make estimates and assumptions that affect the\nreported amounts of assets, liabilities and changes therein, disclosures of contingent assets and\nliabilities, and the actuarial present value of accumulated plan benefits at the date of the financial\nstatements. Actual results could differ from those estimates and those differences could be material.\nInvestment Valuation and Income Recognition\nBank of New York Mellon (the \u201cTrustee\u201d) serves as the trustee of the Plan and the GlaxoSmithKline\nCash Balance Pension Plan Master Trust (\u201cMaster Trust\u201d). The Master Trust holds the investments of\nthe Plan. The Plan has a 100% interest in the net assets of the Master Trust as of December 31, 2024\nand 2023. Investments are stated at fair value as defined by Financial Accounting Standards Board\n(FASB) Accounting Standards Codification (ASC) 820. Plan management determines the Plan\u2019s\nvaluation policies utilizing information provided by the investment advisors, custodians and an\ninsurance company.\nThe following is a description of the valuation methodologies used for the investments measured at fair\nvalue. There have been no changes in methodologies used at December 31, 2024 and 2023.\n\u2022 Foreign currency: valued at the underlying value of the short term investments at the respective\ncurrency exchange rates at year end.\n\u2022 Common stocks, including international common stocks: valued at the closing price reported on\nthe active market on which the individual securities are traded.\n\u2022 Common collective trust funds and managed real estate funds: valued at the Net Asset Value\n(\u201cNAV\u201d) of units held by the Plan at year end. The NAV, as provided by the Trustee, is used as a\npractical expedient to estimate fair value. The NAV is based on the fair value of the underlying\ninvestments held by the fund less its liabilities. This practical expedient is not used when it is\ndetermined to be probable that the fund will sell the investment for an amount different than the\nreported net asset value. Were the Plan to initiate a full redemption of the fund, the investment\nadvisor reserves the right to temporarily delay withdrawal from the trust in order to confirm that\nsecurities liquidations will be carried out in an orderly business manner.\n7\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\n\u2022 U.S. government securities: valued by obtaining live over-the-counter quotations from active\nmarket makers and inter dealer brokers.\n\u2022 Fixed income securities, which includes corporate bonds and municipal bonds: valued based on\nyields currently available on comparable securities of issuers with similar credit ratings.\n\u2022 Registered investment company: valued at the quoted NAV of shares held by the Plan at year\nend.\n\u2022 Variation margin on futures: valued using exchange prices established daily by the exchange\non which they are traded. The fair value is the unrealized profit or loss at the current bid or\noffer market quoted price of the contract.\n\u2022 Variation margin on swap contracts: centrally cleared interest rate swap agreements are valued\nat settlement prices of the clearing house through which the contracts were traded. Daily\nchanges in value are recorded as variation margin.\nThe measurement methods as described above may not be indicative of net realizable value or\nreflective of future fair values. Furthermore, while the Plan believes its valuation methods are\nappropriate and consistent with other market participants, the use of different methodologies or\nassumptions to determine the fair value of certain financial instruments could result in a different\nfair value measurement at the reporting date.\nThe Plan invests in an unallocated immediate participation guarantee (IPG) insurance contract issued by\nJohn Hancock Life Insurance Company which is valued at contract value. The value at December 31,\n2024 and 2023 was reported at contract value. Upon review of FASB ASC 960-325-35-3 (\u201cASC 960\u201d)\nplan management determined reporting at contract value is appropriate. ASC 960 states that insurance\ncontracts (ex., deposit administration contracts, IPG contracts and as defined in the FASB ASC glossary)\nshould be presented in the same manner as specified in the annual report filed by a plan with certain\ngovernmental agencies pursuant to ERISA. This is consistent with the requirements of Form 5500. The\ncurrent Form 5500 permits unallocated insurance contracts to be reported at either current value or as\ndetermined on Schedule A, Insurance Information, that is contract value. This is an exception to the\ngeneral requirement of ASC 960 that plan investments be presented at fair value. As the contract is\nreported as determined on Schedule A, the contract is reported at contract value. The value of the\ncontract is $10.7 million and $10.6 million as of December 31, 2024 and 2023, respectively.\nThe net appreciation/(depreciation) in the fair value of investments consists of both realized gains\nand losses and the change in unrealized appreciation/(depreciation) on investments held during the\nyear.\nDividends are recorded on the ex-dividend date and interest income is accrued as earned. All\nsecurity transactions are recorded on the trade date.\nAmounts due to or due from brokers are amounts relating to securities purchased or sold awaiting\nsettlement.\nChange in Presentation\nCertain amounts in the prior year financial statements and notes to the financial statements have been\nmodified to conform to the current year presentation. Certain investments previously included in fixed\nincome securities are now reported separately as corporate bonds and municipal bonds, both are types\n8\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\nof fixed income securities. Management believes this modification improves the presentation of the\nfinancial statements and enhances comparison with current year amounts.\nBenefits Paid to Participants\nBenefits paid to participants are recorded when paid.\n3. Funding Policy\nContributions to the Plan are made by the Company. No contributions are made by the participants.\nThe Company contributes such amounts that are necessary on an actuarial basis to provide the Plan\nwith assets sufficient to fund the benefits provided by the Plan. The Company made contributions of\n$131 million and $195 million for the Plan years ended December 31, 2024 and 2023, respectively.\nThe Plan met ERISA\u2019s minimum funding requirements at December 31, 2024 and 2023.\n4. Plan Termination\nAlthough the Company has not expressed any intent to terminate the Plan, it may do so at any\ntime. Under provisions of ERISA, if the Plan is terminated, the Company may be obligated to make\ntermination payments to the Plan.\nIn the event the Plan terminates, the net assets of the Plan will be allocated, as prescribed by\nERISA and its related regulations, generally to provide the following benefits in the order indicated:\n1. Benefits attributable to employee contributions, taking into account those paid out before\ntermination.\n2. Annuity benefits that former employees, or their beneficiaries, have been receiving for at least\nthree years, or that employees eligible to retire for that three-year period would have been\nreceiving if they had retired with benefits in the normal form of annuity under the Plan. The priority\namount is limited to the lowest benefit that was payable (or would have been payable) during\nthose three years. The amount is further limited to the lowest benefit that would be payable under\nPlan provisions in effect at any time during the five years preceding Plan termination.\n3. Other vested benefits insured by the Pension Benefit Guaranty Corporation (\u201cPBGC\u201d) (a U.S.\ngovernment agency) up to the applicable limitations (discussed subsequently).\n4. All other vested benefits (that is, vested benefits not insured by the PBGC).\n5. All non-vested benefits.\nCertain benefits under the Plan are insured by the PBGC if the Plan terminates. Generally, the PBGC\nguarantees most vested normal age retirement benefits, early retirement benefits, and certain disability\nand survivor\u2019s pensions. However, the PBGC does not guarantee all types of benefits under covered\nplans, and the amount of benefit protection is subject to limitations. Vested benefits under the Plan are\nguaranteed at the level in effect on the date of the Plan\u2019s termination; however, there is a statutory\nceiling on the amount of an individual\u2019s monthly benefit that the PBGC guarantees.\n9\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\n5. Administrative Expenses\nAdministrative expenses, including investment management, actuarial, custody fees, audit and other\nadministrative expenses, are paid by the Plan and are recorded as deductions in the accompanying\nStatements of Changes in Net Assets Available for Benefits.\nCertain administrative functions are performed by officers or employees of the Company and its\naffiliates. No such officer or employee receives compensation from the Plan.\n6. Tax Status\nThe IRS has determined and informed the Company by a letter on May 4, 2021 that the Plan and\nrelated trust are designed in accordance with applicable sections of the IRC Section 401(a). In\nDecember 2016, the IRS began publishing a Required Amendments List for individually designed plans\nwhich specifies changes in qualification requirements. The list is published annually and requires plans\nto be amended for each item on the list, as applicable, to retain its tax-exempt status. The Plan\nadministrator and the Plan\u2019s counsel believe that the Plan is designed, and is currently being\noperated, in compliance with the applicable requirements of the IRC and, therefore, believe that the\nPlan is qualified, and the related trust is tax-exempt.\n7. Risk and Uncertainties\nThe Plan invests in various investment securities. These investment securities are exposed to various\nrisks, such as interest rate, market and credit risks. Market risks include global events which could\nimpact the value of investment securities, such as a pandemic or international conflict. Due to the level\nof risk associated with certain investment securities, it is at least reasonably possible that changes in\nthe values of investments will occur in the near term and that such changes could materially affect\nparticipants\u2019 account balances and the amounts reported in the Statements of Net Assets Available for\nBenefits.\nPlan contributions are made and the actuarial present value of accumulated plan benefits are reported\nbased on certain assumptions pertaining to interest rates, inflation rates and employee demographics,\nall of which are subject to change. Due to uncertainties inherent in the estimations and\nassumptions process, it is at least reasonably possible that changes in these estimates and\nassumptions in the near term could be material to the financial statements.\nAs of December 31, 2024 and December 31, 2023, the Russell 3000 Index Fund represented 13% and\n11% of the Plan's net assets available for benefits, respectively. The fair value of the investments in\nthe Russell 3000 Index Fund were $385,338,474 as of December 31, 2024 and $334,301,760 as of\nDecember 21, 2023. There were no other investments that represented more than 10% of the Plan\u2019s\nnet assets available for benefits as of December 31, 2024 and 2023.\n8. Exempt-Party-in-Interest Transactions\nBank of New York Mellon (\u201cBNYM\u201d), the Custodian and Trustee of the Plan, is deemed a party-in-\ninterest. The Plan holds a cash account with BNYM, which includes underlying short-term investment\nfunds issued by various investment managers.\nThe Plan also invests in certain BNYM investments. Any fees paid to BNYM represent a party-in-\n10\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\ninterest transaction, which are exempt from the prohibited transaction rules of ERISA.\n9. Actuarial Present Value of Accumulated Benefits\nAccumulated plan benefits are those future periodic payments, including lump-sum distributions, that\nare attributable under the Plan\u2019s provisions to the service employees have rendered. Accumulated\nplan benefits include benefits expected to be paid to (a) retired, disabled or terminated employees or\ntheir beneficiaries, (b) beneficiaries of employees who have died, and (c) present employees or their\nbeneficiaries. Benefits payable under all circumstances \u2013 retirement, death, disability and termination\nof employment \u2013 are included to the extent they are deemed attributable to employee service rendered\nto the valuation date.\nThe actuarial present value of accumulated plan benefits is determined by an independent actuary and\nis the amount that results from applying actuarial assumptions to adjust the accumulated plan benefits\nto reflect the time value of money and the probability of payment between the valuation date and the\nexpected payment date. The actuarial cost method used is the unit credit method.\nThe actuarial present value of accumulated plan benefits presented in the accompanying financial\nstatements at December 31, 2024 and 2023, are presented using beginning of year benefit information\ndate. The actuarial present value of accumulated plan benefits below is measured as of January 1,\n2024. The effect of plan amendments on accumulated plan benefits are recognized during the year in\nwhich such amendments are adopted. There were no amendments effective January 1 recognized in\nthe actuarial present value of accumulated plan benefits in the summary included below. Had the\nvaluations been performed as of December 31, there would be no material differences.\nThe significant actuarial assumptions used in the valuations as of January 1, 2024 were:\nMortality PRI-2012 non-disabled annuitant and employee white collar tables with\nmortality rates decreased by 10.4% and continuous improvements projected\nusing Scale MP-2020.\nAverage retirement age 58\nInvestment return 5.00% as of January 1, 2024\n11\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\nThe actuarial present value of accumulated benefits to participants of the Plan were as follows:\nJanuary 1,\n2024\nVested benefits\nParticipants currently receiving payments $ 1,356,108,325\nOther participants 1,794,260,480\nTotal vested benefits 3,150,368,805\nTotal actuarial present value of accumulated benefits $ 3,150,368,805\nThe changes in actuarial present value of accumulated plan benefits were due to the following:\nActuarial present value of accumulated plan benefits at January 1, 2023 $ 3,263,950,069\nIncrease during the year attributable to\nActuarial gains (20,435,595)\nInterest due to the decrease in the discount period 164,237,059\nBenefits paid (335,530,046)\nChange in actuarial assumptions 77,212,185\nOther 935,133\nNet decrease (113,581,264)\nActuarial present value of accumulated plan benefits at January 1, 2024 $ 3,150,368,805\nThe actuarial assumption for the discount rate has decreased from 5.3% at January 1, 2023 to 5.0% at\nJanuary 1, 2024, resulting in an increase in present value of accumulated plan benefits (PVAB) of $69.8\nmillion. The interest crediting rate increased from 3.9% as of January 1, 2023 to 4.0% as of January 1,\n2024, resulting in an increase in PVAB of $10.2 million. The annuity conversion rate for single participants\nincreased from 3.9% as of January 1, 2023 to 4.0% as of January 1, 2024 and the annuity conversion rate\nfor married participants decreased from 5.5% as of January 1, 2023 to 5.2% as of January 1, 2024,\nresulting in a $3.8 million decrease of PVAB. The mortality projection scale for cash balance annuity\nconversions was updated from MP-2020 at January 1, 2023 to MP-2021 at January 1, 2024 to reflect the\nprojection scale the IRS used in the 417(e) mortality rates. This resulted in a decrease in PVAB of $0.5\nmillion. Certain demographic assumptions were updated to reflect the results of the experience study\ncompleted during 2023. These changes resulted in an increase in PVAB of $1.5 million.\nThe foregoing actuarial assumptions are based on the presumption that the Plan will continue. Should\nthe Plan terminate, different actuarial assumptions and other factors might be applicable in determining\nthe actuarial present value of accumulated plan benefits.\n12\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\n10. Derivatives\nIn the normal course of business, the Plan enters into a variety of derivative instruments including\nfutures and swap agreements to manage risks as specified further below.\nFutures\nThe Plan purchases and sells futures contracts on fixed income securities. Futures contracts represent\ncommitments for future delivery of cash based upon the level of a specified index of fixed income\nsecurities at a specified price at a given date. The Plan uses futures contracts to manage its exposure to\nthe underlying instrument. Buying futures increases the Plan\u2019s exposure to changes in the value of the\nunderlying instrument. Selling futures decreases the Plan\u2019s exposure to changes in the value of the\nunderlying instrument. The Plan uses a combination of short and long term futures contracts in order to\nmanage interest rate risk.\nUpon purchase of a futures contract, the Plan is required to deposit with its custodian, in a segregated\naccount in the name of the futures broker, an amount of cash or U.S. government obligations in\naccordance with the initial margin requirements of the broker or exchange. Securities with an aggregate\nmarket value of $38.6 million and $53.1 million have been pledged as collateral for futures contracts at\nDecember 31, 2024 and 2023, respectively. These had an aggregate market value of $45.5 million and\n$65.1 million at December 31, 2024 and 2023, respectively and are recorded on the Statements of Net\nAssets Available for Benefits within the U.S. government Securities and Corporate bonds. Futures\ncontracts are marked to market daily and the net change in the market value is the variation margin. The\nvariation margin is recorded by the Plan as unrealized appreciation or depreciation. The variation margin\nwas $2.7 million and $5.2 million at December 31, 2024 and 2023, respectively. When the contract is\nclosed, the Plan records a realized gain or loss equal to the difference between the value of the contract\nat the time it was opened and the value at the time it was closed. The variation margins will continue\nuntil the contracts expire or are closed.\nFutures contracts involve, to varying degrees, risk of loss in excess of the variation margin. Losses may\narise from the change in the value of the underlying instrument, if there is an illiquid secondary market\nfor the contracts, or if counterparties do not perform under the contract terms. Futures contracts are\nvalued at the quoted daily settlement prices established each day by the board of trade or exchange on\nwhich they are traded.\nSwap Agreements\nA swap agreement is entered into in order to, among other things, protect the Plan\u2019s value from changes in\ninterest rates. Entering into these agreements involves, to varying degrees, elements of credit, interest rate\nand market risk. Such risks involve the possibility that there will be no liquid market for these agreements,\nthat the counterparty to the agreement may default on its obligation to perform and that there may be\nunfavorable changes in the fluctuations of interest rates.\nDuring 2023, the Plan entered into interest rate swap agreements in order to hedge interest rate risk on\nthe Plan\u2019s liabilities. The swap agreements are centrally cleared through a regulated clearing house.\nFor centrally cleared swaps, the Plan's counterparty credit risk is reduced as the clearing house stands\nbetween the Plan and the counterparty.\nThe Plan is required to interface with the clearing house through a broker. Upon entering into a centrally\ncleared swap, the Plan is required to deposit initial margin with the broker in the form of cash or\nsecurities in an amount that varies depending on the size and risk profile of the particular swap. The\nclearing house requires daily settlement of variation margin representing changes in the market value of\n13\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\neach contract. Securities deposited as initial margin are recorded on the Statements of Net Assets\nAvailable for Benefits within U.S. government securities. Initial margin collateral of $0.02 million was\npledged for swap contracts at December 31, 2023 using U.S. government securities with an aggregate\nmarket value of $0.02 million. The amounts as of December 31, 2023 were residual amounts as GSK\nexited the interest rate swap arrangements in December 2023. The swap contracts are recorded on the\nStatements of Net Assets Available for Benefits within the U.S. government Securities as of December\n31, 2023.\nThe daily change in valuation of centrally cleared swaps is recorded as a receivable or payable for\nvariation margin in the Statements of Net Assets Available for Benefits. Gains or losses are recognized\nimmediately and realized upon daily settlement. The variation margin will continue until the contracts\nexpire or are closed.\nFair values of derivative instruments as of December 31, 2024 and 2023, on the Statements of Net\nAssets Available for Benefits were as follows:\nLocation on Statement of 2024\nNet Assets Fair Value\nAsset Liability\nDerivatives Derivatives\nVariation margin on futures\nInterest Rate Risk * contracts $ 2 ,686,827 $ -\n$ 2 ,686,827 $ -\nLocation on Statement of 2023\nNet Assets Fair Value\nAsset Liability\nDerivatives Derivatives\nVariation margin on futures\nInterest Rate Risk * contracts $ 5 ,232,313 $ -\nVariation margin on swaps\nInterest Rate Risk * contracts - 602\n$ 5 ,232,313 $ 602\n* Only current day variation margin is reported with the Statements of Net Assets Available for\nBenefits.\nThe effect of derivative instruments on the Statements of Changes in Net Assets Available for\nBenefits for the years ended December 31, 2024 and 2023, was as follows:\n14\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\n2024\nChange in Unrealized Appreciation\nRealized Gain or Loss on or Depreciation on Derivatives\nDerivatives Recognized in Net Recognized in Net Appreciation\nAppreciation (Depreciation) in Fair (Depreciation) in Fair Value of\nValue of Investments Investments\nInterest rate risk $ 90,691,948 $ (12,153,937)\n2023\nChange in Unrealized Appreciation\nRealized Gain or Loss on or Depreciation on Derivatives\nDerivatives Recognized in Net Recognized in Net Appreciation\nAppreciation (Depreciation) in Fair (Depreciation) in Fair Value of\nValue of Investments Investments\nInterest rate risk $ ( 30,622,421) $ (13,872,414)\nThe table below summarizes the average balance of derivative holdings by the Plan during the years\nended December 31, 2024 and 2023:\n2024\nAsset Derivative Volume\nFutures (Average Daily Swaps (Weighted Average Monthly\nNotional Amount) Notional Amount)\n$ 69,809,013 $ -\n2024\nLiability Derivative Volume\nFutures (Average Daily Swaps (Weighted Average Monthly\nNotional Amount) Notional Amount)\n$ 66,783,506 $ -\n15\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\n2023\nAsset Derivative Volume\nFutures (Average Daily Swaps (Weighted Average Monthly\nNotional Amount) Notional Amount)\n$ 38,118,837 $ -\n2023\nLiability Derivative Volume\nFutures (Average Daily Swaps (Weighted Average Monthly\nNotional Amount) Notional Amount)\n$ 49,268,038 $ 3,354,111,428\n11. Fair Value Measurements\nThe framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to\nvaluation techniques used to measure fair value. To increase consistency and comparability in fair\nvalue measurements and related disclosures, the Plan utilizes the fair valuation hierarchy required\nby FASB ASC 820-10 which prioritizes the inputs to valuation techniques and to measure fair value\ninto the following three broad levels:\nLevel 1 Inputs to the valuation methodology are unadjusted quoted prices for identical asset or\nliabilities in active markets that the Plan has the ability to access at the measurement\ndate (i.e. common stock, foreign currency and registered investment company).\nLevel 2 Inputs other than quoted prices that are observable for the asset or liability either\ndirectly or indirectly, including inputs in markets that are not considered to be active\n(i.e. U.S. government securities, corporate bonds and municipal bonds).\nLevel 3 Inputs to the valuation methodology are unobservable and significant to the fair value.\n16\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\nThe following table sets forth by level within the fair value hierarchy, the Plan\u2019s assets at fair value as of\nDecember 31, 2024 and 2023:\nAsset Hierarchy at Fair Value as at December 31, 2024\nLevel 1 Level 2 Level 3 Total\nPlan investments\nForeign currency $ 80 $ - $ - $ 80\nCommon stocks 2,993,127 - - 2,993,127\nInternational common stocks 47,952,499 - - 47,952,499\nRegistered investment company 121,769,713 - - 121,769,713\nCorporate bonds - 925,674,665 925,674,665\nMunicipal bonds - 2,915,348 - 2,915,348\nU.S. government securities - 966,914,769 - 966,914,769\nTotal investments at fair value 172,715,419 1,895,504,782 - 2,068,220,201\nFuture contracts 2,686,827 - - 2,686,827\nTotal investments at fair value including\nderivatives $ 1 75,402,246 $ 1,895,504,782 $ - $ 2,070,907,028\nInvestments measured at net asset\nvalue as a practical expedient (a) - - - 664,653,905\nTotal Investments $ 175,402,246 $ 1,895,504,782 $ - $ 2,735,560,933\nAsset Hierarchy at Fair Value as at December 31, 2023\nLevel 1 Level 2 Level 3 Total\nPlan investments\nForeign currency $ 105,750 $ - $ - $ 105,750\nCommon stocks 2,596,542 - - 2,596,542\nInternational common stocks 55,632,527 - - 55,632,527\nRegistered investment company 101,881,156 - - 101,881,156\nCorporate bonds - 984,342,290 - 984,342,290\nMunicipal bonds 4,138,353 - 4,138,353\nU.S. government securities - 887,644,170 - 887,644,170\nTotal investments at fair value 160,215,975 1,876,124,813 - 2,036,340,788\nFuture contracts 5,232,313 - - 5,232,313\nSwap contracts - (602) - (602)\nTotal investments at fair value including\nderivatives $ 1 65,448,288 $ 1,876,124,211 $ - $ 2,041,572,499\nInvestments measured at net asset\nvalue as a practical expedient (a) - - - 655,970,371\nTotal Investments $ 1 65,448,288 $ 1,876,124,211 $ - $ 2,697,542,870\n(a) In accordance with ASU 2015-07, certain investments (common collective trust funds and managed\nreal estate funds) that were measured at net asset value per share (or its equivalent) as practical\nexpedient have not been classified in the fair value hierarchy. The fair value amounts presented in this\ntable are intended to permit reconciliation of the fair value hierarchy to the line items presented in the\nStatements of Net Assets Available for Benefits.\n17\n\nGlaxoSmithKline\nCash Balance Pension Plan\nNotes to Financial Statements\nAs of and for the Years Ended December 31, 2024 and 2023\nThe following summarizes investments measured at fair value based on NAV per share as a practical\nexpedient as of December 31, 2024 and 2023.\nRedemption\nFrequency\nUnfunded (if Currently Redemption\nDecember 31, 2024 Fair Value Commitments Eligible) Notice Period\nOne quarter in advance, i.e., if a redemption request is received by September\nMorgan Stanley Prime Property\n$ 123,671,905 None Quarterly 30th, the redemption will be eligible for payout on December 31st, subject to\nFund\ncash availability as determined by the Adviser.\nState Street MSCI EAFE Index\n93,077,909 None Daily T-1 By 12:00 PM EST\nNon-Lending Fund\nState Street MSCI EGERG Non-\n62,565,617 None Daily T-1 By 12:00 PM EST\nLending Fund\nState Street Russell 3000 Index\n385,338,474 None Daily T-1 By 12:00 PM EST\nNL Fund\nTotal December 31, 2024 $ 664,653,905\nUnfunded (if Currently Redemption\nDecember 31, 2023 Fair Value Commitments Eligible) Notice Period\nOne quarter in advance, i.e., if a redemption request is received by September\nMorgan Stanley Prime Property\n144,551,780 None Quarterly 30th, the redemption will be eligible for payout on December 31st, subject to\nFund\ncash availability as determined by the Adviser.\nMarathon - London International\nFund 56,699,316 None Monthly T-5 (T is the last BD of the month)\nState Street MSCI EAFE Index\n70,902,170 None Daily T-1 By 12:00 PM EST\nNon-Lending Fund\nState Street MSCI EGERG Non-\n49,067,521 None Daily T-1 By 12:00 PM EST\nLending Fund\nState Street Russell 3000 Index\n334,301,760 None Daily T-1 By 12:00 PM EST\nNL Fund\nUp to 1% of the assets of the Fund - 5 business days.\nGenesis Group Trust for Emp Between 1% and 25% of the assets of the Fund - 5 business days + 1 business\n447,824 None Twice Weekly\nBenefit Plans day per % withdrawn e.g. 20% requires 25 business days\nAbove 25% of the assets of the Fund - 45 business days\nTotal December 31, 2023 $ 655,970,371\n12. Subsequent Events\nSubsequent events were evaluated through September 19, 2025, the date the financial statements are\navailable to be issued.\n18\n\nSupplemental Schedules\nEmployer Identification Number (EIN) : 23-1099050\nPlan Number (PN) : 003\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\n(a) (b) (c) (d) (e)\nIdentity of Issue, Borrower, Lessor or Similar Party. Including\nDescription of Investment Cost Current Value\nMaturity Date, Rate of Interest Collateral, Par or Maturity Value\nForeign Currency - CHF (SWISS FRANC) FOREIGN CURRENCY $ 8 1 $ 7 9\nForeign Currency - GBP (GREAT BRITISH POUNDS) FOREIGN CURRENCY 1 1\n$ 8 2 $ 8 0\nMSCI EAFE INDEX - NL COMMON/COLLECTIVE TRUST $ 6 9 ,944,424 $ 9 3 , 077,909\nDAILY MSCI EMG MKTS INDX NL FUND (ZV86) COMMON/COLLECTIVE TRUST 5 7 ,000,000 6 2 , 565,617\nSSGA RUSSELL 3000 IDX NL FD COMMON/COLLECTIVE TRUST 2 5 6,486,736 3 8 5,338,474\n$ 3 8 3,431,160 $ 5 4 0,982,000\nABBOTT LABORATORIES 2.950% 03/15/2025 DD 03/10/15 CORPORATE DEBT INSTRUMENTS $ 1 , 9 19,558 $ 1 , 7 4 3,980\nABBOTT LABORATORIES 4.900% 11/30/2046 DD 11/22/16 CORPORATE DEBT INSTRUMENTS 1 , 9 39,771 1 , 8 2 6,811\nABBOTT LABORATORIES 4.900% 11/30/2046 DD 11/22/16 CORPORATE DEBT INSTRUMENTS 5 9 1 ,940 5 0 2 , 723\nABBVIE INC 4.050% 11/21/2039 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 9 8 2 ,546 7 4 8 , 396\nABBVIE INC 4.050% 11/21/2039 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 9 5 4 ,912 7 8 6 , 030\nABBVIE INC 4.250% 11/21/2049 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 1 , 1 20,406 9 1 1 , 9 71\nABBVIE INC 4.250% 11/21/2049 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 1 , 2 99,383 1 , 0 1 9,454\nABBVIE INC 4.250% 11/21/2049 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 9 9 0 ,449 7 5 3 , 1 90\nABBVIE INC 4.300% 05/14/2036 DD 05/12/16 CORPORATE DEBT INSTRUMENTS 5 8 6 ,912 5 8 4 , 595\nABBVIE INC 4.400% 11/06/2042 DD 05/06/13 CORPORATE DEBT INSTRUMENTS 1 , 3 36,014 1 , 1 7 0,315\nABBVIE INC 4.450% 05/14/2046 DD 05/12/16 CORPORATE DEBT INSTRUMENTS 6 9 , 9 60 7 6 , 6 0 3\nABBVIE INC 4.550% 03/15/2035 DD 09/15/20 CORPORATE DEBT INSTRUMENTS 3 4 2 ,663 2 7 7 , 433\nABBVIE INC 4.700% 05/14/2045 DD 05/14/15 CORPORATE DEBT INSTRUMENTS 1 , 2 79,386 1 , 1 3 0,867\nABBVIE INC 4.700% 05/14/2045 DD 05/14/15 CORPORATE DEBT INSTRUMENTS 5 7 9 ,112 5 8 6 , 637\nABBVIE INC 4.850% 06/15/2044 DD 06/15/20 CORPORATE DEBT INSTRUMENTS 9 4 1 ,593 7 1 7 , 0 83\nABBVIE INC 4.850% 06/15/2044 DD 06/15/20 CORPORATE DEBT INSTRUMENTS 4 7 6 ,604 3 8 5 , 772\nABBVIE INC 4.875% 11/14/2048 DD 09/18/18 CORPORATE DEBT INSTRUMENTS 6 8 9 ,633 6 2 6 , 749\nABBVIE INC 4.875% 11/14/2048 DD 09/18/18 CORPORATE DEBT INSTRUMENTS 6 4 , 4 95 5 8 , 4 4 9\nABBVIE INC 5.050% 03/15/2034 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 8 8 2 ,212 8 7 5 , 2 12\nABBVIE INC 5.350% 03/15/2044 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 2 3 9 ,669 2 3 4 , 226\nABBVIE INC 5.400% 03/15/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 4 8 3 ,336 4 6 7 , 002\nABBVIE INC 5.400% 03/15/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 1 , 5 03,824 1 , 4 5 3,001\nABBVIE INC 5.500% 03/15/2064 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 3 6 3 ,635 3 4 9 , 294\nABBVIE INC 5.500% 03/15/2064 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 4 3 8 ,354 4 2 1 , 0 67\nADOBE INC 4.950% 04/04/2034 DD 04/04/24 CORPORATE DEBT INSTRUMENTS 9 9 8 ,050 9 9 3 , 1 00\nAEP TEXAS INC 3.950% 06/01/2028 DD 12/01/18 CORPORATE DEBT INSTRUMENTS 1 , 9 28,486 1 , 6 3 7,912\nAEP TRANSMISSION CO LLC 3.650% 04/01/2050 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 1 3 4 ,951 9 7 , 6 6 7\nAEP TRANSMISSION CO LLC 5.400% 03/15/2053 DD 03/13/23 CORPORATE DEBT INSTRUMENTS 2 3 3 ,755 2 2 4 , 1 71\nAERCAP IRELAND CAPITAL DAC / A 3.400% 10/29/2033 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 1 8 , 7 16 1 7 , 0 3 8\nAERCAP IRELAND CAPITAL DAC / A 3.850% 10/29/2041 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 1 , 0 91,281 1 , 1 6 8,041\n20\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nAERCAP IRELAND CAPITAL DAC / A 3.850% 10/29/2041 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 1 , 6 09,399 1 , 5 0 1,207\nAERCAP IRELAND CAPITAL DAC / A 4.950% 09/10/2034 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 4 5 7 ,732 4 4 3 , 2 61\nAERCAP IRELAND CAPITAL DAC / A 5.300% 01/19/2034 DD 01/11/24 CORPORATE DEBT INSTRUMENTS 3 6 6 ,483 3 6 7 , 957\nAGREE LP 2.600% 06/15/2033 DD 05/14/21 CORPORATE DEBT INSTRUMENTS 2 7 7 ,670 2 2 5 , 1 45\nAIA GROUP LTD 144A 5.400% 09/30/2054 DD 09/30/24 CORPORATE DEBT INSTRUMENTS 1 , 1 01,972 1 , 0 2 7,958\nAIB GROUP PLC 144A VAR RT 03/28/2035 DD 03/28/24 CORPORATE DEBT INSTRUMENTS 1 , 1 53,865 1 , 1 5 0,379\nAIR PRODUCTS AND CHEMICALS INC 1.850% 05/15/2027 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 1 , 5 45,682 1 , 3 9 1,141\nAKER BP ASA 144A 5.800% 10/01/2054 DD 10/01/24 CORPORATE DEBT INSTRUMENTS 9 0 2 ,195 8 2 1 , 3 96\nALABAMA POWER CO 3.700% 12/01/2047 DD 11/08/17 CORPORATE DEBT INSTRUMENTS 1 , 5 56,989 1 , 1 6 4,651\nALABAMA POWER CO 4.300% 07/15/2048 DD 06/28/18 CORPORATE DEBT INSTRUMENTS 7 0 4 ,654 5 8 3 , 350\nALABAMA POWER CO 6.000% 03/01/2039 DD 03/06/09 CORPORATE DEBT INSTRUMENTS 2 , 2 28,668 2 , 1 0 7,109\nALCON FINANCE CORP 144A 5.750% 12/06/2052 DD 12/06/22 CORPORATE DEBT INSTRUMENTS 1 , 0 03,630 9 5 8 , 804\nALIMENTATION COUCHE-TARD 144A 5.617% 02/12/2054 DD 02/12/24 CORPORATE DEBT INSTRUMENTS 5 5 7 ,000 5 2 6 , 8 11\nALPHABET INC 2.050% 08/15/2050 DD 08/05/20 CORPORATE DEBT INSTRUMENTS 5 9 1 ,974 5 2 7 , 2 12\nAMAZON.COM INC 1.500% 06/03/2030 DD 06/03/20 CORPORATE DEBT INSTRUMENTS 1 , 9 27,309 1 , 6 3 3,131\nAMAZON.COM INC 2.500% 06/03/2050 DD 06/03/20 CORPORATE DEBT INSTRUMENTS 6 2 1 ,885 4 1 2 , 3 65\nAMAZON.COM INC 2.875% 05/12/2041 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 8 5 7 ,934 8 4 8 , 682\nAMAZON.COM INC 2.875% 05/12/2041 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 3 2 3 ,775 2 3 8 , 807\nAMAZON.COM INC 3.100% 05/12/2051 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 5 6 8 ,595 4 0 1 , 9 11\nAMAZON.COM INC 3.250% 05/12/2061 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 2 , 5 79,233 1 , 7 4 4,073\nAMAZON.COM INC 3.250% 05/12/2061 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 1 , 4 59,618 8 7 1 , 7 11\nAMAZON.COM INC 3.875% 08/22/2037 DD 02/22/18 CORPORATE DEBT INSTRUMENTS 2 5 0 ,355 2 3 8 , 540\nAMAZON.COM INC 3.875% 08/22/2037 DD 02/22/18 CORPORATE DEBT INSTRUMENTS 8 1 4 ,941 7 2 4 , 454\nAMAZON.COM INC 3.950% 04/13/2052 DD 04/13/22 CORPORATE DEBT INSTRUMENTS 2 , 3 44,160 1 , 8 5 9,330\nAMAZON.COM INC 3.950% 04/13/2052 DD 04/13/22 CORPORATE DEBT INSTRUMENTS 6 8 2 ,137 5 4 1 , 0 54\nAMAZON.COM INC 4.050% 08/22/2047 DD 02/22/18 CORPORATE DEBT INSTRUMENTS 7 7 9 ,508 6 4 9 , 383\nAMEREN ILLINOIS CO 1.550% 11/15/2030 DD 11/23/20 CORPORATE DEBT INSTRUMENTS 7 8 6 ,658 6 5 5 , 0 13\nAMEREN ILLINOIS CO 3.700% 12/01/2047 DD 11/28/17 CORPORATE DEBT INSTRUMENTS 8 5 8 ,789 6 5 2 , 1 75\nAMEREN ILLINOIS CO 3.700% 12/01/2047 DD 11/28/17 CORPORATE DEBT INSTRUMENTS 4 3 , 6 14 3 0 , 1 5 8\nAMERICA MOVIL SAB DE CV 6.125% 03/30/2040 DD 03/30/10 CORPORATE DEBT INSTRUMENTS 6 9 8 ,045 6 4 1 , 5 94\nAMERICAN ELECTRIC POWER CO INC 3.250% 03/01/2050 DD 03/05/20 CORPORATE DEBT INSTRUMENTS 8 3 8 ,564 5 4 0 , 322\nAMERICAN ELECTRIC POWER CO INC 3.250% 03/01/2050 DD 03/05/20 CORPORATE DEBT INSTRUMENTS 4 4 , 9 23 2 8 , 9 4 6\nAMERICAN EXPRESS CO VAR RT 05/01/2034 DD 05/01/23 CORPORATE DEBT INSTRUMENTS 1 , 2 48,691 1 , 2 5 7,997\nAMERICAN EXPRESS CO VAR RT 07/26/2035 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 7 4 1 ,085 7 2 2 , 043\nAMERICAN INTERNATIONAL GROUP I 4.800% 07/10/2045 DD 07/10/15 CORPORATE DEBT INSTRUMENTS 8 5 8 ,608 7 7 4 , 279\nAMERICAN TOWER CORP 3.100% 06/15/2050 DD 06/03/20 CORPORATE DEBT INSTRUMENTS 2 7 5 ,324 1 7 3 , 4 05\nAMERICAN WATER CAPITAL CORP 3.450% 05/01/2050 DD 04/14/20 CORPORATE DEBT INSTRUMENTS 7 4 , 8 46 5 1 , 8 5 4\nAMERICAN WATER CAPITAL CORP 3.750% 09/01/2047 DD 08/10/17 CORPORATE DEBT INSTRUMENTS 6 8 , 3 00 4 8 , 2 3 1\nAMGEN INC 2.770% 09/01/2053 DD 03/01/21 CORPORATE DEBT INSTRUMENTS 9 7 1 ,511 5 7 1 , 0 60\nAMGEN INC 3.150% 02/21/2040 DD 02/21/20 CORPORATE DEBT INSTRUMENTS 2 0 8 ,163 1 5 6 , 6 45\nAMGEN INC 3.150% 02/21/2040 DD 02/21/20 CORPORATE DEBT INSTRUMENTS 6 3 7 ,349 4 7 2 , 920\nAMGEN INC 4.400% 05/01/2045 DD 05/01/15 CORPORATE DEBT INSTRUMENTS 1 , 3 82,062 1 , 1 7 1,271\nAMGEN INC 4.400% 05/01/2045 DD 05/01/15 CORPORATE DEBT INSTRUMENTS 4 1 1 ,891 3 7 3 , 545\nAMGEN INC 4.663% 06/15/2051 DD 12/15/16 CORPORATE DEBT INSTRUMENTS 1 , 6 30,827 1 , 3 7 6,419\nAMGEN INC 5.150% 11/15/2041 DD 11/10/11 CORPORATE DEBT INSTRUMENTS 8 1 4 ,169 7 6 4 , 786\n21\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nAMGEN INC 5.600% 03/02/2043 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 7 3 0 ,880 7 1 7 , 1 69\nAMGEN INC 5.650% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 1 , 4 02,977 1 , 3 5 5,305\nAMGEN INC 5.650% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 2 , 8 88,609 2 , 7 6 8,488\nAMGEN INC 5.650% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 7 6 9 ,277 7 5 2 , 4 11\nAMGEN INC 5.750% 03/02/2063 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 4 7 6 ,398 4 5 7 , 078\nAMPHENOL CORP 5.375% 11/15/2054 DD 10/31/24 CORPORATE DEBT INSTRUMENTS 6 2 7 ,977 6 0 7 , 695\nANALOG DEVICES INC 2.800% 10/01/2041 DD 10/05/21 CORPORATE DEBT INSTRUMENTS 4 2 3 ,025 3 0 8 , 097\nANALOG DEVICES INC 2.950% 10/01/2051 DD 10/05/21 CORPORATE DEBT INSTRUMENTS 4 7 7 ,022 3 0 6 , 0 17\nANALOG DEVICES INC 2.950% 10/01/2051 DD 10/05/21 CORPORATE DEBT INSTRUMENTS 4 0 1 ,651 2 5 7 , 665\nANGLO AMERICAN CAPITAL PL 144A 3.950% 09/10/2050 DD 09/10/20 CORPORATE DEBT INSTRUMENTS 1 , 3 73,940 1 , 0 2 8,883\nANGLO AMERICAN CAPITAL PL 144A 3.950% 09/10/2050 DD 09/10/20 CORPORATE DEBT INSTRUMENTS 3 0 1 ,491 2 9 2 , 802\nANGLO AMERICAN CAPITAL PL 144A 4.750% 03/16/2052 DD 03/16/22 CORPORATE DEBT INSTRUMENTS 4 6 8 ,871 4 5 5 , 266\nANGLO AMERICAN CAPITAL PL 144A 5.750% 04/05/2034 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 2 9 6 ,124 2 9 6 , 894\nANGLO AMERICAN CAPITAL PL 144A 6.000% 04/05/2054 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 1 , 0 78,752 1 , 0 5 7,438\nANHEUSER-BUSCH COS LLC / ANHEU 4.700% 02/01/2036 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 2 , 8 19,408 2 , 7 7 2,812\nANHEUSER-BUSCH COS LLC / ANHEU 4.700% 02/01/2036 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 1 , 2 72,348 1 , 2 5 1,320\nANHEUSER-BUSCH COS LLC / ANHEU 4.700% 02/01/2036 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 1 , 7 85,969 1 , 7 0 1,606\nANHEUSER-BUSCH COS LLC / ANHEU 4.900% 02/01/2046 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 2 , 2 15,384 2 , 1 2 5,177\nANHEUSER-BUSCH COS LLC / ANHEU 4.900% 02/01/2046 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 4 , 4 37,872 4 , 0 6 8,326\nANHEUSER-BUSCH COS LLC / ANHEU 4.900% 02/01/2046 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 2 , 3 95,361 2 , 2 0 5,269\nANHEUSER-BUSCH INBEV WORLDWIDE 4.375% 04/15/2038 DD 04/04/18 CORPORATE DEBT INSTRUMENTS 4 6 7 ,445 4 5 2 , 380\nANHEUSER-BUSCH INBEV WORLDWIDE 4.439% 10/06/2048 DD 04/06/17 CORPORATE DEBT INSTRUMENTS 3 1 2 ,059 2 6 1 , 1 32\nANHEUSER-BUSCH INBEV WORLDWIDE 4.439% 10/06/2048 DD 04/06/17 CORPORATE DEBT INSTRUMENTS 9 1 , 6 69 8 9 , 0 2 2\nANHEUSER-BUSCH INBEV WORLDWIDE 4.950% 01/15/2042 DD 07/15/16 CORPORATE DEBT INSTRUMENTS 1 1 6 ,546 9 3 , 0 3 8\nANHEUSER-BUSCH INBEV WORLDWIDE 5.450% 01/23/2039 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 1 , 4 25,971 1 , 4 7 8,894\nANHEUSER-BUSCH INBEV WORLDWIDE 5.450% 01/23/2039 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 9 6 1 ,564 9 4 2 , 482\nANHEUSER-BUSCH INBEV WORLDWIDE 5.550% 01/23/2049 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 7 1 6 ,099 7 1 7 , 9 63\nAPOLLO GLOBAL MANAGEMENT INC 5.800% 05/21/2054 DD 05/21/24 CORPORATE DEBT INSTRUMENTS 6 8 2 ,518 6 8 3 , 563\nAPPALACHIAN POWER CO 4.450% 06/01/2045 DD 05/18/15 CORPORATE DEBT INSTRUMENTS 8 7 3 ,638 7 1 1 , 5 68\nAPPLE INC 1.650% 05/11/2030 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 1 , 9 16,815 1 , 6 3 3,658\nAPPLE INC 2.375% 02/08/2041 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 5 3 3 ,640 3 7 5 , 3 14\nAPPLE INC 2.650% 05/11/2050 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 9 1 , 9 91 9 0 , 3 9 3\nAPPLE INC 2.800% 02/08/2061 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 8 1 6 ,976 7 5 6 , 292\nAPPLE INC 2.850% 08/05/2061 DD 08/05/21 CORPORATE DEBT INSTRUMENTS 1 , 6 77,002 1 , 0 0 8,004\nAPPLE INC 2.950% 09/11/2049 DD 09/11/19 CORPORATE DEBT INSTRUMENTS 1 4 7 ,899 8 6 , 7 6 8\nAPPLE INC 3.750% 09/12/2047 DD 09/12/17 CORPORATE DEBT INSTRUMENTS 9 7 , 5 49 6 3 , 0 0 8\nAPPLE INC 3.850% 05/04/2043 DD 05/03/13 CORPORATE DEBT INSTRUMENTS 1 , 2 69,859 1 , 1 2 8,079\nAPPLE INC 3.850% 05/04/2043 DD 05/03/13 CORPORATE DEBT INSTRUMENTS 8 0 3 ,773 7 1 7 , 4 92\nAPPLE INC 3.850% 08/04/2046 DD 08/04/16 CORPORATE DEBT INSTRUMENTS 1 , 7 13,233 1 , 5 0 3,963\nAPPLE INC 3.850% 08/04/2046 DD 08/04/16 CORPORATE DEBT INSTRUMENTS 4 0 4 ,473 3 1 8 , 8 76\nAPPLE INC 3.850% 08/04/2046 DD 08/04/16 CORPORATE DEBT INSTRUMENTS 8 4 7 ,640 6 9 8 , 297\nAPPLE INC 4.375% 05/13/2045 DD 05/13/15 CORPORATE DEBT INSTRUMENTS 3 7 3 ,630 3 3 1 , 5 07\nAPPLE INC 4.375% 05/13/2045 DD 05/13/15 CORPORATE DEBT INSTRUMENTS 5 5 3 ,349 4 8 1 , 7 91\nAPPLE INC 4.650% 02/23/2046 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 4 9 7 ,115 4 5 8 , 270\nAPPLE INC 4.650% 02/23/2046 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 1 , 6 17,271 1 , 3 6 5,645\n22\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nAPPLIED MATERIALS INC 4.350% 04/01/2047 DD 03/31/17 CORPORATE DEBT INSTRUMENTS 5 5 3 ,984 4 7 0 , 590\nAPTIV SWISS HOLDINGS LTD 3.100% 12/01/2051 DD 11/23/21 CORPORATE DEBT INSTRUMENTS 8 8 3 ,528 8 3 1 , 3 92\nAPTIV SWISS HOLDINGS LTD 4.150% 05/01/2052 DD 02/18/22 CORPORATE DEBT INSTRUMENTS 6 6 7 ,662 4 7 4 , 372\nAPTIV SWISS HOLDINGS LTD 5.400% 03/15/2049 DD 03/14/19 CORPORATE DEBT INSTRUMENTS 8 7 2 ,320 7 3 3 , 552\nARCELORMITTAL SA 6.350% 06/17/2054 DD 06/17/24 CORPORATE DEBT INSTRUMENTS 1 5 8 ,918 1 5 8 , 2 43\nARES FINANCE CO IV LLC 144A 3.650% 02/01/2052 DD 01/21/22 CORPORATE DEBT INSTRUMENTS 2 5 3 ,357 2 0 3 , 3 71\nARTHUR J GALLAGHER & CO 5.550% 02/15/2055 DD 12/19/24 CORPORATE DEBT INSTRUMENTS 6 1 8 ,119 6 0 0 , 354\nARTHUR J GALLAGHER & CO 5.550% 02/15/2055 DD 12/19/24 CORPORATE DEBT INSTRUMENTS 9 6 1 ,808 9 3 1 , 4 18\nARTHUR J GALLAGHER & CO 5.750% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 4 8 5 ,994 4 7 6 , 799\nARTHUR J GALLAGHER & CO 5.750% 07/15/2054 DD 02/15/24 CORPORATE DEBT INSTRUMENTS 6 9 1 ,516 6 9 3 , 1 40\nARTHUR J GALLAGHER & CO 5.750% 07/15/2054 DD 02/15/24 CORPORATE DEBT INSTRUMENTS 1 4 8 ,174 1 4 8 , 5 30\nARTHUR J GALLAGHER & CO 6.750% 02/15/2054 DD 11/02/23 CORPORATE DEBT INSTRUMENTS 4 5 1 ,706 4 8 8 , 022\nASTRAZENECA FINANCE LLC 5.000% 02/26/2034 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 9 1 6 ,633 9 1 0 , 0 73\nASTRAZENECA PLC 6.450% 09/15/2037 DD 09/12/07 CORPORATE DEBT INSTRUMENTS 1 , 3 67,034 1 , 1 9 6,013\nASTRAZENECA PLC 6.450% 09/15/2037 DD 09/12/07 CORPORATE DEBT INSTRUMENTS 7 3 6 ,358 6 0 2 , 396\nAT&T INC 3.500% 06/01/2041 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 5 5 , 8 62 6 1 , 3 6 0\nAT&T INC 3.500% 09/15/2053 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 1 , 2 47,702 1 , 0 2 4,728\nAT&T INC 3.500% 09/15/2053 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 3 , 5 56,622 2 , 8 5 9,268\nAT&T INC 3.500% 09/15/2053 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 6 0 3 ,421 5 7 6 , 0 31\nAT&T INC 3.550% 09/15/2055 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 3 , 2 63,036 2 , 7 0 4,912\nAT&T INC 3.550% 09/15/2055 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 3 , 8 22,620 3 , 2 3 1,861\nAT&T INC 3.650% 06/01/2051 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 1 , 1 43,557 8 1 1 , 6 82\nAT&T INC 3.650% 06/01/2051 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 3 1 8 ,742 3 3 9 , 379\nAT&T INC 3.650% 09/15/2059 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 1 , 4 34,778 1 , 0 7 3,882\nAT&T INC 3.650% 09/15/2059 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 1 , 2 64,383 1 , 0 6 8,569\nAT&T INC 3.800% 12/01/2057 DD 06/01/21 CORPORATE DEBT INSTRUMENTS 5 3 1 ,896 3 4 2 , 905\nAT&T INC 3.800% 12/01/2057 DD 06/01/21 CORPORATE DEBT INSTRUMENTS 2 , 8 90,037 1 , 8 6 3,161\nAT&T INC 3.800% 12/01/2057 DD 06/01/21 CORPORATE DEBT INSTRUMENTS 1 , 3 08,580 9 8 9 , 999\nAT&T INC 4.500% 03/09/2048 DD 09/07/16 CORPORATE DEBT INSTRUMENTS 1 , 9 35,024 1 , 5 6 9,808\nAT&T INC 5.150% 02/15/2050 DD 08/14/18 CORPORATE DEBT INSTRUMENTS 1 , 3 12,094 1 , 1 7 8,174\nATHENE HOLDING LTD VAR RT 10/15/2054 DD 10/10/24 CORPORATE DEBT INSTRUMENTS 7 9 0 ,000 7 8 5 , 584\nAUTOMATIC DATA PROCESSING INC 4.450% 09/09/2034 DD 09/09/24 CORPORATE DEBT INSTRUMENTS 7 9 7 ,128 7 6 2 , 264\nAUTOZONE INC 6.550% 11/01/2033 DD 10/25/23 CORPORATE DEBT INSTRUMENTS 9 7 7 ,423 1 , 0 5 4,745\nAVALONBAY COMMUNITIES INC 2.900% 10/15/2026 DD 10/05/16 CORPORATE DEBT INSTRUMENTS 1 , 9 36,643 1 , 7 4 0,019\nAVALONBAY COMMUNITIES INC 4.350% 04/15/2048 DD 03/26/18 CORPORATE DEBT INSTRUMENTS 1 2 6 ,317 8 2 , 8 4 5\nAVALONBAY COMMUNITIES INC 5.350% 06/01/2034 DD 05/14/24 CORPORATE DEBT INSTRUMENTS 4 9 8 ,485 5 0 2 , 345\nBAE SYSTEMS PLC 144A 5.500% 03/26/2054 DD 03/26/24 CORPORATE DEBT INSTRUMENTS 3 5 8 ,945 3 5 5 , 897\nBAE SYSTEMS PLC 144A 5.800% 10/11/2041 DD 10/11/11 CORPORATE DEBT INSTRUMENTS 5 0 7 ,343 5 1 3 , 6 52\nBAE SYSTEMS PLC 144A 5.800% 10/11/2041 DD 10/11/11 CORPORATE DEBT INSTRUMENTS 1 , 8 36,074 1 , 8 1 7,924\nBALTIMORE GAS AND ELECTRIC CO 2.400% 08/15/2026 DD 08/18/16 CORPORATE DEBT INSTRUMENTS 1 , 9 16,360 1 , 7 3 1,978\nBALTIMORE GAS AND ELECTRIC CO 5.400% 06/01/2053 DD 05/10/23 CORPORATE DEBT INSTRUMENTS 4 9 8 ,070 5 4 8 , 446\nBANK OF AMERICA CORP 6.110% 01/29/2037 DD 01/29/07 CORPORATE DEBT INSTRUMENTS 1 , 1 90,959 1 , 0 5 2,839\nBANK OF AMERICA CORP 7.750% 05/14/2038 DD 05/14/08 CORPORATE DEBT INSTRUMENTS 1 , 9 82,536 1 , 7 5 8,592\nBANK OF AMERICA CORP VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 8 2 1 ,095 8 1 1 , 0 93\nBANK OF AMERICA CORP VAR RT 03/20/2051 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 3 2 9 ,948 3 1 3 , 7 00\n23\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nBANK OF AMERICA CORP VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 2 , 5 37,741 1 , 9 3 1,156\nBANK OF AMERICA CORP VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 1 , 7 11,000 1 , 2 8 0,701\nBANK OF AMERICA CORP VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 3 9 2 ,786 3 1 0 , 6 32\nBANK OF AMERICA CORP VAR RT 04/23/2040 DD 04/23/19 CORPORATE DEBT INSTRUMENTS 3 0 0 ,000 2 5 5 , 246\nBANK OF AMERICA CORP VAR RT 04/24/2038 DD 04/24/17 CORPORATE DEBT INSTRUMENTS 1 , 1 80,000 1 , 0 5 0,436\nBANK OF AMERICA CORP VAR RT 04/24/2038 DD 04/24/17 CORPORATE DEBT INSTRUMENTS 1 , 3 34,580 9 8 7 , 232\nBANK OF AMERICA CORP VAR RT 06/19/2041 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 1 6 3 ,900 1 5 9 , 9 26\nBANK OF AMERICA CORP VAR RT 06/19/2041 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 3 , 5 81,421 3 , 2 5 9,012\nBANK OF AMERICA CORP VAR RT 06/19/2041 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 1 , 3 09,768 9 8 7 , 369\nBANK OF AMERICA CORP VAR RT 08/15/2035 DD 08/15/24 CORPORATE DEBT INSTRUMENTS 1 , 1 10,000 1 , 0 8 3,338\nBANK OF AMERICA CORP VAR RT 09/15/2034 DD 09/15/23 CORPORATE DEBT INSTRUMENTS 6 4 9 ,211 6 6 7 , 5 11\nBANK OF AMERICA CORP VAR RT 10/22/2030 DD 10/22/19 CORPORATE DEBT INSTRUMENTS 1 , 9 05,969 1 , 6 1 1,980\nBANK OF AMERICA CORP VAR RT 10/24/2051 DD 10/21/20 CORPORATE DEBT INSTRUMENTS 5 2 2 ,000 3 2 1 , 3 95\nBANK OF AMERICA NA 6.000% 10/15/2036 DD 10/26/06 CORPORATE DEBT INSTRUMENTS 1 , 8 67,101 1 , 6 6 7,434\n* BANK OF NEW YORK MELLON CORP/T VAR RT 03/14/2035 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 6 8 8 ,779 6 9 3 , 497\n* BANK OF NEW YORK MELLON CORP/T VAR RT 10/25/2033 DD 10/25/22 CORPORATE DEBT INSTRUMENTS 4 5 0 ,000 4 6 6 , 1 01\nBARCLAYS PLC VAR RT 09/10/2035 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 9 7 0 ,000 9 3 1 , 9 18\nBAT CAPITAL CORP 4.390% 08/15/2037 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 1 , 6 58,267 1 , 4 2 4,940\nBAT CAPITAL CORP 4.540% 08/15/2047 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 1 2 1 ,079 1 1 9 , 2 69\nBAT CAPITAL CORP 4.758% 09/06/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 1 1 0 ,000 8 9 , 1 7 4\nBAT CAPITAL CORP 5.650% 03/16/2052 DD 03/16/22 CORPORATE DEBT INSTRUMENTS 1 3 5 ,448 1 3 7 , 5 29\nBAT CAPITAL CORP 7.079% 08/02/2043 DD 08/02/23 CORPORATE DEBT INSTRUMENTS 2 4 5 ,000 2 6 4 , 963\nBAYCARE HEALTH SYSTEM INC 3.831% 11/15/2050 DD 04/16/20 CORPORATE DEBT INSTRUMENTS 4 8 0 ,000 3 6 7 , 838\nBAYCARE HEALTH SYSTEM INC 3.831% 11/15/2050 DD 04/16/20 CORPORATE DEBT INSTRUMENTS 1 3 0 ,000 9 9 , 6 2 3\nBAYER US FINANCE II LLC 144A 4.875% 06/25/2048 DD 06/25/18 CORPORATE DEBT INSTRUMENTS 4 2 , 3 39 3 9 , 0 0 9\nBAYER US FINANCE LLC 144A 6.500% 11/21/2033 DD 11/21/23 CORPORATE DEBT INSTRUMENTS 2 4 6 ,163 2 4 9 , 2 12\nBAYER US FINANCE LLC 144A 6.875% 11/21/2053 DD 11/21/23 CORPORATE DEBT INSTRUMENTS 4 8 1 ,659 4 6 9 , 557\nBAYLOR SCOTT & WHITE HOLDINGS 2.839% 11/15/2050 DD 01/21/21 CORPORATE DEBT INSTRUMENTS 3 4 1 ,149 2 4 8 , 266\nBERKSHIRE HATHAWAY ENERGY CO 4.250% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 4 8 2 ,357 3 8 3 , 475\nBERKSHIRE HATHAWAY ENERGY CO 4.250% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 9 1 9 ,959 7 3 1 , 3 70\nBERKSHIRE HATHAWAY ENERGY CO 4.250% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 1 , 1 25,946 8 2 2 , 297\nBERKSHIRE HATHAWAY ENERGY CO 4.450% 01/15/2049 DD 07/25/18 CORPORATE DEBT INSTRUMENTS 2 0 9 ,933 1 7 3 , 4 85\nBERKSHIRE HATHAWAY ENERGY CO 4.600% 05/01/2053 DD 11/01/22 CORPORATE DEBT INSTRUMENTS 1 5 9 ,438 1 5 3 , 7 41\nBERKSHIRE HATHAWAY ENERGY CO 6.125% 04/01/2036 DD 10/01/06 CORPORATE DEBT INSTRUMENTS 3 5 8 ,183 3 2 3 , 1 33\nBERKSHIRE HATHAWAY FINANCE COR 1.850% 03/12/2030 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 1 , 5 35,043 1 , 2 9 9,906\nBERKSHIRE HATHAWAY FINANCE COR 2.850% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 9 6 , 0 59 8 4 , 8 7 0\nBERKSHIRE HATHAWAY FINANCE COR 3.850% 03/15/2052 DD 03/15/22 CORPORATE DEBT INSTRUMENTS 6 0 2 ,864 4 5 8 , 427\nBERKSHIRE HATHAWAY FINANCE COR 3.850% 03/15/2052 DD 03/15/22 CORPORATE DEBT INSTRUMENTS 5 5 , 6 70 5 3 , 0 4 1\nBERKSHIRE HATHAWAY FINANCE COR 4.200% 08/15/2048 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 5 1 2 ,389 4 2 6 , 744\nBERKSHIRE HATHAWAY FINANCE COR 4.200% 08/15/2048 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 1 , 2 90,226 1 , 3 0 0,949\nBERKSHIRE HATHAWAY FINANCE COR 4.200% 08/15/2048 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 4 2 2 ,845 3 5 2 , 1 68\nBERKSHIRE HATHAWAY FINANCE COR 4.250% 01/15/2049 DD 01/11/19 CORPORATE DEBT INSTRUMENTS 4 9 2 ,141 3 3 1 , 1 51\nBERKSHIRE HATHAWAY FINANCE COR 4.300% 05/15/2043 DD 05/15/13 CORPORATE DEBT INSTRUMENTS 3 1 , 3 57 2 5 , 9 8 1\nBETH ISRAEL LAHEY HEALTH INC 3.080% 07/01/2051 DD 11/16/21 CORPORATE DEBT INSTRUMENTS 9 7 4 ,999 5 9 5 , 276\nBG ENERGY CAPITAL PLC 144A 5.125% 10/15/2041 DD 10/12/11 CORPORATE DEBT INSTRUMENTS 8 2 0 ,671 7 7 9 , 1 64\n24\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nBHP BILLITON FINANCE USA LTD 5.000% 09/30/2043 DD 09/30/13 CORPORATE DEBT INSTRUMENTS 1 , 0 31,498 8 1 7 , 3 47\nBHP BILLITON FINANCE USA LTD 5.500% 09/08/2053 DD 09/08/23 CORPORATE DEBT INSTRUMENTS 4 3 4 ,580 4 2 5 , 256\nBHP BILLITON FINANCE USA LTD 5.500% 09/08/2053 DD 09/08/23 CORPORATE DEBT INSTRUMENTS 5 6 4 ,644 5 6 2 , 1 20\nBIOGEN INC 3.250% 02/15/2051 DD 02/15/22 CORPORATE DEBT INSTRUMENTS 4 0 1 ,570 2 5 7 , 048\nBLACKROCK FUNDING INC 5.250% 03/14/2054 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 5 2 4 ,301 5 0 1 , 4 81\nBLACKROCK FUNDING INC 5.250% 03/14/2054 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 4 2 9 ,828 4 1 1 , 5 93\nBLACKROCK FUNDING INC 5.350% 01/08/2055 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 8 2 0 ,993 7 8 4 , 289\nBLACKROCK FUNDING INC 5.350% 01/08/2055 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 4 1 9 ,291 4 0 1 , 7 09\nBLACKSTONE HOLDINGS FINAN 144A 6.250% 08/15/2042 DD 08/17/12 CORPORATE DEBT INSTRUMENTS 1 , 0 44,135 1 , 0 0 2,070\nBMW US CAPITAL LLC 144A 5.150% 04/02/2034 DD 04/02/24 CORPORATE DEBT INSTRUMENTS 6 9 4 ,944 6 8 4 , 735\nBOEING CO/THE 3.600% 05/01/2034 DD 05/02/19 CORPORATE DEBT INSTRUMENTS 7 5 , 1 03 6 2 , 7 8 5\nBOEING CO/THE 3.750% 02/01/2050 DD 07/31/19 CORPORATE DEBT INSTRUMENTS 2 1 9 ,422 1 5 0 , 5 94\nBOEING CO/THE 3.750% 02/01/2050 DD 07/31/19 CORPORATE DEBT INSTRUMENTS 4 0 2 ,792 4 2 0 , 980\nBOEING CO/THE 3.850% 11/01/2048 DD 10/31/18 CORPORATE DEBT INSTRUMENTS 4 5 7 ,332 3 3 6 , 434\nBOEING CO/THE 5.705% 05/01/2040 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 8 0 0 ,000 7 6 1 , 8 00\nBOEING CO/THE 5.705% 05/01/2040 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 2 , 9 21,379 2 , 7 7 1,047\nBOEING CO/THE 5.805% 05/01/2050 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 5 4 5 ,000 5 0 5 , 896\nBOEING CO/THE 5.805% 05/01/2050 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 2 , 2 15,840 1 , 8 8 3,419\nBOEING CO/THE 5.805% 05/01/2050 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 2 , 4 91,795 2 , 1 1 6,410\nBOEING CO/THE 5.930% 05/01/2060 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 3 7 2 ,479 2 5 4 , 856\nBOEING CO/THE 6.625% 02/15/2038 DD 02/24/98 CORPORATE DEBT INSTRUMENTS 4 5 4 ,427 3 5 8 , 3 31\nBOEING CO/THE 6.858% 05/01/2054 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 3 2 0 ,000 3 4 0 , 774\nBOEING CO/THE 6.858% 05/01/2054 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 3 0 3 ,854 3 1 9 , 4 76\nBOEING CO/THE 7.008% 05/01/2064 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 4 1 5 ,754 4 1 9 , 8 81\nBP CAPITAL MARKETS AMERICA INC 2.939% 06/04/2051 DD 12/04/20 CORPORATE DEBT INSTRUMENTS 3 6 4 ,157 2 5 7 , 375\nBP CAPITAL MARKETS AMERICA INC 3.000% 02/24/2050 DD 02/24/20 CORPORATE DEBT INSTRUMENTS 1 6 6 ,403 1 1 2 , 7 19\nBP CAPITAL MARKETS AMERICA INC 3.001% 03/17/2052 DD 09/17/21 CORPORATE DEBT INSTRUMENTS 6 2 8 ,253 4 1 5 , 8 11\nBP CAPITAL MARKETS AMERICA INC 3.060% 06/17/2041 DD 06/17/21 CORPORATE DEBT INSTRUMENTS 7 6 2 ,128 6 3 1 , 8 99\nBP CAPITAL MARKETS AMERICA INC 3.379% 02/08/2061 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 2 , 3 92,481 1 , 5 3 1,738\nBP CAPITAL MARKETS AMERICA INC 3.379% 02/08/2061 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 2 , 1 10,918 1 , 6 3 0,048\nBP CAPITAL MARKETS AMERICA INC 3.543% 04/06/2027 DD 04/06/20 CORPORATE DEBT INSTRUMENTS 1 , 5 27,163 1 , 3 4 7,625\nBRISTOL-MYERS SQUIBB CO 3.700% 03/15/2052 DD 03/02/22 CORPORATE DEBT INSTRUMENTS 1 , 2 39,006 9 4 4 , 029\nBRISTOL-MYERS SQUIBB CO 4.250% 10/26/2049 DD 04/26/20 CORPORATE DEBT INSTRUMENTS 9 4 4 ,045 7 3 2 , 426\nBRISTOL-MYERS SQUIBB CO 4.350% 11/15/2047 DD 05/15/20 CORPORATE DEBT INSTRUMENTS 1 , 8 03,705 1 , 2 3 9,720\nBRISTOL-MYERS SQUIBB CO 5.900% 11/15/2033 DD 11/13/23 CORPORATE DEBT INSTRUMENTS 8 5 7 ,432 8 3 9 , 936\nBRISTOL-MYERS SQUIBB CO 6.400% 11/15/2063 DD 11/13/23 CORPORATE DEBT INSTRUMENTS 8 4 8 ,343 9 0 1 , 4 12\nBROADCOM INC 144A 3.137% 11/15/2035 DD 09/30/21 CORPORATE DEBT INSTRUMENTS 3 7 7 ,079 4 3 2 , 920\nBROADCOM INC 144A 3.500% 02/15/2041 DD 01/19/21 CORPORATE DEBT INSTRUMENTS 7 4 5 ,201 7 2 6 , 572\nBROADCOM INC 144A 3.500% 02/15/2041 DD 01/19/21 CORPORATE DEBT INSTRUMENTS 5 0 4 ,556 4 0 6 , 255\nBROADCOM INC 144A 3.750% 02/15/2051 DD 01/19/21 CORPORATE DEBT INSTRUMENTS 2 , 2 54,159 1 , 7 3 0,445\nBROADCOM INC 4.800% 10/15/2034 DD 10/02/24 CORPORATE DEBT INSTRUMENTS 6 2 3 ,706 6 0 3 , 1 81\nBROOKFIELD FINANCE INC 5.968% 03/04/2054 DD 03/04/24 CORPORATE DEBT INSTRUMENTS 8 7 8 ,000 8 8 8 , 685\nBROOKFIELD FINANCE INC 5.968% 03/04/2054 DD 03/04/24 CORPORATE DEBT INSTRUMENTS 2 2 8 ,778 2 2 7 , 738\nBROWN-FORMAN CORP 4.000% 04/15/2038 DD 03/26/18 CORPORATE DEBT INSTRUMENTS 7 0 6 ,872 6 9 8 , 224\nBURLINGTON NORTHERN SANTA FE L 2.875% 06/15/2052 DD 12/08/21 CORPORATE DEBT INSTRUMENTS 4 1 1 ,180 2 5 5 , 598\n25\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nBURLINGTON NORTHERN SANTA FE L 4.150% 04/01/2045 DD 03/09/15 CORPORATE DEBT INSTRUMENTS 3 2 4 ,738 2 4 6 , 9 21\nBURLINGTON NORTHERN SANTA FE L 4.450% 01/15/2053 DD 06/07/22 CORPORATE DEBT INSTRUMENTS 7 3 2 ,924 6 1 8 , 2 10\nBURLINGTON NORTHERN SANTA FE L 4.450% 03/15/2043 DD 03/12/13 CORPORATE DEBT INSTRUMENTS 3 , 5 76,241 3 , 1 5 4,511\nBURLINGTON NORTHERN SANTA FE L 4.550% 09/01/2044 DD 08/18/14 CORPORATE DEBT INSTRUMENTS 2 2 7 ,854 1 7 0 , 0 63\nBURLINGTON NORTHERN SANTA FE L 4.900% 04/01/2044 DD 03/07/14 CORPORATE DEBT INSTRUMENTS 4 1 4 ,137 3 8 0 , 6 17\nBURLINGTON NORTHERN SANTA FE L 5.150% 09/01/2043 DD 08/22/13 CORPORATE DEBT INSTRUMENTS 3 3 5 ,408 3 0 6 , 570\nBURLINGTON NORTHERN SANTA FE L 5.200% 04/15/2054 DD 06/09/23 CORPORATE DEBT INSTRUMENTS 5 8 , 6 18 5 6 , 5 9 0\nBURLINGTON NORTHERN SANTA FE L 5.500% 03/15/2055 DD 06/07/24 CORPORATE DEBT INSTRUMENTS 3 4 8 ,144 3 4 4 , 886\nBURLINGTON NORTHERN SANTA FE L 6.150% 05/01/2037 DD 04/13/07 CORPORATE DEBT INSTRUMENTS 6 0 4 ,957 5 4 5 , 1 29\nBURLINGTON NORTHERN SANTA FE L 6.150% 05/01/2037 DD 04/13/07 CORPORATE DEBT INSTRUMENTS 4 9 1 ,324 4 8 0 , 996\nBURLINGTON NORTHERN SANTA FE L 6.200% 08/15/2036 DD 08/17/06 CORPORATE DEBT INSTRUMENTS 2 , 3 56,215 2 , 4 0 8,212\nBX COMMERCIAL MORT VLT5 A 144A VAR RT 11/13/2046 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 5 9 3 ,775 5 8 5 , 047\nCAMDEN PROPERTY TRUST 2.800% 05/15/2030 DD 04/20/20 CORPORATE DEBT INSTRUMENTS 1 , 5 46,610 1 , 2 7 8,667\nCAMDEN PROPERTY TRUST 3.350% 11/01/2049 DD 10/07/19 CORPORATE DEBT INSTRUMENTS 8 3 4 ,507 5 7 5 , 290\nCAMERON LNG LLC 144A 3.701% 01/15/2039 DD 12/13/19 CORPORATE DEBT INSTRUMENTS 1 , 2 59,000 1 , 0 1 5,157\nCANADIAN NATIONAL RAILWAY CO 2.750% 03/01/2026 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 1 , 6 37,430 1 , 4 6 9,940\nCANADIAN NATIONAL RAILWAY CO 6.200% 06/01/2036 DD 05/31/06 CORPORATE DEBT INSTRUMENTS 1 , 8 99,401 1 , 6 6 4,690\nCANADIAN NATURAL RESOURCES LTD 4.950% 06/01/2047 DD 05/30/17 CORPORATE DEBT INSTRUMENTS 1 , 2 34,387 1 , 0 5 8,333\nCANADIAN PACIFIC RAILWAY CO 3.000% 12/02/2041 DD 12/02/21 CORPORATE DEBT INSTRUMENTS 1 2 7 ,432 9 4 , 4 7 4\nCANADIAN PACIFIC RAILWAY CO 3.100% 12/02/2051 DD 12/02/21 CORPORATE DEBT INSTRUMENTS 2 9 6 ,875 2 1 4 , 9 09\nCANADIAN PACIFIC RAILWAY CO 4.200% 11/15/2069 DD 04/19/23 CORPORATE DEBT INSTRUMENTS 8 3 3 ,342 7 5 9 , 462\nCANADIAN PACIFIC RAILWAY CO 6.125% 09/15/2115 DD 09/11/15 CORPORATE DEBT INSTRUMENTS 7 4 1 ,274 7 2 7 , 633\nCANADIAN PACIFIC RAILWAY CO 6.125% 09/15/2115 DD 09/11/15 CORPORATE DEBT INSTRUMENTS 2 6 0 ,000 2 6 0 , 585\nCAPITAL ONE FINANCIAL CORP VAR RT 07/26/2035 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 1 8 7 ,127 1 8 1 , 0 96\nCARGILL INC 144A 0.750% 02/02/2026 DD 02/02/21 CORPORATE DEBT INSTRUMENTS 4 8 8 ,125 5 2 8 , 550\nCARLYLE HOLDINGS II FINAN 144A 5.625% 03/30/2043 DD 03/28/13 CORPORATE DEBT INSTRUMENTS 8 4 1 ,384 8 0 8 , 645\nCARRIER GLOBAL CORP 3.377% 04/05/2040 DD 10/05/20 CORPORATE DEBT INSTRUMENTS 6 4 9 ,384 5 2 9 , 560\nCATERPILLAR INC 2.600% 09/19/2029 DD 09/19/19 CORPORATE DEBT INSTRUMENTS 1 , 9 05,476 1 , 6 0 8,003\nCATERPILLAR INC 3.250% 09/19/2049 DD 09/19/19 CORPORATE DEBT INSTRUMENTS 1 , 4 03,114 9 8 4 , 446\nCATERPILLAR INC 3.803% 08/15/2042 DD 08/15/12 CORPORATE DEBT INSTRUMENTS 8 2 4 ,517 6 8 7 , 222\nCATERPILLAR INC 3.803% 08/15/2042 DD 08/15/12 CORPORATE DEBT INSTRUMENTS 8 8 1 ,625 6 9 1 , 2 88\nCELANESE US HOLDINGS LLC VAR RT 11/15/2033 DD 08/24/23 CORPORATE DEBT INSTRUMENTS 5 1 4 ,493 4 9 3 , 254\nCENTERPOINT ENERGY HOUSTON ELE 3.600% 03/01/2052 DD 02/28/22 CORPORATE DEBT INSTRUMENTS 2 4 1 ,808 1 7 5 , 3 34\nCENTERPOINT ENERGY HOUSTON ELE 4.250% 02/01/2049 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 5 4 6 ,661 4 4 4 , 339\nCENTERPOINT ENERGY HOUSTON ELE 4.950% 04/01/2033 DD 03/23/23 CORPORATE DEBT INSTRUMENTS 7 6 0 ,244 7 3 3 , 042\nCENTERPOINT ENERGY INC 3.700% 09/01/2049 DD 08/14/19 CORPORATE DEBT INSTRUMENTS 9 6 , 1 40 6 4 , 0 8 6\nCENTERPOINT ENERGY RESOURCES C 4.400% 07/01/2032 DD 06/09/22 CORPORATE DEBT INSTRUMENTS 2 3 9 ,779 2 2 7 , 330\nCHARLES SCHWAB CORP/THE 4.625% 03/22/2030 DD 03/24/20 CORPORATE DEBT INSTRUMENTS 8 8 4 ,625 6 9 8 , 096\nCHARLES SCHWAB CORP/THE VAR RT 05/19/2034 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 4 8 0 ,000 4 9 4 , 534\nCHARTER COMMUNICATIONS OPERATI 3.500% 06/01/2041 DD 03/04/21 CORPORATE DEBT INSTRUMENTS 3 2 8 ,490 2 3 6 , 632\nCHARTER COMMUNICATIONS OPERATI 3.700% 04/01/2051 DD 04/17/20 CORPORATE DEBT INSTRUMENTS 1 5 2 ,714 1 5 3 , 2 79\nCHARTER COMMUNICATIONS OPERATI 3.850% 04/01/2061 DD 12/04/20 CORPORATE DEBT INSTRUMENTS 2 , 3 47,814 1 , 4 4 2,556\nCHARTER COMMUNICATIONS OPERATI 3.900% 06/01/2052 DD 03/04/21 CORPORATE DEBT INSTRUMENTS 8 4 6 ,314 8 0 0 , 572\nCHARTER COMMUNICATIONS OPERATI 4.400% 12/01/2061 DD 06/02/21 CORPORATE DEBT INSTRUMENTS 9 9 5 ,064 6 6 4 , 432\nCHARTER COMMUNICATIONS OPERATI 4.800% 03/01/2050 DD 10/24/19 CORPORATE DEBT INSTRUMENTS 1 4 9 ,109 1 4 6 , 7 88\n26\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nCHARTER COMMUNICATIONS OPERATI 5.125% 07/01/2049 DD 07/10/19 CORPORATE DEBT INSTRUMENTS 5 2 5 ,643 5 2 3 , 009\nCHARTER COMMUNICATIONS OPERATI 5.375% 05/01/2047 DD 11/01/17 CORPORATE DEBT INSTRUMENTS 2 , 7 56,637 2 , 2 5 8,771\nCHARTER COMMUNICATIONS OPERATI 5.375% 05/01/2047 DD 11/01/17 CORPORATE DEBT INSTRUMENTS 1 3 5 ,744 1 3 9 , 6 84\nCHARTER COMMUNICATIONS OPERATI 5.750% 04/01/2048 DD 04/17/18 CORPORATE DEBT INSTRUMENTS 9 1 6 ,020 8 5 9 , 908\nCHARTER COMMUNICATIONS OPERATI 6.484% 10/23/2045 DD 10/23/16 CORPORATE DEBT INSTRUMENTS 2 8 5 ,000 2 6 9 , 539\nCHARTER COMMUNICATIONS OPERATI 6.484% 10/23/2045 DD 10/23/16 CORPORATE DEBT INSTRUMENTS 1 , 8 13,841 1 , 4 4 6,997\nCHEVRON CORP 1.995% 05/11/2027 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 1 , 5 31,684 1 , 3 9 4,288\nCHEVRON CORP 3.078% 05/11/2050 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 7 9 5 ,000 5 2 6 , 982\nCHUBB INA HOLDINGS LLC 3.050% 12/15/2061 DD 11/18/21 CORPORATE DEBT INSTRUMENTS 7 7 8 ,670 4 7 6 , 5 18\nCHUBB INA HOLDINGS LLC 3.150% 03/15/2025 DD 03/16/15 CORPORATE DEBT INSTRUMENTS 2 , 3 00,225 2 , 0 8 8,086\nCIGNA GROUP/THE 3.400% 03/15/2050 DD 03/16/20 CORPORATE DEBT INSTRUMENTS 1 0 4 ,280 7 2 , 4 3 4\nCIGNA GROUP/THE 3.400% 03/15/2051 DD 03/03/21 CORPORATE DEBT INSTRUMENTS 2 , 1 88,076 1 , 4 3 7,348\nCIGNA GROUP/THE 4.800% 07/15/2046 DD 01/15/20 CORPORATE DEBT INSTRUMENTS 2 , 1 29,076 1 , 6 3 6,968\nCIGNA GROUP/THE 4.900% 12/15/2048 DD 06/15/19 CORPORATE DEBT INSTRUMENTS 9 , 1 6 5 8 , 5 3 3\nCIGNA GROUP/THE 5.600% 02/15/2054 DD 02/13/24 CORPORATE DEBT INSTRUMENTS 3 5 9 ,818 3 4 6 , 979\nCINCINNATI FINANCIAL CORP 6.125% 11/01/2034 DD 11/01/04 CORPORATE DEBT INSTRUMENTS 8 5 0 ,524 8 0 3 , 1 16\nCISCO SYSTEMS INC 3.500% 06/15/2025 DD 06/17/15 CORPORATE DEBT INSTRUMENTS 1 , 9 39,949 1 , 6 9 7,788\nCISCO SYSTEMS INC 5.300% 02/26/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 1 1 9 ,518 1 1 6 , 7 32\nCISCO SYSTEMS INC 5.300% 02/26/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 3 1 9 ,710 3 1 2 , 2 59\nCISCO SYSTEMS INC 5.300% 02/26/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 5 2 8 ,446 5 1 5 , 5 68\nCISCO SYSTEMS INC 5.900% 02/15/2039 DD 02/17/09 CORPORATE DEBT INSTRUMENTS 1 , 0 14,678 9 4 0 , 952\nCISCO SYSTEMS INC 5.900% 02/15/2039 DD 02/17/09 CORPORATE DEBT INSTRUMENTS 1 , 3 20,120 1 , 2 1 3,723\nCITIGROUP INC 4.650% 07/23/2048 DD 07/23/18 CORPORATE DEBT INSTRUMENTS 2 9 1 ,846 2 4 4 , 6 15\nCITIGROUP INC 6.675% 09/13/2043 DD 09/13/13 CORPORATE DEBT INSTRUMENTS 1 , 3 25,204 1 , 1 4 0,316\nCITIGROUP INC 8.125% 07/15/2039 DD 07/23/09 CORPORATE DEBT INSTRUMENTS 2 , 8 13,919 2 , 8 4 0,546\nCITIGROUP INC VAR RT 02/13/2035 DD 02/13/24 CORPORATE DEBT INSTRUMENTS 7 2 6 ,628 7 2 2 , 4 91\nCITIGROUP INC VAR RT 03/20/2030 DD 03/20/19 CORPORATE DEBT INSTRUMENTS 1 , 5 17,441 1 , 2 7 4,912\nCITIGROUP INC VAR RT 03/26/2041 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 1 , 0 00,000 9 6 3 , 500\nCITIGROUP INC VAR RT 04/24/2048 DD 04/25/17 CORPORATE DEBT INSTRUMENTS 2 , 4 86,178 1 , 8 2 4,205\nCITIGROUP INC VAR RT 06/11/2035 DD 06/11/24 CORPORATE DEBT INSTRUMENTS 3 1 5 ,000 3 1 2 , 4 74\nCITIGROUP INC VAR RT 09/19/2039 DD 09/19/24 CORPORATE DEBT INSTRUMENTS 3 9 5 ,000 3 7 6 , 692\nCITIGROUP INC VAR RT 11/03/2042 DD 11/03/21 CORPORATE DEBT INSTRUMENTS 4 1 5 ,000 2 9 0 , 969\nCLEVELAND CLINIC FOUNDATION/TH 4.858% 01/01/2114 DD 09/18/14 CORPORATE DEBT INSTRUMENTS 5 1 8 ,000 4 3 1 , 3 59\nCME GROUP INC 3.000% 03/15/2025 DD 03/09/15 CORPORATE DEBT INSTRUMENTS 1 , 9 17,614 1 , 7 4 3,752\nCOCA-COLA CO/THE 1.650% 06/01/2030 DD 05/01/20 CORPORATE DEBT INSTRUMENTS 1 , 9 08,872 1 , 6 3 3,035\nCOCA-COLA CO/THE 2.500% 03/15/2051 DD 09/18/20 CORPORATE DEBT INSTRUMENTS 6 4 1 ,040 3 7 8 , 802\nCOCA-COLA CO/THE 2.500% 06/01/2040 DD 05/01/20 CORPORATE DEBT INSTRUMENTS 9 0 4 ,756 6 4 4 , 846\nCOCA-COLA CO/THE 5.200% 01/14/2055 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 7 9 4 ,221 7 5 6 , 0 13\nCOCA-COLA CO/THE 5.300% 05/13/2054 DD 05/13/24 CORPORATE DEBT INSTRUMENTS 3 5 , 6 79 3 3 , 8 1 9\nCOCA-COLA CO/THE 5.400% 05/13/2064 DD 05/13/24 CORPORATE DEBT INSTRUMENTS 3 2 2 ,269 3 0 8 , 480\nCOCA-COLA CO/THE 5.400% 05/13/2064 DD 05/13/24 CORPORATE DEBT INSTRUMENTS 7 6 7 ,092 7 1 8 , 1 80\nCOLUMBIA PIPELINE GROUP INC 5.800% 06/01/2045 DD 12/01/15 CORPORATE DEBT INSTRUMENTS 2 0 3 ,009 1 9 2 , 9 14\nCOLUMBIA PIPELINES OPERAT 144A 6.544% 11/15/2053 DD 08/08/23 CORPORATE DEBT INSTRUMENTS 9 7 6 ,590 1 , 0 2 5,371\nCOMCAST CORP 1.950% 01/15/2031 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 1 , 9 20,748 1 , 5 8 9,559\nCOMCAST CORP 2.887% 11/01/2051 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 3 , 2 97,211 2 , 0 7 2,341\n27\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nCOMCAST CORP 2.887% 11/01/2051 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 6 7 5 ,100 4 3 9 , 295\nCOMCAST CORP 2.937% 11/01/2056 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 1 , 9 63,341 1 , 1 7 0,052\nCOMCAST CORP 2.937% 11/01/2056 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 1 , 7 57,980 1 , 1 7 3,557\nCOMCAST CORP 2.987% 11/01/2063 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 2 , 1 19,388 1 , 2 1 8,265\nCOMCAST CORP 2.987% 11/01/2063 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 2 , 8 92,390 1 , 6 7 1,651\nCOMCAST CORP 2.987% 11/01/2063 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 4 3 2 ,485 2 6 8 , 527\nCOMCAST CORP 3.450% 02/01/2050 DD 11/05/19 CORPORATE DEBT INSTRUMENTS 5 9 , 1 20 5 4 , 8 7 8\nCOMCAST CORP 3.750% 04/01/2040 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 1 , 7 34,206 1 , 6 1 4,125\nCOMCAST CORP 3.900% 03/01/2038 DD 02/08/18 CORPORATE DEBT INSTRUMENTS 6 5 0 ,754 5 3 4 , 365\nCOMCAST CORP 3.969% 11/01/2047 DD 10/19/17 CORPORATE DEBT INSTRUMENTS 8 0 3 ,405 5 9 7 , 572\nCOMCAST CORP 4.049% 11/01/2052 DD 10/19/17 CORPORATE DEBT INSTRUMENTS 3 7 3 ,344 2 9 9 , 734\nCOMCAST CORP 4.049% 11/01/2052 DD 10/19/17 CORPORATE DEBT INSTRUMENTS 2 , 6 52,390 1 , 9 2 7,936\nCOMCAST CORP 4.400% 08/15/2035 DD 05/27/15 CORPORATE DEBT INSTRUMENTS 2 6 9 ,834 2 4 8 , 953\nCOMCAST CORP 5.500% 05/15/2064 DD 05/09/23 CORPORATE DEBT INSTRUMENTS 9 8 0 ,371 9 2 0 , 1 97\nCOMCAST CORP 5.500% 05/15/2064 DD 05/09/23 CORPORATE DEBT INSTRUMENTS 8 5 , 5 15 7 9 , 4 0 8\nCOMMONSPIRIT HEALTH 4.350% 11/01/2042 DD 10/31/12 CORPORATE DEBT INSTRUMENTS 8 1 6 ,544 7 1 3 , 9 27\nCOMMONWEALTH EDISON CO 3.000% 03/01/2050 DD 02/25/20 CORPORATE DEBT INSTRUMENTS 5 2 4 ,784 3 3 9 , 076\nCOMMONWEALTH EDISON CO 3.125% 03/15/2051 DD 03/09/21 CORPORATE DEBT INSTRUMENTS 7 4 3 ,987 4 8 3 , 378\nCOMMONWEALTH EDISON CO 3.650% 06/15/2046 DD 06/27/16 CORPORATE DEBT INSTRUMENTS 3 7 , 4 28 2 6 , 1 6 2\nCOMMONWEALTH EDISON CO 3.850% 03/15/2052 DD 03/15/22 CORPORATE DEBT INSTRUMENTS 2 5 4 ,549 1 8 8 , 9 22\nCOMMONWEALTH EDISON CO 4.000% 03/01/2049 DD 02/19/19 CORPORATE DEBT INSTRUMENTS 2 0 8 ,290 1 6 1 , 9 20\nCONNECTICUT LIGHT AND POWER CO 4.000% 04/01/2048 DD 03/28/18 CORPORATE DEBT INSTRUMENTS 8 1 3 ,020 6 3 9 , 865\nCONOCOPHILLIPS CO 3.800% 03/15/2052 DD 03/08/22 CORPORATE DEBT INSTRUMENTS 5 2 8 ,975 4 0 2 , 1 71\nCONOCOPHILLIPS CO 4.025% 03/15/2062 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 2 , 3 02,133 1 , 7 0 7,413\nCONOCOPHILLIPS CO 4.025% 03/15/2062 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 3 8 0 ,437 2 8 2 , 1 57\nCONOCOPHILLIPS CO 5.300% 05/15/2053 DD 05/23/23 CORPORATE DEBT INSTRUMENTS 1 0 7 ,307 1 0 1 , 8 76\nCONOCOPHILLIPS CO 5.500% 01/15/2055 DD 12/05/24 CORPORATE DEBT INSTRUMENTS 1 , 2 25,251 1 , 1 6 0,366\nCONOCOPHILLIPS CO 5.550% 03/15/2054 DD 08/17/23 CORPORATE DEBT INSTRUMENTS 2 7 4 ,299 2 6 5 , 339\nCONOCOPHILLIPS CO 5.650% 01/15/2065 DD 12/05/24 CORPORATE DEBT INSTRUMENTS 1 , 3 94,414 1 , 3 1 9,349\nCONOCOPHILLIPS CO 5.650% 01/15/2065 DD 12/05/24 CORPORATE DEBT INSTRUMENTS 2 4 4 ,897 2 3 1 , 7 14\nCONOCOPHILLIPS CO 5.700% 09/15/2063 DD 08/17/23 CORPORATE DEBT INSTRUMENTS 3 0 4 ,167 2 9 2 , 937\nCONSOLIDATED EDISON CO OF NEW 3.875% 06/15/2047 DD 06/08/17 CORPORATE DEBT INSTRUMENTS 2 3 1 ,142 1 7 7 , 0 67\nCONSOLIDATED EDISON CO OF NEW 3.950% 03/01/2043 DD 02/28/13 CORPORATE DEBT INSTRUMENTS 2 , 1 20,140 1 , 7 0 9,879\nCONSOLIDATED EDISON CO OF NEW 4.625% 12/01/2054 DD 11/24/14 CORPORATE DEBT INSTRUMENTS 9 9 0 ,407 8 4 8 , 097\nCONSOLIDATED EDISON CO OF NEW 5.500% 03/15/2055 DD 11/18/24 CORPORATE DEBT INSTRUMENTS 6 5 3 ,687 6 1 5 , 5 46\nCONSOLIDATED EDISON CO OF NEW 5.900% 11/15/2053 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 5 7 3 ,702 5 8 7 , 477\nCONSOLIDATED EDISON CO OF NEW 5.900% 11/15/2053 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 9 9 5 ,685 1 , 0 1 4,640\nCONSOLIDATED EDISON CO OF NEW 6.150% 11/15/2052 DD 11/14/22 CORPORATE DEBT INSTRUMENTS 1 , 2 89,785 1 , 3 0 6,354\nCONSOLIDATED EDISON CO OF NEW 6.150% 11/15/2052 DD 11/14/22 CORPORATE DEBT INSTRUMENTS 3 3 4 ,231 3 4 6 , 262\nCONSOLIDATED EDISON CO OF NEW 6.300% 08/15/2037 DD 08/28/07 CORPORATE DEBT INSTRUMENTS 5 3 3 ,325 5 3 0 , 880\nCONSTELLATION BRANDS INC 4.100% 02/15/2048 DD 02/07/18 CORPORATE DEBT INSTRUMENTS 1 4 6 ,646 1 2 0 , 3 68\nCONSTELLATION BRANDS INC 4.500% 05/09/2047 DD 05/09/17 CORPORATE DEBT INSTRUMENTS 2 3 8 ,942 1 9 8 , 4 51\nCONSTELLATION BRANDS INC 5.250% 11/15/2048 DD 10/29/18 CORPORATE DEBT INSTRUMENTS 3 1 5 ,790 2 7 4 , 287\nCONSTELLATION ENERGY GENERATIO 6.250% 10/01/2039 DD 09/23/09 CORPORATE DEBT INSTRUMENTS 9 8 3 ,079 9 6 5 , 1 08\nCONSTELLATION ENERGY GENERATIO 6.250% 10/01/2039 DD 09/23/09 CORPORATE DEBT INSTRUMENTS 6 5 6 ,770 5 6 4 , 458\n28\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nCONSTELLATION ENERGY GENERATIO 6.500% 10/01/2053 DD 09/29/23 CORPORATE DEBT INSTRUMENTS 2 3 6 ,068 2 6 5 , 845\nCONSUMERS ENERGY CO 2.500% 05/01/2060 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 3 1 2 ,464 1 8 2 , 1 07\nCONSUMERS ENERGY CO 3.100% 08/15/2050 DD 09/03/19 CORPORATE DEBT INSTRUMENTS 7 9 5 ,321 5 4 1 , 7 96\nCONSUMERS ENERGY CO 3.500% 08/01/2051 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 2 2 9 ,094 1 6 7 , 6 38\nCONSUMERS ENERGY CO 4.200% 09/01/2052 DD 08/11/22 CORPORATE DEBT INSTRUMENTS 2 2 4 ,839 1 8 1 , 5 52\nCONSUMERS ENERGY CO 4.200% 09/01/2052 DD 08/11/22 CORPORATE DEBT INSTRUMENTS 1 5 9 ,886 1 2 9 , 1 04\nCONSUMERS ENERGY CO 4.350% 04/15/2049 DD 11/13/18 CORPORATE DEBT INSTRUMENTS 6 2 7 ,593 5 2 4 , 204\nCONSUMERS ENERGY CO 4.625% 05/15/2033 DD 02/23/23 CORPORATE DEBT INSTRUMENTS 9 9 4 ,510 9 6 4 , 790\nCOOPERATIEVE RABOBANK UA 144A VAR RT 12/15/2027 DD 12/15/21 CORPORATE DEBT INSTRUMENTS 7 0 0 ,000 6 6 3 , 068\nCORNING INC 5.450% 11/15/2079 DD 11/19/19 CORPORATE DEBT INSTRUMENTS 9 8 3 ,744 8 8 7 , 586\nCORNING INC 5.850% 11/15/2068 DD 11/06/18 CORPORATE DEBT INSTRUMENTS 1 , 2 50,917 1 , 1 2 8,925\nCOSTCO WHOLESALE CORP 1.750% 04/20/2032 DD 04/20/20 CORPORATE DEBT INSTRUMENTS 1 , 9 24,592 1 , 5 5 4,568\nCSX CORP 3.800% 11/01/2046 DD 10/18/16 CORPORATE DEBT INSTRUMENTS 3 9 7 ,724 3 0 8 , 028\nCSX CORP 4.500% 11/15/2052 DD 07/28/22 CORPORATE DEBT INSTRUMENTS 2 6 0 ,080 2 8 7 , 1 88\nCSX CORP 4.750% 05/30/2042 DD 11/01/11 CORPORATE DEBT INSTRUMENTS 1 , 6 06,149 1 , 4 4 4,257\nCUMMINS INC 5.450% 02/20/2054 DD 02/20/24 CORPORATE DEBT INSTRUMENTS 8 4 5 ,447 8 2 8 , 444\nCVS HEALTH CORP 4.780% 03/25/2038 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 8 1 3 ,815 8 0 4 , 273\nCVS HEALTH CORP 4.780% 03/25/2038 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 1 , 0 54,861 8 4 3 , 1 90\nCVS HEALTH CORP 5.050% 03/25/2048 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 1 , 6 71,421 1 , 2 8 2,424\nCVS HEALTH CORP 5.050% 03/25/2048 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 2 , 2 31,768 1 , 8 9 2,709\nCVS HEALTH CORP 5.050% 03/25/2048 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 1 , 1 46,934 1 , 0 9 6,864\nCVS HEALTH CORP 5.125% 07/20/2045 DD 07/20/15 CORPORATE DEBT INSTRUMENTS 1 , 8 08,375 1 , 5 2 8,048\nCVS HEALTH CORP 5.125% 07/20/2045 DD 07/20/15 CORPORATE DEBT INSTRUMENTS 1 , 1 10,525 8 5 0 , 3 19\nCVS HEALTH CORP 5.125% 07/20/2045 DD 07/20/15 CORPORATE DEBT INSTRUMENTS 8 4 3 ,763 7 4 1 , 7 14\nCVS HEALTH CORP 5.875% 06/01/2053 DD 06/02/23 CORPORATE DEBT INSTRUMENTS 1 1 8 ,304 1 0 5 , 5 03\nCVS HEALTH CORP 6.000% 06/01/2044 DD 05/09/24 CORPORATE DEBT INSTRUMENTS 9 8 7 ,933 9 3 6 , 896\nCVS HEALTH CORP 6.050% 06/01/2054 DD 05/09/24 CORPORATE DEBT INSTRUMENTS 4 9 5 ,942 4 5 6 , 235\nCVS PASS-THROUGH TRUST 144A 7.507% 01/10/2032 DD 12/22/09 CORPORATE DEBT INSTRUMENTS 1 , 7 14,944 1 , 7 8 8,116\nDANAHER CORP 2.600% 10/01/2050 DD 10/06/20 CORPORATE DEBT INSTRUMENTS 4 8 4 ,953 2 9 1 , 9 96\nDANAHER CORP 2.600% 10/01/2050 DD 10/06/20 CORPORATE DEBT INSTRUMENTS 8 8 , 7 23 5 9 , 5 9 1\nDANAHER CORP 2.800% 12/10/2051 DD 12/10/21 CORPORATE DEBT INSTRUMENTS 7 7 5 ,541 4 8 0 , 594\nDEERE & CO 2.875% 09/07/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 6 3 4 ,746 4 1 5 , 3 53\nDEUTSCHE BANK AG/NEW YORK NY VAR RT 09/11/2035 DD 09/11/24 CORPORATE DEBT INSTRUMENTS 3 4 0 ,000 3 2 2 , 5 41\nDEUTSCHE TELEKOM INTERNAT 144A 4.875% 03/06/2042 DD 03/06/12 CORPORATE DEBT INSTRUMENTS 5 6 6 ,973 5 1 8 , 4 26\nDEVON ENERGY CORP 5.750% 09/15/2054 DD 08/28/24 CORPORATE DEBT INSTRUMENTS 8 9 3 ,944 8 1 3 , 7 07\nDH EUROPE FINANCE II SARL 3.250% 11/15/2039 DD 11/07/19 CORPORATE DEBT INSTRUMENTS 4 1 9 ,221 3 2 7 , 646\nDH EUROPE FINANCE II SARL 3.400% 11/15/2049 DD 11/07/19 CORPORATE DEBT INSTRUMENTS 8 9 , 7 80 6 3 , 7 7 8\nDIAMONDBACK ENERGY INC 4.250% 03/15/2052 DD 03/17/22 CORPORATE DEBT INSTRUMENTS 9 2 9 ,818 9 2 2 , 088\nDIAMONDBACK ENERGY INC 5.750% 04/18/2054 DD 04/18/24 CORPORATE DEBT INSTRUMENTS 5 3 8 ,988 5 0 7 , 740\nDIAMONDBACK ENERGY INC 5.900% 04/18/2064 DD 04/18/24 CORPORATE DEBT INSTRUMENTS 3 1 9 ,853 3 0 0 , 486\nDISCOVERY COMMUNICATIONS LLC 5.000% 09/20/2037 DD 09/21/17 CORPORATE DEBT INSTRUMENTS 1 , 2 79,486 1 , 0 6 1,608\nDOMINION ENERGY INC 3.300% 04/15/2041 DD 04/05/21 CORPORATE DEBT INSTRUMENTS 9 3 0 ,789 6 7 0 , 743\nDOMINION ENERGY INC 4.850% 08/15/2052 DD 08/19/22 CORPORATE DEBT INSTRUMENTS 1 2 8 ,441 1 1 1 , 7 93\nDOMINION ENERGY INC 4.900% 08/01/2041 DD 08/05/11 CORPORATE DEBT INSTRUMENTS 1 , 4 61,840 1 , 2 4 0,725\nDOMINION ENERGY INC VAR RT 06/01/2054 DD 05/20/24 CORPORATE DEBT INSTRUMENTS 6 4 4 ,000 6 8 0 , 0 51\n29\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nDOW CHEMICAL CO/THE 3.600% 11/15/2050 DD 08/26/20 CORPORATE DEBT INSTRUMENTS 8 9 3 ,340 6 1 8 , 9 75\nDOW CHEMICAL CO/THE 4.375% 11/15/2042 DD 11/14/12 CORPORATE DEBT INSTRUMENTS 1 , 4 77,399 1 , 2 3 5,379\nDOW CHEMICAL CO/THE 4.800% 05/15/2049 DD 11/15/19 CORPORATE DEBT INSTRUMENTS 9 9 , 4 03 8 4 , 1 9 2\nDTE ELECTRIC CO 2.950% 03/01/2050 DD 02/26/20 CORPORATE DEBT INSTRUMENTS 9 5 9 ,616 6 2 4 , 672\nDTE ELECTRIC CO 4.050% 05/15/2048 DD 05/07/18 CORPORATE DEBT INSTRUMENTS 7 6 1 ,565 6 1 2 , 7 88\nDUKE ENERGY CAROLINAS LLC 4.000% 09/30/2042 DD 09/21/12 CORPORATE DEBT INSTRUMENTS 3 6 3 ,444 3 0 0 , 795\nDUKE ENERGY CAROLINAS LLC 4.000% 09/30/2042 DD 09/21/12 CORPORATE DEBT INSTRUMENTS 8 4 6 ,428 7 3 5 , 729\nDUKE ENERGY CAROLINAS LLC 5.300% 02/15/2040 DD 11/19/09 CORPORATE DEBT INSTRUMENTS 5 , 0 75,383 4 , 7 4 8,150\nDUKE ENERGY CAROLINAS LLC 5.400% 01/15/2054 DD 06/15/23 CORPORATE DEBT INSTRUMENTS 1 9 1 ,544 1 8 0 , 9 29\nDUKE ENERGY CORP 5.000% 08/15/2052 DD 08/11/22 CORPORATE DEBT INSTRUMENTS 8 , 5 5 5 8 , 7 4 1\nDUKE ENERGY FLORIDA LLC 3.400% 10/01/2046 DD 09/09/16 CORPORATE DEBT INSTRUMENTS 3 , 4 30,611 2 , 4 4 6,291\nDUKE ENERGY FLORIDA LLC 4.200% 07/15/2048 DD 06/21/18 CORPORATE DEBT INSTRUMENTS 3 1 9 ,555 2 5 6 , 608\nDUKE ENERGY FLORIDA LLC 6.200% 11/15/2053 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 2 3 3 ,571 2 4 8 , 0 17\nDUKE ENERGY FLORIDA LLC 6.350% 09/15/2037 DD 09/18/07 CORPORATE DEBT INSTRUMENTS 1 , 5 60,845 1 , 3 0 8,068\nDUKE ENERGY INDIANA LLC 2.750% 04/01/2050 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 2 5 9 ,680 1 5 7 , 2 58\nDUKE ENERGY INDIANA LLC 2.750% 04/01/2050 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 5 6 7 ,301 3 4 3 , 549\nDUKE ENERGY INDIANA LLC 3.250% 10/01/2049 DD 09/27/19 CORPORATE DEBT INSTRUMENTS 1 , 2 41,590 8 5 4 , 875\nDUKE ENERGY INDIANA LLC 6.350% 08/15/2038 DD 08/21/08 CORPORATE DEBT INSTRUMENTS 2 9 6 ,312 2 5 2 , 1 71\nDUKE ENERGY OHIO INC 2.125% 06/01/2030 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 1 , 9 22,641 1 , 6 1 6,708\nDUKE ENERGY OHIO INC 4.300% 02/01/2049 DD 01/08/19 CORPORATE DEBT INSTRUMENTS 6 7 9 ,897 4 7 0 , 439\nDUKE ENERGY OHIO INC 5.550% 03/15/2054 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 4 2 3 ,891 4 1 0 , 8 18\nDUKE ENERGY OHIO INC 5.650% 04/01/2053 DD 03/22/23 CORPORATE DEBT INSTRUMENTS 1 7 5 ,479 1 6 6 , 6 31\nDUPONT DE NEMOURS INC 5.319% 11/15/2038 DD 11/28/18 CORPORATE DEBT INSTRUMENTS 7 8 8 ,550 7 4 9 , 473\nDUPONT DE NEMOURS INC 5.419% 11/15/2048 DD 11/28/18 CORPORATE DEBT INSTRUMENTS 4 2 5 ,000 4 2 3 , 687\nEASTERN ENERGY GAS HOLDINGS LL 5.650% 10/15/2054 DD 10/09/24 CORPORATE DEBT INSTRUMENTS 8 6 8 ,366 8 2 0 , 875\nEASTERN ENERGY GAS HOLDINGS LL 5.650% 10/15/2054 DD 10/09/24 CORPORATE DEBT INSTRUMENTS 1 6 4 ,880 1 5 5 , 8 62\nEATON CORP 4.150% 03/15/2033 DD 08/23/22 CORPORATE DEBT INSTRUMENTS 4 6 8 ,945 4 7 0 , 1 45\nECOLAB INC 2.700% 11/01/2026 DD 10/18/16 CORPORATE DEBT INSTRUMENTS 1 , 5 36,133 1 , 3 3 6,378\nELECTRICITE DE FRANCE SA 144A 5.000% 09/21/2048 DD 09/21/18 CORPORATE DEBT INSTRUMENTS 3 6 8 ,798 3 3 1 , 0 83\nELECTRONIC ARTS INC 2.950% 02/15/2051 DD 02/11/21 CORPORATE DEBT INSTRUMENTS 1 , 2 40,295 1 , 1 6 4,254\nELEVANCE HEALTH INC 3.600% 03/15/2051 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 4 2 5 ,150 2 8 9 , 388\nELEVANCE HEALTH INC 3.700% 09/15/2049 DD 09/09/19 CORPORATE DEBT INSTRUMENTS 7 8 0 ,204 5 5 9 , 956\nELEVANCE HEALTH INC 3.700% 09/15/2049 DD 09/09/19 CORPORATE DEBT INSTRUMENTS 9 8 , 4 29 8 9 , 1 6 5\nELEVANCE HEALTH INC 4.375% 12/01/2047 DD 11/21/17 CORPORATE DEBT INSTRUMENTS 3 5 4 ,996 2 8 6 , 7 51\nELEVANCE HEALTH INC 4.375% 12/01/2047 DD 11/21/17 CORPORATE DEBT INSTRUMENTS 1 , 7 45,324 1 , 4 2 8,102\nELEVANCE HEALTH INC 4.550% 03/01/2048 DD 03/02/18 CORPORATE DEBT INSTRUMENTS 3 9 3 ,653 3 2 4 , 824\nELEVANCE HEALTH INC 4.650% 01/15/2043 DD 09/10/12 CORPORATE DEBT INSTRUMENTS 1 , 8 74,343 1 , 6 6 4,020\nELEVANCE HEALTH INC 5.100% 01/15/2044 DD 08/06/13 CORPORATE DEBT INSTRUMENTS 8 7 , 1 35 6 8 , 2 3 4\nELEVANCE HEALTH INC 5.650% 06/15/2054 DD 05/30/24 CORPORATE DEBT INSTRUMENTS 2 9 9 ,781 2 8 8 , 870\nELEVANCE HEALTH INC 5.700% 02/15/2055 DD 10/31/24 CORPORATE DEBT INSTRUMENTS 4 4 7 ,539 4 3 4 , 290\nELI LILLY & CO 4.150% 03/15/2059 DD 02/22/19 CORPORATE DEBT INSTRUMENTS 7 4 , 8 67 6 6 , 6 3 5\nELI LILLY & CO 4.600% 08/14/2034 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 3 0 6 ,930 2 8 8 , 060\nELI LILLY & CO 4.700% 02/27/2033 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 6 9 6 ,028 6 8 6 , 259\nELI LILLY & CO 4.875% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 4 0 4 ,745 3 6 7 , 392\nELI LILLY & CO 4.875% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 5 7 3 ,923 5 2 3 , 420\n30\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nELI LILLY & CO 4.950% 02/27/2063 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 5 5 4 ,020 5 0 3 , 278\nELI LILLY & CO 5.000% 02/09/2054 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 8 2 9 ,094 7 7 2 , 4 81\nELI LILLY & CO 5.000% 02/09/2054 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 3 8 2 ,809 3 5 4 , 054\nELI LILLY & CO 5.050% 08/14/2054 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 2 7 3 ,653 2 5 5 , 1 83\nELI LILLY & CO 5.100% 02/09/2064 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 1 , 6 74,006 1 , 5 3 4,613\nELI LILLY & CO 5.100% 02/09/2064 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 9 1 2 ,779 8 3 7 , 8 11\nELI LILLY & CO 5.200% 08/14/2064 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 3 3 1 ,954 3 0 7 , 609\nEMERSON ELECTRIC CO 2.750% 10/15/2050 DD 04/29/20 CORPORATE DEBT INSTRUMENTS 4 0 9 ,500 2 5 5 , 709\nEMERSON ELECTRIC CO 2.800% 12/21/2051 DD 12/21/21 CORPORATE DEBT INSTRUMENTS 5 8 3 ,701 3 6 2 , 1 56\nEMERSON ELECTRIC CO 2.800% 12/21/2051 DD 12/21/21 CORPORATE DEBT INSTRUMENTS 1 , 3 11,083 8 1 3 , 4 58\nEMPOWER FINANCE 2020 LP 144A 1.776% 03/17/2031 DD 09/17/20 CORPORATE DEBT INSTRUMENTS 5 6 7 ,127 4 6 2 , 385\nENBRIDGE INC 6.700% 11/15/2053 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 5 7 2 ,255 6 2 2 , 7 19\nENBRIDGE INC 6.700% 11/15/2053 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 4 0 9 ,467 4 4 5 , 576\nENERGY TRANSFER LP 5.000% 05/15/2050 DD 01/22/20 CORPORATE DEBT INSTRUMENTS 2 , 4 00,513 2 , 3 4 4,758\nENERGY TRANSFER LP 5.150% 02/01/2043 DD 01/22/13 CORPORATE DEBT INSTRUMENTS 1 3 3 ,787 1 2 7 , 9 91\nENERGY TRANSFER LP 5.300% 04/15/2047 DD 01/17/17 CORPORATE DEBT INSTRUMENTS 8 9 4 ,885 8 0 1 , 5 49\nENERGY TRANSFER LP 5.350% 05/15/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 6 3 0 ,752 5 7 2 , 262\nENERGY TRANSFER LP 5.350% 05/15/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 5 08,838 1 , 3 6 8,923\nENERGY TRANSFER LP 5.350% 05/15/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 2 7 , 2 22 2 7 , 0 3 6\nENERGY TRANSFER LP 5.400% 10/01/2047 DD 09/21/17 CORPORATE DEBT INSTRUMENTS 9 8 3 ,862 8 8 1 , 0 79\nENERGY TRANSFER LP 5.800% 06/15/2038 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 6 2 , 5 92 5 8 , 9 7 2\nENERGY TRANSFER LP 5.950% 10/01/2043 DD 09/19/13 CORPORATE DEBT INSTRUMENTS 1 , 9 59,367 1 , 8 3 5,549\nENERGY TRANSFER LP 6.500% 02/01/2042 DD 01/17/12 CORPORATE DEBT INSTRUMENTS 7 7 , 2 14 7 2 , 5 5 1\nENERGY TRANSFER LP 6.550% 12/01/2033 DD 10/13/23 CORPORATE DEBT INSTRUMENTS 5 8 4 ,333 6 2 2 , 7 91\nENI SPA 144A 5.700% 10/01/2040 DD 10/01/10 CORPORATE DEBT INSTRUMENTS 3 0 8 ,199 2 6 8 , 040\nENI SPA 144A 5.950% 05/15/2054 DD 05/15/24 CORPORATE DEBT INSTRUMENTS 4 0 5 ,195 3 9 4 , 609\nENTERGY ARKANSAS LLC 5.750% 06/01/2054 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 1 , 1 92,611 1 , 1 7 3,707\nENTERGY ARKANSAS LLC 5.750% 06/01/2054 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 4 9 4 ,788 4 9 2 , 264\nENTERGY CORP 3.750% 06/15/2050 DD 05/19/20 CORPORATE DEBT INSTRUMENTS 6 9 3 ,261 4 4 3 , 675\nENTERGY LOUISIANA LLC 2.900% 03/15/2051 DD 03/06/20 CORPORATE DEBT INSTRUMENTS 1 6 8 ,702 1 0 7 , 7 70\nENTERGY LOUISIANA LLC 3.100% 06/15/2041 DD 03/10/21 CORPORATE DEBT INSTRUMENTS 7 3 0 ,325 5 2 7 , 9 21\nENTERGY LOUISIANA LLC 4.750% 09/15/2052 DD 08/24/22 CORPORATE DEBT INSTRUMENTS 1 5 4 ,158 1 3 3 , 7 32\nENTERGY LOUISIANA LLC 5.700% 03/15/2054 DD 03/08/24 CORPORATE DEBT INSTRUMENTS 3 9 4 ,431 3 9 0 , 659\nENTERGY MISSISSIPPI LLC 2.850% 06/01/2028 DD 05/13/16 CORPORATE DEBT INSTRUMENTS 1 , 5 68,074 1 , 3 6 0,419\nENTERGY MISSISSIPPI LLC 5.850% 06/01/2054 DD 05/16/24 CORPORATE DEBT INSTRUMENTS 4 6 4 ,786 4 6 9 , 357\nENTERGY TEXAS INC 5.000% 09/15/2052 DD 08/25/22 CORPORATE DEBT INSTRUMENTS 2 3 3 ,651 2 1 0 , 3 60\nENTERGY TEXAS INC 5.550% 09/15/2054 DD 08/15/24 CORPORATE DEBT INSTRUMENTS 3 3 7 ,566 3 3 0 , 1 03\nENTERPRISE PRODUCTS OPERATING 3.200% 02/15/2052 DD 08/07/20 CORPORATE DEBT INSTRUMENTS 5 0 7 ,024 4 6 5 , 200\nENTERPRISE PRODUCTS OPERATING 3.700% 01/31/2051 DD 01/15/20 CORPORATE DEBT INSTRUMENTS 3 0 3 ,681 2 0 8 , 336\nENTERPRISE PRODUCTS OPERATING 4.250% 02/15/2048 DD 02/15/18 CORPORATE DEBT INSTRUMENTS 4 9 4 ,031 3 9 3 , 6 71\nENTERPRISE PRODUCTS OPERATING 4.450% 02/15/2043 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 1 1 8 ,426 1 1 5 , 2 28\nENTERPRISE PRODUCTS OPERATING 4.800% 02/01/2049 DD 10/11/18 CORPORATE DEBT INSTRUMENTS 4 3 2 ,347 3 7 4 , 896\nENTERPRISE PRODUCTS OPERATING 4.850% 01/31/2034 DD 01/11/24 CORPORATE DEBT INSTRUMENTS 9 5 7 ,168 9 2 8 , 8 19\nENTERPRISE PRODUCTS OPERATING 4.850% 03/15/2044 DD 03/18/13 CORPORATE DEBT INSTRUMENTS 4 1 3 ,428 3 6 6 , 979\nENTERPRISE PRODUCTS OPERATING 4.900% 05/15/2046 DD 05/07/15 CORPORATE DEBT INSTRUMENTS 3 6 8 ,650 3 3 0 , 1 73\n31\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nENTERPRISE PRODUCTS OPERATING 4.900% 05/15/2046 DD 05/07/15 CORPORATE DEBT INSTRUMENTS 4 0 4 ,745 3 7 0 , 329\nENTERPRISE PRODUCTS OPERATING 4.950% 10/15/2054 DD 10/14/14 CORPORATE DEBT INSTRUMENTS 1 , 0 37,656 9 2 2 , 787\nENTERPRISE PRODUCTS OPERATING 5.100% 02/15/2045 DD 02/12/14 CORPORATE DEBT INSTRUMENTS 2 8 9 ,551 2 6 7 , 537\nENTERPRISE PRODUCTS OPERATING 5.100% 02/15/2045 DD 02/12/14 CORPORATE DEBT INSTRUMENTS 3 0 , 7 70 3 2 , 2 8 9\nENTERPRISE PRODUCTS OPERATING 5.550% 02/16/2055 DD 08/08/24 CORPORATE DEBT INSTRUMENTS 1 1 4 ,612 1 1 0 , 8 13\nENTERPRISE PRODUCTS OPERATING 5.700% 02/15/2042 DD 08/24/11 CORPORATE DEBT INSTRUMENTS 7 7 0 ,318 7 5 5 , 955\nENTERPRISE PRODUCTS OPERATING 5.700% 02/15/2042 DD 08/24/11 CORPORATE DEBT INSTRUMENTS 2 8 1 ,047 2 9 4 , 982\nENTERPRISE PRODUCTS OPERATING 6.450% 09/01/2040 DD 05/20/10 CORPORATE DEBT INSTRUMENTS 2 , 9 17,473 2 , 6 4 5,456\nENTERPRISE PRODUCTS OPERATING 6.450% 09/01/2040 DD 05/20/10 CORPORATE DEBT INSTRUMENTS 9 7 , 3 94 9 6 , 9 4 3\nEOG RESOURCES INC 5.650% 12/01/2054 DD 11/21/24 CORPORATE DEBT INSTRUMENTS 8 8 1 ,776 8 6 9 , 8 01\nEQUINIX INC 2.950% 09/15/2051 DD 10/07/20 CORPORATE DEBT INSTRUMENTS 8 6 0 ,139 5 3 1 , 5 17\nEQUINOR ASA 3.700% 04/06/2050 DD 04/06/20 CORPORATE DEBT INSTRUMENTS 1 , 2 25,923 9 1 6 , 1 60\nEQUITABLE HOLDINGS INC 5.000% 04/20/2048 DD 10/20/18 CORPORATE DEBT INSTRUMENTS 7 2 1 ,442 6 3 5 , 1 32\nERP OPERATING LP 3.375% 06/01/2025 DD 05/14/15 CORPORATE DEBT INSTRUMENTS 1 , 9 25,827 1 , 7 5 0,091\nERP OPERATING LP 4.500% 07/01/2044 DD 06/19/14 CORPORATE DEBT INSTRUMENTS 1 0 2 ,953 1 0 3 , 6 90\nESSEX PORTFOLIO LP 4.500% 03/15/2048 DD 03/08/18 CORPORATE DEBT INSTRUMENTS 9 4 3 ,018 7 8 1 , 4 45\nEXELON CORP 4.100% 03/15/2052 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 1 6 9 ,881 1 2 9 , 4 35\nEXELON CORP 4.950% 06/15/2035 DD 12/15/15 CORPORATE DEBT INSTRUMENTS 2 , 1 19,093 2 , 0 1 3,140\nEXELON CORP 4.950% 06/15/2035 DD 12/15/15 CORPORATE DEBT INSTRUMENTS 5 5 3 ,457 5 2 5 , 785\nEXELON CORP 5.600% 03/15/2053 DD 02/21/23 CORPORATE DEBT INSTRUMENTS 5 4 4 ,313 5 2 6 , 306\nEXELON CORP 5.625% 06/15/2035 DD 06/09/05 CORPORATE DEBT INSTRUMENTS 1 , 0 20,546 8 4 5 , 427\nEXTRA SPACE STORAGE LP 5.400% 02/01/2034 DD 01/19/24 CORPORATE DEBT INSTRUMENTS 3 4 9 ,314 3 4 6 , 5 91\nEXXON MOBIL CORP 3.095% 08/16/2049 DD 08/16/19 CORPORATE DEBT INSTRUMENTS 2 3 5 ,409 1 6 0 , 1 54\nEXXON MOBIL CORP 3.452% 04/15/2051 DD 04/15/20 CORPORATE DEBT INSTRUMENTS 9 2 , 1 99 8 7 , 7 5 7\nEXXON MOBIL CORP 3.452% 04/15/2051 DD 04/15/20 CORPORATE DEBT INSTRUMENTS 1 , 7 12,163 1 , 0 7 5,556\nEXXON MOBIL CORP 3.452% 04/15/2051 DD 04/15/20 CORPORATE DEBT INSTRUMENTS 6 0 1 ,978 4 2 8 , 257\nEXXON MOBIL CORP 4.227% 03/19/2040 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 7 80,000 1 , 5 6 3,071\nEXXON MOBIL CORP 4.227% 03/19/2040 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 9 0 1 ,834 7 4 6 , 4 10\nEXXON MOBIL CORP 4.327% 03/19/2050 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 6 76,703 1 , 3 2 9,936\nEXXON MOBIL CORP 4.327% 03/19/2050 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 5 87,000 1 , 3 0 6,879\nFEDEX CORP 4.050% 02/15/2048 DD 01/31/18 CORPORATE DEBT INSTRUMENTS 6 2 3 ,159 6 2 0 , 646\nFIRST REPUBLIC BANK/CA 4.625% 02/13/2047 DD 02/13/17 CORPORATE DEBT INSTRUMENTS 7 7 5 ,609 1 8 6\nFIRSTENERGY PENNSYLVANIA ELECT 6.150% 10/01/2038 DD 09/30/09 CORPORATE DEBT INSTRUMENTS 2 , 2 22,314 2 , 1 5 5,037\nFIRSTENERGY TRANSMISSION 144A 5.450% 07/15/2044 DD 05/19/14 CORPORATE DEBT INSTRUMENTS 2 8 5 ,685 2 6 8 , 335\nFLORIDA POWER & LIGHT CO 2.850% 04/01/2025 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 2 , 3 01,310 2 , 1 0 4,848\nFLORIDA POWER & LIGHT CO 3.150% 10/01/2049 DD 09/13/19 CORPORATE DEBT INSTRUMENTS 5 4 1 ,528 3 6 8 , 044\nFLORIDA POWER & LIGHT CO 3.800% 12/15/2042 DD 12/20/12 CORPORATE DEBT INSTRUMENTS 1 , 4 51,360 1 , 2 6 8,832\nFLORIDA POWER & LIGHT CO 3.990% 03/01/2049 DD 02/26/19 CORPORATE DEBT INSTRUMENTS 5 0 4 ,732 3 9 5 , 425\nFLORIDA POWER & LIGHT CO 5.690% 03/01/2040 DD 02/09/10 CORPORATE DEBT INSTRUMENTS 1 , 2 86,997 1 , 2 6 1,021\nFLORIDA POWER & LIGHT CO 5.960% 04/01/2039 DD 03/17/09 CORPORATE DEBT INSTRUMENTS 8 1 4 ,398 6 7 9 , 8 15\nFOUNDRY JV HOLDCO LLC 144A 6.400% 01/25/2038 DD 05/07/24 CORPORATE DEBT INSTRUMENTS 7 0 3 ,224 7 1 0 , 5 43\nFOX CORP 5.476% 01/25/2039 DD 01/25/20 CORPORATE DEBT INSTRUMENTS 1 8 6 ,060 1 9 0 , 0 62\nGA GLOBAL FUNDING TRUST 144A 2.900% 01/06/2032 DD 01/06/22 CORPORATE DEBT INSTRUMENTS 7 4 3 ,778 6 2 4 , 1 31\nGATX CORP 3.100% 06/01/2051 DD 02/03/21 CORPORATE DEBT INSTRUMENTS 1 , 5 23,839 9 8 0 , 979\nGENERAL DYNAMICS CORP 2.850% 06/01/2041 DD 05/10/21 CORPORATE DEBT INSTRUMENTS 2 2 5 ,271 1 5 6 , 9 77\n32\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nGENERAL DYNAMICS CORP 3.625% 04/01/2030 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 , 8 99,827 1 , 5 5 3,653\nGENERAL DYNAMICS CORP 4.250% 04/01/2040 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 7 4 1 ,482 6 0 2 , 798\nGENERAL DYNAMICS CORP 4.250% 04/01/2040 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 1 3 ,129 9 6 , 0 9 8\nGENERAL DYNAMICS CORP 4.250% 04/01/2050 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 6 0 , 2 69 5 7 , 8 8 2\nGENERAL MOTORS CO 5.150% 04/01/2038 DD 08/07/17 CORPORATE DEBT INSTRUMENTS 2 4 3 ,663 2 0 2 , 633\nGENERAL MOTORS CO 5.600% 10/15/2032 DD 08/02/22 CORPORATE DEBT INSTRUMENTS 6 7 8 ,341 6 8 6 , 208\nGENERAL MOTORS CO 6.250% 10/02/2043 DD 04/02/14 CORPORATE DEBT INSTRUMENTS 5 9 0 ,815 4 5 6 , 3 61\nGENERAL MOTORS CO 6.600% 04/01/2036 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 8 4 6 ,322 8 8 9 , 3 16\nGENERAL MOTORS CO 6.600% 04/01/2036 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 3 2 7 ,651 3 1 4 , 9 88\nGENERAL MOTORS FINANCIAL CO IN 6.400% 01/09/2033 DD 01/09/23 CORPORATE DEBT INSTRUMENTS 3 7 5 ,065 3 6 8 , 0 11\nGEORGIA POWER CO 2.650% 09/15/2029 DD 09/10/19 CORPORATE DEBT INSTRUMENTS 1 , 5 25,204 1 , 3 1 9,539\nGEORGIA POWER CO 3.700% 01/30/2050 DD 01/10/20 CORPORATE DEBT INSTRUMENTS 7 6 6 ,112 5 2 9 , 459\nGEORGIA POWER CO 4.300% 03/15/2042 DD 03/06/12 CORPORATE DEBT INSTRUMENTS 2 , 0 38,960 1 , 7 3 6,285\nGEORGIA POWER CO 4.300% 03/15/2042 DD 03/06/12 CORPORATE DEBT INSTRUMENTS 7 8 0 ,021 7 0 2 , 1 74\nGILEAD SCIENCES INC 4.150% 03/01/2047 DD 09/20/16 CORPORATE DEBT INSTRUMENTS 1 6 7 ,395 1 0 4 , 3 28\nGILEAD SCIENCES INC 4.150% 03/01/2047 DD 09/20/16 CORPORATE DEBT INSTRUMENTS 7 2 , 0 98 6 4 , 2 0 2\nGILEAD SCIENCES INC 4.500% 02/01/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 7 44,698 1 , 5 0 5,808\nGILEAD SCIENCES INC 4.500% 02/01/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 1 6 ,812 9 4 , 3 8 1\nGILEAD SCIENCES INC 4.750% 03/01/2046 DD 09/14/15 CORPORATE DEBT INSTRUMENTS 2 2 1 ,054 1 9 8 , 4 36\nGILEAD SCIENCES INC 4.800% 04/01/2044 DD 03/07/14 CORPORATE DEBT INSTRUMENTS 3 7 6 ,510 3 3 1 , 4 61\nGILEAD SCIENCES INC 5.500% 11/15/2054 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 3 3 6 ,320 3 2 6 , 454\nGILEAD SCIENCES INC 5.500% 11/15/2054 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 1 , 3 30,503 1 , 2 6 1,965\nGILEAD SCIENCES INC 5.600% 11/15/2064 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 1 7 4 ,474 1 6 4 , 3 37\nGLENCORE FINANCE CANADA L 144A 6.000% 11/15/2041 DD 11/10/11 CORPORATE DEBT INSTRUMENTS 1 , 5 16,153 1 , 5 0 2,523\nGLOBAL ATLANTIC FIN CO 144A 6.750% 03/15/2054 DD 03/15/24 CORPORATE DEBT INSTRUMENTS 4 4 2 ,001 4 5 2 , 298\nGLOBAL ATLANTIC FIN CO 144A 6.750% 03/15/2054 DD 03/15/24 CORPORATE DEBT INSTRUMENTS 5 9 2 ,347 5 8 9 , 5 12\nGLOBAL PAYMENTS INC 5.950% 08/15/2052 DD 08/22/22 CORPORATE DEBT INSTRUMENTS 7 1 1 ,840 6 9 4 , 086\nGOLDMAN SACHS GROUP INC/THE 2.600% 02/07/2030 DD 02/07/20 CORPORATE DEBT INSTRUMENTS 1 , 5 16,008 1 , 3 1 0,806\nGOLDMAN SACHS GROUP INC/THE 4.800% 07/08/2044 DD 07/08/14 CORPORATE DEBT INSTRUMENTS 1 1 4 ,484 9 7 , 3 2 1\nGOLDMAN SACHS GROUP INC/THE 5.150% 05/22/2045 DD 05/22/15 CORPORATE DEBT INSTRUMENTS 5 7 9 ,467 5 3 5 , 050\nGOLDMAN SACHS GROUP INC/THE 6.250% 02/01/2041 DD 01/28/11 CORPORATE DEBT INSTRUMENTS 2 8 9 ,840 2 8 4 , 386\nGOLDMAN SACHS GROUP INC/THE 6.250% 02/01/2041 DD 01/28/11 CORPORATE DEBT INSTRUMENTS 2 , 9 86,034 2 , 6 8 2,704\nGOLDMAN SACHS GROUP INC/THE 6.750% 10/01/2037 DD 10/03/07 CORPORATE DEBT INSTRUMENTS 1 , 7 94,865 1 , 9 4 0,086\nGOLDMAN SACHS GROUP INC/THE VAR RT 02/24/2043 DD 01/24/22 CORPORATE DEBT INSTRUMENTS 5 2 0 ,299 4 1 7 , 1 38\nGOLDMAN SACHS GROUP INC/THE VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 7 4 6 ,681 7 4 2 , 054\nGOLDMAN SACHS GROUP INC/THE VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 3 6 5 ,000 2 6 6 , 322\nGOLDMAN SACHS GROUP INC/THE VAR RT 04/23/2039 DD 04/23/18 CORPORATE DEBT INSTRUMENTS 5 6 2 ,001 5 0 7 , 368\nGOLDMAN SACHS GROUP INC/THE VAR RT 07/23/2035 DD 07/23/24 CORPORATE DEBT INSTRUMENTS 1 , 0 05,000 9 8 7 , 523\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/23/2035 DD 10/23/24 CORPORATE DEBT INSTRUMENTS 3 9 0 ,000 3 7 3 , 487\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/31/2038 DD 10/31/17 CORPORATE DEBT INSTRUMENTS 5 7 0 ,000 4 8 2 , 847\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/31/2038 DD 10/31/17 CORPORATE DEBT INSTRUMENTS 9 9 5 ,969 9 8 0 , 095\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/31/2038 DD 10/31/17 CORPORATE DEBT INSTRUMENTS 5 9 , 0 33 4 6 , 5 9 0\nGOLDMAN SACHS GROUP INC/THE VAR RT 11/19/2045 DD 11/19/24 CORPORATE DEBT INSTRUMENTS 1 , 9 22,453 1 , 8 5 1,077\nGUARDIAN LIFE INSURANCE C 144A 4.875% 06/19/2064 DD 06/19/14 CORPORATE DEBT INSTRUMENTS 7 4 2 ,504 6 3 0 , 009\nHCA INC 4.375% 03/15/2042 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 1 8 ,111 9 8 , 0 3 0\n33\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nHCA INC 4.625% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 2 3 7 ,853 2 2 2 , 0 61\nHCA INC 5.125% 06/15/2039 DD 06/12/19 CORPORATE DEBT INSTRUMENTS 6 4 5 ,050 5 9 3 , 250\nHCA INC 5.500% 06/15/2047 DD 06/22/17 CORPORATE DEBT INSTRUMENTS 7 9 , 2 94 7 7 , 4 2 1\nHCA INC 5.950% 09/15/2054 DD 08/12/24 CORPORATE DEBT INSTRUMENTS 1 , 0 90,067 1 , 0 1 4,530\nHCA INC 5.950% 09/15/2054 DD 08/12/24 CORPORATE DEBT INSTRUMENTS 6 1 7 ,737 5 7 1 , 5 66\nHCA INC 6.000% 04/01/2054 DD 02/23/24 CORPORATE DEBT INSTRUMENTS 4 3 3 ,385 4 0 5 , 463\nHCA INC 6.100% 04/01/2064 DD 02/23/24 CORPORATE DEBT INSTRUMENTS 7 8 , 7 34 7 1 , 6 4 7\nHEALTH CARE SERVICE CORP 144A 5.875% 06/15/2054 DD 06/10/24 CORPORATE DEBT INSTRUMENTS 9 2 6 ,588 8 7 3 , 6 10\nHERSHEY CO/THE 2.450% 11/15/2029 DD 10/31/19 CORPORATE DEBT INSTRUMENTS 1 , 9 31,761 1 , 6 1 8,498\nHESS CORP 5.800% 04/01/2047 DD 09/28/16 CORPORATE DEBT INSTRUMENTS 6 0 2 ,332 5 1 6 , 1 48\nHESS CORP 6.000% 01/15/2040 DD 12/14/09 CORPORATE DEBT INSTRUMENTS 8 1 , 6 56 8 3 , 3 5 4\nHOME DEPOT INC/THE 2.375% 03/15/2051 DD 01/07/21 CORPORATE DEBT INSTRUMENTS 7 3 , 8 35 6 8 , 0 3 5\nHOME DEPOT INC/THE 2.500% 04/15/2027 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 1 , 9 16,992 1 , 6 8 4,003\nHOME DEPOT INC/THE 3.125% 12/15/2049 DD 01/13/20 CORPORATE DEBT INSTRUMENTS 4 3 8 ,858 3 7 4 , 1 78\nHOME DEPOT INC/THE 3.125% 12/15/2049 DD 01/13/20 CORPORATE DEBT INSTRUMENTS 1 4 4 ,433 8 7 , 1 7 4\nHOME DEPOT INC/THE 3.300% 04/15/2040 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 3 0 4 ,315 2 3 7 , 845\nHOME DEPOT INC/THE 3.350% 04/15/2050 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 9 5 3 ,980 6 7 3 , 879\nHOME DEPOT INC/THE 3.350% 04/15/2050 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 3 1 8 ,213 2 6 1 , 8 70\nHOME DEPOT INC/THE 3.625% 04/15/2052 DD 03/28/22 CORPORATE DEBT INSTRUMENTS 8 1 9 ,172 6 7 6 , 343\nHOME DEPOT INC/THE 3.900% 06/15/2047 DD 06/05/17 CORPORATE DEBT INSTRUMENTS 7 2 8 ,615 4 7 5 , 997\nHOME DEPOT INC/THE 3.900% 06/15/2047 DD 06/05/17 CORPORATE DEBT INSTRUMENTS 1 , 0 61,539 8 3 7 , 692\nHOME DEPOT INC/THE 4.200% 04/01/2043 DD 04/05/13 CORPORATE DEBT INSTRUMENTS 5 5 2 ,658 4 6 9 , 7 41\nHOME DEPOT INC/THE 4.250% 04/01/2046 DD 06/02/15 CORPORATE DEBT INSTRUMENTS 6 4 , 2 30 6 2 , 6 1 0\nHOME DEPOT INC/THE 4.500% 12/06/2048 DD 12/06/18 CORPORATE DEBT INSTRUMENTS 5 5 0 ,491 4 7 8 , 934\nHOME DEPOT INC/THE 4.500% 12/06/2048 DD 12/06/18 CORPORATE DEBT INSTRUMENTS 6 0 1 ,113 5 1 3 , 1 44\nHOME DEPOT INC/THE 4.875% 02/15/2044 DD 09/10/13 CORPORATE DEBT INSTRUMENTS 7 4 5 ,037 6 8 2 , 062\nHOME DEPOT INC/THE 5.300% 06/25/2054 DD 06/25/24 CORPORATE DEBT INSTRUMENTS 9 5 3 ,655 9 2 5 , 6 18\nHOME DEPOT INC/THE 5.300% 06/25/2054 DD 06/25/24 CORPORATE DEBT INSTRUMENTS 2 8 4 ,286 2 6 8 , 573\nHOME DEPOT INC/THE 5.400% 06/25/2064 DD 06/25/24 CORPORATE DEBT INSTRUMENTS 1 5 8 ,359 1 5 3 , 6 11\nHONEYWELL INTERNATIONAL INC 1.950% 06/01/2030 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 1 , 5 34,819 1 , 2 8 6,198\nHONEYWELL INTERNATIONAL INC 5.250% 03/01/2054 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 1 , 1 42,424 1 , 0 7 4,159\nHONEYWELL INTERNATIONAL INC 5.250% 03/01/2054 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 1 , 7 99,941 1 , 6 9 2,387\nHONEYWELL INTERNATIONAL INC 5.250% 03/01/2054 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 3 6 8 ,994 3 4 7 , 1 08\nHONEYWELL INTERNATIONAL INC 5.350% 03/01/2064 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 3 0 9 ,237 2 9 1 , 2 08\nHORMEL FOODS CORP 1.700% 06/03/2028 DD 06/03/21 CORPORATE DEBT INSTRUMENTS 5 5 7 ,751 5 4 3 , 684\nHSBC BANK USA NA 7.000% 01/15/2039 DD 06/18/08 CORPORATE DEBT INSTRUMENTS 3 , 5 06,939 3 , 1 5 9,579\nHSBC BANK USA NA 7.000% 01/15/2039 DD 06/18/08 CORPORATE DEBT INSTRUMENTS 8 3 0 ,667 7 1 3 , 2 74\nHSBC HOLDINGS PLC 6.800% 06/01/2038 DD 06/01/22 CORPORATE DEBT INSTRUMENTS 1 , 8 00,006 1 , 4 0 5,486\nHSBC HOLDINGS PLC VAR RT 03/09/2044 DD 03/09/23 CORPORATE DEBT INSTRUMENTS 4 7 6 ,294 4 7 5 , 447\nHUMANA INC 4.950% 10/01/2044 DD 09/19/14 CORPORATE DEBT INSTRUMENTS 3 5 3 ,289 3 0 1 , 8 56\nHUMANA INC 5.500% 03/15/2053 DD 03/13/23 CORPORATE DEBT INSTRUMENTS 4 8 3 ,312 4 5 5 , 9 14\nHUMANA INC 5.750% 04/15/2054 DD 03/13/24 CORPORATE DEBT INSTRUMENTS 1 , 0 28,654 9 6 5 , 297\nHUNTINGTON BANCSHARES INC/OH VAR RT 11/18/2039 DD 11/18/24 CORPORATE DEBT INSTRUMENTS 2 5 5 ,000 2 5 4 , 850\nIBM INTERNATIONAL CAPITAL PTE 5.250% 02/05/2044 DD 02/05/24 CORPORATE DEBT INSTRUMENTS 4 8 , 9 53 4 7 , 4 1 5\nIBM INTERNATIONAL CAPITAL PTE 5.300% 02/05/2054 DD 02/05/24 CORPORATE DEBT INSTRUMENTS 6 5 6 ,271 6 0 9 , 886\n34\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nIDAHO POWER CO 4.200% 03/01/2048 DD 03/16/18 CORPORATE DEBT INSTRUMENTS 7 7 2 ,380 5 8 8 , 0 71\nINDIANA MICHIGAN POWER CO 4.250% 08/15/2048 DD 08/08/18 CORPORATE DEBT INSTRUMENTS 3 5 2 ,969 2 8 0 , 248\nINDIANA MICHIGAN POWER CO 5.625% 04/01/2053 DD 03/23/23 CORPORATE DEBT INSTRUMENTS 4 3 8 ,935 4 1 9 , 5 90\nINTEL CORP 3.250% 11/15/2049 DD 11/21/19 CORPORATE DEBT INSTRUMENTS 1 , 1 58,706 1 , 0 2 8,336\nINTEL CORP 3.734% 12/08/2047 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 3 8 2 ,505 2 6 6 , 069\nINTEL CORP 3.734% 12/08/2047 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 6 8 8 ,073 4 9 5 , 1 65\nINTEL CORP 3.734% 12/08/2047 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 5 6 0 ,326 3 8 6 , 229\nINTEL CORP 4.750% 03/25/2050 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 7 4 ,654 1 6 2 , 4 75\nINTEL CORP 4.900% 08/05/2052 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 4 8 9 ,005 3 8 7 , 458\nINTEL CORP 4.900% 08/05/2052 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 2 6 1 ,967 2 1 3 , 4 97\nINTEL CORP 5.050% 08/05/2062 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 2 7 9 ,378 2 1 8 , 7 30\nINTEL CORP 5.600% 02/21/2054 DD 02/21/24 CORPORATE DEBT INSTRUMENTS 3 9 6 ,097 3 6 7 , 238\nINTEL CORP 5.625% 02/10/2043 DD 02/10/23 CORPORATE DEBT INSTRUMENTS 1 0 9 ,934 1 0 1 , 0 41\nINTEL CORP 5.700% 02/10/2053 DD 02/10/23 CORPORATE DEBT INSTRUMENTS 7 9 1 ,659 7 0 1 , 4 59\nINTERCONTINENTAL EXCHANGE INC 3.000% 06/15/2050 DD 05/26/20 CORPORATE DEBT INSTRUMENTS 4 9 9 ,813 3 1 7 , 2 68\nINTERCONTINENTAL EXCHANGE INC 4.950% 06/15/2052 DD 05/23/22 CORPORATE DEBT INSTRUMENTS 4 4 6 ,703 4 0 4 , 0 18\nINTERNATIONAL BUSINESS MACHINE 4.900% 07/27/2052 DD 07/27/22 CORPORATE DEBT INSTRUMENTS 2 0 4 ,936 2 0 9 , 392\nINTERNATIONAL FLAVORS & F 144A 3.268% 11/15/2040 DD 09/16/20 CORPORATE DEBT INSTRUMENTS 1 , 1 07,025 8 8 5 , 5 71\nINTERNATIONAL FLAVORS & F 144A 3.468% 12/01/2050 DD 09/16/20 CORPORATE DEBT INSTRUMENTS 1 , 3 67,576 1 , 0 6 7,186\nINTERNATIONAL FLAVORS & FRAGRA 5.000% 09/26/2048 DD 09/26/18 CORPORATE DEBT INSTRUMENTS 2 3 6 ,448 1 8 4 , 7 28\nINTUIT INC 5.500% 09/15/2053 DD 09/15/23 CORPORATE DEBT INSTRUMENTS 1 9 5 ,286 1 9 1 , 2 42\nJBS USA HOLDING LUX SARL/ JBS 4.375% 02/02/2052 DD 08/02/23 CORPORATE DEBT INSTRUMENTS 6 1 5 ,584 4 6 3 , 495\nJBS USA HOLDING LUX SARL/ JBS 6.500% 12/01/2052 DD 06/01/23 CORPORATE DEBT INSTRUMENTS 1 , 3 08,777 1 , 3 5 2,903\nJBS USA HOLDING LUX SARL/ JBS 7.250% 11/15/2053 DD 11/15/24 CORPORATE DEBT INSTRUMENTS 7 9 2 ,581 8 4 8 , 394\nJOHN DEERE CAPITAL CORP 2.800% 07/18/2029 DD 07/18/19 CORPORATE DEBT INSTRUMENTS 1 , 5 37,764 1 , 2 8 5,799\nJOHNSON & JOHNSON 2.950% 03/03/2027 DD 03/03/17 CORPORATE DEBT INSTRUMENTS 2 , 3 05,841 2 , 0 0 2,905\nJOHNSON & JOHNSON 3.700% 03/01/2046 DD 03/01/16 CORPORATE DEBT INSTRUMENTS 6 1 , 8 25 5 9 , 3 2 7\nJPMORGAN CHASE & CO 5.400% 01/06/2042 DD 12/22/11 CORPORATE DEBT INSTRUMENTS 9 8 9 ,455 9 1 8 , 5 24\nJPMORGAN CHASE & CO 5.400% 01/06/2042 DD 12/22/11 CORPORATE DEBT INSTRUMENTS 1 5 7 ,285 1 2 9 , 3 83\nJPMORGAN CHASE & CO 5.500% 10/15/2040 DD 10/21/10 CORPORATE DEBT INSTRUMENTS 3 6 , 3 17 2 9 , 8 7 2\nJPMORGAN CHASE & CO 5.600% 07/15/2041 DD 07/21/11 CORPORATE DEBT INSTRUMENTS 3 , 0 47,693 3 , 0 4 4,034\nJPMORGAN CHASE & CO 5.600% 07/15/2041 DD 07/21/11 CORPORATE DEBT INSTRUMENTS 1 , 5 45,546 1 , 3 0 2,423\nJPMORGAN CHASE & CO 5.600% 07/15/2041 DD 07/21/11 CORPORATE DEBT INSTRUMENTS 5 7 7 ,143 5 2 5 , 008\nJPMORGAN CHASE & CO 6.400% 05/15/2038 DD 05/22/08 CORPORATE DEBT INSTRUMENTS 1 , 1 43,390 9 6 0 , 8 10\nJPMORGAN CHASE & CO VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 1 5 0 ,208 1 4 9 , 3 13\nJPMORGAN CHASE & CO VAR RT 04/22/2035 DD 04/22/24 CORPORATE DEBT INSTRUMENTS 5 1 5 ,000 5 2 6 , 938\nJPMORGAN CHASE & CO VAR RT 04/22/2041 DD 04/22/20 CORPORATE DEBT INSTRUMENTS 6 6 6 ,081 4 9 7 , 1 47\nJPMORGAN CHASE & CO VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 2 0 4 ,908 2 0 2 , 1 17\nJPMORGAN CHASE & CO VAR RT 04/22/2051 DD 04/22/20 CORPORATE DEBT INSTRUMENTS 7 4 , 9 45 4 3 , 1 2 2\nJPMORGAN CHASE & CO VAR RT 04/22/2052 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 3 5 8 ,795 2 5 7 , 340\nJPMORGAN CHASE & CO VAR RT 05/06/2030 DD 05/06/19 CORPORATE DEBT INSTRUMENTS 1 , 9 08,347 1 , 5 9 5,442\nJPMORGAN CHASE & CO VAR RT 07/22/2035 DD 07/22/24 CORPORATE DEBT INSTRUMENTS 9 0 0 ,163 8 8 0 , 504\nJPMORGAN CHASE & CO VAR RT 07/24/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 1 9 0 ,029 1 7 9 , 3 11\nJPMORGAN CHASE & CO VAR RT 07/24/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 1 , 7 90,843 1 , 2 8 4,205\nJPMORGAN CHASE & CO VAR RT 07/24/2048 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 7 7 3 ,035 6 1 5 , 8 33\n35\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nJPMORGAN CHASE & CO VAR RT 07/24/2048 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 4 6 9 ,069 3 6 7 , 1 31\nJPMORGAN CHASE & CO VAR RT 10/22/2035 DD 10/22/24 CORPORATE DEBT INSTRUMENTS 6 4 6 ,180 6 2 6 , 1 58\nJPMORGAN CHASE & CO VAR RT 11/15/2048 DD 11/10/17 CORPORATE DEBT INSTRUMENTS 9 3 5 ,905 8 9 9 , 9 10\nJPMORGAN CHASE & CO VAR RT 11/15/2048 DD 11/10/17 CORPORATE DEBT INSTRUMENTS 5 0 9 ,055 4 0 6 , 9 16\nJPMORGAN CHASE & CO VAR RT 11/19/2041 DD 11/19/20 CORPORATE DEBT INSTRUMENTS 5 6 , 3 33 5 4 , 2 4 9\nJPMORGAN CHASE & CO VAR RT 11/29/2045 DD 11/29/24 CORPORATE DEBT INSTRUMENTS 3 1 0 ,000 3 0 2 , 858\nKAISER FOUNDATION HOSPITALS 2.810% 06/01/2041 DD 06/15/21 CORPORATE DEBT INSTRUMENTS 5 7 7 ,540 4 0 7 , 347\nKAISER FOUNDATION HOSPITALS 3.002% 06/01/2051 DD 06/15/21 CORPORATE DEBT INSTRUMENTS 7 7 8 ,794 5 0 4 , 076\nKAISER FOUNDATION HOSPITALS 3.266% 11/01/2049 DD 10/31/19 CORPORATE DEBT INSTRUMENTS 7 2 0 ,000 4 9 9 , 802\nKAISER FOUNDATION HOSPITALS 3.266% 11/01/2049 DD 10/31/19 CORPORATE DEBT INSTRUMENTS 3 6 0 ,000 2 4 9 , 9 01\nKAISER FOUNDATION HOSPITALS 4.150% 05/01/2047 DD 05/03/17 CORPORATE DEBT INSTRUMENTS 1 8 8 ,197 1 5 5 , 1 31\nKENTUCKY UTILITIES CO 5.125% 11/01/2040 DD 05/01/11 CORPORATE DEBT INSTRUMENTS 3 6 0 ,731 3 0 7 , 895\nKENVUE INC 5.000% 03/22/2030 DD 09/22/23 CORPORATE DEBT INSTRUMENTS 6 9 3 ,256 7 0 0 , 727\nKENVUE INC 5.100% 03/22/2043 DD 09/22/23 CORPORATE DEBT INSTRUMENTS 1 4 3 ,500 1 3 9 , 2 28\nKEURIG DR PEPPER INC 4.500% 04/15/2052 DD 04/22/22 CORPORATE DEBT INSTRUMENTS 7 1 8 ,519 5 9 6 , 965\nKILROY REALTY LP 2.650% 11/15/2033 DD 10/07/21 CORPORATE DEBT INSTRUMENTS 3 4 , 8 03 3 4 , 4 3 2\nKILROY REALTY LP 6.250% 01/15/2036 DD 01/12/24 CORPORATE DEBT INSTRUMENTS 5 0 , 5 56 4 9 , 6 1 9\nKIMBERLY-CLARK CORP 3.100% 03/26/2030 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 1 , 5 33,233 1 , 2 4 3,385\nKINDER MORGAN ENERGY PARTNERS 4.700% 11/01/2042 DD 11/08/12 CORPORATE DEBT INSTRUMENTS 1 6 2 ,198 1 1 7 , 7 46\nKINDER MORGAN ENERGY PARTNERS 5.400% 09/01/2044 DD 09/11/14 CORPORATE DEBT INSTRUMENTS 1 1 1 ,514 1 1 8 , 7 23\nKINDER MORGAN ENERGY PARTNERS 5.500% 03/01/2044 DD 02/24/14 CORPORATE DEBT INSTRUMENTS 1 , 0 79,263 9 8 7 , 436\nKINDER MORGAN ENERGY PARTNERS 5.500% 03/01/2044 DD 02/24/14 CORPORATE DEBT INSTRUMENTS 2 1 5 ,742 2 1 3 , 2 49\nKINDER MORGAN ENERGY PARTNERS 5.625% 09/01/2041 DD 08/17/11 CORPORATE DEBT INSTRUMENTS 1 , 4 05,540 1 , 3 0 6,761\nKINDER MORGAN ENERGY PARTNERS 6.375% 03/01/2041 DD 03/04/11 CORPORATE DEBT INSTRUMENTS 3 0 3 ,266 3 1 1 , 8 75\nKINDER MORGAN ENERGY PARTNERS 6.950% 01/15/2038 DD 06/21/07 CORPORATE DEBT INSTRUMENTS 2 1 9 ,704 1 9 5 , 2 05\nKINDER MORGAN INC 5.050% 02/15/2046 DD 02/26/15 CORPORATE DEBT INSTRUMENTS 3 , 1 00,659 2 , 6 7 9,777\nKINDER MORGAN INC 5.050% 02/15/2046 DD 02/26/15 CORPORATE DEBT INSTRUMENTS 6 1 1 ,981 4 7 4 , 335\nKINDER MORGAN INC 5.200% 03/01/2048 DD 03/01/18 CORPORATE DEBT INSTRUMENTS 5 7 7 ,939 5 6 5 , 920\nKINDER MORGAN INC 5.200% 03/01/2048 DD 03/01/18 CORPORATE DEBT INSTRUMENTS 1 2 9 ,516 1 1 4 , 9 53\nKINDER MORGAN INC 5.550% 06/01/2045 DD 11/26/14 CORPORATE DEBT INSTRUMENTS 5 6 5 ,936 4 5 3 , 1 65\nKINDER MORGAN INC 5.550% 06/01/2045 DD 11/26/14 CORPORATE DEBT INSTRUMENTS 3 5 , 6 59 3 2 , 7 0 3\nKKR GROUP FINANCE CO II L 144A 5.500% 02/01/2043 DD 02/01/13 CORPORATE DEBT INSTRUMENTS 9 7 2 ,060 9 3 8 , 988\nKKR GROUP FINANCE CO III 144A 5.125% 06/01/2044 DD 05/29/14 CORPORATE DEBT INSTRUMENTS 4 3 5 ,232 3 2 0 , 037\nKLA CORP 4.700% 02/01/2034 DD 02/01/24 CORPORATE DEBT INSTRUMENTS 4 8 9 ,900 4 8 5 , 405\nKLA CORP 4.950% 07/15/2052 DD 06/23/22 CORPORATE DEBT INSTRUMENTS 1 7 7 ,553 1 6 2 , 0 23\nKLA CORP 4.950% 07/15/2052 DD 06/23/22 CORPORATE DEBT INSTRUMENTS 3 6 2 ,639 3 2 7 , 686\nKLA CORP 5.000% 03/15/2049 DD 03/20/19 CORPORATE DEBT INSTRUMENTS 6 6 9 ,134 6 1 9 , 7 23\nKRAFT HEINZ FOODS CO 4.375% 06/01/2046 DD 05/24/16 CORPORATE DEBT INSTRUMENTS 1 , 2 15,026 1 , 1 6 1,225\nKRAFT HEINZ FOODS CO 4.875% 10/01/2049 DD 10/01/20 CORPORATE DEBT INSTRUMENTS 2 6 5 ,398 2 4 4 , 836\nKRAFT HEINZ FOODS CO 5.200% 07/15/2045 DD 07/15/16 CORPORATE DEBT INSTRUMENTS 6 0 0 ,870 5 6 5 , 288\nKRAFT HEINZ FOODS CO 5.500% 06/01/2050 DD 12/01/20 CORPORATE DEBT INSTRUMENTS 2 3 4 ,504 2 3 0 , 1 70\nKROGER CO/THE 4.450% 02/01/2047 DD 01/24/17 CORPORATE DEBT INSTRUMENTS 1 , 2 49,153 1 , 0 1 7,294\nKROGER CO/THE 4.450% 02/01/2047 DD 01/24/17 CORPORATE DEBT INSTRUMENTS 1 , 7 86,424 1 , 4 8 3,520\nKROGER CO/THE 5.500% 09/15/2054 DD 08/27/24 CORPORATE DEBT INSTRUMENTS 3 2 7 ,645 3 1 0 , 2 67\nKROGER CO/THE 5.650% 09/15/2064 DD 08/27/24 CORPORATE DEBT INSTRUMENTS 2 9 3 ,687 2 7 7 , 858\n36\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nL3HARRIS TECHNOLOGIES INC 5.500% 08/15/2054 DD 08/02/24 CORPORATE DEBT INSTRUMENTS 1 , 3 46,586 1 , 3 1 3,198\nL3HARRIS TECHNOLOGIES INC 5.600% 07/31/2053 DD 07/31/23 CORPORATE DEBT INSTRUMENTS 3 0 5 ,517 2 9 6 , 900\nLELAND STANFORD JUNIOR UNIVERS 1.289% 06/01/2027 DD 06/04/20 CORPORATE DEBT INSTRUMENTS 2 , 1 00,987 1 , 9 0 8,768\nLOCKHEED MARTIN CORP 1.850% 06/15/2030 DD 05/20/20 CORPORATE DEBT INSTRUMENTS 1 , 9 19,606 1 , 6 0 7,438\nLOCKHEED MARTIN CORP 4.090% 09/15/2052 DD 09/07/17 CORPORATE DEBT INSTRUMENTS 8 1 8 ,599 7 5 4 , 795\nLOCKHEED MARTIN CORP 4.090% 09/15/2052 DD 09/07/17 CORPORATE DEBT INSTRUMENTS 8 4 , 3 66 7 5 , 2 4 2\nLOCKHEED MARTIN CORP 4.700% 05/15/2046 DD 11/23/15 CORPORATE DEBT INSTRUMENTS 1 , 9 58,167 1 , 6 3 1,767\nLOCKHEED MARTIN CORP 5.200% 02/15/2055 DD 05/25/23 CORPORATE DEBT INSTRUMENTS 1 3 3 ,974 1 2 7 , 2 40\nLOCKHEED MARTIN CORP 5.200% 02/15/2064 DD 01/29/24 CORPORATE DEBT INSTRUMENTS 6 6 2 ,865 6 1 8 , 4 23\nLOCKHEED MARTIN CORP 5.200% 02/15/2064 DD 01/29/24 CORPORATE DEBT INSTRUMENTS 6 9 4 ,763 6 4 8 , 1 82\nLOCKHEED MARTIN CORP 5.700% 11/15/2054 DD 10/24/22 CORPORATE DEBT INSTRUMENTS 9 2 2 ,374 9 4 7 , 828\nLOUISVILLE GAS AND ELECTRIC CO 3.300% 10/01/2025 DD 09/28/15 CORPORATE DEBT INSTRUMENTS 1 , 9 69,069 1 , 7 4 7,350\nLOUISVILLE GAS AND ELECTRIC CO 4.650% 11/15/2043 DD 11/14/13 CORPORATE DEBT INSTRUMENTS 7 6 9 ,620 6 3 9 , 4 13\nLOWE'S COS INC 3.000% 10/15/2050 DD 10/22/20 CORPORATE DEBT INSTRUMENTS 9 8 5 ,967 6 0 0 , 539\nLOWE'S COS INC 3.700% 04/15/2046 DD 04/20/16 CORPORATE DEBT INSTRUMENTS 8 7 8 ,895 6 6 6 , 846\nLOWE'S COS INC 4.050% 05/03/2047 DD 05/03/17 CORPORATE DEBT INSTRUMENTS 3 1 2 ,997 2 4 4 , 774\nLOWE'S COS INC 4.050% 05/03/2047 DD 05/03/17 CORPORATE DEBT INSTRUMENTS 1 , 1 18,839 8 7 4 , 970\nLOWE'S COS INC 4.250% 04/01/2052 DD 03/24/22 CORPORATE DEBT INSTRUMENTS 4 9 6 ,553 4 4 1 , 8 07\nLOWE'S COS INC 4.450% 04/01/2062 DD 03/24/22 CORPORATE DEBT INSTRUMENTS 1 0 9 ,918 8 5 , 3 4 9\nLOWE'S COS INC 4.550% 04/05/2049 DD 04/05/19 CORPORATE DEBT INSTRUMENTS 1 5 5 ,198 1 0 3 , 3 39\nLOWE'S COS INC 5.800% 09/15/2062 DD 09/08/22 CORPORATE DEBT INSTRUMENTS 1 , 2 04,822 1 , 1 7 5,407\nLOWE'S COS INC 5.800% 09/15/2062 DD 09/08/22 CORPORATE DEBT INSTRUMENTS 7 4 , 8 55 7 2 , 6 1 6\nLSEG US FIN CORP 144A 5.297% 03/28/2034 DD 03/28/24 CORPORATE DEBT INSTRUMENTS 5 0 7 ,765 4 9 7 , 985\nLYB INTERNATIONAL FINANCE III 4.200% 05/01/2050 DD 04/20/20 CORPORATE DEBT INSTRUMENTS 1 , 5 20,407 1 , 1 4 1,824\nM&T BANK CORP VAR RT 01/16/2036 DD 12/17/24 CORPORATE DEBT INSTRUMENTS 5 2 0 ,000 5 0 4 , 1 97\nMARATHON PETROLEUM CORP 4.750% 09/15/2044 DD 09/05/14 CORPORATE DEBT INSTRUMENTS 1 9 5 ,809 1 4 1 , 2 21\nMARATHON PETROLEUM CORP 6.500% 03/01/2041 DD 09/01/11 CORPORATE DEBT INSTRUMENTS 8 8 9 ,982 8 3 7 , 686\nMARATHON PETROLEUM CORP 6.500% 03/01/2041 DD 09/01/11 CORPORATE DEBT INSTRUMENTS 1 6 9 ,911 1 3 4 , 7 76\nMARKEL GROUP INC 5.000% 05/20/2049 DD 05/20/19 CORPORATE DEBT INSTRUMENTS 1 , 2 92,966 1 , 1 2 5,410\nMARSH & MCLENNAN COS INC 2.250% 11/15/2030 DD 05/07/20 CORPORATE DEBT INSTRUMENTS 1 , 5 31,522 1 , 2 7 3,338\nMARSH & MCLENNAN COS INC 4.200% 03/01/2048 DD 03/01/18 CORPORATE DEBT INSTRUMENTS 7 2 7 ,036 5 9 2 , 6 14\nMARSH & MCLENNAN COS INC 4.350% 01/30/2047 DD 01/12/17 CORPORATE DEBT INSTRUMENTS 3 0 3 ,603 3 2 5 , 8 61\nMARSH & MCLENNAN COS INC 4.750% 03/15/2039 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 7 5 6 ,440 7 4 0 , 880\nMARSH & MCLENNAN COS INC 4.900% 03/15/2049 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 9 5 3 ,978 8 5 5 , 986\nMARSH & MCLENNAN COS INC 4.900% 03/15/2049 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 9 2 , 6 48 9 4 , 1 1 4\nMARSH & MCLENNAN COS INC 5.400% 03/15/2055 DD 11/08/24 CORPORATE DEBT INSTRUMENTS 2 3 0 ,884 2 2 2 , 657\nMARSH & MCLENNAN COS INC 5.450% 03/15/2054 DD 02/20/24 CORPORATE DEBT INSTRUMENTS 5 9 , 4 76 5 8 , 0 1 9\nMARSH & MCLENNAN COS INC 5.700% 09/15/2053 DD 09/11/23 CORPORATE DEBT INSTRUMENTS 8 4 9 ,444 8 5 5 , 2 21\nMARTIN MARIETTA MATERIALS INC 5.500% 12/01/2054 DD 11/04/24 CORPORATE DEBT INSTRUMENTS 7 6 4 ,447 7 3 6 , 9 21\nMASS GENERAL BRIGHAM INC 3.192% 07/01/2049 DD 01/29/20 CORPORATE DEBT INSTRUMENTS 1 , 0 96,103 7 4 0 , 1 32\nMASSACHUSETTS INSTITUTE OF TEC 3.067% 04/01/2052 DD 03/08/22 CORPORATE DEBT INSTRUMENTS 1 , 0 00,000 6 7 2 , 1 90\nMASSACHUSETTS INSTITUTE OF TEC 5.600% 07/01/2111 DD 05/18/11 CORPORATE DEBT INSTRUMENTS 7 4 3 ,740 5 8 4 , 408\nMASSACHUSETTS MUTUAL LIFE 144A 3.375% 04/15/2050 DD 04/16/20 CORPORATE DEBT INSTRUMENTS 2 0 4 ,155 1 3 7 , 0 65\nMASSACHUSETTS MUTUAL LIFE 144A 3.729% 10/15/2070 DD 10/11/19 CORPORATE DEBT INSTRUMENTS 2 8 2 ,471 1 9 4 , 0 16\nMASTERCARD INC 3.300% 03/26/2027 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 1 , 9 17,164 1 , 6 5 2,828\n37\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nMASTERCARD INC 3.650% 06/01/2049 DD 05/31/19 CORPORATE DEBT INSTRUMENTS 4 6 1 ,561 3 2 8 , 673\nMCDONALD'S CORP 3.625% 09/01/2049 DD 08/12/19 CORPORATE DEBT INSTRUMENTS 5 1 2 ,198 3 7 1 , 8 04\nMCDONALD'S CORP 3.625% 09/01/2049 DD 08/12/19 CORPORATE DEBT INSTRUMENTS 6 7 4 ,195 4 5 0 , 497\nMCDONALD'S CORP 4.450% 03/01/2047 DD 03/09/17 CORPORATE DEBT INSTRUMENTS 1 , 1 29,427 9 5 3 , 627\nMCDONALD'S CORP 4.450% 03/01/2047 DD 03/09/17 CORPORATE DEBT INSTRUMENTS 1 , 3 33,263 1 , 1 3 2,590\nMCDONALD'S CORP 4.600% 05/26/2045 DD 05/26/15 CORPORATE DEBT INSTRUMENTS 3 2 9 ,699 2 8 6 , 440\nMCDONALD'S CORP 5.150% 09/09/2052 DD 09/09/22 CORPORATE DEBT INSTRUMENTS 4 7 9 ,103 4 7 6 , 450\nMEDTRONIC INC 4.375% 03/15/2035 DD 03/15/15 CORPORATE DEBT INSTRUMENTS 4 5 4 ,020 4 4 1 , 6 31\nMEMORIAL HEALTH SERVICES 3.447% 11/01/2049 DD 12/12/19 CORPORATE DEBT INSTRUMENTS 4 0 5 ,000 2 8 8 , 1 53\nMERCEDES-BENZ FINANCE NOR 144A 5.000% 01/11/2034 DD 01/11/24 CORPORATE DEBT INSTRUMENTS 5 8 8 ,042 5 8 0 , 452\nMERCK & CO INC 2.350% 06/24/2040 DD 06/24/20 CORPORATE DEBT INSTRUMENTS 1 0 6 ,961 8 1 , 3 1 3\nMERCK & CO INC 2.750% 02/10/2025 DD 02/10/15 CORPORATE DEBT INSTRUMENTS 1 , 5 30,860 1 , 4 1 2,312\nMERCK & CO INC 2.750% 12/10/2051 DD 12/10/21 CORPORATE DEBT INSTRUMENTS 1 7 8 ,263 1 6 0 , 8 92\nMERCK & CO INC 2.900% 12/10/2061 DD 12/10/21 CORPORATE DEBT INSTRUMENTS 8 2 2 ,674 4 7 4 , 062\nMERCK & CO INC 3.700% 02/10/2045 DD 02/10/15 CORPORATE DEBT INSTRUMENTS 5 5 1 ,809 4 3 0 , 264\nMERCK & CO INC 4.150% 05/18/2043 DD 05/20/13 CORPORATE DEBT INSTRUMENTS 5 9 3 ,179 4 9 8 , 860\nMERCK & CO INC 4.900% 05/17/2044 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 1 , 1 24,103 1 , 0 4 4,425\nMERCK & CO INC 5.000% 05/17/2053 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 4 4 8 ,196 4 1 0 , 1 75\nMERCK & CO INC 5.150% 05/17/2063 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 3 4 3 ,492 3 1 6 , 1 17\nMETA PLATFORMS INC 3.850% 08/15/2032 DD 08/09/22 CORPORATE DEBT INSTRUMENTS 5 5 7 ,358 5 5 7 , 796\nMETA PLATFORMS INC 4.450% 08/15/2052 DD 08/09/22 CORPORATE DEBT INSTRUMENTS 1 2 9 ,085 1 2 2 , 4 15\nMETA PLATFORMS INC 4.450% 08/15/2052 DD 08/09/22 CORPORATE DEBT INSTRUMENTS 5 4 1 ,931 4 7 6 , 1 51\nMETA PLATFORMS INC 4.750% 08/15/2034 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 0 3 ,851 5 8 9 , 270\nMETA PLATFORMS INC 5.400% 08/15/2054 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 8 2 ,267 6 6 3 , 786\nMETA PLATFORMS INC 5.400% 08/15/2054 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 1 6 ,530 5 9 9 , 830\nMETA PLATFORMS INC 5.400% 08/15/2054 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 4 3 3 ,264 4 2 1 , 5 28\nMETA PLATFORMS INC 5.550% 08/15/2064 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 2 2 ,300 6 1 1 , 8 88\nMETA PLATFORMS INC 5.550% 08/15/2064 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 8 5 6 ,285 8 4 1 , 9 57\nMETA PLATFORMS INC 5.600% 05/15/2053 DD 05/03/23 CORPORATE DEBT INSTRUMENTS 2 , 3 61,095 2 , 3 7 4,100\nMETA PLATFORMS INC 5.750% 05/15/2063 DD 05/03/23 CORPORATE DEBT INSTRUMENTS 1 3 9 ,583 1 4 1 , 6 09\nMETLIFE INC 4.050% 03/01/2045 DD 03/05/15 CORPORATE DEBT INSTRUMENTS 2 , 6 17,989 2 , 1 6 0,601\nMETLIFE INC 4.050% 03/01/2045 DD 03/05/15 CORPORATE DEBT INSTRUMENTS 1 2 6 ,075 1 0 0 , 1 76\nMETLIFE INC 4.125% 08/13/2042 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 3 2 8 ,960 2 4 9 , 078\nMETLIFE INC 4.875% 11/13/2043 DD 11/13/13 CORPORATE DEBT INSTRUMENTS 8 7 8 ,448 7 9 5 , 1 83\nMETLIFE INC 5.000% 07/15/2052 DD 07/11/22 CORPORATE DEBT INSTRUMENTS 8 8 , 9 44 8 6 , 1 1 5\nMETLIFE INC 5.250% 01/15/2054 DD 01/06/23 CORPORATE DEBT INSTRUMENTS 1 , 0 81,182 1 , 0 3 1,415\nMETLIFE INC 5.700% 06/15/2035 DD 06/23/05 CORPORATE DEBT INSTRUMENTS 2 8 0 ,405 2 5 1 , 8 89\nMETLIFE INC 5.875% 02/06/2041 DD 08/06/10 CORPORATE DEBT INSTRUMENTS 5 1 5 ,779 4 6 9 , 982\nMETLIFE INC 5.875% 02/06/2041 DD 08/06/10 CORPORATE DEBT INSTRUMENTS 3 2 2 ,467 3 2 6 , 944\nMETLIFE INC VAR RT 12/15/2044 DD 09/15/14 CORPORATE DEBT INSTRUMENTS 1 9 6 ,790 1 7 2 , 3 31\nMETLIFE INC VAR RT 12/15/2044 DD 09/15/14 CORPORATE DEBT INSTRUMENTS 1 8 2 ,948 1 2 8 , 1 44\nMETROPOLITAN LIFE GLOBAL 144A 4.300% 08/25/2029 DD 08/25/22 CORPORATE DEBT INSTRUMENTS 5 9 9 ,424 5 8 3 , 1 64\nMICROSOFT CORP 2.525% 06/01/2050 DD 06/01/20 CORPORATE DEBT INSTRUMENTS 7 3 3 ,205 7 2 8 , 367\nMICROSOFT CORP 2.525% 06/01/2050 DD 06/01/20 CORPORATE DEBT INSTRUMENTS 1 , 0 93,314 7 4 9 , 9 71\nMICROSOFT CORP 2.675% 06/01/2060 DD 06/01/20 CORPORATE DEBT INSTRUMENTS 1 , 5 81,126 9 6 5 , 480\n38\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nMICROSOFT CORP 2.921% 03/17/2052 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 1 , 9 82,256 1 , 3 6 5,574\nMICROSOFT CORP 2.921% 03/17/2052 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 5 5 2 ,910 3 8 1 , 1 68\nMICROSOFT CORP 3.041% 03/17/2062 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 2 , 0 85,308 1 , 3 5 6,965\nMICROSOFT CORP 3.300% 02/06/2027 DD 02/06/17 CORPORATE DEBT INSTRUMENTS 2 , 2 93,620 1 , 9 6 2,975\nMICROSOFT CORP 3.700% 08/08/2046 DD 08/08/16 CORPORATE DEBT INSTRUMENTS 1 , 3 81,635 1 , 2 0 9,767\nMIDAMERICAN ENERGY CO 3.150% 04/15/2050 DD 10/15/19 CORPORATE DEBT INSTRUMENTS 6 0 1 ,588 4 0 6 , 608\nMIDAMERICAN ENERGY CO 5.300% 02/01/2055 DD 01/24/24 CORPORATE DEBT INSTRUMENTS 5 7 5 ,549 5 4 6 , 886\nMIDAMERICAN ENERGY CO 5.800% 10/15/2036 DD 10/06/06 CORPORATE DEBT INSTRUMENTS 6 6 6 ,394 5 7 3 , 7 31\nMIDAMERICAN ENERGY CO 5.850% 09/15/2054 DD 09/07/23 CORPORATE DEBT INSTRUMENTS 2 9 6 ,655 3 0 2 , 503\nMINERA MEXICO SA DE CV 144A 4.500% 01/26/2050 DD 09/26/19 CORPORATE DEBT INSTRUMENTS 7 6 8 ,707 6 0 7 , 232\nMONONGAHELA POWER CO 144A 5.400% 12/15/2043 DD 11/27/13 CORPORATE DEBT INSTRUMENTS 3 2 4 ,378 2 8 3 , 602\nMOODY'S CORP 4.875% 12/17/2048 DD 12/17/18 CORPORATE DEBT INSTRUMENTS 5 2 8 ,021 4 7 8 , 080\nMOODY'S CORP 5.250% 07/15/2044 DD 07/16/14 CORPORATE DEBT INSTRUMENTS 8 7 6 ,959 8 2 4 , 377\nMORGAN STANLEY 4.300% 01/27/2045 DD 01/27/15 CORPORATE DEBT INSTRUMENTS 1 , 0 81,795 9 0 7 , 489\nMORGAN STANLEY 4.300% 01/27/2045 DD 01/27/15 CORPORATE DEBT INSTRUMENTS 7 4 1 ,802 6 1 4 , 6 18\nMORGAN STANLEY 4.375% 01/22/2047 DD 01/20/17 CORPORATE DEBT INSTRUMENTS 4 1 , 9 11 4 5 , 9 8 2\nMORGAN STANLEY 6.375% 07/24/2042 DD 07/24/12 CORPORATE DEBT INSTRUMENTS 1 , 2 92,104 1 , 1 4 1,278\nMORGAN STANLEY VAR RT 01/23/2030 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 1 , 5 27,528 1 , 2 5 5,880\nMORGAN STANLEY VAR RT 01/25/2052 DD 01/25/21 CORPORATE DEBT INSTRUMENTS 9 1 4 ,000 5 5 9 , 1 76\nMORGAN STANLEY VAR RT 04/19/2035 DD 04/19/24 CORPORATE DEBT INSTRUMENTS 1 4 6 ,247 1 4 8 , 0 26\nMORGAN STANLEY VAR RT 04/22/2039 DD 04/24/18 CORPORATE DEBT INSTRUMENTS 3 6 3 ,120 3 0 9 , 9 61\nMORGAN STANLEY VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 7 9 5 ,000 5 8 9 , 0 31\nMORGAN STANLEY VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 1 , 3 03,000 9 6 5 , 4 19\nMORGAN STANLEY VAR RT 07/19/2035 DD 07/19/24 CORPORATE DEBT INSTRUMENTS 3 8 5 ,000 3 7 8 , 828\nMORGAN STANLEY VAR RT 07/21/2032 DD 07/20/21 CORPORATE DEBT INSTRUMENTS 3 0 1 ,063 3 2 7 , 392\nMORGAN STANLEY VAR RT 07/22/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 3 9 5 ,515 3 5 3 , 090\nMORGAN STANLEY VAR RT 07/22/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 4 1 5 ,000 3 5 3 , 090\nMORGAN STANLEY VAR RT 11/19/2055 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 8 0 0 ,000 7 7 2 , 672\nMPLX LP 4.500% 04/15/2038 DD 02/08/18 CORPORATE DEBT INSTRUMENTS 6 7 6 ,401 5 9 2 , 8 51\nMPLX LP 5.500% 02/15/2049 DD 11/15/18 CORPORATE DEBT INSTRUMENTS 1 , 0 96,967 1 , 0 2 8,809\nMULTICARE HEALTH SYSTEM 2.803% 08/15/2050 DD 07/22/20 CORPORATE DEBT INSTRUMENTS 6 1 0 ,000 3 5 8 , 7 41\nNASDAQ INC 5.950% 08/15/2053 DD 06/28/23 CORPORATE DEBT INSTRUMENTS 4 5 , 9 39 4 5 , 4 4 5\nNASDAQ INC 6.100% 06/28/2063 DD 06/28/23 CORPORATE DEBT INSTRUMENTS 2 3 1 ,211 2 3 9 , 496\nNATIONAL RURAL UTILITIES COOPE 3.250% 11/01/2025 DD 10/27/15 CORPORATE DEBT INSTRUMENTS 1 , 9 21,446 1 , 6 9 9,085\nNATIONAL RURAL UTILITIES COOPE 4.300% 03/15/2049 DD 01/31/19 CORPORATE DEBT INSTRUMENTS 6 3 7 ,811 5 1 7 , 9 90\nNATIONWIDE CHILDREN'S HOSPITAL 4.556% 11/01/2052 DD 05/12/22 CORPORATE DEBT INSTRUMENTS 3 7 5 ,000 3 2 8 , 076\nNATIONWIDE MUTUAL INSURAN 144A 4.350% 04/30/2050 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 7 4 5 ,259 5 5 9 , 398\nNESTLE CAPITAL CORP 144A 5.100% 03/12/2054 DD 03/12/24 CORPORATE DEBT INSTRUMENTS 6 6 6 ,868 6 3 6 , 633\nNESTLE HOLDINGS INC 144A 3.625% 09/24/2028 DD 09/24/18 CORPORATE DEBT INSTRUMENTS 1 , 7 47,665 1 , 4 4 3,975\nNESTLE HOLDINGS INC 144A 3.900% 09/24/2038 DD 09/24/18 CORPORATE DEBT INSTRUMENTS 6 3 3 ,158 5 5 1 , 5 33\nNETFLIX INC 5.400% 08/15/2054 DD 08/01/24 CORPORATE DEBT INSTRUMENTS 6 0 9 ,717 5 9 7 , 448\nNEVADA POWER CO 6.000% 03/15/2054 DD 09/13/23 CORPORATE DEBT INSTRUMENTS 4 0 8 ,176 4 5 5 , 1 10\nNEW ENGLAND POWER CO 144A 3.800% 12/05/2047 DD 12/05/17 CORPORATE DEBT INSTRUMENTS 9 3 8 ,631 7 0 1 , 2 75\nNEW YORK AND PRESBYTERIAN HOSP 4.763% 08/01/2116 DD 06/28/16 CORPORATE DEBT INSTRUMENTS 8 7 4 ,302 6 3 1 , 3 63\nNEW YORK LIFE INSURANCE C 144A 3.750% 05/15/2050 DD 04/14/20 CORPORATE DEBT INSTRUMENTS 2 2 3 ,625 1 6 3 , 8 32\n39\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nNEW YORK LIFE INSURANCE C 144A 5.875% 05/15/2033 DD 05/08/03 CORPORATE DEBT INSTRUMENTS 9 2 5 ,669 7 9 1 , 2 29\nNEW YORK LIFE INSURANCE C 144A 6.750% 11/15/2039 DD 10/08/09 CORPORATE DEBT INSTRUMENTS 1 , 5 74,732 1 , 3 9 7,403\nNIAGARA MOHAWK POWER CORP 144A 4.119% 11/28/2042 DD 11/28/12 CORPORATE DEBT INSTRUMENTS 1 , 9 29,348 1 , 5 1 8,917\nNIKE INC 2.850% 03/27/2030 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 1 , 9 08,294 1 , 5 7 5,684\nNIKE INC 3.250% 03/27/2040 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 1 , 0 75,090 9 4 5 , 602\nNISOURCE INC 3.950% 03/30/2048 DD 09/14/17 CORPORATE DEBT INSTRUMENTS 6 7 8 ,267 5 1 8 , 2 67\nNISOURCE INC 4.375% 05/15/2047 DD 05/22/17 CORPORATE DEBT INSTRUMENTS 4 7 4 ,611 3 8 8 , 764\nNNN REIT INC 3.500% 04/15/2051 DD 03/10/21 CORPORATE DEBT INSTRUMENTS 1 , 2 28,613 8 4 7 , 779\nNORFOLK SOUTHERN CORP 3.155% 05/15/2055 DD 05/15/20 CORPORATE DEBT INSTRUMENTS 7 1 4 ,059 6 9 0 , 297\nNORFOLK SOUTHERN CORP 3.942% 11/01/2047 DD 05/01/18 CORPORATE DEBT INSTRUMENTS 2 0 3 ,012 1 5 3 , 9 28\nNORFOLK SOUTHERN CORP 4.150% 02/28/2048 DD 02/28/18 CORPORATE DEBT INSTRUMENTS 8 0 3 ,296 6 4 2 , 888\nNORFOLK SOUTHERN CORP 4.837% 10/01/2041 DD 04/01/12 CORPORATE DEBT INSTRUMENTS 7 3 5 ,066 5 9 3 , 502\nNORFOLK SOUTHERN CORP 5.100% 08/01/2118 DD 08/02/18 CORPORATE DEBT INSTRUMENTS 1 , 3 03,466 1 , 1 1 1,302\nNORFOLK SOUTHERN CORP 5.950% 03/15/2064 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 4 8 3 ,647 4 9 8 , 604\nNORFOLK SOUTHERN CORP 5.950% 03/15/2064 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 1 4 9 ,582 1 5 4 , 2 08\nNORTHERN NATURAL GAS CO 144A 4.300% 01/15/2049 DD 07/17/18 CORPORATE DEBT INSTRUMENTS 8 7 4 ,016 6 7 0 , 8 71\nNORTHERN STATES POWER CO/MN 2.900% 03/01/2050 DD 09/10/19 CORPORATE DEBT INSTRUMENTS 2 7 4 ,599 1 7 9 , 4 41\nNORTHERN STATES POWER CO/MN 3.400% 08/15/2042 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 1 , 0 15,464 8 1 7 , 7 49\nNORTHERN STATES POWER CO/MN 3.400% 08/15/2042 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 3 3 2 ,353 3 0 0 , 1 96\nNORTHERN STATES POWER CO/MN 5.100% 05/15/2053 DD 05/08/23 CORPORATE DEBT INSTRUMENTS 4 2 6 ,792 3 9 8 , 429\nNORTHERN STATES POWER CO/MN 5.100% 05/15/2053 DD 05/08/23 CORPORATE DEBT INSTRUMENTS 3 3 2 ,501 3 1 0 , 4 04\nNORTHERN STATES POWER CO/MN 6.200% 07/01/2037 DD 06/26/07 CORPORATE DEBT INSTRUMENTS 2 , 5 30,246 2 , 3 8 1,237\nNORTHROP GRUMMAN CORP 3.850% 04/15/2045 DD 02/06/15 CORPORATE DEBT INSTRUMENTS 1 , 4 63,745 1 , 2 0 1,199\nNORTHROP GRUMMAN CORP 4.030% 10/15/2047 DD 10/13/17 CORPORATE DEBT INSTRUMENTS 7 1 6 ,520 5 5 3 , 876\nNORTHROP GRUMMAN CORP 4.030% 10/15/2047 DD 10/13/17 CORPORATE DEBT INSTRUMENTS 7 7 7 ,786 6 2 0 , 656\nNORTHROP GRUMMAN CORP 4.750% 06/01/2043 DD 05/31/13 CORPORATE DEBT INSTRUMENTS 1 , 2 93,757 1 , 1 6 1,576\nNORTHROP GRUMMAN CORP 4.750% 06/01/2043 DD 05/31/13 CORPORATE DEBT INSTRUMENTS 5 5 4 ,491 5 0 6 , 788\nNORTHROP GRUMMAN CORP 4.950% 03/15/2053 DD 02/08/23 CORPORATE DEBT INSTRUMENTS 6 2 1 ,005 5 8 1 , 9 55\nNORTHROP GRUMMAN CORP 5.150% 05/01/2040 DD 03/23/20 CORPORATE DEBT INSTRUMENTS 3 1 8 ,802 3 1 1 , 2 04\nNORTHROP GRUMMAN CORP 5.200% 06/01/2054 DD 01/31/24 CORPORATE DEBT INSTRUMENTS 4 6 3 ,205 4 3 2 , 529\nNORTHROP GRUMMAN CORP 5.200% 06/01/2054 DD 01/31/24 CORPORATE DEBT INSTRUMENTS 9 , 7 7 7 9 , 3 0 2\nNORTHWELL HEALTHCARE INC 4.260% 11/01/2047 DD 09/26/17 CORPORATE DEBT INSTRUMENTS 2 3 5 ,000 1 8 8 , 0 80\nNORTHWESTERN MUTUAL LIFE 144A 3.625% 09/30/2059 DD 09/20/19 CORPORATE DEBT INSTRUMENTS 1 , 8 90,526 1 , 2 5 8,823\nNOVANT HEALTH INC 3.168% 11/01/2051 DD 04/15/21 CORPORATE DEBT INSTRUMENTS 1 , 0 65,000 7 0 4 , 700\nNOVARTIS CAPITAL CORP 2.200% 08/14/2030 DD 02/14/20 CORPORATE DEBT INSTRUMENTS 1 , 5 33,781 1 , 2 6 9,765\nNOVARTIS CAPITAL CORP 4.400% 05/06/2044 DD 02/21/14 CORPORATE DEBT INSTRUMENTS 7 6 9 ,223 6 8 9 , 2 14\nNSTAR ELECTRIC CO 3.950% 04/01/2030 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 8 5 2 ,040 6 6 9 , 256\nNSTAR ELECTRIC CO 4.400% 03/01/2044 DD 03/07/14 CORPORATE DEBT INSTRUMENTS 1 , 9 11,698 1 , 6 2 6,644\nNVIDIA CORP 2.000% 06/15/2031 DD 06/16/21 CORPORATE DEBT INSTRUMENTS 4 8 1 ,844 4 6 7 , 4 12\nNVIDIA CORP 3.500% 04/01/2040 DD 03/31/20 CORPORATE DEBT INSTRUMENTS 3 7 0 ,524 3 0 6 , 1 97\nNVIDIA CORP 3.500% 04/01/2050 DD 03/31/20 CORPORATE DEBT INSTRUMENTS 7 5 6 ,773 5 3 5 , 838\nNXP BV / NXP FUNDING LLC / NXP 3.250% 05/11/2041 DD 05/11/22 CORPORATE DEBT INSTRUMENTS 1 , 1 70,252 8 6 1 , 9 20\nOCCIDENTAL PETROLEUM CORP 4.400% 04/15/2046 DD 04/04/16 CORPORATE DEBT INSTRUMENTS 1 1 9 ,075 1 2 2 , 4 33\nOCCIDENTAL PETROLEUM CORP 6.050% 10/01/2054 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 6 1 3 ,625 5 8 3 , 506\nOCCIDENTAL PETROLEUM CORP 6.050% 10/01/2054 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 8 1 6 ,449 7 7 8 , 957\n40\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nOCCIDENTAL PETROLEUM CORP 6.050% 10/01/2054 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 2 0 3 ,542 1 8 9 , 7 58\nOCCIDENTAL PETROLEUM CORP 6.200% 03/15/2040 DD 09/15/19 CORPORATE DEBT INSTRUMENTS 2 3 9 ,477 2 4 1 , 4 87\nOCCIDENTAL PETROLEUM CORP 6.600% 03/15/2046 DD 09/15/19 CORPORATE DEBT INSTRUMENTS 3 0 , 7 02 3 0 , 3 0 8\nOCCIDENTAL PETROLEUM CORP 7.950% 06/15/2039 DD 06/15/19 CORPORATE DEBT INSTRUMENTS 3 2 , 0 94 3 4 , 2 1 8\nOGLETHORPE POWER CORP 3.750% 08/01/2050 DD 02/01/21 CORPORATE DEBT INSTRUMENTS 3 3 9 ,935 2 4 5 , 864\nOGLETHORPE POWER CORP 4.500% 04/01/2047 DD 04/01/23 CORPORATE DEBT INSTRUMENTS 3 9 3 ,246 3 2 3 , 975\nOGLETHORPE POWER CORP 5.050% 10/01/2048 DD 04/01/19 CORPORATE DEBT INSTRUMENTS 1 4 8 ,843 1 2 7 , 8 13\nOGLETHORPE POWER CORP 5.375% 11/01/2040 DD 11/09/10 CORPORATE DEBT INSTRUMENTS 1 , 0 26,663 9 0 3 , 974\nOGLETHORPE POWER CORP 6.200% 12/01/2053 DD 12/05/23 CORPORATE DEBT INSTRUMENTS 1 8 2 ,277 1 9 0 , 8 16\nOHIOHEALTH CORP 2.297% 11/15/2031 DD 10/26/21 CORPORATE DEBT INSTRUMENTS 6 2 5 ,000 5 2 3 , 9 31\nONCOR ELECTRIC DELIVERY CO LLC 2.700% 11/15/2051 DD 11/16/21 CORPORATE DEBT INSTRUMENTS 3 9 7 ,220 2 3 9 , 1 69\nONCOR ELECTRIC DELIVERY CO LLC 2.750% 05/15/2030 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 1 , 5 31,068 1 , 2 5 2,236\nONCOR ELECTRIC DELIVERY CO LLC 3.750% 04/01/2045 DD 10/01/15 CORPORATE DEBT INSTRUMENTS 4 2 1 ,664 3 2 6 , 880\nONCOR ELECTRIC DELIVERY CO LLC 3.800% 09/30/2047 DD 03/30/18 CORPORATE DEBT INSTRUMENTS 9 7 8 ,599 7 4 3 , 869\nONCOR ELECTRIC DELIVERY CO LLC 4.550% 12/01/2041 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 3 6 5 ,194 3 2 9 , 336\nONCOR ELECTRIC DELIVERY CO LLC 4.950% 09/15/2052 DD 09/08/22 CORPORATE DEBT INSTRUMENTS 6 8 7 ,449 6 6 8 , 348\nONCOR ELECTRIC DELIVERY CO LLC 5.300% 06/01/2042 DD 05/18/12 CORPORATE DEBT INSTRUMENTS 6 4 6 ,689 6 0 8 , 368\nONCOR ELECTRIC DELIVERY CO LLC 5.300% 06/01/2042 DD 05/18/12 CORPORATE DEBT INSTRUMENTS 4 0 3 ,676 3 5 6 , 398\nONCOR ELECTRIC DELIVERY CO LLC 5.350% 10/01/2052 DD 04/01/21 CORPORATE DEBT INSTRUMENTS 1 , 7 81,866 1 , 0 4 0,203\nONCOR ELECTRIC DELIVERY CO LLC 5.350% 10/01/2052 DD 04/01/21 CORPORATE DEBT INSTRUMENTS 5 5 7 ,646 3 2 5 , 538\nONEOK INC 4.250% 09/15/2046 DD 09/13/16 CORPORATE DEBT INSTRUMENTS 3 4 0 ,729 2 6 5 , 295\nONTARIO TEACHERS' CADILLA 144A 2.500% 10/15/2031 DD 10/15/21 CORPORATE DEBT INSTRUMENTS 3 7 1 ,033 3 1 1 , 6 89\nORACLE CORP 3.600% 04/01/2040 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 3 , 1 50,101 2 , 1 2 4,252\nORACLE CORP 3.600% 04/01/2050 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 1 , 9 85,983 1 , 3 3 2,318\nORACLE CORP 3.600% 04/01/2050 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 6 8 9 ,165 6 2 7 , 592\nORACLE CORP 3.650% 03/25/2041 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 6 4 3 ,116 5 9 7 , 1 36\nORACLE CORP 3.800% 11/15/2037 DD 11/09/17 CORPORATE DEBT INSTRUMENTS 2 6 8 ,985 2 2 5 , 620\nORACLE CORP 3.850% 07/15/2036 DD 07/07/16 CORPORATE DEBT INSTRUMENTS 1 4 3 ,569 1 1 1 , 4 11\nORACLE CORP 3.900% 05/15/2035 DD 05/05/15 CORPORATE DEBT INSTRUMENTS 1 , 0 42,913 9 2 0 , 1 47\nORACLE CORP 3.950% 03/25/2051 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 1 , 2 87,578 9 5 9 , 996\nORACLE CORP 3.950% 03/25/2051 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 3 , 6 91,426 2 , 8 4 3,665\nORACLE CORP 3.950% 03/25/2051 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 4 2 2 ,800 4 0 7 , 7 21\nORACLE CORP 4.000% 07/15/2046 DD 07/07/16 CORPORATE DEBT INSTRUMENTS 4 7 9 ,502 3 6 9 , 792\nORACLE CORP 4.000% 11/15/2047 DD 11/09/17 CORPORATE DEBT INSTRUMENTS 6 7 1 ,966 7 6 0 , 6 11\nORACLE CORP 4.000% 11/15/2047 DD 11/09/17 CORPORATE DEBT INSTRUMENTS 1 4 1 ,851 1 4 1 , 1 37\nORACLE CORP 4.125% 05/15/2045 DD 05/05/15 CORPORATE DEBT INSTRUMENTS 8 7 , 4 84 7 1 , 0 5 8\nORACLE CORP 4.375% 05/15/2055 DD 05/05/15 CORPORATE DEBT INSTRUMENTS 1 , 6 92,333 1 , 3 3 2,562\nORACLE CORP 5.375% 09/27/2054 DD 09/27/24 CORPORATE DEBT INSTRUMENTS 1 , 0 18,136 9 7 6 , 885\nORACLE CORP 5.500% 09/27/2064 DD 09/27/24 CORPORATE DEBT INSTRUMENTS 2 3 1 ,406 2 1 5 , 4 15\nORACLE CORP 6.900% 11/09/2052 DD 11/09/22 CORPORATE DEBT INSTRUMENTS 7 5 9 ,930 8 2 4 , 824\nOTIS WORLDWIDE CORP 3.112% 02/15/2040 DD 08/15/20 CORPORATE DEBT INSTRUMENTS 4 0 0 ,027 3 1 0 , 7 06\nOTIS WORLDWIDE CORP 3.362% 02/15/2050 DD 08/15/20 CORPORATE DEBT INSTRUMENTS 4 5 2 ,273 3 1 0 , 1 63\nOWENS CORNING 5.950% 06/15/2054 DD 05/31/24 CORPORATE DEBT INSTRUMENTS 1 , 1 75,492 1 , 1 5 7,891\nPACIFIC GAS AND ELECTRIC CO 3.300% 08/01/2040 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 3 9 5 ,457 3 1 8 , 4 02\nPACIFIC GAS AND ELECTRIC CO 3.500% 08/01/2050 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 2 3 6 ,576 2 9 1 , 7 07\n41\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nPACIFIC GAS AND ELECTRIC CO 3.500% 08/01/2050 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 5 6 0 ,440 4 0 4 , 958\nPACIFIC GAS AND ELECTRIC CO 4.200% 06/01/2041 DD 03/11/21 CORPORATE DEBT INSTRUMENTS 4 7 5 ,278 3 9 5 , 7 12\nPACIFIC GAS AND ELECTRIC CO 4.500% 07/01/2040 DD 07/02/20 CORPORATE DEBT INSTRUMENTS 5 1 0 ,255 5 4 2 , 649\nPACIFIC GAS AND ELECTRIC CO 4.950% 07/01/2050 DD 07/02/20 CORPORATE DEBT INSTRUMENTS 7 4 0 ,897 7 6 7 , 304\nPACIFIC GAS AND ELECTRIC CO 5.250% 03/01/2052 DD 02/18/22 CORPORATE DEBT INSTRUMENTS 1 , 1 27,526 1 , 0 2 2,854\nPACIFIC GAS AND ELECTRIC CO 5.250% 03/01/2052 DD 02/18/22 CORPORATE DEBT INSTRUMENTS 2 6 , 9 46 2 6 , 9 1 7\nPACIFIC GAS AND ELECTRIC CO 5.900% 10/01/2054 DD 09/05/24 CORPORATE DEBT INSTRUMENTS 3 1 3 ,485 3 1 1 , 4 41\nPACIFIC GAS AND ELECTRIC CO 5.900% 10/01/2054 DD 09/05/24 CORPORATE DEBT INSTRUMENTS 2 9 8 ,557 2 9 6 , 6 10\nPACIFIC GAS AND ELECTRIC CO 6.700% 04/01/2053 DD 03/30/23 CORPORATE DEBT INSTRUMENTS 2 7 4 ,013 2 9 8 , 034\nPACIFIC GAS AND ELECTRIC CO 6.750% 01/15/2053 DD 01/06/23 CORPORATE DEBT INSTRUMENTS 1 , 7 77,085 1 , 8 6 4,128\nPACIFIC LIFECORP 144A 3.350% 09/15/2050 DD 09/15/20 CORPORATE DEBT INSTRUMENTS 8 4 3 ,472 5 6 5 , 3 10\nPACIFICORP 5.500% 05/15/2054 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 3 9 4 ,349 3 8 8 , 037\nPACIFICORP 5.750% 04/01/2037 DD 03/14/07 CORPORATE DEBT INSTRUMENTS 2 , 0 72,041 2 , 0 0 1,014\nPACIFICORP 5.800% 01/15/2055 DD 01/05/24 CORPORATE DEBT INSTRUMENTS 1 8 0 ,412 1 7 7 , 2 10\nPACIFICORP 6.000% 01/15/2039 DD 01/08/09 CORPORATE DEBT INSTRUMENTS 7 8 0 ,813 6 5 3 , 062\nPACIFICORP 6.350% 07/15/2038 DD 07/17/08 CORPORATE DEBT INSTRUMENTS 1 , 6 52,750 1 , 4 5 4,482\nPARKER-HANNIFIN CORP 4.000% 06/14/2049 DD 06/14/19 CORPORATE DEBT INSTRUMENTS 2 8 4 ,200 1 8 3 , 7 30\nPARKER-HANNIFIN CORP 4.450% 11/21/2044 DD 11/21/14 CORPORATE DEBT INSTRUMENTS 6 6 9 ,116 5 7 4 , 525\nPAYPAL HOLDINGS INC 3.250% 06/01/2050 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 6 8 7 ,364 4 6 7 , 834\nPECO ENERGY CO 3.000% 09/15/2049 DD 09/10/19 CORPORATE DEBT INSTRUMENTS 8 6 2 ,840 5 6 8 , 223\nPECO ENERGY CO 3.700% 09/15/2047 DD 09/18/17 CORPORATE DEBT INSTRUMENTS 2 9 8 ,869 2 2 5 , 009\nPECO ENERGY CO 4.375% 08/15/2052 DD 08/23/22 CORPORATE DEBT INSTRUMENTS 2 6 3 ,906 2 1 9 , 1 13\nPECO ENERGY CO 5.250% 09/15/2054 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 8 4 2 ,964 8 0 0 , 849\nPEPSICO INC 2.625% 10/21/2041 DD 10/21/21 CORPORATE DEBT INSTRUMENTS 6 1 , 6 23 4 3 , 7 6 5\nPEPSICO INC 2.750% 03/19/2030 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 9 28,978 1 , 5 9 9,066\nPEPSICO INC 2.875% 10/15/2049 DD 10/09/19 CORPORATE DEBT INSTRUMENTS 1 4 7 ,216 8 4 , 9 9 9\nPEPSICO INC 3.625% 03/19/2050 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 7 3 6 ,108 5 5 1 , 7 74\nPEPSICO INC 5.250% 07/17/2054 DD 07/17/24 CORPORATE DEBT INSTRUMENTS 6 2 3 ,406 6 0 5 , 588\nPEPSICO INC 5.250% 07/17/2054 DD 07/17/24 CORPORATE DEBT INSTRUMENTS 6 7 0 ,313 6 4 9 , 1 90\nPFIZER INC 2.550% 05/28/2040 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 2 2 2 ,629 1 6 6 , 3 70\nPFIZER INC 3.900% 03/15/2039 DD 03/11/19 CORPORATE DEBT INSTRUMENTS 4 4 0 ,015 4 2 2 , 1 55\nPFIZER INC 4.100% 09/15/2038 DD 09/07/18 CORPORATE DEBT INSTRUMENTS 3 7 9 ,880 3 4 9 , 464\nPFIZER INC 4.400% 05/15/2044 DD 05/15/14 CORPORATE DEBT INSTRUMENTS 3 9 3 ,496 3 4 6 , 508\nPFIZER INC 7.200% 03/15/2039 DD 03/24/09 CORPORATE DEBT INSTRUMENTS 9 3 7 ,115 7 7 9 , 956\nPFIZER INVESTMENT ENTERPRISES 5.110% 05/19/2043 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 1 , 7 87,286 1 , 7 1 5,646\nPFIZER INVESTMENT ENTERPRISES 5.300% 05/19/2053 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 2 , 3 31,928 2 , 1 8 5,074\nPFIZER INVESTMENT ENTERPRISES 5.340% 05/19/2063 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 3 0 7 ,500 2 8 6 , 865\nPG&E RECOVERY FUNDING LLC 5.529% 06/01/2051 DD 08/01/24 CORPORATE DEBT INSTRUMENTS 2 , 2 04,917 2 , 1 9 0,447\nPG&E WILDFIRE RECOVERY FUNDING 4.451% 12/01/2049 DD 05/10/22 CORPORATE DEBT INSTRUMENTS 8 6 9 ,118 8 8 4 , 475\nPHILIP MORRIS INTERNATIONAL IN 1.500% 05/01/2025 DD 05/01/20 CORPORATE DEBT INSTRUMENTS 1 , 9 24,209 1 , 8 6 9,720\nPHILIP MORRIS INTERNATIONAL IN 3.875% 08/21/2042 DD 08/21/12 CORPORATE DEBT INSTRUMENTS 6 6 3 ,149 6 6 1 , 0 53\nPHILIP MORRIS INTERNATIONAL IN 3.875% 08/21/2042 DD 08/21/12 CORPORATE DEBT INSTRUMENTS 1 3 4 ,159 1 2 2 , 7 10\nPHILIP MORRIS INTERNATIONAL IN 4.125% 03/04/2043 DD 03/04/13 CORPORATE DEBT INSTRUMENTS 8 0 , 6 68 7 3 , 1 9 7\nPHILIP MORRIS INTERNATIONAL IN 4.500% 03/20/2042 DD 03/20/12 CORPORATE DEBT INSTRUMENTS 9 9 5 ,047 8 9 3 , 607\nPHILIP MORRIS INTERNATIONAL IN 4.500% 03/20/2042 DD 03/20/12 CORPORATE DEBT INSTRUMENTS 1 4 8 ,566 1 3 4 , 4 75\n42\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nPHILLIPS 66 3.300% 03/15/2052 DD 11/15/21 CORPORATE DEBT INSTRUMENTS 1 3 8 ,968 9 0 , 3 3 1\nPHILLIPS 66 4.650% 11/15/2034 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 5 0 7 ,863 4 8 4 , 905\nPHILLIPS 66 4.875% 11/15/2044 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 1 96,808 1 , 0 5 5,019\nPHILLIPS 66 4.875% 11/15/2044 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 3 98,775 1 , 0 2 8,212\nPHILLIPS 66 CO 4.680% 02/15/2045 DD 02/15/23 CORPORATE DEBT INSTRUMENTS 1 , 6 40,741 1 , 4 3 4,735\nPNC BANK NA 3.250% 06/01/2025 DD 06/01/15 CORPORATE DEBT INSTRUMENTS 1 , 9 28,028 1 , 7 3 8,730\nPNC FINANCIAL SERVICES GROUP I VAR RT 07/23/2035 DD 07/23/24 CORPORATE DEBT INSTRUMENTS 4 8 4 ,989 4 8 1 , 7 70\nPOTOMAC ELECTRIC POWER CO 5.500% 03/15/2054 DD 03/04/24 CORPORATE DEBT INSTRUMENTS 6 5 3 ,124 6 3 4 , 707\nPPL ELECTRIC UTILITIES CORP 3.000% 10/01/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 8 0 6 ,232 5 3 9 , 2 16\nPPL ELECTRIC UTILITIES CORP 3.950% 06/01/2047 DD 05/11/17 CORPORATE DEBT INSTRUMENTS 4 7 0 ,203 3 7 3 , 265\nPPL ELECTRIC UTILITIES CORP 6.250% 05/15/2039 DD 05/22/09 CORPORATE DEBT INSTRUMENTS 1 , 1 05,348 8 6 7 , 885\nPRESIDENT AND FELLOWS OF HARVA 3.745% 11/15/2052 DD 04/19/22 CORPORATE DEBT INSTRUMENTS 4 5 0 ,000 3 4 5 , 497\nPRESIDENT AND FELLOWS OF HARVA 4.609% 02/15/2035 DD 03/12/24 CORPORATE DEBT INSTRUMENTS 7 0 0 ,000 6 7 9 , 700\nPROCTER & GAMBLE CO/THE 3.000% 03/25/2030 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 , 9 13,554 1 , 5 4 6,608\nPROLOGIS LP 2.250% 04/15/2030 DD 02/18/20 CORPORATE DEBT INSTRUMENTS 1 , 5 76,718 1 , 3 0 3,303\nPROLOGIS LP 3.000% 04/15/2050 DD 02/18/20 CORPORATE DEBT INSTRUMENTS 9 2 6 ,042 6 0 3 , 273\nPROLOGIS LP 5.250% 03/15/2054 DD 01/25/24 CORPORATE DEBT INSTRUMENTS 1 2 8 ,523 1 2 1 , 4 46\nPROLOGIS LP 5.250% 03/15/2054 DD 01/25/24 CORPORATE DEBT INSTRUMENTS 6 1 9 ,893 5 9 7 , 888\nPROLOGIS LP 5.250% 06/15/2053 DD 03/30/23 CORPORATE DEBT INSTRUMENTS 2 5 7 ,972 2 4 7 , 688\nPROLOGIS TARGETED US LOGI 144A 5.500% 04/01/2034 DD 03/07/24 CORPORATE DEBT INSTRUMENTS 7 8 9 ,260 7 9 6 , 1 13\nPRUDENTIAL FINANCIAL INC 3.905% 12/07/2047 DD 12/07/17 CORPORATE DEBT INSTRUMENTS 2 5 2 ,999 1 6 7 , 8 47\nPRUDENTIAL FINANCIAL INC 3.935% 12/07/2049 DD 12/07/17 CORPORATE DEBT INSTRUMENTS 2 7 9 ,570 1 8 8 , 7 50\nPRUDENTIAL FINANCIAL INC 5.700% 12/14/2036 DD 12/14/06 CORPORATE DEBT INSTRUMENTS 2 , 4 77,024 2 , 4 8 2,017\nPUBLIC SERVICE CO OF COLORADO 1.900% 01/15/2031 DD 05/15/20 CORPORATE DEBT INSTRUMENTS 1 , 9 29,898 1 , 5 9 0,370\nPUBLIC SERVICE CO OF COLORADO 3.800% 06/15/2047 DD 06/19/17 CORPORATE DEBT INSTRUMENTS 7 9 6 ,736 5 9 4 , 488\nPUBLIC SERVICE CO OF COLORADO 3.950% 03/15/2043 DD 03/26/13 CORPORATE DEBT INSTRUMENTS 1 , 6 63,283 1 , 3 9 7,192\nPUBLIC SERVICE CO OF COLORADO 4.500% 06/01/2052 DD 05/17/22 CORPORATE DEBT INSTRUMENTS 2 2 7 ,491 1 9 0 , 4 26\nPUBLIC SERVICE CO OF COLORADO 6.250% 09/01/2037 DD 08/15/07 CORPORATE DEBT INSTRUMENTS 1 , 4 03,534 1 , 1 6 2,348\nPUBLIC SERVICE ELECTRIC AND GA 2.250% 09/15/2026 DD 09/13/16 CORPORATE DEBT INSTRUMENTS 1 , 9 22,706 1 , 7 3 1,708\nPUBLIC SERVICE ELECTRIC AND GA 3.200% 08/01/2049 DD 08/12/19 CORPORATE DEBT INSTRUMENTS 7 3 4 ,635 5 0 5 , 1 91\nPUBLIC SERVICE ELECTRIC AND GA 3.600% 12/01/2047 DD 12/06/17 CORPORATE DEBT INSTRUMENTS 5 2 4 ,617 3 8 7 , 660\nPUBLIC SERVICE ELECTRIC AND GA 5.300% 08/01/2054 DD 08/05/24 CORPORATE DEBT INSTRUMENTS 6 8 1 ,842 6 5 3 , 1 13\nPUBLIC STORAGE OPERATING CO 3.094% 09/15/2027 DD 09/18/17 CORPORATE DEBT INSTRUMENTS 1 , 9 18,994 1 , 6 5 8,553\nPUBLIC STORAGE OPERATING CO 5.350% 08/01/2053 DD 07/26/23 CORPORATE DEBT INSTRUMENTS 1 7 1 ,936 1 6 6 , 6 35\nPUGET SOUND ENERGY INC 2.893% 09/15/2051 DD 09/15/21 CORPORATE DEBT INSTRUMENTS 7 3 0 ,000 4 4 6 , 424\nPUGET SOUND ENERGY INC 5.685% 06/15/2054 DD 06/11/24 CORPORATE DEBT INSTRUMENTS 1 6 9 ,998 1 6 6 , 8 50\nRAYMOND JAMES FINANCIAL INC 4.950% 07/15/2046 DD 07/12/16 CORPORATE DEBT INSTRUMENTS 1 , 2 59,305 8 6 5 , 256\nREALTY INCOME CORP 0.750% 03/15/2026 DD 12/14/20 CORPORATE DEBT INSTRUMENTS 7 8 3 ,617 7 5 3 , 399\nREALTY INCOME CORP 5.125% 02/15/2034 DD 01/16/24 CORPORATE DEBT INSTRUMENTS 2 0 5 ,618 1 9 6 , 0 12\nREALTY INCOME CORP 5.375% 09/01/2054 DD 08/26/24 CORPORATE DEBT INSTRUMENTS 3 2 9 ,553 3 1 8 , 5 11\nREALTY INCOME CORP 5.375% 09/01/2054 DD 08/26/24 CORPORATE DEBT INSTRUMENTS 3 1 4 ,797 3 0 4 , 250\nREGENCY CENTERS LP 4.400% 02/01/2047 DD 01/26/17 CORPORATE DEBT INSTRUMENTS 1 2 5 ,952 1 0 7 , 1 21\nREGENCY CENTERS LP 4.650% 03/15/2049 DD 03/06/19 CORPORATE DEBT INSTRUMENTS 5 4 2 ,657 4 4 4 , 560\nREYNOLDS AMERICAN INC 5.850% 08/15/2045 DD 06/12/15 CORPORATE DEBT INSTRUMENTS 1 , 1 13,799 8 9 1 , 6 25\nREYNOLDS AMERICAN INC 6.150% 09/15/2043 DD 09/17/13 CORPORATE DEBT INSTRUMENTS 3 6 5 ,241 2 9 6 , 982\n43\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nRIO TINTO FINANCE USA LTD 2.750% 11/02/2051 DD 11/02/21 CORPORATE DEBT INSTRUMENTS 9 2 1 ,850 6 2 3 , 200\nRIO TINTO FINANCE USA LTD 5.200% 11/02/2040 DD 11/02/10 CORPORATE DEBT INSTRUMENTS 1 , 1 24,188 9 1 2 , 9 94\nRIO TINTO FINANCE USA PLC 5.125% 03/09/2053 DD 03/09/23 CORPORATE DEBT INSTRUMENTS 5 7 , 6 64 5 5 , 6 0 4\nROCHE HOLDINGS INC 144A 1.930% 12/13/2028 DD 12/13/21 CORPORATE DEBT INSTRUMENTS 7 8 0 ,000 7 0 2 , 086\nROCHE HOLDINGS INC 144A 2.607% 12/13/2051 DD 12/13/21 CORPORATE DEBT INSTRUMENTS 3 6 9 ,273 2 2 0 , 527\nROCHE HOLDINGS INC 144A 4.592% 09/09/2034 DD 09/09/24 CORPORATE DEBT INSTRUMENTS 5 0 0 ,000 4 7 9 , 425\nROGERS COMMUNICATIONS INC 4.550% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 6 8 6 ,484 5 5 6 , 005\nROGERS COMMUNICATIONS INC 5.000% 03/15/2044 DD 03/10/14 CORPORATE DEBT INSTRUMENTS 2 , 2 17,813 1 , 9 8 1,260\nROYAL BANK OF CANADA 2.300% 11/03/2031 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 5 4 4 ,368 4 5 7 , 7 13\nRTX CORP 3.030% 03/15/2052 DD 11/16/21 CORPORATE DEBT INSTRUMENTS 9 1 , 3 69 6 0 , 1 9 6\nRTX CORP 3.125% 07/01/2050 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 7 6 , 2 98 6 8 , 8 9 1\nRTX CORP 4.350% 04/15/2047 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 2 , 6 49,861 1 , 6 8 9,662\nRTX CORP 4.450% 11/16/2038 DD 08/16/18 CORPORATE DEBT INSTRUMENTS 2 6 4 ,545 2 3 5 , 879\nRTX CORP 4.500% 06/01/2042 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 2 , 4 73,959 2 , 0 1 8,782\nRTX CORP 4.500% 06/01/2042 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 1 , 0 11,044 8 0 2 , 3 14\nRTX CORP 4.500% 06/01/2042 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 2 , 1 32,662 1 , 7 3 2,860\nRTX CORP 5.375% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 4 7 9 ,597 5 0 4 , 0 51\nRTX CORP 5.375% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 7 9 , 4 34 8 0 , 8 3 8\nRTX CORP 6.400% 03/15/2054 DD 11/08/23 CORPORATE DEBT INSTRUMENTS 3 9 1 ,526 4 2 8 , 1 26\nRTX CORP 6.400% 03/15/2054 DD 11/08/23 CORPORATE DEBT INSTRUMENTS 2 0 0 ,588 2 1 6 , 7 87\nS&P GLOBAL INC 3.700% 03/01/2052 DD 03/01/23 CORPORATE DEBT INSTRUMENTS 8 6 0 ,983 6 5 4 , 1 85\nS&P GLOBAL INC 5.250% 09/15/2033 DD 03/15/24 CORPORATE DEBT INSTRUMENTS 8 2 5 ,809 8 0 8 , 432\nSABAL TRAIL TRANSMISSION 144A 4.682% 05/01/2038 DD 04/30/18 CORPORATE DEBT INSTRUMENTS 4 0 5 ,391 3 5 7 , 1 49\nSABAL TRAIL TRANSMISSION 144A 4.832% 05/01/2048 DD 04/30/18 CORPORATE DEBT INSTRUMENTS 1 3 8 ,330 1 1 3 , 4 00\nSALESFORCE INC 2.700% 07/15/2041 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 8 1 4 ,821 6 0 7 , 4 01\nSALESFORCE INC 2.900% 07/15/2051 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 1 5 4 ,113 1 5 0 , 4 61\nSALESFORCE INC 2.900% 07/15/2051 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 4 2 7 ,598 2 7 8 , 5 13\nSALESFORCE INC 3.050% 07/15/2061 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 2 9 9 ,034 1 8 5 , 4 18\nSAN DIEGO GAS & ELECTRIC CO 3.000% 03/15/2032 DD 03/11/22 CORPORATE DEBT INSTRUMENTS 5 2 0 ,296 5 2 2 , 702\nSAN DIEGO GAS & ELECTRIC CO 3.320% 04/15/2050 DD 04/07/20 CORPORATE DEBT INSTRUMENTS 1 0 4 ,860 7 1 , 0 1 7\nSCENTRE GROUP TRUST 1 / S 144A 3.625% 01/28/2026 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 1 , 0 81,680 9 8 5 , 340\nSCENTRE GROUP TRUST 1 / S 144A 4.375% 05/28/2030 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 5 8 7 ,208 4 9 5 , 554\nSEMPRA 3.800% 02/01/2038 DD 01/12/18 CORPORATE DEBT INSTRUMENTS 7 7 6 ,506 6 4 9 , 093\nSEMPRA 3.800% 02/01/2038 DD 01/12/18 CORPORATE DEBT INSTRUMENTS 5 1 4 ,374 4 2 9 , 972\nSEMPRA 4.000% 02/01/2048 DD 01/12/18 CORPORATE DEBT INSTRUMENTS 2 2 , 6 90 1 7 , 4 1 5\nSEMPRA 6.000% 10/15/2039 DD 10/08/09 CORPORATE DEBT INSTRUMENTS 2 , 1 09,388 1 , 8 7 1,241\nSHELL FINANCE US INC 2.375% 11/07/2029 DD 05/07/24 CORPORATE DEBT INSTRUMENTS 1 , 3 43,536 1 , 3 0 9,386\nSHELL FINANCE US INC 3.250% 04/06/2050 DD 10/06/24 CORPORATE DEBT INSTRUMENTS 8 1 , 6 22 7 4 , 1 1 0\nSHELL FINANCE US INC 3.750% 09/12/2046 DD 09/12/24 CORPORATE DEBT INSTRUMENTS 3 0 1 ,216 2 7 4 , 520\nSHELL FINANCE US INC 4.000% 05/10/2046 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 5 0 2 ,713 4 7 4 , 332\nSHELL FINANCE US INC 4.000% 05/10/2046 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 5 5 7 ,312 5 0 5 , 693\nSHELL FINANCE US INC 4.375% 05/11/2045 DD 05/11/24 CORPORATE DEBT INSTRUMENTS 2 , 8 52,186 2 , 5 9 5,010\nSHELL INTERNATIONAL FINANCE BV 3.000% 11/26/2051 DD 11/26/21 CORPORATE DEBT INSTRUMENTS 6 9 3 ,360 4 4 0 , 6 51\nSHELL INTERNATIONAL FINANCE BV 5.500% 03/25/2040 DD 03/25/10 CORPORATE DEBT INSTRUMENTS 2 , 0 54,059 2 , 0 0 0,012\nSHERWIN-WILLIAMS CO/THE 2.900% 03/15/2052 DD 11/10/21 CORPORATE DEBT INSTRUMENTS 1 7 5 ,476 1 7 6 , 6 80\n44\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nSHERWIN-WILLIAMS CO/THE 3.300% 05/15/2050 DD 03/17/20 CORPORATE DEBT INSTRUMENTS 8 0 6 ,570 5 3 6 , 698\nSIEMENS FINANCIERINGSMAAT 144A 2.150% 03/11/2031 DD 03/11/21 CORPORATE DEBT INSTRUMENTS 4 8 0 ,755 4 6 8 , 6 17\nSIEMENS FINANCIERINGSMAAT 144A 2.875% 03/11/2041 DD 03/11/21 CORPORATE DEBT INSTRUMENTS 9 4 7 ,343 7 1 1 , 8 00\nSIEMENS FINANCIERINGSMAAT 144A 4.400% 05/27/2045 DD 05/27/15 CORPORATE DEBT INSTRUMENTS 5 9 2 ,570 5 1 9 , 2 23\nSIMON PROPERTY GROUP LP 3.250% 09/13/2049 DD 09/13/19 CORPORATE DEBT INSTRUMENTS 6 5 2 ,387 4 4 0 , 6 91\nSIMON PROPERTY GROUP LP 3.250% 09/13/2049 DD 09/13/19 CORPORATE DEBT INSTRUMENTS 2 0 1 ,015 2 1 1 , 9 35\nSIMON PROPERTY GROUP LP 3.800% 07/15/2050 DD 07/09/20 CORPORATE DEBT INSTRUMENTS 6 4 , 3 37 7 3 , 7 2 1\nSIMON PROPERTY GROUP LP 4.250% 11/30/2046 DD 11/23/16 CORPORATE DEBT INSTRUMENTS 1 , 3 59,562 1 , 0 6 4,043\nSIMON PROPERTY GROUP LP 4.250% 11/30/2046 DD 11/23/16 CORPORATE DEBT INSTRUMENTS 8 1 , 4 75 6 1 , 2 4 6\nSIMON PROPERTY GROUP LP 5.850% 03/08/2053 DD 03/08/23 CORPORATE DEBT INSTRUMENTS 1 , 1 42,692 1 , 1 6 3,446\nSIMON PROPERTY GROUP LP 5.850% 03/08/2053 DD 03/08/23 CORPORATE DEBT INSTRUMENTS 4 1 8 ,421 4 3 3 , 896\nSIMON PROPERTY GROUP LP 6.250% 01/15/2034 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 1 , 1 12,600 1 , 0 6 0,710\nSIMON PROPERTY GROUP LP 6.650% 01/15/2054 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 2 6 8 ,012 2 9 5 , 372\nSNAP-ON INC 3.100% 05/01/2050 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 1 , 2 26,159 8 1 8 , 6 20\nSOLVENTUM CORP 144A 5.900% 04/30/2054 DD 02/27/24 CORPORATE DEBT INSTRUMENTS 1 , 3 63,844 1 , 2 8 5,944\nSOLVENTUM CORP 144A 6.000% 05/15/2064 DD 02/27/24 CORPORATE DEBT INSTRUMENTS 6 1 9 ,357 6 0 5 , 752\nSOUTHERN CALIFORNIA EDISON CO 3.900% 03/15/2043 DD 03/07/13 CORPORATE DEBT INSTRUMENTS 4 5 3 ,909 3 3 5 , 368\nSOUTHERN CALIFORNIA EDISON CO 4.000% 04/01/2047 DD 03/24/17 CORPORATE DEBT INSTRUMENTS 1 5 0 ,783 1 1 1 , 7 17\nSOUTHERN CALIFORNIA EDISON CO 4.125% 03/01/2048 DD 03/05/18 CORPORATE DEBT INSTRUMENTS 7 3 3 ,663 5 9 2 , 329\nSOUTHERN CALIFORNIA EDISON CO 4.500% 09/01/2040 DD 08/30/10 CORPORATE DEBT INSTRUMENTS 8 4 2 ,793 7 0 4 , 359\nSOUTHERN CALIFORNIA EDISON CO 4.650% 10/01/2043 DD 10/02/13 CORPORATE DEBT INSTRUMENTS 7 5 9 ,737 6 6 3 , 706\nSOUTHERN CALIFORNIA GAS CO 3.750% 09/15/2042 DD 09/21/12 CORPORATE DEBT INSTRUMENTS 4 2 2 ,718 3 6 8 , 574\nSOUTHERN CALIFORNIA GAS CO 5.600% 04/01/2054 DD 03/18/24 CORPORATE DEBT INSTRUMENTS 4 2 0 ,750 4 1 6 , 6 57\nSOUTHERN CALIFORNIA GAS CO 5.750% 06/01/2053 DD 05/23/23 CORPORATE DEBT INSTRUMENTS 4 5 2 ,128 4 5 0 , 7 71\nSOUTHERN NATURAL GAS CO L 144A 4.800% 03/15/2047 DD 03/14/17 CORPORATE DEBT INSTRUMENTS 4 1 6 ,885 3 4 8 , 6 71\nSOUTHWESTERN ELECTRIC POWER CO 6.200% 03/15/2040 DD 03/08/10 CORPORATE DEBT INSTRUMENTS 1 , 7 93,885 1 , 5 5 0,225\nSOUTHWESTERN PUBLIC SERVICE CO 4.400% 11/15/2048 DD 11/05/18 CORPORATE DEBT INSTRUMENTS 3 9 7 ,420 3 2 4 , 576\nSOUTHWESTERN PUBLIC SERVICE CO 6.000% 06/01/2054 DD 06/06/24 CORPORATE DEBT INSTRUMENTS 3 9 7 ,032 4 0 4 , 808\nSTARBUCKS CORP 3.350% 03/12/2050 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 1 9 4 ,244 1 3 7 , 1 25\nSTARBUCKS CORP 3.500% 11/15/2050 DD 05/07/20 CORPORATE DEBT INSTRUMENTS 8 1 4 ,506 5 6 7 , 760\nSTARBUCKS CORP 4.450% 08/15/2049 DD 05/13/19 CORPORATE DEBT INSTRUMENTS 3 5 9 ,366 2 9 5 , 096\nSTRYKER CORP 4.100% 04/01/2043 DD 03/25/13 CORPORATE DEBT INSTRUMENTS 8 8 2 ,299 7 3 4 , 3 21\nSUN COMMUNITIES OPERATING LP 4.200% 04/15/2032 DD 04/12/22 CORPORATE DEBT INSTRUMENTS 5 9 5 ,013 5 5 2 , 1 11\nSUNCOR ENERGY INC 6.800% 05/15/2038 DD 05/15/08 CORPORATE DEBT INSTRUMENTS 5 5 5 ,346 4 9 1 , 9 79\nSUNCOR ENERGY INC 6.800% 05/15/2038 DD 05/15/08 CORPORATE DEBT INSTRUMENTS 2 3 , 7 31 1 8 , 1 0 3\nSUTTER HEALTH 3.361% 08/15/2050 DD 10/29/20 CORPORATE DEBT INSTRUMENTS 2 8 0 ,000 1 9 7 , 1 20\nSUTTER HEALTH 5.547% 08/15/2053 DD 06/08/23 CORPORATE DEBT INSTRUMENTS 5 2 0 ,000 5 1 9 , 6 83\nTAKEDA PHARMACEUTICAL CO LTD 3.025% 07/09/2040 DD 07/09/20 CORPORATE DEBT INSTRUMENTS 1 , 0 10,000 7 3 5 , 3 91\nTARGET CORP 1.950% 01/15/2027 DD 01/24/22 CORPORATE DEBT INSTRUMENTS 6 8 3 ,836 6 5 1 , 6 20\nTARGET CORP 2.950% 01/15/2052 DD 01/24/22 CORPORATE DEBT INSTRUMENTS 2 1 9 ,581 1 5 3 , 1 70\nTARGET CORP 4.500% 09/15/2034 DD 09/06/24 CORPORATE DEBT INSTRUMENTS 4 9 7 ,125 4 7 5 , 7 10\nTEXAS EASTERN TRANSMISSIO 144A 4.150% 01/15/2048 DD 01/09/18 CORPORATE DEBT INSTRUMENTS 3 9 6 ,468 3 0 8 , 320\nTEXAS INSTRUMENTS INC 3.875% 03/15/2039 DD 03/11/19 CORPORATE DEBT INSTRUMENTS 5 3 0 ,420 4 9 4 , 1 61\nTEXAS INSTRUMENTS INC 5.000% 03/14/2053 DD 03/14/23 CORPORATE DEBT INSTRUMENTS 9 7 2 ,275 8 8 9 , 956\nTEXAS INSTRUMENTS INC 5.050% 05/18/2063 DD 05/18/23 CORPORATE DEBT INSTRUMENTS 5 5 0 ,377 5 0 0 , 993\n45\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nTEXAS INSTRUMENTS INC 5.050% 05/18/2063 DD 05/18/23 CORPORATE DEBT INSTRUMENTS 6 8 7 ,653 6 4 4 , 5 21\nTHERMO FISHER SCIENTIFIC INC 2.800% 10/15/2041 DD 08/23/21 CORPORATE DEBT INSTRUMENTS 4 1 3 ,189 2 9 2 , 206\nTHERMO FISHER SCIENTIFIC INC 4.100% 08/15/2047 DD 08/14/17 CORPORATE DEBT INSTRUMENTS 4 7 9 ,301 3 9 4 , 1 06\nTIME WARNER CABLE LLC 4.500% 09/15/2042 DD 08/10/12 CORPORATE DEBT INSTRUMENTS 4 0 4 ,715 3 3 6 , 9 51\nTIME WARNER CABLE LLC 5.875% 11/15/2040 DD 11/15/10 CORPORATE DEBT INSTRUMENTS 7 8 9 ,743 7 5 6 , 250\nTIME WARNER CABLE LLC 5.875% 11/15/2040 DD 11/15/10 CORPORATE DEBT INSTRUMENTS 5 1 8 ,103 4 3 4 , 060\nTIME WARNER CABLE LLC 6.550% 05/01/2037 DD 04/09/07 CORPORATE DEBT INSTRUMENTS 1 , 5 15,025 1 , 0 9 2,168\nTIME WARNER CABLE LLC 6.550% 05/01/2037 DD 04/09/07 CORPORATE DEBT INSTRUMENTS 1 6 4 ,105 1 3 0 , 4 80\nTIME WARNER CABLE LLC 6.750% 06/15/2039 DD 06/29/09 CORPORATE DEBT INSTRUMENTS 4 4 6 ,374 3 6 7 , 785\nTIME WARNER CABLE LLC 7.300% 07/01/2038 DD 06/19/08 CORPORATE DEBT INSTRUMENTS 5 4 0 ,016 4 3 8 , 007\nT-MOBILE USA INC 3.000% 02/15/2041 DD 02/15/21 CORPORATE DEBT INSTRUMENTS 5 7 3 ,219 4 4 2 , 7 61\nT-MOBILE USA INC 3.300% 02/15/2051 DD 02/15/21 CORPORATE DEBT INSTRUMENTS 1 , 9 87,653 1 , 3 5 1,029\nT-MOBILE USA INC 3.400% 10/15/2052 DD 04/15/22 CORPORATE DEBT INSTRUMENTS 1 , 3 76,525 9 5 2 , 670\nT-MOBILE USA INC 3.600% 11/15/2060 DD 05/15/21 CORPORATE DEBT INSTRUMENTS 1 , 0 43,204 7 6 8 , 245\nT-MOBILE USA INC 5.500% 01/15/2055 DD 01/12/24 CORPORATE DEBT INSTRUMENTS 1 3 9 ,854 1 3 1 , 8 93\nT-MOBILE USA INC 5.650% 01/15/2053 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 9 2 5 ,545 9 1 6 , 6 88\nT-MOBILE USA INC 5.650% 01/15/2053 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 5 5 7 ,720 5 4 2 , 252\nT-MOBILE USA INC 5.750% 01/15/2054 DD 05/11/23 CORPORATE DEBT INSTRUMENTS 7 0 9 ,116 6 9 7 , 1 62\nT-MOBILE USA INC 6.000% 06/15/2054 DD 09/14/23 CORPORATE DEBT INSTRUMENTS 3 0 8 ,986 3 1 9 , 9 27\nTOTALENERGIES CAPITAL INTERNAT 2.434% 01/10/2025 DD 07/10/19 CORPORATE DEBT INSTRUMENTS 1 , 5 25,622 1 , 4 3 9,194\nTOTALENERGIES CAPITAL INTERNAT 2.986% 06/29/2041 DD 06/29/20 CORPORATE DEBT INSTRUMENTS 4 3 9 ,123 3 1 6 , 2 10\nTOTALENERGIES CAPITAL INTERNAT 3.127% 05/29/2050 DD 05/29/20 CORPORATE DEBT INSTRUMENTS 9 0 5 ,000 5 9 3 , 780\nTOTALENERGIES CAPITAL INTERNAT 3.127% 05/29/2050 DD 05/29/20 CORPORATE DEBT INSTRUMENTS 1 , 1 74,051 7 6 4 , 368\nTOTALENERGIES CAPITAL SA 5.275% 09/10/2054 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 1 9 9 ,544 1 8 5 , 2 04\nTOTALENERGIES CAPITAL SA 5.425% 09/10/2064 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 4 8 8 ,099 4 5 0 , 3 13\nTOTALENERGIES CAPITAL SA 5.488% 04/05/2054 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 3 5 0 ,551 3 3 6 , 028\nTOTALENERGIES CAPITAL SA 5.638% 04/05/2064 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 9 5 0 ,000 9 1 0 , 1 86\nTOTALENERGIES CAPITAL SA 5.638% 04/05/2064 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 9 0 8 ,507 8 7 1 , 8 62\nTOYOTA MOTOR CREDIT CORP 4.450% 06/29/2029 DD 06/30/22 CORPORATE DEBT INSTRUMENTS 6 2 4 ,925 6 1 5 , 0 63\nTOYOTA MOTOR CREDIT CORP 4.800% 01/05/2034 DD 01/05/24 CORPORATE DEBT INSTRUMENTS 3 0 7 ,920 2 9 1 , 5 82\nTRANSCANADA PIPELINES LTD 6.100% 06/01/2040 DD 06/01/10 CORPORATE DEBT INSTRUMENTS 1 , 5 50,514 1 , 5 1 7,215\nTRANSCANADA PIPELINES LTD 6.200% 10/15/2037 DD 10/05/07 CORPORATE DEBT INSTRUMENTS 1 , 1 01,020 9 1 2 , 3 64\nTRANSCONTINENTAL GAS PIPE LINE 4.600% 03/15/2048 DD 09/15/18 CORPORATE DEBT INSTRUMENTS 1 , 0 01,695 8 3 9 , 488\nTRANSCONTINENTAL GAS PIPE LINE 5.400% 08/15/2041 DD 02/15/12 CORPORATE DEBT INSTRUMENTS 7 7 9 ,645 6 9 6 , 606\nTRAVELERS COS INC/THE 5.450% 05/25/2053 DD 05/25/23 CORPORATE DEBT INSTRUMENTS 5 9 4 ,122 5 6 5 , 1 75\nTRUIST FINANCIAL CORP VAR RT 01/24/2035 DD 01/24/24 CORPORATE DEBT INSTRUMENTS 1 , 1 13,253 1 , 1 1 3,685\nTRUIST FINANCIAL CORP VAR RT 01/26/2034 DD 01/26/23 CORPORATE DEBT INSTRUMENTS 3 2 4 ,396 3 2 5 , 587\nTRUIST FINANCIAL CORP VAR RT 01/26/2034 DD 01/26/23 CORPORATE DEBT INSTRUMENTS 2 6 7 ,429 2 6 2 , 4 13\nTRUIST FINANCIAL CORP VAR RT 06/08/2034 DD 06/08/23 CORPORATE DEBT INSTRUMENTS 4 8 5 ,000 4 9 3 , 900\nTRUIST FINANCIAL CORP VAR RT 06/08/2034 DD 06/08/23 CORPORATE DEBT INSTRUMENTS 5 1 3 ,519 5 2 4 , 450\nTRUSTEES OF COLUMBIA UNIVERSIT 4.355% 10/01/2035 DD 10/09/24 CORPORATE DEBT INSTRUMENTS 7 7 5 ,000 7 3 1 , 7 24\nTTX CO 144A 4.600% 02/01/2049 DD 01/18/19 CORPORATE DEBT INSTRUMENTS 8 9 7 ,964 7 6 4 , 862\nUBER TECHNOLOGIES INC 5.350% 09/15/2054 DD 09/09/24 CORPORATE DEBT INSTRUMENTS 9 7 9 ,745 9 1 2 , 2 42\nUBS GROUP AG 144A 4.253% 03/23/2028 DD 03/23/17 CORPORATE DEBT INSTRUMENTS 1 , 1 35,490 9 7 1 , 8 40\nUBS GROUP AG 144A VAR RT 02/08/2035 DD 01/08/24 CORPORATE DEBT INSTRUMENTS 5 7 9 ,954 5 8 3 , 944\nUBS GROUP AG 144A VAR RT 08/05/2033 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 1 5 5 ,000 1 5 0 , 3 33\n46\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nUDR INC 3.100% 11/01/2034 DD 10/11/19 CORPORATE DEBT INSTRUMENTS 6 1 0 ,284 4 9 9 , 368\nUNILEVER CAPITAL CORP 2.125% 09/06/2029 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 1 , 9 18,116 1 , 6 1 9,836\nUNION ELECTRIC CO 4.000% 04/01/2048 DD 04/06/18 CORPORATE DEBT INSTRUMENTS 2 7 3 ,809 2 1 3 , 8 40\nUNION ELECTRIC CO 5.125% 03/15/2055 DD 10/07/24 CORPORATE DEBT INSTRUMENTS 1 0 4 ,875 9 6 , 3 5 3\nUNION ELECTRIC CO 5.125% 03/15/2055 DD 10/07/24 CORPORATE DEBT INSTRUMENTS 1 5 4 ,816 1 4 2 , 2 36\nUNION PACIFIC CORP 2.375% 05/20/2031 DD 05/20/21 CORPORATE DEBT INSTRUMENTS 6 7 0 ,995 5 6 1 , 2 49\nUNION PACIFIC CORP 2.950% 03/10/2052 DD 09/10/21 CORPORATE DEBT INSTRUMENTS 3 3 6 ,118 2 0 5 , 585\nUNION PACIFIC CORP 2.973% 09/16/2062 DD 03/16/21 CORPORATE DEBT INSTRUMENTS 5 5 2 ,622 3 1 9 , 9 52\nUNION PACIFIC CORP 3.250% 02/05/2050 DD 01/31/20 CORPORATE DEBT INSTRUMENTS 6 5 4 ,439 4 2 3 , 235\nUNION PACIFIC CORP 3.375% 02/14/2042 DD 02/14/22 CORPORATE DEBT INSTRUMENTS 1 2 4 ,838 9 5 , 1 6 0\nUNION PACIFIC CORP 3.500% 02/14/2053 DD 02/14/22 CORPORATE DEBT INSTRUMENTS 3 7 1 ,608 2 8 9 , 358\nUNION PACIFIC CORP 3.550% 08/15/2039 DD 08/05/19 CORPORATE DEBT INSTRUMENTS 1 4 6 ,199 1 1 7 , 7 27\nUNION PACIFIC CORP 3.799% 10/01/2051 DD 10/04/16 CORPORATE DEBT INSTRUMENTS 4 3 6 ,558 3 3 2 , 468\nUNION PACIFIC CORP 3.839% 03/20/2060 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 1 , 1 82,375 7 8 6 , 5 11\nUNION PACIFIC CORP 3.839% 03/20/2060 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 9 9 3 ,966 7 5 7 , 1 96\nUNION PACIFIC CORP 3.839% 03/20/2060 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 2 4 0 ,384 1 7 1 , 6 02\nUNION PACIFIC CORP 3.950% 08/15/2059 DD 08/05/19 CORPORATE DEBT INSTRUMENTS 5 9 5 ,218 4 3 6 , 950\nUNION PACIFIC CORP 4.000% 04/15/2047 DD 04/05/17 CORPORATE DEBT INSTRUMENTS 3 , 1 37,229 2 , 5 1 6,398\nUNION PACIFIC CORP 4.950% 05/15/2053 DD 02/21/23 CORPORATE DEBT INSTRUMENTS 5 7 , 0 70 5 4 , 8 9 9\nUNITED PARCEL SERVICE INC 5.050% 03/03/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 8 0 4 ,509 7 4 3 , 758\nUNITED PARCEL SERVICE INC 5.200% 04/01/2040 DD 03/24/20 CORPORATE DEBT INSTRUMENTS 3 8 8 ,124 3 8 0 , 2 19\nUNITED PARCEL SERVICE INC 5.500% 05/22/2054 DD 05/22/24 CORPORATE DEBT INSTRUMENTS 8 0 8 ,506 7 8 1 , 0 72\nUNITED PARCEL SERVICE INC 6.200% 01/15/2038 DD 01/15/08 CORPORATE DEBT INSTRUMENTS 6 6 2 ,388 6 4 2 , 384\nUNITEDHEALTH GROUP INC 2.900% 05/15/2050 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 2 8 8 ,410 1 8 0 , 3 13\nUNITEDHEALTH GROUP INC 2.950% 10/15/2027 DD 10/25/17 CORPORATE DEBT INSTRUMENTS 1 , 5 44,026 1 , 3 2 5,708\nUNITEDHEALTH GROUP INC 3.050% 05/15/2041 DD 05/19/21 CORPORATE DEBT INSTRUMENTS 5 0 0 ,551 3 8 3 , 466\nUNITEDHEALTH GROUP INC 3.250% 05/15/2051 DD 05/19/21 CORPORATE DEBT INSTRUMENTS 5 3 5 ,033 3 4 2 , 5 12\nUNITEDHEALTH GROUP INC 3.700% 08/15/2049 DD 07/25/19 CORPORATE DEBT INSTRUMENTS 1 , 0 41,970 7 5 0 , 386\nUNITEDHEALTH GROUP INC 3.750% 10/15/2047 DD 10/25/17 CORPORATE DEBT INSTRUMENTS 3 2 6 ,951 2 4 6 , 256\nUNITEDHEALTH GROUP INC 4.200% 01/15/2047 DD 12/20/16 CORPORATE DEBT INSTRUMENTS 4 8 6 ,340 3 9 6 , 337\nUNITEDHEALTH GROUP INC 4.250% 06/15/2048 DD 06/19/18 CORPORATE DEBT INSTRUMENTS 5 3 8 ,271 4 3 5 , 486\nUNITEDHEALTH GROUP INC 4.450% 12/15/2048 DD 12/17/18 CORPORATE DEBT INSTRUMENTS 1 , 1 62,215 9 6 2 , 227\nUNITEDHEALTH GROUP INC 4.750% 05/15/2052 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 8 7 8 ,543 7 8 1 , 0 44\nUNITEDHEALTH GROUP INC 4.750% 05/15/2052 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 2 , 0 05,722 1 , 8 7 8,797\nUNITEDHEALTH GROUP INC 4.750% 05/15/2052 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 4 4 9 ,156 3 9 9 , 1 05\nUNITEDHEALTH GROUP INC 4.750% 07/15/2045 DD 07/23/15 CORPORATE DEBT INSTRUMENTS 2 1 4 ,116 1 8 9 , 5 93\nUNITEDHEALTH GROUP INC 4.750% 07/15/2045 DD 07/23/15 CORPORATE DEBT INSTRUMENTS 6 4 , 9 26 6 1 , 7 2 8\nUNITEDHEALTH GROUP INC 4.950% 05/15/2062 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 1 7 8 ,236 1 5 5 , 3 78\nUNITEDHEALTH GROUP INC 5.050% 04/15/2053 DD 03/28/23 CORPORATE DEBT INSTRUMENTS 1 6 4 ,767 1 4 8 , 8 18\nUNITEDHEALTH GROUP INC 5.200% 04/15/2063 DD 03/28/23 CORPORATE DEBT INSTRUMENTS 2 4 9 ,204 2 2 9 , 783\nUNITEDHEALTH GROUP INC 5.500% 04/15/2064 DD 03/21/24 CORPORATE DEBT INSTRUMENTS 5 3 3 ,764 5 0 0 , 744\nUNITEDHEALTH GROUP INC 5.500% 07/15/2044 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 8 9 6 ,683 8 7 9 , 506\nUNITEDHEALTH GROUP INC 5.625% 07/15/2054 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 9 8 2 ,777 9 5 7 , 932\nUNITEDHEALTH GROUP INC 5.750% 07/15/2064 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 1 3 6 ,341 1 2 6 , 7 71\nUNITEDHEALTH GROUP INC 5.750% 07/15/2064 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 2 2 8 ,613 2 2 4 , 287\n47\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nUNITEDHEALTH GROUP INC 5.800% 03/15/2036 DD 03/02/06 CORPORATE DEBT INSTRUMENTS 3 8 8 ,839 3 9 2 , 1 52\nUNITEDHEALTH GROUP INC 5.875% 02/15/2053 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 3 0 6 ,255 2 6 9 , 1 01\nUNITEDHEALTH GROUP INC 5.875% 02/15/2053 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 3 3 2 ,175 3 3 1 , 3 56\nUNITEDHEALTH GROUP INC 5.950% 02/15/2041 DD 02/17/11 CORPORATE DEBT INSTRUMENTS 4 8 , 6 88 4 6 , 1 4 0\nUNITEDHEALTH GROUP INC 6.050% 02/15/2063 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 7 4 1 ,150 7 6 6 , 853\nUNITEDHEALTH GROUP INC 6.050% 02/15/2063 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 2 8 1 ,637 2 9 1 , 4 04\nUNITEDHEALTH GROUP INC 6.625% 11/15/2037 DD 11/19/07 CORPORATE DEBT INSTRUMENTS 1 , 0 37,824 1 , 2 3 8,018\nUNIVERSITY OF NOTRE DAME DU LA 1.637% 02/15/2030 DD 06/10/20 CORPORATE DEBT INSTRUMENTS 2 , 3 36,202 1 , 9 4 4,075\nUNIVERSITY OF SOUTHERN CALIFOR 3.028% 10/01/2039 DD 08/22/16 CORPORATE DEBT INSTRUMENTS 4 8 4 ,980 4 7 4 , 648\nUS BANCORP 1.375% 07/22/2030 DD 07/20/20 CORPORATE DEBT INSTRUMENTS 3 6 7 ,628 3 0 5 , 505\nUS BANCORP VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 7 5 1 ,673 7 5 6 , 848\nUS BANCORP VAR RT 02/01/2034 DD 02/01/23 CORPORATE DEBT INSTRUMENTS 8 7 0 ,000 8 3 2 , 990\nVERISK ANALYTICS INC 3.625% 05/15/2050 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 1 , 3 83,601 9 8 1 , 6 62\nVERIZON COMMUNICATIONS INC 2.650% 11/20/2040 DD 11/20/20 CORPORATE DEBT INSTRUMENTS 1 , 3 26,594 9 3 1 , 0 02\nVERIZON COMMUNICATIONS INC 2.987% 10/30/2056 DD 04/30/21 CORPORATE DEBT INSTRUMENTS 5 4 0 ,919 3 8 6 , 896\nVERIZON COMMUNICATIONS INC 2.987% 10/30/2056 DD 04/30/21 CORPORATE DEBT INSTRUMENTS 1 , 0 65,123 7 6 9 , 037\nVERIZON COMMUNICATIONS INC 3.400% 03/22/2041 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 7 2 0 ,929 5 6 0 , 269\nVERIZON COMMUNICATIONS INC 3.550% 03/22/2051 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 4 , 3 91,414 2 , 9 0 8,391\nVERIZON COMMUNICATIONS INC 3.550% 03/22/2051 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 4 8 3 ,403 3 5 0 , 366\nVERIZON COMMUNICATIONS INC 3.700% 03/22/2061 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 4 , 5 30,582 3 , 0 8 3,523\nVERIZON COMMUNICATIONS INC 3.700% 03/22/2061 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 2 , 5 44,441 1 , 7 1 2,238\nVERIZON COMMUNICATIONS INC 4.272% 01/15/2036 DD 07/15/15 CORPORATE DEBT INSTRUMENTS 3 8 8 ,423 3 8 2 , 343\nVERIZON COMMUNICATIONS INC 4.272% 01/15/2036 DD 07/15/15 CORPORATE DEBT INSTRUMENTS 3 , 3 23,683 3 , 0 3 1,753\nVERIZON COMMUNICATIONS INC 4.400% 11/01/2034 DD 10/29/14 CORPORATE DEBT INSTRUMENTS 4 1 6 ,959 3 8 9 , 227\nVIATRIS INC 4.000% 06/22/2050 DD 06/22/21 CORPORATE DEBT INSTRUMENTS 7 2 8 ,102 4 9 8 , 1 23\nVICI PROPERTIES LP 5.625% 05/15/2052 DD 04/29/22 CORPORATE DEBT INSTRUMENTS 4 1 9 ,062 4 1 8 , 6 80\nVIRGINIA ELECTRIC AND POWER CO 2.450% 12/15/2050 DD 12/15/20 CORPORATE DEBT INSTRUMENTS 2 7 7 ,511 1 5 8 , 8 82\nVIRGINIA ELECTRIC AND POWER CO 2.875% 07/15/2029 DD 07/10/19 CORPORATE DEBT INSTRUMENTS 1 , 5 26,035 1 , 2 7 5,987\nVIRGINIA ELECTRIC AND POWER CO 3.750% 05/15/2027 DD 05/31/22 CORPORATE DEBT INSTRUMENTS 1 7 9 ,438 1 7 6 , 2 51\nVIRGINIA ELECTRIC AND POWER CO 4.650% 08/15/2043 DD 08/15/13 CORPORATE DEBT INSTRUMENTS 1 , 1 59,443 1 , 0 1 8,225\nVIRGINIA ELECTRIC AND POWER CO 5.350% 01/15/2054 DD 01/08/24 CORPORATE DEBT INSTRUMENTS 8 3 7 ,866 7 9 3 , 565\nVIRGINIA ELECTRIC AND POWER CO 5.450% 04/01/2053 DD 03/30/23 CORPORATE DEBT INSTRUMENTS 4 8 1 ,628 4 6 1 , 3 10\nVIRGINIA ELECTRIC AND POWER CO 5.550% 08/15/2054 DD 08/12/24 CORPORATE DEBT INSTRUMENTS 1 1 9 ,478 1 1 6 , 1 73\nVIRGINIA ELECTRIC AND POWER CO 8.875% 11/15/2038 DD 11/06/08 CORPORATE DEBT INSTRUMENTS 3 , 2 54,394 2 , 7 8 4,060\nVISA INC 2.050% 04/15/2030 DD 04/02/20 CORPORATE DEBT INSTRUMENTS 1 , 5 33,284 1 , 2 8 1,450\nVISA INC 2.700% 04/15/2040 DD 04/02/20 CORPORATE DEBT INSTRUMENTS 3 1 6 ,685 2 2 9 , 783\nVISA INC 4.300% 12/14/2045 DD 12/14/15 CORPORATE DEBT INSTRUMENTS 1 , 1 45,919 9 5 0 , 582\nVISA INC 4.300% 12/14/2045 DD 12/14/15 CORPORATE DEBT INSTRUMENTS 4 0 1 ,382 2 7 8 , 324\nVODAFONE GROUP PLC 4.250% 09/17/2050 DD 09/17/19 CORPORATE DEBT INSTRUMENTS 4 5 3 ,447 3 4 9 , 956\nVODAFONE GROUP PLC 5.625% 02/10/2053 DD 02/10/23 CORPORATE DEBT INSTRUMENTS 2 4 8 ,958 2 3 8 , 095\nVODAFONE GROUP PLC 5.750% 06/28/2054 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 4 2 7 ,566 4 1 5 , 1 31\nVODAFONE GROUP PLC 5.750% 06/28/2054 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 2 , 2 35,103 2 , 1 5 7,714\nVODAFONE GROUP PLC 5.875% 06/28/2064 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 4 0 6 ,074 3 8 3 , 004\nVODAFONE GROUP PLC 5.875% 06/28/2064 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 4 5 0 ,942 4 3 6 , 334\n48\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nVULCAN MATERIALS CO 5.700% 12/01/2054 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 6 0 3 ,566 5 6 6 , 405\nWALMART INC 1.800% 09/22/2031 DD 09/22/21 CORPORATE DEBT INSTRUMENTS 1 , 8 68,194 1 , 5 6 4,988\nWALMART INC 2.375% 09/24/2029 DD 09/24/19 CORPORATE DEBT INSTRUMENTS 2 2 4 ,717 1 8 8 , 4 26\nWALMART INC 2.500% 09/22/2041 DD 09/22/21 CORPORATE DEBT INSTRUMENTS 7 9 6 ,780 5 7 0 , 409\nWALMART INC 2.650% 09/22/2051 DD 09/22/21 CORPORATE DEBT INSTRUMENTS 8 3 1 ,911 5 1 7 , 2 91\nWALT DISNEY CO/THE 2.750% 09/01/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 8 5 0 ,147 5 1 1 , 1 85\nWALT DISNEY CO/THE 2.750% 09/01/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 8 5 6 ,459 5 5 3 , 054\nWALT DISNEY CO/THE 3.350% 03/24/2025 DD 03/23/20 CORPORATE DEBT INSTRUMENTS 1 , 5 32,059 1 , 3 9 1,094\nWALT DISNEY CO/THE 3.500% 05/13/2040 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 6 2 2 ,189 6 1 7 , 9 64\nWALT DISNEY CO/THE 3.500% 05/13/2040 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 7 2 5 ,408 6 3 8 , 027\nWALT DISNEY CO/THE 3.600% 01/13/2051 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 1 , 8 13,319 1 , 3 9 5,971\nWALT DISNEY CO/THE 3.600% 01/13/2051 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 6 4 3 ,124 4 7 4 , 409\nWALT DISNEY CO/THE 3.600% 01/13/2051 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 3 3 1 ,356 2 3 5 , 7 31\nWALT DISNEY CO/THE 3.800% 05/13/2060 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 1 , 1 86,301 8 6 4 , 496\nWARNERMEDIA HOLDINGS INC 5.050% 03/15/2042 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 3 4 0 ,000 2 7 3 , 863\nWARNERMEDIA HOLDINGS INC 5.050% 03/15/2042 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 , 4 06,482 1 , 2 4 8,494\nWARNERMEDIA HOLDINGS INC 5.141% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 , 0 54,002 8 3 6 , 1 25\nWARNERMEDIA HOLDINGS INC 5.141% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 6 1 4 ,071 5 4 4 , 228\nWARNERMEDIA HOLDINGS INC 5.141% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 2 , 1 5 1,111 2 , 0 3 4,322\nWARNERMEDIA HOLDINGS INC 5.391% 03/15/2062 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 , 2 77,894 9 7 5 , 374\nWARNERMEDIA HOLDINGS INC 5.391% 03/15/2062 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 2 4 6 ,183 2 2 8 , 892\nWASTE MANAGEMENT INC 3.900% 03/01/2035 DD 02/26/15 CORPORATE DEBT INSTRUMENTS 9 2 4 ,142 8 3 5 , 923\nWASTE MANAGEMENT INC 5.350% 10/15/2054 DD 11/04/24 CORPORATE DEBT INSTRUMENTS 8 6 6 ,645 8 3 4 , 1 58\nWELLS FARGO & CO 3.900% 05/01/2045 DD 04/30/15 CORPORATE DEBT INSTRUMENTS 2 , 4 50,354 1 , 8 7 9,757\nWELLS FARGO & CO 4.650% 11/04/2044 DD 11/04/14 CORPORATE DEBT INSTRUMENTS 1 , 0 16,171 8 5 7 , 2 18\nWELLS FARGO & CO 4.750% 12/07/2046 DD 12/08/16 CORPORATE DEBT INSTRUMENTS 1 , 0 97,258 9 2 9 , 062\nWELLS FARGO & CO 4.750% 12/07/2046 DD 12/08/16 CORPORATE DEBT INSTRUMENTS 4 8 6 ,578 4 0 1 , 5 51\nWELLS FARGO & CO 4.900% 11/17/2045 DD 11/17/15 CORPORATE DEBT INSTRUMENTS 5 8 3 ,970 4 9 0 , 2 51\nWELLS FARGO & CO 5.606% 01/15/2044 DD 11/26/13 CORPORATE DEBT INSTRUMENTS 2 3 8 ,786 2 0 5 , 9 16\nWELLS FARGO & CO VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 3 4 1 ,172 3 3 4 , 045\nWELLS FARGO & CO VAR RT 02/11/2031 DD 02/11/20 CORPORATE DEBT INSTRUMENTS 1 , 8 92,619 1 , 6 2 7,179\nWELLS FARGO & CO VAR RT 04/04/2051 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 1 0 8 ,700 9 7 , 7 8 1\nWELLS FARGO & CO VAR RT 04/25/2053 DD 04/25/22 CORPORATE DEBT INSTRUMENTS 1 , 6 35,210 1 , 4 1 1,036\nWELLS FARGO & CO VAR RT 04/30/2041 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 3 9 0 ,000 2 8 4 , 1 35\nWELLS FARGO & CO VAR RT 04/30/2041 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 1 2 9 ,845 1 2 7 , 4 96\nWELLS FARGO BANK NA 5.850% 02/01/2037 DD 01/29/07 CORPORATE DEBT INSTRUMENTS 2 , 9 46,345 2 , 6 0 7,173\nWELLS FARGO BANK NA 6.600% 01/15/2038 DD 12/07/07 CORPORATE DEBT INSTRUMENTS 2 , 1 51,329 2 , 1 6 0,002\nWESTPAC BANKING CORP 3.133% 11/18/2041 DD 11/18/21 CORPORATE DEBT INSTRUMENTS 3 6 0 ,000 2 5 8 , 448\nWESTPAC BANKING CORP VAR RT 11/20/2035 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 4 1 5 ,000 4 0 7 , 974\nWILLIAMS COS INC/THE 5.750% 06/24/2044 DD 06/24/14 CORPORATE DEBT INSTRUMENTS 1 4 4 ,491 1 3 0 , 9 19\nWILLIAMS COS INC/THE 5.800% 11/15/2043 DD 11/15/13 CORPORATE DEBT INSTRUMENTS 1 4 3 ,382 1 4 1 , 6 85\nWILLIAMS COS INC/THE 6.300% 04/15/2040 DD 02/09/10 CORPORATE DEBT INSTRUMENTS 4 1 8 ,949 3 2 8 , 302\nWW GRAINGER INC 4.600% 06/15/2045 DD 06/11/15 CORPORATE DEBT INSTRUMENTS 3 3 9 ,725 3 0 3 , 773\nWYETH LLC 5.950% 04/01/2037 DD 03/27/07 CORPORATE DEBT INSTRUMENTS 3 7 2 ,643 3 5 5 , 055\nWYETH LLC 6.000% 02/15/2036 DD 11/14/05 CORPORATE DEBT INSTRUMENTS 1 , 2 80,888 1 , 2 0 6,326\n49\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nXL GROUP LTD 5.250% 12/15/2043 DD 11/21/13 CORPORATE DEBT INSTRUMENTS 1 , 7 33,238 1 , 2 7 9,243\nYALE UNIVERSITY 1.482% 04/15/2030 DD 06/09/20 CORPORATE DEBT INSTRUMENTS 1 , 5 52,760 1 , 3 0 5,364\nZOETIS INC 3.000% 05/15/2050 DD 05/12/20 CORPORATE DEBT INSTRUMENTS 3 7 5 ,839 2 4 4 , 2 41\n$ 1 ,083,138,462 $ 9 2 5,674,665\nADIDAS AG CORPORATE STOCK - COMMON $ 3 0 2 ,773 $ 8 0 4 , 277\nAIA GROUP LTD HK/01299 CORPORATE STOCK - COMMON 8 3 8 ,526 1 , 1 0 8,903\nAIR LIQUIDE SA CORPORATE STOCK - COMMON 7 8 6 ,696 1 , 5 8 1,846\nALIMENTATION COUCHE-TARD INC CORPORATE STOCK - COMMON 8 4 1 ,131 1 , 8 9 4,611\nAMADEUS IT GROUP SA CORPORATE STOCK - COMMON 8 8 0 ,558 1 , 0 2 0,475\nASML HOLDING NV CORPORATE STOCK - COMMON 7 6 0 ,854 1 , 6 8 6,705\nATLAS COPCO AB CORPORATE STOCK - COMMON 6 6 4 ,268 7 7 5 , 299\nCANADIAN NATIONAL RAILWAY CO CORPORATE STOCK - COMMON 1 , 0 18,536 9 6 5 , 2 17\nCAPITALAND ASCENDAS REIT CORPORATE STOCK - COMMON 9 6 6 ,143 8 7 4 , 4 18\nCLP HOLDINGS LTD HK/00002 CORPORATE STOCK - COMMON 4 9 5 ,229 5 5 4 , 8 18\nCOCHLEAR LTD CORPORATE STOCK - COMMON 2 1 0 ,524 5 3 4 , 848\nCOLOPLAST A/S CORPORATE STOCK - COMMON 5 6 6 ,600 8 8 3 , 1 87\nCOMPASS GROUP PLC CORPORATE STOCK - COMMON 7 2 5 ,563 1 , 4 7 6,579\nCSL LTD CORPORATE STOCK - COMMON 1 7 9 ,134 9 3 6 , 207\nDAIKIN INDUSTRIES LTD CORPORATE STOCK - COMMON 1 5 0 ,651 7 2 4 , 268\nDASSAULT SYSTEMES SE CORPORATE STOCK - COMMON 8 2 5 ,522 7 4 9 , 288\nDIAGEO PLC CORPORATE STOCK - COMMON 9 6 6 ,589 8 8 6 , 652\nEXPERIAN PLC CORPORATE STOCK - COMMON 3 8 6 ,242 1 , 0 3 4,621\nFANUC CORP CORPORATE STOCK - COMMON 2 8 1 ,522 5 4 4 , 588\nFERRARI NV CORPORATE STOCK - COMMON 4 8 1 ,715 7 0 4 , 6 16\nHERMES INTERNATIONAL SCA CORPORATE STOCK - COMMON 4 3 5 ,395 7 6 9 , 4 18\nHOYA CORP CORPORATE STOCK - COMMON 7 8 7 ,327 8 1 9 , 5 31\nINDUSTRIA DE DISENO TEXTIL SA CORPORATE STOCK - COMMON 3 2 1 ,414 1 , 4 4 4,402\nINFINEON TECHNOLOGIES AG CORPORATE STOCK - COMMON 1 , 1 66,788 1 , 0 9 8,997\nJARDINE MATHESON HOLDINGS LTD CORPORATE STOCK - COMMON 8 8 7 ,469 5 8 1 , 7 74\nKAP RESOURCES LTD CORPORATE STOCK - COMMON 8 5 , 1 97 -\nKEYENCE CORP CORPORATE STOCK - COMMON 1 4 1 ,556 1 , 4 0 4,785\nKONE OYJ CORPORATE STOCK - COMMON 6 9 1 ,077 9 1 0 , 1 01\nKUEHNE + NAGEL INTERNATIONAL A CORPORATE STOCK - COMMON 5 1 2 ,280 8 0 4 , 8 31\nLONZA GROUP AG CORPORATE STOCK - COMMON 1 , 0 76,641 9 2 2 , 3 15\nL'OREAL SA CORPORATE STOCK - COMMON 2 0 9 ,159 1 , 0 7 2,577\nLVMH MOET HENNESSY LOUIS VUITT CORPORATE STOCK - COMMON 3 4 7 ,844 1 , 2 4 3,734\nMERCK KGAA CORPORATE STOCK - COMMON 1 , 0 68,579 8 3 1 , 5 33\nMISUMI GROUP INC CORPORATE STOCK - COMMON 6 5 4 ,741 3 6 3 , 970\nMURATA MANUFACTURING CO LTD CORPORATE STOCK - COMMON 3 6 8 ,076 4 7 0 , 664\nNOVARTIS AG CORPORATE STOCK - COMMON 3 9 3 ,534 9 8 4 , 6 31\nNOVO NORDISK A/S CORPORATE STOCK - COMMON 1 7 9 ,772 1 , 4 6 6,544\nOBIC CO LTD CORPORATE STOCK - COMMON 8 7 1 ,843 9 2 5 , 700\nRECORDATI INDUSTRIA CHIMICA E CORPORATE STOCK - COMMON 6 6 0 ,891 5 2 9 , 203\nROCHE HOLDING AG CORPORATE STOCK - COMMON 1 , 0 01,982 1 , 2 4 0,497\n50\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nSAGE GROUP PLC/THE CORPORATE STOCK - COMMON 5 7 4 ,129 6 6 6 , 420\nSAP SE CORPORATE STOCK - COMMON 1 9 7 ,958 1 , 3 0 9,084\nSGS SA CORPORATE STOCK - COMMON 4 9 9 ,747 1 , 0 2 2,068\nSHIMADZU CORP CORPORATE STOCK - COMMON 5 3 7 ,824 4 7 4 , 0 31\nSHIN-ETSU CHEMICAL CO LTD CORPORATE STOCK - COMMON 3 8 4 ,615 1 , 0 5 8,122\nSMC CORP CORPORATE STOCK - COMMON 6 0 8 ,025 9 4 9 , 555\nSYSMEX CORP CORPORATE STOCK - COMMON 1 , 0 94,652 1 , 0 3 7,365\nTAIWAN SEMICONDUCTOR MANUFACTU ADR CORPORATE STOCK - COMMON 1 5 8 ,625 2 , 4 1 1,353\nTERUMO CORP CORPORATE STOCK - COMMON 7 6 4 ,713 8 7 0 , 905\nTOTALENERGIES SE CORPORATE STOCK - COMMON 7 1 9 ,496 8 0 2 , 442\nUNIVERSAL MUSIC GROUP NV CORPORATE STOCK - COMMON 1 , 2 02,453 1 , 1 0 6,762\nVAT GROUP AG CORPORATE STOCK - COMMON 1 6 4 ,178 5 1 6 , 3 28\nWOLTERS KLUWER NV CORPORATE STOCK - COMMON 1 , 0 02,174 1 , 0 9 4,561\n$ 3 2 ,098,930 $ 5 0 , 945,626\nEQUITABLE REAL ESTATE PARTNERSHIP/JOINT VENTURE $ 6 7 ,606,999 $ 1 2 3 ,671,905\n$ 6 7 ,606,999 $ 1 2 3 ,671,905\nBLACKROCK LIQ T FUND INSTL REGISTERED INVESTMENT COMPANY $ 1 2 1,769,713 $ 1 2 1 ,769,713\n$ 1 2 1,769,713 $ 1 2 1 ,769,713\nRESOLUTION FDG CORP PRIN STRIP 0.000% 04/15/2030 DD 04/15/90 U. S. GOVERNMENT SECURITIES $ 1 4 ,619,531$ 2 1 , 5 49,933\nU S TREASURY BD CPN STRIP 0.000% 02/15/2035 DD 02/15/06 U. S. GOVERNMENT SECURITIES 4 , 0 41,650 3 , 0 8 7,700\nU S TREASURY BD CPN STRIP 0.000% 02/15/2036 DD 02/15/06 U. S. GOVERNMENT SECURITIES 9 , 3 28,480 8 , 2 2 2,620\nU S TREASURY BD CPN STRIP 0.000% 02/15/2039 DD 02/17/09 U. S. GOVERNMENT SECURITIES 6 , 7 39,980 6 , 4 5 7,100\nU S TREASURY BD CPN STRIP 0.000% 05/15/2034 DD 08/15/07 U. S. GOVERNMENT SECURITIES 2 5 ,228,531 2 2 , 199,383\nU S TREASURY BD CPN STRIP 0.000% 05/15/2039 DD 05/15/09 U. S. GOVERNMENT SECURITIES 6 , 6 37,410 6 , 3 5 5,440\nU S TREASURY BD CPN STRIP 0.000% 08/15/2034 DD 02/15/06 U. S. GOVERNMENT SECURITIES 2 0 ,596,196 1 7 , 689,280\nU S TREASURY BD CPN STRIP 0.000% 08/15/2039 DD 08/17/09 U. S. GOVERNMENT SECURITIES 6 , 5 46,020 6 , 2 5 2,220\nU S TREASURY BD CPN STRIP 0.000% 11/15/2039 DD 11/16/09 U. S. GOVERNMENT SECURITIES 6 , 4 52,030 6 , 1 7 8,120\nU S TREASURY BD PRIN STRIP 0.000% 05/15/2043 DD 05/15/13 U. S. GOVERNMENT SECURITIES 1 5 ,481,200 1 4 , 431,550\nU S TREASURY BD PRIN STRIP 0.000% 08/15/2043 DD 08/15/13 U. S. GOVERNMENT SECURITIES 2 4 ,168,925 2 2 , 451,000\nU S TREASURY BD PRIN STRIP 0.000% 11/15/2043 DD 11/15/13 U. S. GOVERNMENT SECURITIES 3 0 ,572,800 2 8 , 235,200\nU S TREASURY BOND 1.375% 11/15/2040 DD 11/15/20 U. S. GOVERNMENT SECURITIES 4 , 7 73,242 3 , 0 9 8,450\nU S TREASURY BOND 2.250% 08/15/2046 DD 08/15/16 U. S. GOVERNMENT SECURITIES 1 , 6 70,787 1 , 5 0 6,782\nU S TREASURY BOND 2.375% 02/15/2042 DD 02/15/22 U. S. GOVERNMENT SECURITIES 1 4 ,044,703 1 0 , 690,500\nU S TREASURY BOND 2.875% 05/15/2043 DD 05/15/13 U. S. GOVERNMENT SECURITIES 6 , 1 56,047 5 , 5 5 0,610\nU S TREASURY BOND 3.375% 05/15/2044 DD 05/15/14 U. S. GOVERNMENT SECURITIES 4 , 9 58,284 4 , 5 8 0,184\nU S TREASURY BOND 3.375% 08/15/2042 DD 08/15/22 U. S. GOVERNMENT SECURITIES 3 , 7 40,124 3 , 4 0 3,818\nU S TREASURY BOND 3.375% 08/15/2042 DD 08/15/22 U. S. GOVERNMENT SECURITIES 1 3 ,583,528 1 2 , 395,550\nU S TREASURY BOND 3.500% 02/15/2039 DD 02/15/09 U. S. GOVERNMENT SECURITIES 5 , 0 69,380 4 , 3 8 6,550\nU S TREASURY BOND 3.625% 08/15/2043 DD 08/15/13 U. S. GOVERNMENT SECURITIES 8 , 4 79,835 8 , 1 1 5,456\nU S TREASURY BOND 3.875% 02/15/2043 DD 02/15/23 U. S. GOVERNMENT SECURITIES 9 , 5 32,028 8 , 8 3 2,800\nU S TREASURY BOND 3.875% 05/15/2043 DD 05/15/23 U. S. GOVERNMENT SECURITIES 8 , 5 67,831 8 , 1 2 7,778\nU S TREASURY BOND 3.875% 05/15/2043 DD 05/15/23 U. S. GOVERNMENT SECURITIES 3 , 1 64,995 2 , 9 3 8,335\nU S TREASURY BOND 3.875% 08/15/2040 DD 08/15/10 U. S. GOVERNMENT SECURITIES 2 9 ,069,118 2 7 , 023,400\nU S TREASURY BOND 4.000% 11/15/2042 DD 11/15/22 U. S. GOVERNMENT SECURITIES 1 4 ,634,679 1 3 , 5 11,100\nU S TREASURY BOND 4.250% 08/15/2054 DD 08/15/24 U. S. GOVERNMENT SECURITIES 1 , 0 37,011 9 8 8 , 027\nU S TREASURY BOND 4.250% 08/15/2054 DD 08/15/24 U. S. GOVERNMENT SECURITIES 1 2 ,934,793 1 2 , 400,656\n51\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(i)\nSchedule of Assets (Held at End of Year)\nAs of December 31, 2024\nU S TREASURY BOND 4.250% 11/15/2040 DD 11/15/10 U. S. GOVERNMENT SECURITIES 2 7 ,390,814 2 3 , 520,500\nU S TREASURY BOND 4.375% 08/15/2043 DD 08/15/23 U. S. GOVERNMENT SECURITIES 2 , 2 98,144 2 , 2 1 8,198\nU S TREASURY BOND 4.375% 11/15/2039 DD 11/15/09 U. S. GOVERNMENT SECURITIES 4 1 ,695,866 4 1 , 251,620\nU S TREASURY BOND 4.500% 02/15/2044 DD 02/15/24 U. S. GOVERNMENT SECURITIES 2 , 3 79,132 2 , 2 8 0,707\nU S TREASURY BOND 4.500% 08/15/2039 DD 08/15/09 U. S. GOVERNMENT SECURITIES 4 4 ,520,634 4 3 , 841,700\nU S TREASURY BOND 4.625% 05/15/2044 DD 05/15/24 U. S. GOVERNMENT SECURITIES 2 , 8 27,444 2 , 7 0 2,759\nU S TREASURY BOND 4.625% 05/15/2044 DD 05/15/24 U. S. GOVERNMENT SECURITIES 1 2 3 ,225 1 1 6 , 4 56\nU S TREASURY BOND 4.625% 11/15/2044 DD 11/15/24 U. S. GOVERNMENT SECURITIES 2 0 ,727,233 1 9 , 970,712\nU S TREASURY BOND 4.625% 11/15/2044 DD 11/15/24 U. S. GOVERNMENT SECURITIES 1 , 4 32,775 1 , 4 0 2,560\nU S TREASURY BOND 4.750% 02/15/2041 DD 02/15/11 U. S. GOVERNMENT SECURITIES 2 6 ,747,900 2 2 , 914,670\nU S TREASURY NOTE 0.625% 03/31/2027 DD 03/31/20 U. S. GOVERNMENT SECURITIES 1 5 ,134,180 1 3 , 847,400\nU S TREASURY NOTE 2.375% 04/30/2026 DD 04/30/19 U. S. GOVERNMENT SECURITIES 1 5 ,739,493 1 4 , 636,100\nU S TREASURY NOTE 2.625% 02/15/2029 DD 02/15/19 U. S. GOVERNMENT SECURITIES 2 1 ,616,581 1 8 , 696,200\nU S TREASURY NOTE 3.500% 09/30/2029 DD 09/30/24 U. S. GOVERNMENT SECURITIES 4 , 9 33,825 4 , 7 5 2,626\nU S TREASURY NOTE 3.750% 08/31/2031 DD 08/31/24 U. S. GOVERNMENT SECURITIES 3 7 ,343,974 3 5 , 446,370\nU S TREASURY NOTE 3.875% 08/15/2034 DD 08/15/24 U. S. GOVERNMENT SECURITIES 2 , 5 25,222 2 , 4 4 4,841\nU S TREASURY NOTE 4.000% 01/31/2029 DD 01/31/24 U. S. GOVERNMENT SECURITIES 3 , 6 95,667 3 , 6 9 8,138\nU S TREASURY NOTE 4.000% 01/31/2031 DD 01/31/24 U. S. GOVERNMENT SECURITIES 1 6 ,658,740 1 6 , 584,350\nU S TREASURY NOTE 4.000% 02/28/2030 DD 02/28/23 U. S. GOVERNMENT SECURITIES 2 5 ,333,660 2 4 , 534,250\nU S TREASURY NOTE 4.000% 07/31/2029 DD 07/31/24 U. S. GOVERNMENT SECURITIES 5 0 ,589,844 4 9 , 201,000\nU S TREASURY NOTE 4.125% 07/31/2031 DD 07/31/24 U. S. GOVERNMENT SECURITIES 4 2 ,872,227 4 1 , 160,000\nU S TREASURY NOTE 4.250% 01/31/2026 DD 01/31/24 U. S. GOVERNMENT SECURITIES 2 3 ,793,830 2 4 , 000,000\nU S TREASURY NOTE 4.250% 02/28/2029 DD 02/29/24 U. S. GOVERNMENT SECURITIES 2 0 ,139,130 1 9 , 904,000\nU S TREASURY NOTE 4.250% 02/28/2031 DD 02/29/24 U. S. GOVERNMENT SECURITIES 3 0 ,260,276 2 9 , 656,800\nU S TREASURY NOTE 4.250% 11/15/2034 DD 11/15/24 U. S. GOVERNMENT SECURITIES 1 1 1,573,822 1 0 9,624,106\nU S TREASURY NOTE 4.250% 11/15/2034 DD 11/15/24 U. S. GOVERNMENT SECURITIES 1 2 0 ,235 1 1 6 , 9 06\nU S TREASURY NOTE 4.375% 05/15/2034 DD 05/15/24 U. S. GOVERNMENT SECURITIES 5 6 ,618,788 5 3 , 476,812\nU S TREASURY NOTE 4.375% 08/31/2028 DD 08/31/23 U. S. GOVERNMENT SECURITIES 1 0 ,094,565 1 0 , 006,600\nU S TREASURY NOTE 4.500% 11/15/2033 DD 11/15/23 U. S. GOVERNMENT SECURITIES 1 9 ,676,801 1 9 , 1 16,096\nU S TREASURY NOTE 4.625% 06/30/2026 DD 06/30/24 U. S. GOVERNMENT SECURITIES 2 5 ,296,875 2 5 , 132,750\n$ 1 ,015,990,040 $ 9 6 6 ,914,769\nJOHN HANCOCK GROUP ANNUITY 0.000% 12/31/2049 DD 01/01/96 UNALLOCATED INSURANCE CONTRACT $ 1 0 ,659,514 $ 1 0 , 6 59,514\nCHICAGO IL MET WTR RECLAMATION 5.720% 12/01/2038 DD 08/26/09 MUNICIPAL BONDS $ 4 0 9 ,749 $ 3 0 1 , 203\nMUNI ELEC AUTH OF GEORGIA 6.637% 04/01/2057 DD 03/11/10 MUNICIPAL BONDS 4 9 2 ,353 3 5 6 , 3 71\nRUTGERS NJ ST UNIV 3.915% 05/01/2119 DD 09/16/19 MUNICIPAL BONDS 4 2 9 ,000 2 9 1 , 0 64\nTEXAS TRANSPRTN COMMISSION ST 5.178% 04/01/2030 DD 08/05/10 MUNICIPAL BONDS 1 , 9 43,970 1 , 5 1 4,130\nUNIV OF CALIFORNIA REVENUES 4.767% 05/15/2115 DD 04/08/15 MUNICIPAL BONDS 7 3 6 ,807 4 5 2 , 580\n$ 4 , 0 11,879 $ 2 , 9 1 5,348\nTOTAL INVESTMENTS: $ 2 , 743,533,620\nVariation Margin on Futures $ 2 , 6 8 6,827\n$ 2 , 6 8 6,827\nTOTAL ASSETS: $ 2 , 746,220,447\n52\n\nGlaxoSmithKline\nCash Balance Pension Plan\nSchedule H, Line 4(j) \u2013 Schedule of Reportable Transactions\nFor the Year Ended December 31, 2024\nNumber of (h) Current Value of Asset\n(a) Identity of Party Involved (b) Description of Asset (c) Purchase Price (d) Selling Price Transactions (g) Cost of Asset on Transaction Date (i) Net Gain or (Loss)\nCategory 3 - Series transactions\nin excess of 5% of plan assets\nBLACKROCK LIQ T FUND INSTL VAR RT 12/31/2049 DD 01/31/12 $ 2 ,014,228,227 $ - 882 $ - $ 2,014,228,227 $ -\nBLACKROCK LIQ T FUND INSTL VAR RT 12/31/2049 DD 01/31/12 - 1 ,994,339,670 582 1 ,994,339,670 1 ,994,339,670 -\nU S TREASURY BOND 4.750% 11/15/2043 DD 11/15/23 49,511,169 - 13 - 49,511,169 -\nU S TREASURY BOND 4.750% 11/15/2043 DD 11/15/23 - 1 95,445,772 18 2 01,164,155 2 01,164,155 - 5 ,718,383\nU S TREASURY BOND 4.500% 02/15/2044 DD 02/15/24 89,507,704 - 27 - 89,507,704 -\nU S TREASURY BOND 4.500% 02/15/2044 DD 02/15/24 - 87,266,616 11 87,128,572 87,128,572 1 38,044\nU S TREASURY NOTE 4.500% 11/15/2033 DD 11/15/23 - 1 23,225,861 32 1 23,670,787 1 23,670,787 - 4 44,926\nU S TREASURY NOTE 4.500% 11/15/2033 DD 11/15/23 92,372,459 - 42 - 92,372,459 -\nU S TREASURY NOTE 4.000% 02/15/2034 DD 02/15/24 - 1 11,745,990 31 1 14,522,280 1 14,522,280 - 2 ,776,291\nU S TREASURY NOTE 4.000% 02/15/2034 DD 02/15/24 114,522,280 - 46 - 1 14,522,280 -\nU S TREASURY NOTE 4.375% 05/15/2034 DD 05/15/24 156,772,250 - 38 - 1 56,772,250 -\nU S TREASURY NOTE 4.375% 05/15/2034 DD 05/15/24 - 1 04,407,491 26 1 00,153,461 1 00,153,461 4 ,254,030\nU S TREASURY NOTE 3.875% 08/15/2034 DD 08/15/24 - 1 24,010,499 36 1 28,207,698 1 28,207,698 - 4 ,197,199\nU S TREASURY NOTE 3.875% 08/15/2034 DD 08/15/24 130,732,920 - 46 - 1 30,732,920 -\nThe accompanying notes are an integral part of these financial statements\n53",
    "char_count": 198755
  },
  {
    "chunk_id": "GLAXOSMITHKLINE_231099050_003_2024_SB_ATTACHMENTS",
    "schedule_type": "SB_ATTACHMENTS",
    "page_range": "91-144",
    "page_count": 54,
    "raw_text": "SCHEDULE SB ATTACHMENTS\nSchedule SB, Line 26a\nSchedule of Active Participant Data as of January 1, 2024\nAge nearest\nbirthday <1 1-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40 & Over\n<25 Count 0 4 3 0 0 0 0 0 0 0\nAverage Account Balance - - - - - - - - - -\n25-29 Count 0 101 74 0 0 0 0 0 0 0\nAverage Account Balance - 2,436 9,348 - - - - - - -\n30-34 Count 0 133 284 22 0 0 0 0 0 0\nAverage Account Balance - 3,151 16,941 36,464 - - - - - -\n35-39 Count 0 102 318 96 50 2 0 0 0 0\nAverage Account Balance - 3,848 20,913 40,993 71,145 - - - - -\n40-44 Count 1 118 289 151 274 73 5 0 0 0\nAverage Account Balance - 4,846 26,074 55,173 82,555 106,267 - - - -\n45-49 Count 0 125 241 155 335 353 74 4 0 0\nAverage Account Balance - 5,375 27,235 67,354 100,381 136,343 152,962 - - -\n50-54 Count 0 99 191 135 282 486 252 67 2 0\nAverage Account Balance - 6,202 30,451 75,087 102,576 158,328 178,751 181,533 - -\n55-59 Count 0 60 132 127 205 351 236 221 55 3\nAverage Account Balance - 5,075 29,596 71,022 107,502 156,620 214,804 237,923 220,788 -\n60-64 Count 0 46 96 67 104 168 142 139 110 21\nAverage Account Balance - 4,990 28,880 75,732 91,411 153,307 215,370 269,020 289,216 287,586\n65-69 Count 0 15 34 30 22 38 30 34 30 19\nAverage Account Balance - - 31,472 62,517 97,285 166,142 204,201 307,568 411,478 -\n70 & up Count 0 2 5 4 6 10 6 6 2 11\nAverage Account Balance - - - - - - - - - -\nAverage Age: 50.3 Average Service: 16.9\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB, Part V\nStatement of Actuarial Assumptions/Methods\nEconomic Assumptions\nInterest rate basis:\n\u2022 Applicable month September 2023 (Based on 24-month average of bond yields\nthrough August 2023, with interest rate stabilization)\n\u2022 Yield curve basis Segment rates\nInterest rates:\nReflecting Not Reflecting\nstabilization stabilization\n\u2022 First segment rate 4.75% 3.62%\n\u2022 Second segment rate 4.87% 4.46%\n\u2022 Third segment rate 5.59% 4.52%\n\u2022 Effective interest rate 4.96% 4.35%\nAnnual rates of increase\n\u2022 Compensation: N/A\n\u2022 Statutory limits on compensation N/A\n\u2022 Cash balance interest crediting 30-year Treasury bond yield as of the last day of the prior plan year,\nrate rounding up to the next 10 basis points (4.00%)\n\u2022 Cash balance annuity conversion\nrate (single employees) Same as the cash balance interest crediting rate\n\u2022 Cash balance annuity conversion\nrates (married employees)\nReflecting Not Reflecting\nstabilization stabilization\n\u2013 First segment rate\n4.75% 3.62%\n\u2013 Second segment rate\n4.87% 4.46%\n\u2013 Third segment rate\n5.59% 4.52%\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nDemographic Assumptions\nInclusion date First day of plan year\nMortality\n\u2022 Healthy Separate rates for non-annuitants and annuitants based on Pri-2012\n\u201cEmployees\u201d and \u201cHealthy Annuitants\u201d (participants and beneficiaries\ncombined) tables, respectively, without collar or amount adjustments and then\nprojected forward with a generational projection as specified in the regulations\nunder \u00a71.430(h)(3)-1 using the IRS adjusted Scale MP-2021 (i.e., MP-2021\nwith no mortality improvement for 2020-2023 and future mortality improvement\ncapped at 0.78% for years after 2024).\n\u2022 Disabled Same as Healthy\n\u2022 Cash Balance Current IRS Prescribed 417(e)(3) unisex table for 2024 with future projections\nAnnuity Conversion based upon MP-2021\nTermination Rates ranging by age and service; sample rates:\nRepresentative Termination Rates:\nPercentage leaving during the year\nAttained Age Service\n0-4 5+\n25 13.0% 12.0%\n40 13.0% 10.0%\n50 13.0% 8.0%\nDisability Rates varying by age; sample rates:\nRepresentative Disability Rates:\nPercentage becoming disabled during the year\nAge Males Females\n25 0.043% 0.056%\n40 0.098% 0.149%\n50 0.323% 0.355%\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nRetirement Rates varying by age, average retirement age of 58\nRepresentative Retirement Rates:\nPercentage retiring during the year\nAge Rate\n50 8.0%\n55 9.0%\n60 15.0%\n65 30.0%\n70 100.0%\nBenefit commencement\ndate\n\u2022 Disability: Deferred to age 65 (form based on current active participants not electing\nimmediate payment below)\n\u2022 Death: Lump sums: immediate\nAnnuities: immediate if over age 50, otherwise, deferred to age 62\n\u2022 All other benefits: In accordance with the tables below\nForm of payment\nCurrent Active Participants Electing Immediate Payment\nTermination % Electing % Electing % Electing % Electing\nage: Immediate LS JS annuity SLA\n<55 35% 100.00% 0.00% 0.00%\n55-61 35% 85.00% 10.00% 5.00%\n62+ 100% 85.00% 10.00% 5.00%\nCurrent Active Participants Not Electing Immediate Payment\nTermination Deferral % Electing % Electing % Electing\nage: age LS JS annuity SLA\n20-49 55 85.00% 10.00% 5.00%\n50-62 62 85.00% 10.00% 5.00%\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nExisting Terminated Cash Balance Participants\nAge Annual% % Electing % Electing % Electing\nRange Commencing LS JS annuity SLA\n<55 5% 85.00% 10.00% 5.00%\n55-61 10% 85.00% 10.00% 5.00%\n62-64 10% 85.00% 10.00% 5.00%\n65-69 20% 85.00% 10.00% 5.00%\n70+ 100% 85.00% 10.00% 5.00%\nExisting Terminated Participants with Traditional Benefits\nAge Annual% % Electing % Electing % Electing\nRange Commencing LS annuity SLA\n<55 5% 85.00% 10.00% 5.00%\n55-61 10% 85.00% 10.00% 5.00%\n62-64 10% 85.00% 10.00% 5.00%\n65-69 20% 85.00% 10.00% 5.00%\n70+ 100% 85.00% 10.00% 5.00%\nPercent married 80%\nSpouse age Wife two years younger than husband.\nCovered pay N/A\nAdministrative expenses $13,100,000\nMethods\nValuation date First day of plan year\nFunding target Present value of accrued benefits as required by regulations under\nIRC \u00a7430. Disability benefit considered fully accumulated at eligibility\nfor continued accrual.\nTarget normal cost Present value of benefits expected to accrue during the plan year plus\nplan-related expenses expected to be paid from plan assets during\nthe plan year as required by regulations under IRC \u00a7430.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nActuarial value of assets Average of the fair market value of assets on the valuation date and\nthe dates that are 12 and 24 months preceding the valuation date,\nadjusted for contributions, benefits, administrative expenses and\nexpected earnings at 5.25% (with such expected earnings limited as\ndescribed in IRS Notice 2009-22). The average asset value must be\nwithin 10% of market value, including discounted contributions\nreceivable (discounted using the effective interest rate for the 2023\nplan year.)\nThe method of computing the actuarial value of assets complies with\nrules governing the calculation of such values under the Pension\nProtection Act of 2006 (PPA). These rules produce smoothed values\nthat reflect the underlying market value of plan assets, but fluctuate\nless than the market value. As a result, the actuarial value of assets\nwill be lower than the market value in some years and greater in other\nyears. However, over the long term under PPA's smoothing rules, the\nmethod has a significant bias to produce an actuarial value of assets\nthat is below the market value of assets.\nFunding policy The company\u2019s funding policy is to contribute an amount for a plan\nyear equal to the minimum required. GlaxoSmithKline may contribute\na different amount to the plan if appropriate to its tax and cash\npositions and the plan\u2019s funded position.\nSources of Data and Other Information\nIn preparing the valuation contained in this report, WTW has relied upon data and information\nregarding plan provisions, participants, assets, contributions, and sponsor funding elections and\naccounting policies and methods provided to us by GlaxoSmithKline and other persons or\norganizations designated by GlaxoSmithKline. We have relied on all the data and information provided\nas complete and accurate. We have reviewed this data and information for overall reasonableness and\nconsistency, but have neither audited nor independently verified this information. Based on\ndiscussions with and concurrence by the plan sponsor, assumptions or estimates may have been\nmade if data were not available. The data was not adjusted to reflect any significant events that\noccurred between the date the data was collected and the measurement date since the data collection\ndate and the measurement date are the same. We are not aware of any material errors, omissions or\ninconsistencies in the data that would have a significant effect on the results of our calculations.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nChange in assumptions and methods since prior valuation\n\u2022 The segment interest rates used to calculate the funding target and target normal cost were\nupdated to the current valuation date as required by IRC \u00a7430.\n\u2022 The mortality assumption used to calculate the funding target and target normal cost was changed\nfrom using a static projection of mortality improvement to a generational projection as required by\nguidance issued by IRS under IRC \u00a7430.\n\u2022 The mortality projection scale for cash balance annuity conversions was updated from MP-2020 to\nMP-2021.\n\u2022 The cash balance annuity conversion rates for married participants were changed from segment\nrates of 4.75% for the first 5 years, 5.00% for the next 15 years, and 5.74% thereafter to 4.75% for\nthe first 5 years, 4.87% for the next 15 years, and 5.59% thereafter.\n\u2022 The cash balance interest crediting rate assumption was changed to be based on the 30-year\ntreasury bond yield as of the last day of the prior plan year, rounded to the nearest 10 basis points.\nThe change in the approach did not change the 2024 assumption of 4.00% and increased from the\n2.75% used for 2023 valuations.\n\u2022 The retirement and termination assumptions were updated to reflect the results of the experience\nstudy completed during 2023.\n\u2022 The commencement rates for current terminated vested participants were updated to reflect the\nresults of the experience study completed during 2023.\n\u2022 The spouse age assumption was updated from 3 years to 2 years to reflect the results of the\nexperience study completed in 2023.\n\u2022 The form of payment assumption was updated to reflect the results of the experience study\ncompleted in 2023.\n\u2022 The expected administrative expenses were updated from $20,000,000 to $13,100,000 to account\nfor lower expected expenses to be paid from the trust.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nAssumptions Rationale \u2013 Significant Economic Assumptions\nDiscount rate The basis chosen was selected by the plan sponsor from among\nchoices prescribed by law, all of which are based on observed market\ndata over certain periods of time.\nCash balance interest The plan credits interest to cash balance accounts using the 24-month\ncrediting rate average of 30-year Treasury bond yields. This assumption is set based\non the actual 30-year Treasury bond yield at the end of prior plan year\n(December 31st). The assumption represents the best estimate of future\nexperience.\nCash balance annuity This rate mirrors the cash balance interest crediting rate, and the\nconversion rate (single assumption is set to be the same as the cash balance interest crediting\nemployees) rate for the current plan year.\nCash balance annuity This rate is determined by the IRS. It is based upon the same\nconversion rates (Married underlying bonds that are used in setting the segment rates. As a\nemployees) result, this assumption is set to equal to the valuation segment rates.\nAssumptions Rationale \u2013 Significant Demographic Assumptions\nRetirement Retirement rates were based on an experience study conducted in\n2023. They represent a best estimate of future experience.\nTermination Termination rates were selected based on an experience study\nconducted in 2023. They represent a best estimate of future\nexperience.\nDisability Disability rates were selected based on the plan sponsor\u2019s\nexpectation and represent a best estimate of future experience.\nBenefit commencement Assumptions were based on an experience study conducted in\ndate and form of payment 2023. They represent a best estimate of future experience\nPercent married Assumption was selected based on an experience study conducted\nin 2023. It represents a best estimate of future experience\nSpouse age Assumption was selected based on an experience study conducted\nin 2023. It represents a best estimate of future experience\nAdministrative expenses Assumption was selected based on the plan sponsor\u2019s expectation\nfor the year.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(j) - Schedule of Reportable Transactions\nFor the Year Ended December 31, 2024\nNumber of (h) Current Value of Asset\n(a) Identity of Party Involved (b) Description of Asset (c) Purchase Price (d) Selling Price Transactions (g) Cost of Asset on Transaction Date (i) Net Gain or (Loss)\nCategory 3 - Series transactions\nin excess of 5% of plan assets\nBLACKROCK LIQ T FUND INSTL VAR RT 12/31/2049 DD 01/31/12 $ 2,014,228,227 $ - 882 $ - $ 2,014,228,227 $ -\nBLACKROCK LIQ T FUND INSTL VAR RT 12/31/2049 DD 01/31/12 - 1,994,339,670 582 1 ,994,339,670 1 ,994,339,670 -\nU S TREASURY BOND 4.750% 11/15/2043 DD 11/15/23 49,511,169 - 13 - 49,511,169 -\nU S TREASURY BOND 4.750% 11/15/2043 DD 11/15/23 - 1 95,445,772 18 2 01,164,155 201,164,155 - 5,718,383\nU S TREASURY BOND 4.500% 02/15/2044 DD 02/15/24 89,507,704 - 27 - 89,507,704 -\nU S TREASURY BOND 4.500% 02/15/2044 DD 02/15/24 - 87,266,616 11 87,128,572 87,128,572 138,044\nU S TREASURY NOTE 4.500% 11/15/2033 DD 11/15/23 - 1 23,225,861 32 1 23,670,787 123,670,787 - 4 44,926\nU S TREASURY NOTE 4.500% 11/15/2033 DD 11/15/23 92,372,459 - 42 - 92,372,459 -\nU S TREASURY NOTE 4.000% 02/15/2034 DD 02/15/24 - 1 11,745,990 31 1 14,522,280 114,522,280 - 2,776,291\nU S TREASURY NOTE 4.000% 02/15/2034 DD 02/15/24 114,522,280 - 46 - 114,522,280 -\nU S TREASURY NOTE 4.375% 05/15/2034 DD 05/15/24 156,772,250 - 38 - 156,772,250 -\nU S TREASURY NOTE 4.375% 05/15/2034 DD 05/15/24 - 104,407,491 26 1 00,153,461 1 00,153,461 4 ,254,030\nU S TREASURY NOTE 3.875% 08/15/2034 DD 08/15/24 - 124,010,499 36 1 28,207,698 1 28,207,698 - 4,197,199\nU S TREASURY NOTE 3.875% 08/15/2034 DD 08/15/24 130,732,920 - 46 - 130,732,920 -\n\nSCHEDULE SB Single-Employer Defined Benefit Plan OMB No. 1210-0110\n(Form 5500) Actuarial Information\n2024\nDepartment of the Treasury\nInternal Revenue Service\nThis schedule is required to be filed under section 104 of the Employee\nDepartment of Labor Retirement Income Security Act of 1974 (ERISA) and section 6059 ofthe This Form is Open to Public\nEmployee Benefits Security Administration Internal Revenue Code (the Code). Inspection\nPension Benefit Guaranty Corporation\nFile as an attachment to Form 5500 or 5500-SF.\nFor calendar plan year 2024 or fiscal plan year beginning and ending\nRound off amounts to nearest dollar.\nCaution:A penalty of $1,000 will be assessed for late filing of this report unless reasonable cause is established.\nA Name of plan B Three-digit\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI plan number (PN) 001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nC -SF D Employer Identification Number (EIN)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 012345678\nABCDEFGHI ABCDEFGHI\nE Type of plan: X Single X Multiple-A X Multiple-B F Prior year plan size: X 100 or fewer X 101-500 X More than 500\nPart I Basic Information\n1 Enter the valuation date: Month _________ Day _________ Year _________\n2 Assets:\naMarket value......................................................................................................................................................... 2a -123456789012345\nbActuarial value...................................................................................................................................................... 2b -123456789012345\n3 Funding target/participant count breakdown (1) Number of (2) Vested Funding (3) Total Funding\nparticipants Target Target\naFor retired participants and beneficiaries receiving payment.....................................\nbFor terminated vested participants.............................................................................\ncFor active participants................................................................................................\ndTotal............................................................................................................................\n4 If the plan is in at-riskstatus, check the box and complete lines(a) and (b)..............................X\naFunding target disregarding prescribedat-riskassumptions................................................................................. 4a -123456789012345\nbFunding target reflecting at-riskassumptions, but disregarding transition rule for plans that have been in 4b\nat-risk statusfor fewer than five consecutive years and disregarding loading factor............................................. -123456789012345\n5 Effective interest rate................................................................................................................................................. 5 123.12%\n6 Target normal cost\naPresent value of current plan year accruals.......................................................................................................... 6a\nbExpectedplan-related expenses........................................................................................................................... 6b\ncTarget normal cost................................................................................................................................................. 6c\nStatement by Enrolled Actuary\nTo the best of my knowledge, the information supplied in this schedule and accompanying schedules, statements and attachments, if any, is complete and accurate. Each prescribed assumption was applied in\naccordance with applicable law and regulations. In my opinion, each other assumption is reasonable (taking into account the experience of the plan and reasonable expectations) and such other assumptions, in\ncombination, offer my best estimate of anticipated experience under the plan.\nSIGN\nHERE Sheri X. DeCristofaro September 9, 2025\nSignature of actuary Date\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE YYYY-MM-DD\nType or print name of actuary Most recent enrollment number\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE 1234567\nFirm name Telephone number (including area code)\n123456789 ABCDEFGHI ABCDEFGHI ABCDE 1234567890\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nUK\nAddress of the firm\nIf the actuary has not fully reflected any regulation or ruling promulgated under the statute in completing this schedule, checkthe box and see instructions X\nFor Paperwork Reduction Act Notice, see the Instructions for Form5500 or 5500-SF. Schedule SB (Form 5500) 2024\nv.240311\n\nSchedule SB (Form 5500) 2024 Page2- 1-x\nPart II Beginning of Year CarryoverandPrefunding Balances\n(a) Carryover balance (b) Prefunding balance\n7 Balance at beginning of prior year after applicable adjustments (line13 from prior -123456789012345 -123456789012345\nyear)...............................................................................................................................\n8 Portion elected for use line35 from prior\nyear) ............................................................................................................................. -123456789012345 -123456789012345\n9 Amount remaining (line7 minus line8).......................................................................... -123456789012345 -123456789012345\n10 Interest on line %................................ -123456789012345 -123456789012345\n11\naPresent value of excesscontributions (line38afrom prior year)................................ -123456789012345\nb(1)Interest on the excess, if any, of line 38a over line 38b from prior year\nSchedule SB, using prior year's effective interest rate of %..............\n-123456789012345\nb(2)Interest on line 38b from prior year Schedule SB, using prior year's actual\nreturn....................................................................................................................\ncTotal available at beginning of current plan year to add to prefunding balance.................\ndPortion of (c) to be added to prefunding balance....................................................... -123456789012345\n123456789012345\n12 Other reductionsin balances due to elections or deemed elections.............................. -123456789012345 -123456789012345\n13 Balance at beginning of current year (line9 + line10 + line11d line12).................... -123456789012345 -123456789012345\nPart III Funding Percentages\n14 Funding target attainment percentage..................................................................................................................................................................... 14 123.12%\n15 Adjusted funding target attainment percentage.......................................................................................................................................... 15 123.12%\n16 nt\n16\nrequirement......................................................................................................................................................................... 123.12%\n17 If the current value of the assets of the plan is less than 70 percent of the funding target, enter such percentage................................... 17 123.12%\nPart IV Contributions and Liquidity Shortfalls\n18 Contributions made to the plan for the plan year by employer(s) and employees:\n(a)Date (b)Amount paid by (c)Amount paid by (a)Date (b)Amount paid by (c) Amount paid by\n(MM-DD-YYYY) employer(s) employees (MM-DD-YYYY) employer(s) employees\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\nYYYY-MM-DD 12345678901234 1\n1\n2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n4\n4\nYYYY-MM-DD 1\n1\n2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n4\n4\n123456789012345 -\nYYYY-MM-DD 12345678901234 YYYY-MM-DD 123456789012345 -\n12345678901234 12345678901234\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345 -\n12345678901234 123456789012345\nYYYY-MM-DD YYYY-MM-DD -\nYYYY MM-DD 12345678901234 -MM-DD 12345678901234 -\n12345678901234 123456789012345\nYYYY-MM-DD YYYY-MM-DD -\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\nYYYY-MM-DD 12345678901234 12345678901234\n19 Discounted employer contributions see instructions for small plan with a valuation date after the beginning of the year:\naContributions allocated toward unpaid minimum required contributionsfrom prior years....................................... 19a -123456789012345\nbContributions made to avoid restrictions adjusted to valuation date........................................................................ 19b -123456789012345\ncContributions allocated toward minimum required contribution for current year adjusted to valuation date..................... 19c -123456789012345\n20 Quarterly contributions and liquidity shortfalls:\na .............................................................................................................................X Yes X No\nb Ifline manner?.....................................................X Yes X No\nc Ifline\nLiquidity shortfall as of end of quarter of this plan year\n(1) 1st (2) 2nd (3) 3rd (4) 4th\n-123456789012345 -123456789012345 -123456789012345\n\nSchedule SB (Form 5500) 2024 Page 3\nPart V Assumptions Used to Determine Funding Target and Target Normal Cost\n21 Discount rate:\na Segment rates: 1st segment: 2nd segment: 3rd segment:\nXN/A, full yield curve used\n123.12_% 123.12_% 123.12 %\nbApplicable month (enter code) ............................................................................................................................ 21b 1\n22 Weighted average retirement age ............................................................................................................................ 22 12\n23 Mortality table(s) (see instructions) _ Prescribed - combined _ Prescribed - separate _ Substitute\nPart VI Miscellaneous Items\n24 Has a change been made in the non-\nattachment. ........................................................................................................................................................................................................ X Yes X No\n25 instructions regarding required attachment. ................................ X Yes X No\n26 Demographic and benefit information\na ............... X Yes X No\nb Is the plan required to provide a projection of expected benefit payments? see instructions regarding required attachment ... X Yes X No\n27 If the plan is subject to alternative funding rules, enter applicable code and see instructions regarding 27\nattachment..............................................................................................................................................................\nPart VII Reconciliation of Unpaid Minimum Required Contributions For Prior Years\n28 Unpaid minimum required contributions for all prior years ..................................................................................... 28 -123456789012345\n29 Discounted employer contributions allocated toward unpaid minimum required contributions from prior years\n29\n(line19a)................................................................................................................................................................. -123456789012345\n30 Remaining amount of unpaid minimum required contributions (line 28 minus line 29) ............................................ 30 -123456789012345\nPart VIII Minimum Required Contribution For Current Year\n31 Target normal cost and excess assets (see instructions):\na Target normal cost (line 6c) ................................................................................................................................. 31a -123456789012345\nb Excess assets, if applicable, but not greater than line 31a .................................................................................. 31b\n32 Amortization installments: Outstanding Balance Installment\na Net shortfall amortization installment ............................................................................... -123456789012345 -123456789012345\nb Waiver amortization installment ....................................................................................... -123456789012345 -123456789012345\n33 If a waiver has been approved for this plan year, enter the date of the ruling letter granting the approval\n33\n(Month _________ Day _________ Year _________ )_and the waived amount ............................................. -123456789012345\n34 Total funding requirement before reflecting carryover/prefunding balances (lines 31a - 31b + 32a + 32b - 33)..... 34 -123456789012345\nCarryover balance Prefunding balance Total balance\n35 Balances elected for use to offset funding\nrequirement ................................................................ -123456789012345 -123456789012345 -123456789012345\n36 Additional cash requirement (line 34 minus line 35) ............................................................................................... 36 -123456789012345\n37 Contributions allocated toward minimum required contribution for current year adjusted to valuation date (line\n37 -123456789012345\n19c) ...........................................................................................................................................................................\n38 Present value of excess contributions for current year (see instructions)\na Total (excess, if any, of line 37 over line 36) 38a\nb Portion included in line 38a attributable to use of prefunding and funding standard carryover balances ............. 38b\n39 Unpaid minimum required contribution for current year (excess, if any, of line 36 over line 37) ............................ 39 -123456789012345\n40 Unpaid minimum required contributions for all years ............................................................................................... 40 -123456789012345\nPart IX Pension Funding Relief Under the American Rescue Plan Act of 2021 (See Instructions)\n41 If an election was made to use the extended amortization rule for a plan year beginning on or before December 31, 2021, check the box to indicate the first\nplan year for which the rule applies. X 2019 X 2020 X 2021\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB \u2013 Statement by Enrolled Actuary\nPlan Sponsor GlaxoSmithKline, LLC\nEIN/PN 23-1099050/003\nPlan Name GlaxoSmithKline Cash Balance Pension Plan\nValuation Date January 1, 2024\nEnrolled Actuary Sheri X. DeCristofaro, FSA, EA\nEnrollment Number 23-06629\nThe actuarial assumptions that are not mandated by IRC \u00a7 430 and regulations, represent the\nenrolled actuary's best estimate of anticipated experience under the plan, subject to the following\nconditions:\nThe actuarial valuation, on which the information in this Schedule SB is based, has been prepared in\nreliance upon the employee and financial data furnished by the plan administrator and the trustee.\nThe enrolled actuary has not made a rigorous check of the accuracy of this information but has\naccepted it after reviewing it and concluding it is reasonable in relation to similar information furnished\nin previous years. The amounts of contributions and dates paid shown in Item 18 of Schedule SB\nwere listed in reliance on information provided by the plan administrator and/or trustee.\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB, Line 22\nDescription of Weighted Average Retirement Age\nas of January 1, 2024\nAssumed Number Assumed Number Age X Number\nAge Retirement Rate\nEligible Retiring Retiring\n50 8.00% 1,000 80 4,000\n51 8.00% 920 74 3,774\n52 8.00% 846 68 3,536\n53 8.00% 778 62 3,286\n54 8.00% 716 57 3,078\n55 9.00% 659 59 3,245\n56 11.00% 600 66 3,696\n57 11.00% 534 59 3,363\n58 11.00% 475 52 3,016\n59 13.00% 423 55 3,245\n60 15.00% 368 55 3,300\n61 18.00% 313 56 3,416\n62 20.00% 257 51 3,162\n63 20.00% 206 41 2,583\n64 23.00% 165 38 2,432\n65 30.00% 127 38 2,470\n66 40.00% 89 36 2,376\n67 40.00% 53 21 1,407\n68 40.00% 32 13 884\n69 40.00% 19 8 552\n70 100.00% 11 11 770\n57,5 91\nNumber of Eligible 1,000\nWeighted Average Retirement Age 58\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB, Line 26b\nSchedule of Projection of Expected Benefit Payments\nRetired\nTerminated Participants and\nActive\nPlan Year Vested Beneficiaries Total\nParticipants\nParticipants Receiving\nPayments\n2024 74,498,442 161,579,326 135,808,346 371,886,114\n2025 61,599,128 104,840,402 130,987,549 297,427,079\n2026 60,696,148 100,691,618 126,041,929 287,429,695\n2027 59,228,874 96,565,198 121,060,635 276,854,707\n2028 58,006,065 91,411,886 115,950,030 265,367,981\n2029 58,417,942 85,871,926 110,701,857 254,991,725\n2030 58,204,438 80,224,925 105,365,226 243,794,589\n2031 58,286,192 73,240,998 99,997,901 231,525,091\n2032 59,691,004 71,689,652 94,568,169 225,948,825\n2033 56,986,926 64,957,802 89,066,877 211,011,605\n2034 52,712,324 60,076,729 83,507,928 196,296,981\n2035 49,869,817 54,732,702 77,916,125 182,518,644\n2036 50,865,550 49,772,302 72,346,354 172,984,206\n2037 42,873,410 46,937,118 66,825,708 156,636,236\n2038 40,126,426 42,687,064 61,322,412 144,135,902\n2039 33,857,020 38,993,032 55,936,059 128,786,111\n2040 28,912,114 37,767,761 50,726,786 117,406,661\n2041 26,022,973 33,536,160 45,703,389 105,262,522\n2042 22,152,791 31,692,824 40,944,017 94,789,632\n2043 20,350,804 28,768,978 36,448,796 85,568,578\n2044 17,475,344 26,131,424 32,242,728 75,849,496\n2045 16,089,268 24,204,722 28,348,210 68,642,200\n2046 14,518,185 22,005,467 24,759,854 61,283,506\n2047 12,662,309 19,935,068 21,483,068 54,080,445\n2048 11,686,730 18,113,544 18,517,103 48,317,377\n2049 10,343,487 16,380,744 15,856,314 42,580,545\n2050 9,293,910 14,913,521 13,490,801 37,698,232\n2051 8,488,365 13,392,422 11,406,485 33,287,272\n2052 7,882,669 11,988,928 9,586,534 29,458,131\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nRetired\nTerminated Participants and\nActive\nPlan Year Vested Beneficiaries Total\nParticipants\nParticipants Receiving\nPayments\n2053 7,294,139 10,779,494 8,011,621 26,085,254\n2054 6,766,133 9,898,759 6,660,952 23,325,844\n2055 6,336,868 8,800,644 5,512,906 20,650,418\n2056 5,841,810 7,957,002 4,545,613 18,344,425\n2057 5,394,679 7,006,509 3,737,509 16,138,697\n2058 4,994,920 6,276,808 3,067,831 14,339,559\n2059 4,584,142 5,497,145 2,516,987 12,598,274\n2060 4,198,084 4,858,427 2,066,889 11,123,400\n2061 3,834,154 4,244,571 1,701,209 9,779,934\n2062 3,481,656 3,675,463 1,405,433 8,562,552\n2063 3,148,050 3,202,825 1,166,897 7,517,772\n2064 2,830,905 2,775,306 974,756 6,580,967\n2065 2,531,922 2,382,014 819,865 5,733,801\n2066 2,251,919 2,058,813 694,639 5,005,371\n2067 1,990,965 1,751,947 592,887 4,335,799\n2068 1,749,724 1,502,515 509,632 3,761,871\n2069 1,528,449 1,294,337 440,912 3,263,698\n2070 1,326,953 1,082,659 383,616 2,793,228\n2071 1,145,008 915,913 335,337 2,396,258\n2072 982,017 771,581 294,240 2,047,838\n2073 837,175 650,204 258,915 1,746,294\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB, Part V\nSummary of Plan Provisions\nThe most recent amendment reflected in the following plan provisions was adopted August 26, 2020\nand effective December 31, 2020.\nDefinitions\nEligibility for Participation One year of service\nPay This included base pay, overtime, shift differential, regularly\nscheduled variable/incentive pay and bonuses, contributions to\nthe Flexible Compensation Plan (i.e., pre-tax contributions to\nmedical, dental, etc.) and contributions to the GlaxoSmithKline\nRetirement Savings Plan received each pay period.\nPlan Benefits A cash balance account is established for each active\nparticipant. The account will be increased with company credits,\ninterest credits, and transition credits, if any. Effective\nDecember 31, 2020, the Company Credits were eliminated\nprospectively.\nCompany Credits: 5% of pay (through December 31, 2020)\nInterest Credits: Based on the 24-month average yield of 30-\nyear Treasury Bonds as of June 30 of the previous year.\nTransition Credits: For each active participant on December 31,\n1996 (December 31, 1998 for former SmithKline Beecham\nparticipants), a transition amount was calculated individually and\ncredited to the participant\u2019s account for up to seven years. For\neach active participant of the Viiv joint venture on December 31,\n2009, a transition amount was calculated individually and\ncredited to the participant\u2019s account.\nBenefit Commencement Participants may elect to receive benefits immediately following\ntermination/retirement. Alternatively, benefits may be deferred\nuntil any subsequent month, but no later than the April 1\nfollowing attainment of age 70 1/2.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nForms of Distribution\n\u2022 Normal Form 100% joint and survivor annuity for married participants; single life\nannuity for single participants\n\u2022 Optional Forms Lump sum (automatic if under $5,000, option if over $5,000), life\nannuity, 100% J&S, 50% J&S, 20-year certain and life, 15-year\ncertain and life, 10-year certain and life, 5-year certain and life,\nSocial Security level income option.\nActuarial Equivalence To convert the cash balance account to a single life annuity, the\n24-month average of 30-year Treasury Bonds as of June 30 of the\nprior year and the mortality table pursuant to Code Section\n417(e)(3) are used\nTo convert the cash balance account to the QJSA for married\nemployees (100% J&S annuity), the segment rates under Code\nSection 417(e)(3) in effect for the November preceding the Plan\nYear of distribution and the mortality table pursuant to Code\nSection 417(e)(3) are used\nFor optional forms of payment, an interest rate equal to 7% and\nmortality pursuant to code section 417(e)(3), except for the Social\nSecurity level income option, where the interest rate will be based\non the lesser of 7% or the segment rates under 417(e)(3) in effect\nfor the November preceding the Plan Year of distribution are used\nEligibility for Benefits\nNormal retirement Age 65\nEarly retirement Age 50\nVested Immediate upon participation\ntermination/Disability/Death\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nBenefits Paid Upon the Following Events\nRetirement/Termination Account balance (or actuarially equivalent annuity) payable upon\nBenefits retirement/termination\nDisability Benefits Account balance (or actuarially equivalent annuity) deferred to age 65,\nwith continuing benefit accruals. No future accruals after December\n31, 2020 for those become disabled on or after January 1, 2021.\nDeath Benefits Account balance (or actuarially equivalent annuity) payable upon\ndeath\nEffective January 1, 2002, participants at least age 55 with 10 years of\nservice or whose age plus service is at least 75 with a minimum of 20\nyears of service, who elected to receive an annuity upon retirement\nprior to January 1, 2010, were eligible for a postretirement life\ninsurance benefit equal to six times the value of the single life annuity\nbenefit\nOther Provisions\nPension Increases None\nRetiree Contributions None\nFuture Plan Changes\nWTW is not aware of any future plan changes which are required to be reflected.\nChanges in Benefits Valued Since Prior Year\nThere have been no changes in the benefits valued since the prior valuation.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\n(a) (b) (c) (d) (e)\nIdentity of Issue, Borrower, Lessor or Similar Party. Including\nDescription of Investment Cost Current Value\nMaturity Date, Rate of Interest Collateral, Par or Maturity Value\nForeign Currency - CHF (SWISS FRANC) FOREIGN CURRENCY $ 8 1 $ 7 9\nForeign Currency - GBP (GREAT BRITISH POUNDS) FOREIGN CURRENCY 1 1\n$ 8 2 $ 8 0\nMSCI EAFE INDEX - NL COMMON/COLLECTIVE TRUST $ 6 9 ,944,424 $ 9 3 , 077,909\nDAILY MSCI EMG MKTS INDX NL FUND (ZV86) COMMON/COLLECTIVE TRUST 5 7 ,000,000 6 2 , 565,617\nSSGA RUSSELL 3000 IDX NL FD COMMON/COLLECTIVE TRUST 2 5 6,486,736 3 8 5,338,474\n$ 3 8 3,431,160 $ 5 4 0,982,000\nABBOTT LABORATORIES 2.950% 03/15/2025 DD 03/10/15 CORPORATE DEBT INSTRUMENTS $ 1 , 9 19,558 $ 1 , 7 4 3,980\nABBOTT LABORATORIES 4.900% 11/30/2046 DD 11/22/16 CORPORATE DEBT INSTRUMENTS 1 , 9 39,771 1 , 8 2 6,811\nABBOTT LABORATORIES 4.900% 11/30/2046 DD 11/22/16 CORPORATE DEBT INSTRUMENTS 5 9 1 ,940 5 0 2 , 723\nABBVIE INC 4.050% 11/21/2039 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 9 8 2 ,546 7 4 8 , 396\nABBVIE INC 4.050% 11/21/2039 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 9 5 4 ,912 7 8 6 , 030\nABBVIE INC 4.250% 11/21/2049 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 1 , 1 20,406 9 1 1 , 9 71\nABBVIE INC 4.250% 11/21/2049 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 1 , 2 99,383 1 , 0 1 9,454\nABBVIE INC 4.250% 11/21/2049 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 9 9 0 ,449 7 5 3 , 1 90\nABBVIE INC 4.300% 05/14/2036 DD 05/12/16 CORPORATE DEBT INSTRUMENTS 5 8 6 ,912 5 8 4 , 595\nABBVIE INC 4.400% 11/06/2042 DD 05/06/13 CORPORATE DEBT INSTRUMENTS 1 , 3 36,014 1 , 1 7 0,315\nABBVIE INC 4.450% 05/14/2046 DD 05/12/16 CORPORATE DEBT INSTRUMENTS 6 9 , 9 60 7 6 , 6 0 3\nABBVIE INC 4.550% 03/15/2035 DD 09/15/20 CORPORATE DEBT INSTRUMENTS 3 4 2 ,663 2 7 7 , 433\nABBVIE INC 4.700% 05/14/2045 DD 05/14/15 CORPORATE DEBT INSTRUMENTS 1 , 2 79,386 1 , 1 3 0,867\nABBVIE INC 4.700% 05/14/2045 DD 05/14/15 CORPORATE DEBT INSTRUMENTS 5 7 9 ,112 5 8 6 , 637\nABBVIE INC 4.850% 06/15/2044 DD 06/15/20 CORPORATE DEBT INSTRUMENTS 9 4 1 ,593 7 1 7 , 0 83\nABBVIE INC 4.850% 06/15/2044 DD 06/15/20 CORPORATE DEBT INSTRUMENTS 4 7 6 ,604 3 8 5 , 772\nABBVIE INC 4.875% 11/14/2048 DD 09/18/18 CORPORATE DEBT INSTRUMENTS 6 8 9 ,633 6 2 6 , 749\nABBVIE INC 4.875% 11/14/2048 DD 09/18/18 CORPORATE DEBT INSTRUMENTS 6 4 , 4 95 5 8 , 4 4 9\nABBVIE INC 5.050% 03/15/2034 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 8 8 2 ,212 8 7 5 , 2 12\nABBVIE INC 5.350% 03/15/2044 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 2 3 9 ,669 2 3 4 , 226\nABBVIE INC 5.400% 03/15/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 4 8 3 ,336 4 6 7 , 002\nABBVIE INC 5.400% 03/15/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 1 , 5 03,824 1 , 4 5 3,001\nABBVIE INC 5.500% 03/15/2064 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 3 6 3 ,635 3 4 9 , 294\nABBVIE INC 5.500% 03/15/2064 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 4 3 8 ,354 4 2 1 , 0 67\nADOBE INC 4.950% 04/04/2034 DD 04/04/24 CORPORATE DEBT INSTRUMENTS 9 9 8 ,050 9 9 3 , 1 00\nAEP TEXAS INC 3.950% 06/01/2028 DD 12/01/18 CORPORATE DEBT INSTRUMENTS 1 , 9 28,486 1 , 6 3 7,912\nAEP TRANSMISSION CO LLC 3.650% 04/01/2050 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 1 3 4 ,951 9 7 , 6 6 7\nAEP TRANSMISSION CO LLC 5.400% 03/15/2053 DD 03/13/23 CORPORATE DEBT INSTRUMENTS 2 3 3 ,755 2 2 4 , 1 71\nAERCAP IRELAND CAPITAL DAC / A 3.400% 10/29/2033 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 1 8 , 7 16 1 7 , 0 3 8\nAERCAP IRELAND CAPITAL DAC / A 3.850% 10/29/2041 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 1 , 0 91,281 1 , 1 6 8,041\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nAERCAP IRELAND CAPITAL DAC / A 3.850% 10/29/2041 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 1 , 6 09,399 1 , 5 0 1,207\nAERCAP IRELAND CAPITAL DAC / A 4.950% 09/10/2034 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 4 5 7 ,732 4 4 3 , 2 61\nAERCAP IRELAND CAPITAL DAC / A 5.300% 01/19/2034 DD 01/11/24 CORPORATE DEBT INSTRUMENTS 3 6 6 ,483 3 6 7 , 957\nAGREE LP 2.600% 06/15/2033 DD 05/14/21 CORPORATE DEBT INSTRUMENTS 2 7 7 ,670 2 2 5 , 1 45\nAIA GROUP LTD 144A 5.400% 09/30/2054 DD 09/30/24 CORPORATE DEBT INSTRUMENTS 1 , 1 01,972 1 , 0 2 7,958\nAIB GROUP PLC 144A VAR RT 03/28/2035 DD 03/28/24 CORPORATE DEBT INSTRUMENTS 1 , 1 53,865 1 , 1 5 0,379\nAIR PRODUCTS AND CHEMICALS INC 1.850% 05/15/2027 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 1 , 5 45,682 1 , 3 9 1,141\nAKER BP ASA 144A 5.800% 10/01/2054 DD 10/01/24 CORPORATE DEBT INSTRUMENTS 9 0 2 ,195 8 2 1 , 3 96\nALABAMA POWER CO 3.700% 12/01/2047 DD 11/08/17 CORPORATE DEBT INSTRUMENTS 1 , 5 56,989 1 , 1 6 4,651\nALABAMA POWER CO 4.300% 07/15/2048 DD 06/28/18 CORPORATE DEBT INSTRUMENTS 7 0 4 ,654 5 8 3 , 350\nALABAMA POWER CO 6.000% 03/01/2039 DD 03/06/09 CORPORATE DEBT INSTRUMENTS 2 , 2 28,668 2 , 1 0 7,109\nALCON FINANCE CORP 144A 5.750% 12/06/2052 DD 12/06/22 CORPORATE DEBT INSTRUMENTS 1 , 0 03,630 9 5 8 , 804\nALIMENTATION COUCHE-TARD 144A 5.617% 02/12/2054 DD 02/12/24 CORPORATE DEBT INSTRUMENTS 5 5 7 ,000 5 2 6 , 8 11\nALPHABET INC 2.050% 08/15/2050 DD 08/05/20 CORPORATE DEBT INSTRUMENTS 5 9 1 ,974 5 2 7 , 2 12\nAMAZON.COM INC 1.500% 06/03/2030 DD 06/03/20 CORPORATE DEBT INSTRUMENTS 1 , 9 27,309 1 , 6 3 3,131\nAMAZON.COM INC 2.500% 06/03/2050 DD 06/03/20 CORPORATE DEBT INSTRUMENTS 6 2 1 ,885 4 1 2 , 3 65\nAMAZON.COM INC 2.875% 05/12/2041 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 8 5 7 ,934 8 4 8 , 682\nAMAZON.COM INC 2.875% 05/12/2041 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 3 2 3 ,775 2 3 8 , 807\nAMAZON.COM INC 3.100% 05/12/2051 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 5 6 8 ,595 4 0 1 , 9 11\nAMAZON.COM INC 3.250% 05/12/2061 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 2 , 5 79,233 1 , 7 4 4,073\nAMAZON.COM INC 3.250% 05/12/2061 DD 05/12/21 CORPORATE DEBT INSTRUMENTS 1 , 4 59,618 8 7 1 , 7 11\nAMAZON.COM INC 3.875% 08/22/2037 DD 02/22/18 CORPORATE DEBT INSTRUMENTS 2 5 0 ,355 2 3 8 , 540\nAMAZON.COM INC 3.875% 08/22/2037 DD 02/22/18 CORPORATE DEBT INSTRUMENTS 8 1 4 ,941 7 2 4 , 454\nAMAZON.COM INC 3.950% 04/13/2052 DD 04/13/22 CORPORATE DEBT INSTRUMENTS 2 , 3 44,160 1 , 8 5 9,330\nAMAZON.COM INC 3.950% 04/13/2052 DD 04/13/22 CORPORATE DEBT INSTRUMENTS 6 8 2 ,137 5 4 1 , 0 54\nAMAZON.COM INC 4.050% 08/22/2047 DD 02/22/18 CORPORATE DEBT INSTRUMENTS 7 7 9 ,508 6 4 9 , 383\nAMEREN ILLINOIS CO 1.550% 11/15/2030 DD 11/23/20 CORPORATE DEBT INSTRUMENTS 7 8 6 ,658 6 5 5 , 0 13\nAMEREN ILLINOIS CO 3.700% 12/01/2047 DD 11/28/17 CORPORATE DEBT INSTRUMENTS 8 5 8 ,789 6 5 2 , 1 75\nAMEREN ILLINOIS CO 3.700% 12/01/2047 DD 11/28/17 CORPORATE DEBT INSTRUMENTS 4 3 , 6 14 3 0 , 1 5 8\nAMERICA MOVIL SAB DE CV 6.125% 03/30/2040 DD 03/30/10 CORPORATE DEBT INSTRUMENTS 6 9 8 ,045 6 4 1 , 5 94\nAMERICAN ELECTRIC POWER CO INC 3.250% 03/01/2050 DD 03/05/20 CORPORATE DEBT INSTRUMENTS 8 3 8 ,564 5 4 0 , 322\nAMERICAN ELECTRIC POWER CO INC 3.250% 03/01/2050 DD 03/05/20 CORPORATE DEBT INSTRUMENTS 4 4 , 9 23 2 8 , 9 4 6\nAMERICAN EXPRESS CO VAR RT 05/01/2034 DD 05/01/23 CORPORATE DEBT INSTRUMENTS 1 , 2 48,691 1 , 2 5 7,997\nAMERICAN EXPRESS CO VAR RT 07/26/2035 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 7 4 1 ,085 7 2 2 , 043\nAMERICAN INTERNATIONAL GROUP I 4.800% 07/10/2045 DD 07/10/15 CORPORATE DEBT INSTRUMENTS 8 5 8 ,608 7 7 4 , 279\nAMERICAN TOWER CORP 3.100% 06/15/2050 DD 06/03/20 CORPORATE DEBT INSTRUMENTS 2 7 5 ,324 1 7 3 , 4 05\nAMERICAN WATER CAPITAL CORP 3.450% 05/01/2050 DD 04/14/20 CORPORATE DEBT INSTRUMENTS 7 4 , 8 46 5 1 , 8 5 4\nAMERICAN WATER CAPITAL CORP 3.750% 09/01/2047 DD 08/10/17 CORPORATE DEBT INSTRUMENTS 6 8 , 3 00 4 8 , 2 3 1\nAMGEN INC 2.770% 09/01/2053 DD 03/01/21 CORPORATE DEBT INSTRUMENTS 9 7 1 ,511 5 7 1 , 0 60\nAMGEN INC 3.150% 02/21/2040 DD 02/21/20 CORPORATE DEBT INSTRUMENTS 2 0 8 ,163 1 5 6 , 6 45\nAMGEN INC 3.150% 02/21/2040 DD 02/21/20 CORPORATE DEBT INSTRUMENTS 6 3 7 ,349 4 7 2 , 920\nAMGEN INC 4.400% 05/01/2045 DD 05/01/15 CORPORATE DEBT INSTRUMENTS 1 , 3 82,062 1 , 1 7 1,271\nAMGEN INC 4.400% 05/01/2045 DD 05/01/15 CORPORATE DEBT INSTRUMENTS 4 1 1 ,891 3 7 3 , 545\nAMGEN INC 4.663% 06/15/2051 DD 12/15/16 CORPORATE DEBT INSTRUMENTS 1 , 6 30,827 1 , 3 7 6,419\nAMGEN INC 5.150% 11/15/2041 DD 11/10/11 CORPORATE DEBT INSTRUMENTS 8 1 4 ,169 7 6 4 , 786\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nAMGEN INC 5.600% 03/02/2043 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 7 3 0 ,880 7 1 7 , 1 69\nAMGEN INC 5.650% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 1 , 4 02,977 1 , 3 5 5,305\nAMGEN INC 5.650% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 2 , 8 88,609 2 , 7 6 8,488\nAMGEN INC 5.650% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 7 6 9 ,277 7 5 2 , 4 11\nAMGEN INC 5.750% 03/02/2063 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 4 7 6 ,398 4 5 7 , 078\nAMPHENOL CORP 5.375% 11/15/2054 DD 10/31/24 CORPORATE DEBT INSTRUMENTS 6 2 7 ,977 6 0 7 , 695\nANALOG DEVICES INC 2.800% 10/01/2041 DD 10/05/21 CORPORATE DEBT INSTRUMENTS 4 2 3 ,025 3 0 8 , 097\nANALOG DEVICES INC 2.950% 10/01/2051 DD 10/05/21 CORPORATE DEBT INSTRUMENTS 4 7 7 ,022 3 0 6 , 0 17\nANALOG DEVICES INC 2.950% 10/01/2051 DD 10/05/21 CORPORATE DEBT INSTRUMENTS 4 0 1 ,651 2 5 7 , 665\nANGLO AMERICAN CAPITAL PL 144A 3.950% 09/10/2050 DD 09/10/20 CORPORATE DEBT INSTRUMENTS 1 , 3 73,940 1 , 0 2 8,883\nANGLO AMERICAN CAPITAL PL 144A 3.950% 09/10/2050 DD 09/10/20 CORPORATE DEBT INSTRUMENTS 3 0 1 ,491 2 9 2 , 802\nANGLO AMERICAN CAPITAL PL 144A 4.750% 03/16/2052 DD 03/16/22 CORPORATE DEBT INSTRUMENTS 4 6 8 ,871 4 5 5 , 266\nANGLO AMERICAN CAPITAL PL 144A 5.750% 04/05/2034 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 2 9 6 ,124 2 9 6 , 894\nANGLO AMERICAN CAPITAL PL 144A 6.000% 04/05/2054 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 1 , 0 78,752 1 , 0 5 7,438\nANHEUSER-BUSCH COS LLC / ANHEU 4.700% 02/01/2036 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 2 , 8 19,408 2 , 7 7 2,812\nANHEUSER-BUSCH COS LLC / ANHEU 4.700% 02/01/2036 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 1 , 2 72,348 1 , 2 5 1,320\nANHEUSER-BUSCH COS LLC / ANHEU 4.700% 02/01/2036 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 1 , 7 85,969 1 , 7 0 1,606\nANHEUSER-BUSCH COS LLC / ANHEU 4.900% 02/01/2046 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 2 , 2 15,384 2 , 1 2 5,177\nANHEUSER-BUSCH COS LLC / ANHEU 4.900% 02/01/2046 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 4 , 4 37,872 4 , 0 6 8,326\nANHEUSER-BUSCH COS LLC / ANHEU 4.900% 02/01/2046 DD 02/01/19 CORPORATE DEBT INSTRUMENTS 2 , 3 95,361 2 , 2 0 5,269\nANHEUSER-BUSCH INBEV WORLDWIDE 4.375% 04/15/2038 DD 04/04/18 CORPORATE DEBT INSTRUMENTS 4 6 7 ,445 4 5 2 , 380\nANHEUSER-BUSCH INBEV WORLDWIDE 4.439% 10/06/2048 DD 04/06/17 CORPORATE DEBT INSTRUMENTS 3 1 2 ,059 2 6 1 , 1 32\nANHEUSER-BUSCH INBEV WORLDWIDE 4.439% 10/06/2048 DD 04/06/17 CORPORATE DEBT INSTRUMENTS 9 1 , 6 69 8 9 , 0 2 2\nANHEUSER-BUSCH INBEV WORLDWIDE 4.950% 01/15/2042 DD 07/15/16 CORPORATE DEBT INSTRUMENTS 1 1 6 ,546 9 3 , 0 3 8\nANHEUSER-BUSCH INBEV WORLDWIDE 5.450% 01/23/2039 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 1 , 4 25,971 1 , 4 7 8,894\nANHEUSER-BUSCH INBEV WORLDWIDE 5.450% 01/23/2039 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 9 6 1 ,564 9 4 2 , 482\nANHEUSER-BUSCH INBEV WORLDWIDE 5.550% 01/23/2049 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 7 1 6 ,099 7 1 7 , 9 63\nAPOLLO GLOBAL MANAGEMENT INC 5.800% 05/21/2054 DD 05/21/24 CORPORATE DEBT INSTRUMENTS 6 8 2 ,518 6 8 3 , 563\nAPPALACHIAN POWER CO 4.450% 06/01/2045 DD 05/18/15 CORPORATE DEBT INSTRUMENTS 8 7 3 ,638 7 1 1 , 5 68\nAPPLE INC 1.650% 05/11/2030 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 1 , 9 16,815 1 , 6 3 3,658\nAPPLE INC 2.375% 02/08/2041 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 5 3 3 ,640 3 7 5 , 3 14\nAPPLE INC 2.650% 05/11/2050 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 9 1 , 9 91 9 0 , 3 9 3\nAPPLE INC 2.800% 02/08/2061 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 8 1 6 ,976 7 5 6 , 292\nAPPLE INC 2.850% 08/05/2061 DD 08/05/21 CORPORATE DEBT INSTRUMENTS 1 , 6 77,002 1 , 0 0 8,004\nAPPLE INC 2.950% 09/11/2049 DD 09/11/19 CORPORATE DEBT INSTRUMENTS 1 4 7 ,899 8 6 , 7 6 8\nAPPLE INC 3.750% 09/12/2047 DD 09/12/17 CORPORATE DEBT INSTRUMENTS 9 7 , 5 49 6 3 , 0 0 8\nAPPLE INC 3.850% 05/04/2043 DD 05/03/13 CORPORATE DEBT INSTRUMENTS 1 , 2 69,859 1 , 1 2 8,079\nAPPLE INC 3.850% 05/04/2043 DD 05/03/13 CORPORATE DEBT INSTRUMENTS 8 0 3 ,773 7 1 7 , 4 92\nAPPLE INC 3.850% 08/04/2046 DD 08/04/16 CORPORATE DEBT INSTRUMENTS 1 , 7 13,233 1 , 5 0 3,963\nAPPLE INC 3.850% 08/04/2046 DD 08/04/16 CORPORATE DEBT INSTRUMENTS 4 0 4 ,473 3 1 8 , 8 76\nAPPLE INC 3.850% 08/04/2046 DD 08/04/16 CORPORATE DEBT INSTRUMENTS 8 4 7 ,640 6 9 8 , 297\nAPPLE INC 4.375% 05/13/2045 DD 05/13/15 CORPORATE DEBT INSTRUMENTS 3 7 3 ,630 3 3 1 , 5 07\nAPPLE INC 4.375% 05/13/2045 DD 05/13/15 CORPORATE DEBT INSTRUMENTS 5 5 3 ,349 4 8 1 , 7 91\nAPPLE INC 4.650% 02/23/2046 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 4 9 7 ,115 4 5 8 , 270\nAPPLE INC 4.650% 02/23/2046 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 1 , 6 17,271 1 , 3 6 5,645\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nAPPLIED MATERIALS INC 4.350% 04/01/2047 DD 03/31/17 CORPORATE DEBT INSTRUMENTS 5 5 3 ,984 4 7 0 , 590\nAPTIV SWISS HOLDINGS LTD 3.100% 12/01/2051 DD 11/23/21 CORPORATE DEBT INSTRUMENTS 8 8 3 ,528 8 3 1 , 3 92\nAPTIV SWISS HOLDINGS LTD 4.150% 05/01/2052 DD 02/18/22 CORPORATE DEBT INSTRUMENTS 6 6 7 ,662 4 7 4 , 372\nAPTIV SWISS HOLDINGS LTD 5.400% 03/15/2049 DD 03/14/19 CORPORATE DEBT INSTRUMENTS 8 7 2 ,320 7 3 3 , 552\nARCELORMITTAL SA 6.350% 06/17/2054 DD 06/17/24 CORPORATE DEBT INSTRUMENTS 1 5 8 ,918 1 5 8 , 2 43\nARES FINANCE CO IV LLC 144A 3.650% 02/01/2052 DD 01/21/22 CORPORATE DEBT INSTRUMENTS 2 5 3 ,357 2 0 3 , 3 71\nARTHUR J GALLAGHER & CO 5.550% 02/15/2055 DD 12/19/24 CORPORATE DEBT INSTRUMENTS 6 1 8 ,119 6 0 0 , 354\nARTHUR J GALLAGHER & CO 5.550% 02/15/2055 DD 12/19/24 CORPORATE DEBT INSTRUMENTS 9 6 1 ,808 9 3 1 , 4 18\nARTHUR J GALLAGHER & CO 5.750% 03/02/2053 DD 03/02/23 CORPORATE DEBT INSTRUMENTS 4 8 5 ,994 4 7 6 , 799\nARTHUR J GALLAGHER & CO 5.750% 07/15/2054 DD 02/15/24 CORPORATE DEBT INSTRUMENTS 6 9 1 ,516 6 9 3 , 1 40\nARTHUR J GALLAGHER & CO 5.750% 07/15/2054 DD 02/15/24 CORPORATE DEBT INSTRUMENTS 1 4 8 ,174 1 4 8 , 5 30\nARTHUR J GALLAGHER & CO 6.750% 02/15/2054 DD 11/02/23 CORPORATE DEBT INSTRUMENTS 4 5 1 ,706 4 8 8 , 022\nASTRAZENECA FINANCE LLC 5.000% 02/26/2034 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 9 1 6 ,633 9 1 0 , 0 73\nASTRAZENECA PLC 6.450% 09/15/2037 DD 09/12/07 CORPORATE DEBT INSTRUMENTS 1 , 3 67,034 1 , 1 9 6,013\nASTRAZENECA PLC 6.450% 09/15/2037 DD 09/12/07 CORPORATE DEBT INSTRUMENTS 7 3 6 ,358 6 0 2 , 396\nAT&T INC 3.500% 06/01/2041 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 5 5 , 8 62 6 1 , 3 6 0\nAT&T INC 3.500% 09/15/2053 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 1 , 2 47,702 1 , 0 2 4,728\nAT&T INC 3.500% 09/15/2053 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 3 , 5 56,622 2 , 8 5 9,268\nAT&T INC 3.500% 09/15/2053 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 6 0 3 ,421 5 7 6 , 0 31\nAT&T INC 3.550% 09/15/2055 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 3 , 2 63,036 2 , 7 0 4,912\nAT&T INC 3.550% 09/15/2055 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 3 , 8 22,620 3 , 2 3 1,861\nAT&T INC 3.650% 06/01/2051 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 1 , 1 43,557 8 1 1 , 6 82\nAT&T INC 3.650% 06/01/2051 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 3 1 8 ,742 3 3 9 , 379\nAT&T INC 3.650% 09/15/2059 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 1 , 4 34,778 1 , 0 7 3,882\nAT&T INC 3.650% 09/15/2059 DD 03/15/21 CORPORATE DEBT INSTRUMENTS 1 , 2 64,383 1 , 0 6 8,569\nAT&T INC 3.800% 12/01/2057 DD 06/01/21 CORPORATE DEBT INSTRUMENTS 5 3 1 ,896 3 4 2 , 905\nAT&T INC 3.800% 12/01/2057 DD 06/01/21 CORPORATE DEBT INSTRUMENTS 2 , 8 90,037 1 , 8 6 3,161\nAT&T INC 3.800% 12/01/2057 DD 06/01/21 CORPORATE DEBT INSTRUMENTS 1 , 3 08,580 9 8 9 , 999\nAT&T INC 4.500% 03/09/2048 DD 09/07/16 CORPORATE DEBT INSTRUMENTS 1 , 9 35,024 1 , 5 6 9,808\nAT&T INC 5.150% 02/15/2050 DD 08/14/18 CORPORATE DEBT INSTRUMENTS 1 , 3 12,094 1 , 1 7 8,174\nATHENE HOLDING LTD VAR RT 10/15/2054 DD 10/10/24 CORPORATE DEBT INSTRUMENTS 7 9 0 ,000 7 8 5 , 584\nAUTOMATIC DATA PROCESSING INC 4.450% 09/09/2034 DD 09/09/24 CORPORATE DEBT INSTRUMENTS 7 9 7 ,128 7 6 2 , 264\nAUTOZONE INC 6.550% 11/01/2033 DD 10/25/23 CORPORATE DEBT INSTRUMENTS 9 7 7 ,423 1 , 0 5 4,745\nAVALONBAY COMMUNITIES INC 2.900% 10/15/2026 DD 10/05/16 CORPORATE DEBT INSTRUMENTS 1 , 9 36,643 1 , 7 4 0,019\nAVALONBAY COMMUNITIES INC 4.350% 04/15/2048 DD 03/26/18 CORPORATE DEBT INSTRUMENTS 1 2 6 ,317 8 2 , 8 4 5\nAVALONBAY COMMUNITIES INC 5.350% 06/01/2034 DD 05/14/24 CORPORATE DEBT INSTRUMENTS 4 9 8 ,485 5 0 2 , 345\nBAE SYSTEMS PLC 144A 5.500% 03/26/2054 DD 03/26/24 CORPORATE DEBT INSTRUMENTS 3 5 8 ,945 3 5 5 , 897\nBAE SYSTEMS PLC 144A 5.800% 10/11/2041 DD 10/11/11 CORPORATE DEBT INSTRUMENTS 5 0 7 ,343 5 1 3 , 6 52\nBAE SYSTEMS PLC 144A 5.800% 10/11/2041 DD 10/11/11 CORPORATE DEBT INSTRUMENTS 1 , 8 36,074 1 , 8 1 7,924\nBALTIMORE GAS AND ELECTRIC CO 2.400% 08/15/2026 DD 08/18/16 CORPORATE DEBT INSTRUMENTS 1 , 9 16,360 1 , 7 3 1,978\nBALTIMORE GAS AND ELECTRIC CO 5.400% 06/01/2053 DD 05/10/23 CORPORATE DEBT INSTRUMENTS 4 9 8 ,070 5 4 8 , 446\nBANK OF AMERICA CORP 6.110% 01/29/2037 DD 01/29/07 CORPORATE DEBT INSTRUMENTS 1 , 1 90,959 1 , 0 5 2,839\nBANK OF AMERICA CORP 7.750% 05/14/2038 DD 05/14/08 CORPORATE DEBT INSTRUMENTS 1 , 9 82,536 1 , 7 5 8,592\nBANK OF AMERICA CORP VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 8 2 1 ,095 8 1 1 , 0 93\nBANK OF AMERICA CORP VAR RT 03/20/2051 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 3 2 9 ,948 3 1 3 , 7 00\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nBANK OF AMERICA CORP VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 2 ,5 37,741 1 ,9 3 1,156\nBANK OF AMERICA CORP VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 1 , 7 11,000 1 , 2 8 0,701\nBANK OF AMERICA CORP VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 3 9 2 ,786 3 1 0 , 6 32\nBANK OF AMERICA CORP VAR RT 04/23/2040 DD 04/23/19 CORPORATE DEBT INSTRUMENTS 3 0 0 ,000 2 5 5 , 246\nBANK OF AMERICA CORP VAR RT 04/24/2038 DD 04/24/17 CORPORATE DEBT INSTRUMENTS 1 , 1 80,000 1 , 0 5 0,436\nBANK OF AMERICA CORP VAR RT 04/24/2038 DD 04/24/17 CORPORATE DEBT INSTRUMENTS 1 ,3 34,580 9 8 7 , 232\nBANK OF AMERICA CORP VAR RT 06/19/2041 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 1 6 3 ,900 1 5 9 , 9 26\nBANK OF AMERICA CORP VAR RT 06/19/2041 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 3 , 5 81,421 3 , 2 5 9,012\nBANK OF AMERICA CORP VAR RT 06/19/2041 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 1 ,3 09,768 9 8 7 , 369\nBANK OF AMERICA CORP VAR RT 08/15/2035 DD 08/15/24 CORPORATE DEBT INSTRUMENTS 1 , 1 10,000 1 , 0 8 3,338\nBANK OF AMERICA CORP VAR RT 09/15/2034 DD 09/15/23 CORPORATE DEBT INSTRUMENTS 6 4 9 ,211 6 6 7 , 5 11\nBANK OF AMERICA CORP VAR RT 10/22/2030 DD 10/22/19 CORPORATE DEBT INSTRUMENTS 1 ,9 05,969 1 ,6 1 1,980\nBANK OF AMERICA CORP VAR RT 10/24/2051 DD 10/21/20 CORPORATE DEBT INSTRUMENTS 5 2 2 ,000 3 2 1 , 3 95\nBANK OF AMERICA NA 6.000% 10/15/2036 DD 10/26/06 CORPORATE DEBT INSTRUMENTS 1 , 8 67,101 1 , 6 6 7,434\n* BANK OF NEW YORK MELLON CORP/T VAR RT 03/14/2035 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 6 8 8 ,779 6 9 3 , 497\n* BANK OF NEW YORK MELLON CORP/T VAR RT 10/25/2033 DD 10/25/22 CORPORATE DEBT INSTRUMENTS 4 5 0 ,000 4 6 6 , 1 01\nBARCLAYS PLC VAR RT 09/10/2035 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 9 7 0 ,000 9 3 1 , 9 18\nBAT CAPITAL CORP 4.390% 08/15/2037 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 1 ,6 58,267 1 , 4 2 4,940\nBAT CAPITAL CORP 4.540% 08/15/2047 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 1 2 1 ,079 1 1 9 , 2 69\nBAT CAPITAL CORP 4.758% 09/06/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 1 1 0 ,000 8 9 , 1 7 4\nBAT CAPITAL CORP 5.650% 03/16/2052 DD 03/16/22 CORPORATE DEBT INSTRUMENTS 1 3 5 ,448 1 3 7 , 5 29\nBAT CAPITAL CORP 7.079% 08/02/2043 DD 08/02/23 CORPORATE DEBT INSTRUMENTS 2 4 5 ,000 2 6 4 , 963\nBAYCARE HEALTH SYSTEM INC 3.831% 11/15/2050 DD 04/16/20 CORPORATE DEBT INSTRUMENTS 4 8 0 ,000 3 6 7 , 838\nBAYCARE HEALTH SYSTEM INC 3.831% 11/15/2050 DD 04/16/20 CORPORATE DEBT INSTRUMENTS 1 3 0 ,000 9 9 , 6 2 3\nBAYER US FINANCE II LLC 144A 4.875% 06/25/2048 DD 06/25/18 CORPORATE DEBT INSTRUMENTS 4 2 , 3 39 3 9 , 0 0 9\nBAYER US FINANCE LLC 144A 6.500% 11/21/2033 DD 11/21/23 CORPORATE DEBT INSTRUMENTS 2 4 6 ,163 2 4 9 , 2 12\nBAYER US FINANCE LLC 144A 6.875% 11/21/2053 DD 11/21/23 CORPORATE DEBT INSTRUMENTS 4 8 1 ,659 4 6 9 , 557\nBAYLOR SCOTT & WHITE HOLDINGS 2.839% 11/15/2050 DD 01/21/21 CORPORATE DEBT INSTRUMENTS 3 4 1 ,149 2 4 8 , 266\nBERKSHIRE HATHAWAY ENERGY CO 4.250% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 4 8 2 ,357 3 8 3 , 475\nBERKSHIRE HATHAWAY ENERGY CO 4.250% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 9 1 9 ,959 7 3 1 , 3 70\nBERKSHIRE HATHAWAY ENERGY CO 4.250% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 1 , 1 25,946 8 2 2 , 297\nBERKSHIRE HATHAWAY ENERGY CO 4.450% 01/15/2049 DD 07/25/18 CORPORATE DEBT INSTRUMENTS 2 0 9 ,933 1 7 3 , 4 85\nBERKSHIRE HATHAWAY ENERGY CO 4.600% 05/01/2053 DD 11/01/22 CORPORATE DEBT INSTRUMENTS 1 5 9 ,438 1 5 3 , 7 41\nBERKSHIRE HATHAWAY ENERGY CO 6.125% 04/01/2036 DD 10/01/06 CORPORATE DEBT INSTRUMENTS 3 5 8 ,183 3 2 3 , 1 33\nBERKSHIRE HATHAWAY FINANCE COR 1.850% 03/12/2030 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 1 , 5 35,043 1 , 2 9 9,906\nBERKSHIRE HATHAWAY FINANCE COR 2.850% 10/15/2050 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 9 6 , 0 59 8 4 , 8 7 0\nBERKSHIRE HATHAWAY FINANCE COR 3.850% 03/15/2052 DD 03/15/22 CORPORATE DEBT INSTRUMENTS 6 0 2 ,864 4 5 8 , 427\nBERKSHIRE HATHAWAY FINANCE COR 3.850% 03/15/2052 DD 03/15/22 CORPORATE DEBT INSTRUMENTS 5 5 , 6 70 5 3 , 0 4 1\nBERKSHIRE HATHAWAY FINANCE COR 4.200% 08/15/2048 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 5 1 2 ,389 4 2 6 , 744\nBERKSHIRE HATHAWAY FINANCE COR 4.200% 08/15/2048 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 1 , 2 90,226 1 , 3 0 0,949\nBERKSHIRE HATHAWAY FINANCE COR 4.200% 08/15/2048 DD 08/15/18 CORPORATE DEBT INSTRUMENTS 4 2 2 ,845 3 5 2 , 1 68\nBERKSHIRE HATHAWAY FINANCE COR 4.250% 01/15/2049 DD 01/11/19 CORPORATE DEBT INSTRUMENTS 4 9 2 ,141 3 3 1 , 1 51\nBERKSHIRE HATHAWAY FINANCE COR 4.300% 05/15/2043 DD 05/15/13 CORPORATE DEBT INSTRUMENTS 3 1 , 3 57 2 5 , 9 8 1\nBETH ISRAEL LAHEY HEALTH INC 3.080% 07/01/2051 DD 11/16/21 CORPORATE DEBT INSTRUMENTS 9 7 4 ,999 5 9 5 , 276\nBG ENERGY CAPITAL PLC 144A 5.125% 10/15/2041 DD 10/12/11 CORPORATE DEBT INSTRUMENTS 8 2 0 ,671 7 7 9 , 1 64\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nBHP BILLITON FINANCE USA LTD 5.000% 09/30/2043 DD 09/30/13 CORPORATE DEBT INSTRUMENTS 1 , 0 31,498 8 1 7 , 3 47\nBHP BILLITON FINANCE USA LTD 5.500% 09/08/2053 DD 09/08/23 CORPORATE DEBT INSTRUMENTS 4 3 4 ,580 4 2 5 , 256\nBHP BILLITON FINANCE USA LTD 5.500% 09/08/2053 DD 09/08/23 CORPORATE DEBT INSTRUMENTS 5 6 4 ,644 5 6 2 , 1 20\nBIOGEN INC 3.250% 02/15/2051 DD 02/15/22 CORPORATE DEBT INSTRUMENTS 4 0 1 ,570 2 5 7 , 048\nBLACKROCK FUNDING INC 5.250% 03/14/2054 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 5 2 4 ,301 5 0 1 , 4 81\nBLACKROCK FUNDING INC 5.250% 03/14/2054 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 4 2 9 ,828 4 1 1 , 5 93\nBLACKROCK FUNDING INC 5.350% 01/08/2055 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 8 2 0 ,993 7 8 4 , 289\nBLACKROCK FUNDING INC 5.350% 01/08/2055 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 4 1 9 ,291 4 0 1 , 7 09\nBLACKSTONE HOLDINGS FINAN 144A 6.250% 08/15/2042 DD 08/17/12 CORPORATE DEBT INSTRUMENTS 1 , 0 44,135 1 , 0 0 2,070\nBMW US CAPITAL LLC 144A 5.150% 04/02/2034 DD 04/02/24 CORPORATE DEBT INSTRUMENTS 6 9 4 ,944 6 8 4 , 735\nBOEING CO/THE 3.600% 05/01/2034 DD 05/02/19 CORPORATE DEBT INSTRUMENTS 7 5 , 1 03 6 2 , 7 8 5\nBOEING CO/THE 3.750% 02/01/2050 DD 07/31/19 CORPORATE DEBT INSTRUMENTS 2 1 9 ,422 1 5 0 , 5 94\nBOEING CO/THE 3.750% 02/01/2050 DD 07/31/19 CORPORATE DEBT INSTRUMENTS 4 0 2 ,792 4 2 0 , 980\nBOEING CO/THE 3.850% 11/01/2048 DD 10/31/18 CORPORATE DEBT INSTRUMENTS 4 5 7 ,332 3 3 6 , 434\nBOEING CO/THE 5.705% 05/01/2040 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 8 0 0 ,000 7 6 1 , 8 00\nBOEING CO/THE 5.705% 05/01/2040 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 2 , 9 21,379 2 , 7 7 1,047\nBOEING CO/THE 5.805% 05/01/2050 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 5 4 5 ,000 5 0 5 , 896\nBOEING CO/THE 5.805% 05/01/2050 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 2 , 2 15,840 1 , 8 8 3,419\nBOEING CO/THE 5.805% 05/01/2050 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 2 , 4 91,795 2 , 1 1 6,410\nBOEING CO/THE 5.930% 05/01/2060 DD 05/04/20 CORPORATE DEBT INSTRUMENTS 3 7 2 ,479 2 5 4 , 856\nBOEING CO/THE 6.625% 02/15/2038 DD 02/24/98 CORPORATE DEBT INSTRUMENTS 4 5 4 ,427 3 5 8 , 3 31\nBOEING CO/THE 6.858% 05/01/2054 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 3 2 0 ,000 3 4 0 , 774\nBOEING CO/THE 6.858% 05/01/2054 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 3 0 3 ,854 3 1 9 , 4 76\nBOEING CO/THE 7.008% 05/01/2064 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 4 1 5 ,754 4 1 9 , 8 81\nBP CAPITAL MARKETS AMERICA INC 2.939% 06/04/2051 DD 12/04/20 CORPORATE DEBT INSTRUMENTS 3 6 4 ,157 2 5 7 , 375\nBP CAPITAL MARKETS AMERICA INC 3.000% 02/24/2050 DD 02/24/20 CORPORATE DEBT INSTRUMENTS 1 6 6 ,403 1 1 2 , 7 19\nBP CAPITAL MARKETS AMERICA INC 3.001% 03/17/2052 DD 09/17/21 CORPORATE DEBT INSTRUMENTS 6 2 8 ,253 4 1 5 , 8 11\nBP CAPITAL MARKETS AMERICA INC 3.060% 06/17/2041 DD 06/17/21 CORPORATE DEBT INSTRUMENTS 7 6 2 ,128 6 3 1 , 8 99\nBP CAPITAL MARKETS AMERICA INC 3.379% 02/08/2061 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 2 , 3 92,481 1 , 5 3 1,738\nBP CAPITAL MARKETS AMERICA INC 3.379% 02/08/2061 DD 02/08/21 CORPORATE DEBT INSTRUMENTS 2 , 1 10,918 1 , 6 3 0,048\nBP CAPITAL MARKETS AMERICA INC 3.543% 04/06/2027 DD 04/06/20 CORPORATE DEBT INSTRUMENTS 1 , 5 27,163 1 , 3 4 7,625\nBRISTOL-MYERS SQUIBB CO 3.700% 03/15/2052 DD 03/02/22 CORPORATE DEBT INSTRUMENTS 1 , 2 39,006 9 4 4 , 029\nBRISTOL-MYERS SQUIBB CO 4.250% 10/26/2049 DD 04/26/20 CORPORATE DEBT INSTRUMENTS 9 4 4 ,045 7 3 2 , 426\nBRISTOL-MYERS SQUIBB CO 4.350% 11/15/2047 DD 05/15/20 CORPORATE DEBT INSTRUMENTS 1 , 8 03,705 1 , 2 3 9,720\nBRISTOL-MYERS SQUIBB CO 5.900% 11/15/2033 DD 11/13/23 CORPORATE DEBT INSTRUMENTS 8 5 7 ,432 8 3 9 , 936\nBRISTOL-MYERS SQUIBB CO 6.400% 11/15/2063 DD 11/13/23 CORPORATE DEBT INSTRUMENTS 8 4 8 ,343 9 0 1 , 4 12\nBROADCOM INC 144A 3.137% 11/15/2035 DD 09/30/21 CORPORATE DEBT INSTRUMENTS 3 7 7 ,079 4 3 2 , 920\nBROADCOM INC 144A 3.500% 02/15/2041 DD 01/19/21 CORPORATE DEBT INSTRUMENTS 7 4 5 ,201 7 2 6 , 572\nBROADCOM INC 144A 3.500% 02/15/2041 DD 01/19/21 CORPORATE DEBT INSTRUMENTS 5 0 4 ,556 4 0 6 , 255\nBROADCOM INC 144A 3.750% 02/15/2051 DD 01/19/21 CORPORATE DEBT INSTRUMENTS 2 , 2 54,159 1 , 7 3 0,445\nBROADCOM INC 4.800% 10/15/2034 DD 10/02/24 CORPORATE DEBT INSTRUMENTS 6 2 3 ,706 6 0 3 , 1 81\nBROOKFIELD FINANCE INC 5.968% 03/04/2054 DD 03/04/24 CORPORATE DEBT INSTRUMENTS 8 7 8 ,000 8 8 8 , 685\nBROOKFIELD FINANCE INC 5.968% 03/04/2054 DD 03/04/24 CORPORATE DEBT INSTRUMENTS 2 2 8 ,778 2 2 7 , 738\nBROWN-FORMAN CORP 4.000% 04/15/2038 DD 03/26/18 CORPORATE DEBT INSTRUMENTS 7 0 6 ,872 6 9 8 , 224\nBURLINGTON NORTHERN SANTA FE L 2.875% 06/15/2052 DD 12/08/21 CORPORATE DEBT INSTRUMENTS 4 1 1 ,180 2 5 5 , 598\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nBURLINGTON NORTHERN SANTA FE L 4.150% 04/01/2045 DD 03/09/15 CORPORATE DEBT INSTRUMENTS 3 2 4 ,738 2 4 6 , 9 21\nBURLINGTON NORTHERN SANTA FE L 4.450% 01/15/2053 DD 06/07/22 CORPORATE DEBT INSTRUMENTS 7 3 2 ,924 6 1 8 , 2 10\nBURLINGTON NORTHERN SANTA FE L 4.450% 03/15/2043 DD 03/12/13 CORPORATE DEBT INSTRUMENTS 3 , 5 76,241 3 , 1 5 4,511\nBURLINGTON NORTHERN SANTA FE L 4.550% 09/01/2044 DD 08/18/14 CORPORATE DEBT INSTRUMENTS 2 2 7 ,854 1 7 0 , 0 63\nBURLINGTON NORTHERN SANTA FE L 4.900% 04/01/2044 DD 03/07/14 CORPORATE DEBT INSTRUMENTS 4 1 4 ,137 3 8 0 , 6 17\nBURLINGTON NORTHERN SANTA FE L 5.150% 09/01/2043 DD 08/22/13 CORPORATE DEBT INSTRUMENTS 3 3 5 ,408 3 0 6 , 570\nBURLINGTON NORTHERN SANTA FE L 5.200% 04/15/2054 DD 06/09/23 CORPORATE DEBT INSTRUMENTS 5 8 , 6 18 5 6 , 5 9 0\nBURLINGTON NORTHERN SANTA FE L 5.500% 03/15/2055 DD 06/07/24 CORPORATE DEBT INSTRUMENTS 3 4 8 ,144 3 4 4 , 886\nBURLINGTON NORTHERN SANTA FE L 6.150% 05/01/2037 DD 04/13/07 CORPORATE DEBT INSTRUMENTS 6 0 4 ,957 5 4 5 , 1 29\nBURLINGTON NORTHERN SANTA FE L 6.150% 05/01/2037 DD 04/13/07 CORPORATE DEBT INSTRUMENTS 4 9 1 ,324 4 8 0 , 996\nBURLINGTON NORTHERN SANTA FE L 6.200% 08/15/2036 DD 08/17/06 CORPORATE DEBT INSTRUMENTS 2 , 3 56,215 2 , 4 0 8,212\nBX COMMERCIAL MORT VLT5 A 144A VAR RT 11/13/2046 DD 11/01/24 CORPORATE DEBT INSTRUMENTS 5 9 3 ,775 5 8 5 , 047\nCAMDEN PROPERTY TRUST 2.800% 05/15/2030 DD 04/20/20 CORPORATE DEBT INSTRUMENTS 1 , 5 46,610 1 , 2 7 8,667\nCAMDEN PROPERTY TRUST 3.350% 11/01/2049 DD 10/07/19 CORPORATE DEBT INSTRUMENTS 8 3 4 ,507 5 7 5 , 290\nCAMERON LNG LLC 144A 3.701% 01/15/2039 DD 12/13/19 CORPORATE DEBT INSTRUMENTS 1 , 2 59,000 1 , 0 1 5,157\nCANADIAN NATIONAL RAILWAY CO 2.750% 03/01/2026 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 1 , 6 37,430 1 , 4 6 9,940\nCANADIAN NATIONAL RAILWAY CO 6.200% 06/01/2036 DD 05/31/06 CORPORATE DEBT INSTRUMENTS 1 , 8 99,401 1 , 6 6 4,690\nCANADIAN NATURAL RESOURCES LTD 4.950% 06/01/2047 DD 05/30/17 CORPORATE DEBT INSTRUMENTS 1 , 2 34,387 1 , 0 5 8,333\nCANADIAN PACIFIC RAILWAY CO 3.000% 12/02/2041 DD 12/02/21 CORPORATE DEBT INSTRUMENTS 1 2 7 ,432 9 4 , 4 7 4\nCANADIAN PACIFIC RAILWAY CO 3.100% 12/02/2051 DD 12/02/21 CORPORATE DEBT INSTRUMENTS 2 9 6 ,875 2 1 4 , 9 09\nCANADIAN PACIFIC RAILWAY CO 4.200% 11/15/2069 DD 04/19/23 CORPORATE DEBT INSTRUMENTS 8 3 3 ,342 7 5 9 , 462\nCANADIAN PACIFIC RAILWAY CO 6.125% 09/15/2115 DD 09/11/15 CORPORATE DEBT INSTRUMENTS 7 4 1 ,274 7 2 7 , 633\nCANADIAN PACIFIC RAILWAY CO 6.125% 09/15/2115 DD 09/11/15 CORPORATE DEBT INSTRUMENTS 2 6 0 ,000 2 6 0 , 585\nCAPITAL ONE FINANCIAL CORP VAR RT 07/26/2035 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 1 8 7 ,127 1 8 1 , 0 96\nCARGILL INC 144A 0.750% 02/02/2026 DD 02/02/21 CORPORATE DEBT INSTRUMENTS 4 8 8 ,125 5 2 8 , 550\nCARLYLE HOLDINGS II FINAN 144A 5.625% 03/30/2043 DD 03/28/13 CORPORATE DEBT INSTRUMENTS 8 4 1 ,384 8 0 8 , 645\nCARRIER GLOBAL CORP 3.377% 04/05/2040 DD 10/05/20 CORPORATE DEBT INSTRUMENTS 6 4 9 ,384 5 2 9 , 560\nCATERPILLAR INC 2.600% 09/19/2029 DD 09/19/19 CORPORATE DEBT INSTRUMENTS 1 , 9 05,476 1 , 6 0 8,003\nCATERPILLAR INC 3.250% 09/19/2049 DD 09/19/19 CORPORATE DEBT INSTRUMENTS 1 , 4 03,114 9 8 4 , 446\nCATERPILLAR INC 3.803% 08/15/2042 DD 08/15/12 CORPORATE DEBT INSTRUMENTS 8 2 4 ,517 6 8 7 , 222\nCATERPILLAR INC 3.803% 08/15/2042 DD 08/15/12 CORPORATE DEBT INSTRUMENTS 8 8 1 ,625 6 9 1 , 2 88\nCELANESE US HOLDINGS LLC VAR RT 11/15/2033 DD 08/24/23 CORPORATE DEBT INSTRUMENTS 5 1 4 ,493 4 9 3 , 254\nCENTERPOINT ENERGY HOUSTON ELE 3.600% 03/01/2052 DD 02/28/22 CORPORATE DEBT INSTRUMENTS 2 4 1 ,808 1 7 5 , 3 34\nCENTERPOINT ENERGY HOUSTON ELE 4.250% 02/01/2049 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 5 4 6 ,661 4 4 4 , 339\nCENTERPOINT ENERGY HOUSTON ELE 4.950% 04/01/2033 DD 03/23/23 CORPORATE DEBT INSTRUMENTS 7 6 0 ,244 7 3 3 , 042\nCENTERPOINT ENERGY INC 3.700% 09/01/2049 DD 08/14/19 CORPORATE DEBT INSTRUMENTS 9 6 , 1 40 6 4 , 0 8 6\nCENTERPOINT ENERGY RESOURCES C 4.400% 07/01/2032 DD 06/09/22 CORPORATE DEBT INSTRUMENTS 2 3 9 ,779 2 2 7 , 330\nCHARLES SCHWAB CORP/THE 4.625% 03/22/2030 DD 03/24/20 CORPORATE DEBT INSTRUMENTS 8 8 4 ,625 6 9 8 , 096\nCHARLES SCHWAB CORP/THE VAR RT 05/19/2034 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 4 8 0 ,000 4 9 4 , 534\nCHARTER COMMUNICATIONS OPERATI 3.500% 06/01/2041 DD 03/04/21 CORPORATE DEBT INSTRUMENTS 3 2 8 ,490 2 3 6 , 632\nCHARTER COMMUNICATIONS OPERATI 3.700% 04/01/2051 DD 04/17/20 CORPORATE DEBT INSTRUMENTS 1 5 2 ,714 1 5 3 , 2 79\nCHARTER COMMUNICATIONS OPERATI 3.850% 04/01/2061 DD 12/04/20 CORPORATE DEBT INSTRUMENTS 2 , 3 47,814 1 , 4 4 2,556\nCHARTER COMMUNICATIONS OPERATI 3.900% 06/01/2052 DD 03/04/21 CORPORATE DEBT INSTRUMENTS 8 4 6 ,314 8 0 0 , 572\nCHARTER COMMUNICATIONS OPERATI 4.400% 12/01/2061 DD 06/02/21 CORPORATE DEBT INSTRUMENTS 9 9 5 ,064 6 6 4 , 432\nCHARTER COMMUNICATIONS OPERATI 4.800% 03/01/2050 DD 10/24/19 CORPORATE DEBT INSTRUMENTS 1 4 9 ,109 1 4 6 , 7 88\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nCHARTER COMMUNICATIONS OPERATI 5.125% 07/01/2049 DD 07/10/19 CORPORATE DEBT INSTRUMENTS 5 2 5 ,643 5 2 3 , 009\nCHARTER COMMUNICATIONS OPERATI 5.375% 05/01/2047 DD 11/01/17 CORPORATE DEBT INSTRUMENTS 2 , 7 56,637 2 , 2 5 8,771\nCHARTER COMMUNICATIONS OPERATI 5.375% 05/01/2047 DD 11/01/17 CORPORATE DEBT INSTRUMENTS 1 3 5 ,744 1 3 9 , 6 84\nCHARTER COMMUNICATIONS OPERATI 5.750% 04/01/2048 DD 04/17/18 CORPORATE DEBT INSTRUMENTS 9 1 6 ,020 8 5 9 , 908\nCHARTER COMMUNICATIONS OPERATI 6.484% 10/23/2045 DD 10/23/16 CORPORATE DEBT INSTRUMENTS 2 8 5 ,000 2 6 9 , 539\nCHARTER COMMUNICATIONS OPERATI 6.484% 10/23/2045 DD 10/23/16 CORPORATE DEBT INSTRUMENTS 1 , 8 13,841 1 , 4 4 6,997\nCHEVRON CORP 1.995% 05/11/2027 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 1 , 5 31,684 1 , 3 9 4,288\nCHEVRON CORP 3.078% 05/11/2050 DD 05/11/20 CORPORATE DEBT INSTRUMENTS 7 9 5 ,000 5 2 6 , 982\nCHUBB INA HOLDINGS LLC 3.050% 12/15/2061 DD 11/18/21 CORPORATE DEBT INSTRUMENTS 7 7 8 ,670 4 7 6 , 5 18\nCHUBB INA HOLDINGS LLC 3.150% 03/15/2025 DD 03/16/15 CORPORATE DEBT INSTRUMENTS 2 , 3 00,225 2 , 0 8 8,086\nCIGNA GROUP/THE 3.400% 03/15/2050 DD 03/16/20 CORPORATE DEBT INSTRUMENTS 1 0 4 ,280 7 2 , 4 3 4\nCIGNA GROUP/THE 3.400% 03/15/2051 DD 03/03/21 CORPORATE DEBT INSTRUMENTS 2 , 1 88,076 1 , 4 3 7,348\nCIGNA GROUP/THE 4.800% 07/15/2046 DD 01/15/20 CORPORATE DEBT INSTRUMENTS 2 , 1 29,076 1 , 6 3 6,968\nCIGNA GROUP/THE 4.900% 12/15/2048 DD 06/15/19 CORPORATE DEBT INSTRUMENTS 9 , 1 6 5 8 , 5 3 3\nCIGNA GROUP/THE 5.600% 02/15/2054 DD 02/13/24 CORPORATE DEBT INSTRUMENTS 3 5 9 ,818 3 4 6 , 979\nCINCINNATI FINANCIAL CORP 6.125% 11/01/2034 DD 11/01/04 CORPORATE DEBT INSTRUMENTS 8 5 0 ,524 8 0 3 , 1 16\nCISCO SYSTEMS INC 3.500% 06/15/2025 DD 06/17/15 CORPORATE DEBT INSTRUMENTS 1 , 9 39,949 1 , 6 9 7,788\nCISCO SYSTEMS INC 5.300% 02/26/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 1 1 9 ,518 1 1 6 , 7 32\nCISCO SYSTEMS INC 5.300% 02/26/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 3 1 9 ,710 3 1 2 , 2 59\nCISCO SYSTEMS INC 5.300% 02/26/2054 DD 02/26/24 CORPORATE DEBT INSTRUMENTS 5 2 8 ,446 5 1 5 , 5 68\nCISCO SYSTEMS INC 5.900% 02/15/2039 DD 02/17/09 CORPORATE DEBT INSTRUMENTS 1 , 0 14,678 9 4 0 , 952\nCISCO SYSTEMS INC 5.900% 02/15/2039 DD 02/17/09 CORPORATE DEBT INSTRUMENTS 1 , 3 20,120 1 , 2 1 3,723\nCITIGROUP INC 4.650% 07/23/2048 DD 07/23/18 CORPORATE DEBT INSTRUMENTS 2 9 1 ,846 2 4 4 , 6 15\nCITIGROUP INC 6.675% 09/13/2043 DD 09/13/13 CORPORATE DEBT INSTRUMENTS 1 , 3 25,204 1 , 1 4 0,316\nCITIGROUP INC 8.125% 07/15/2039 DD 07/23/09 CORPORATE DEBT INSTRUMENTS 2 , 8 13,919 2 , 8 4 0,546\nCITIGROUP INC VAR RT 02/13/2035 DD 02/13/24 CORPORATE DEBT INSTRUMENTS 7 2 6 ,628 7 2 2 , 4 91\nCITIGROUP INC VAR RT 03/20/2030 DD 03/20/19 CORPORATE DEBT INSTRUMENTS 1 , 5 17,441 1 , 2 7 4,912\nCITIGROUP INC VAR RT 03/26/2041 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 1 , 0 00,000 9 6 3 , 500\nCITIGROUP INC VAR RT 04/24/2048 DD 04/25/17 CORPORATE DEBT INSTRUMENTS 2 , 4 86,178 1 , 8 2 4,205\nCITIGROUP INC VAR RT 06/11/2035 DD 06/11/24 CORPORATE DEBT INSTRUMENTS 3 1 5 ,000 3 1 2 , 4 74\nCITIGROUP INC VAR RT 09/19/2039 DD 09/19/24 CORPORATE DEBT INSTRUMENTS 3 9 5 ,000 3 7 6 , 692\nCITIGROUP INC VAR RT 11/03/2042 DD 11/03/21 CORPORATE DEBT INSTRUMENTS 4 1 5 ,000 2 9 0 , 969\nCLEVELAND CLINIC FOUNDATION/TH 4.858% 01/01/2114 DD 09/18/14 CORPORATE DEBT INSTRUMENTS 5 1 8 ,000 4 3 1 , 3 59\nCME GROUP INC 3.000% 03/15/2025 DD 03/09/15 CORPORATE DEBT INSTRUMENTS 1 , 9 17,614 1 , 7 4 3,752\nCOCA-COLA CO/THE 1.650% 06/01/2030 DD 05/01/20 CORPORATE DEBT INSTRUMENTS 1 , 9 08,872 1 , 6 3 3,035\nCOCA-COLA CO/THE 2.500% 03/15/2051 DD 09/18/20 CORPORATE DEBT INSTRUMENTS 6 4 1 ,040 3 7 8 , 802\nCOCA-COLA CO/THE 2.500% 06/01/2040 DD 05/01/20 CORPORATE DEBT INSTRUMENTS 9 0 4 ,756 6 4 4 , 846\nCOCA-COLA CO/THE 5.200% 01/14/2055 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 7 9 4 ,221 7 5 6 , 0 13\nCOCA-COLA CO/THE 5.300% 05/13/2054 DD 05/13/24 CORPORATE DEBT INSTRUMENTS 3 5 , 6 79 3 3 , 8 1 9\nCOCA-COLA CO/THE 5.400% 05/13/2064 DD 05/13/24 CORPORATE DEBT INSTRUMENTS 3 2 2 ,269 3 0 8 , 480\nCOCA-COLA CO/THE 5.400% 05/13/2064 DD 05/13/24 CORPORATE DEBT INSTRUMENTS 7 6 7 ,092 7 1 8 , 1 80\nCOLUMBIA PIPELINE GROUP INC 5.800% 06/01/2045 DD 12/01/15 CORPORATE DEBT INSTRUMENTS 2 0 3 ,009 1 9 2 , 9 14\nCOLUMBIA PIPELINES OPERAT 144A 6.544% 11/15/2053 DD 08/08/23 CORPORATE DEBT INSTRUMENTS 9 7 6 ,590 1 , 0 2 5,371\nCOMCAST CORP 1.950% 01/15/2031 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 1 , 9 20,748 1 , 5 8 9,559\nCOMCAST CORP 2.887% 11/01/2051 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 3 , 2 97,211 2 , 0 7 2,341\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nCOMCAST CORP 2.887% 11/01/2051 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 6 7 5 ,100 4 3 9 , 295\nCOMCAST CORP 2.937% 11/01/2056 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 1 , 9 63,341 1 , 1 7 0,052\nCOMCAST CORP 2.937% 11/01/2056 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 1 , 7 57,980 1 , 1 7 3,557\nCOMCAST CORP 2.987% 11/01/2063 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 2 , 1 19,388 1 , 2 1 8,265\nCOMCAST CORP 2.987% 11/01/2063 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 2 , 8 92,390 1 , 6 7 1,651\nCOMCAST CORP 2.987% 11/01/2063 DD 05/01/22 CORPORATE DEBT INSTRUMENTS 4 3 2 ,485 2 6 8 , 527\nCOMCAST CORP 3.450% 02/01/2050 DD 11/05/19 CORPORATE DEBT INSTRUMENTS 5 9 , 1 20 5 4 , 8 7 8\nCOMCAST CORP 3.750% 04/01/2040 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 1 , 7 34,206 1 , 6 1 4,125\nCOMCAST CORP 3.900% 03/01/2038 DD 02/08/18 CORPORATE DEBT INSTRUMENTS 6 5 0 ,754 5 3 4 , 365\nCOMCAST CORP 3.969% 11/01/2047 DD 10/19/17 CORPORATE DEBT INSTRUMENTS 8 0 3 ,405 5 9 7 , 572\nCOMCAST CORP 4.049% 11/01/2052 DD 10/19/17 CORPORATE DEBT INSTRUMENTS 3 7 3 ,344 2 9 9 , 734\nCOMCAST CORP 4.049% 11/01/2052 DD 10/19/17 CORPORATE DEBT INSTRUMENTS 2 , 6 52,390 1 , 9 2 7,936\nCOMCAST CORP 4.400% 08/15/2035 DD 05/27/15 CORPORATE DEBT INSTRUMENTS 2 6 9 ,834 2 4 8 , 953\nCOMCAST CORP 5.500% 05/15/2064 DD 05/09/23 CORPORATE DEBT INSTRUMENTS 9 8 0 ,371 9 2 0 , 1 97\nCOMCAST CORP 5.500% 05/15/2064 DD 05/09/23 CORPORATE DEBT INSTRUMENTS 8 5 , 5 15 7 9 , 4 0 8\nCOMMONSPIRIT HEALTH 4.350% 11/01/2042 DD 10/31/12 CORPORATE DEBT INSTRUMENTS 8 1 6 ,544 7 1 3 , 9 27\nCOMMONWEALTH EDISON CO 3.000% 03/01/2050 DD 02/25/20 CORPORATE DEBT INSTRUMENTS 5 2 4 ,784 3 3 9 , 076\nCOMMONWEALTH EDISON CO 3.125% 03/15/2051 DD 03/09/21 CORPORATE DEBT INSTRUMENTS 7 4 3 ,987 4 8 3 , 378\nCOMMONWEALTH EDISON CO 3.650% 06/15/2046 DD 06/27/16 CORPORATE DEBT INSTRUMENTS 3 7 , 4 28 2 6 , 1 6 2\nCOMMONWEALTH EDISON CO 3.850% 03/15/2052 DD 03/15/22 CORPORATE DEBT INSTRUMENTS 2 5 4 ,549 1 8 8 , 9 22\nCOMMONWEALTH EDISON CO 4.000% 03/01/2049 DD 02/19/19 CORPORATE DEBT INSTRUMENTS 2 0 8 ,290 1 6 1 , 9 20\nCONNECTICUT LIGHT AND POWER CO 4.000% 04/01/2048 DD 03/28/18 CORPORATE DEBT INSTRUMENTS 8 1 3 ,020 6 3 9 , 865\nCONOCOPHILLIPS CO 3.800% 03/15/2052 DD 03/08/22 CORPORATE DEBT INSTRUMENTS 5 2 8 ,975 4 0 2 , 1 71\nCONOCOPHILLIPS CO 4.025% 03/15/2062 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 2 , 3 02,133 1 , 7 0 7,413\nCONOCOPHILLIPS CO 4.025% 03/15/2062 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 3 8 0 ,437 2 8 2 , 1 57\nCONOCOPHILLIPS CO 5.300% 05/15/2053 DD 05/23/23 CORPORATE DEBT INSTRUMENTS 1 0 7 ,307 1 0 1 , 8 76\nCONOCOPHILLIPS CO 5.500% 01/15/2055 DD 12/05/24 CORPORATE DEBT INSTRUMENTS 1 , 2 25,251 1 , 1 6 0,366\nCONOCOPHILLIPS CO 5.550% 03/15/2054 DD 08/17/23 CORPORATE DEBT INSTRUMENTS 2 7 4 ,299 2 6 5 , 339\nCONOCOPHILLIPS CO 5.650% 01/15/2065 DD 12/05/24 CORPORATE DEBT INSTRUMENTS 1 , 3 94,414 1 , 3 1 9,349\nCONOCOPHILLIPS CO 5.650% 01/15/2065 DD 12/05/24 CORPORATE DEBT INSTRUMENTS 2 4 4 ,897 2 3 1 , 7 14\nCONOCOPHILLIPS CO 5.700% 09/15/2063 DD 08/17/23 CORPORATE DEBT INSTRUMENTS 3 0 4 ,167 2 9 2 , 937\nCONSOLIDATED EDISON CO OF NEW 3.875% 06/15/2047 DD 06/08/17 CORPORATE DEBT INSTRUMENTS 2 3 1 ,142 1 7 7 , 0 67\nCONSOLIDATED EDISON CO OF NEW 3.950% 03/01/2043 DD 02/28/13 CORPORATE DEBT INSTRUMENTS 2 , 1 20,140 1 , 7 0 9,879\nCONSOLIDATED EDISON CO OF NEW 4.625% 12/01/2054 DD 11/24/14 CORPORATE DEBT INSTRUMENTS 9 9 0 ,407 8 4 8 , 097\nCONSOLIDATED EDISON CO OF NEW 5.500% 03/15/2055 DD 11/18/24 CORPORATE DEBT INSTRUMENTS 6 5 3 ,687 6 1 5 , 5 46\nCONSOLIDATED EDISON CO OF NEW 5.900% 11/15/2053 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 5 7 3 ,702 5 8 7 , 477\nCONSOLIDATED EDISON CO OF NEW 5.900% 11/15/2053 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 9 9 5 ,685 1 , 0 1 4,640\nCONSOLIDATED EDISON CO OF NEW 6.150% 11/15/2052 DD 11/14/22 CORPORATE DEBT INSTRUMENTS 1 , 2 89,785 1 , 3 0 6,354\nCONSOLIDATED EDISON CO OF NEW 6.150% 11/15/2052 DD 11/14/22 CORPORATE DEBT INSTRUMENTS 3 3 4 ,231 3 4 6 , 262\nCONSOLIDATED EDISON CO OF NEW 6.300% 08/15/2037 DD 08/28/07 CORPORATE DEBT INSTRUMENTS 5 3 3 ,325 5 3 0 , 880\nCONSTELLATION BRANDS INC 4.100% 02/15/2048 DD 02/07/18 CORPORATE DEBT INSTRUMENTS 1 4 6 ,646 1 2 0 , 3 68\nCONSTELLATION BRANDS INC 4.500% 05/09/2047 DD 05/09/17 CORPORATE DEBT INSTRUMENTS 2 3 8 ,942 1 9 8 , 4 51\nCONSTELLATION BRANDS INC 5.250% 11/15/2048 DD 10/29/18 CORPORATE DEBT INSTRUMENTS 3 1 5 ,790 2 7 4 , 287\nCONSTELLATION ENERGY GENERATIO 6.250% 10/01/2039 DD 09/23/09 CORPORATE DEBT INSTRUMENTS 9 8 3 ,079 9 6 5 , 1 08\nCONSTELLATION ENERGY GENERATIO 6.250% 10/01/2039 DD 09/23/09 CORPORATE DEBT INSTRUMENTS 6 5 6 ,770 5 6 4 , 458\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nCONSTELLATION ENERGY GENERATIO 6.500% 10/01/2053 DD 09/29/23 CORPORATE DEBT INSTRUMENTS 2 3 6 ,068 2 6 5 , 845\nCONSUMERS ENERGY CO 2.500% 05/01/2060 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 3 1 2 ,464 1 8 2 , 1 07\nCONSUMERS ENERGY CO 3.100% 08/15/2050 DD 09/03/19 CORPORATE DEBT INSTRUMENTS 7 9 5 ,321 5 4 1 , 7 96\nCONSUMERS ENERGY CO 3.500% 08/01/2051 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 2 2 9 ,094 1 6 7 , 6 38\nCONSUMERS ENERGY CO 4.200% 09/01/2052 DD 08/11/22 CORPORATE DEBT INSTRUMENTS 2 2 4 ,839 1 8 1 , 5 52\nCONSUMERS ENERGY CO 4.200% 09/01/2052 DD 08/11/22 CORPORATE DEBT INSTRUMENTS 1 5 9 ,886 1 2 9 , 1 04\nCONSUMERS ENERGY CO 4.350% 04/15/2049 DD 11/13/18 CORPORATE DEBT INSTRUMENTS 6 2 7 ,593 5 2 4 , 204\nCONSUMERS ENERGY CO 4.625% 05/15/2033 DD 02/23/23 CORPORATE DEBT INSTRUMENTS 9 9 4 ,510 9 6 4 , 790\nCOOPERATIEVE RABOBANK UA 144A VAR RT 12/15/2027 DD 12/15/21 CORPORATE DEBT INSTRUMENTS 7 0 0 ,000 6 6 3 , 068\nCORNING INC 5.450% 11/15/2079 DD 11/19/19 CORPORATE DEBT INSTRUMENTS 9 8 3 ,744 8 8 7 , 586\nCORNING INC 5.850% 11/15/2068 DD 11/06/18 CORPORATE DEBT INSTRUMENTS 1 , 2 50,917 1 , 1 2 8,925\nCOSTCO WHOLESALE CORP 1.750% 04/20/2032 DD 04/20/20 CORPORATE DEBT INSTRUMENTS 1 , 9 24,592 1 , 5 5 4,568\nCSX CORP 3.800% 11/01/2046 DD 10/18/16 CORPORATE DEBT INSTRUMENTS 3 9 7 ,724 3 0 8 , 028\nCSX CORP 4.500% 11/15/2052 DD 07/28/22 CORPORATE DEBT INSTRUMENTS 2 6 0 ,080 2 8 7 , 1 88\nCSX CORP 4.750% 05/30/2042 DD 11/01/11 CORPORATE DEBT INSTRUMENTS 1 , 6 06,149 1 , 4 4 4,257\nCUMMINS INC 5.450% 02/20/2054 DD 02/20/24 CORPORATE DEBT INSTRUMENTS 8 4 5 ,447 8 2 8 , 444\nCVS HEALTH CORP 4.780% 03/25/2038 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 8 1 3 ,815 8 0 4 , 273\nCVS HEALTH CORP 4.780% 03/25/2038 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 1 , 0 54,861 8 4 3 , 1 90\nCVS HEALTH CORP 5.050% 03/25/2048 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 1 , 6 71,421 1 , 2 8 2,424\nCVS HEALTH CORP 5.050% 03/25/2048 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 2 , 2 31,768 1 , 8 9 2,709\nCVS HEALTH CORP 5.050% 03/25/2048 DD 03/09/18 CORPORATE DEBT INSTRUMENTS 1 , 1 46,934 1 , 0 9 6,864\nCVS HEALTH CORP 5.125% 07/20/2045 DD 07/20/15 CORPORATE DEBT INSTRUMENTS 1 , 8 08,375 1 , 5 2 8,048\nCVS HEALTH CORP 5.125% 07/20/2045 DD 07/20/15 CORPORATE DEBT INSTRUMENTS 1 , 1 10,525 8 5 0 , 3 19\nCVS HEALTH CORP 5.125% 07/20/2045 DD 07/20/15 CORPORATE DEBT INSTRUMENTS 8 4 3 ,763 7 4 1 , 7 14\nCVS HEALTH CORP 5.875% 06/01/2053 DD 06/02/23 CORPORATE DEBT INSTRUMENTS 1 1 8 ,304 1 0 5 , 5 03\nCVS HEALTH CORP 6.000% 06/01/2044 DD 05/09/24 CORPORATE DEBT INSTRUMENTS 9 8 7 ,933 9 3 6 , 896\nCVS HEALTH CORP 6.050% 06/01/2054 DD 05/09/24 CORPORATE DEBT INSTRUMENTS 4 9 5 ,942 4 5 6 , 235\nCVS PASS-THROUGH TRUST 144A 7.507% 01/10/2032 DD 12/22/09 CORPORATE DEBT INSTRUMENTS 1 , 7 14,944 1 , 7 8 8,116\nDANAHER CORP 2.600% 10/01/2050 DD 10/06/20 CORPORATE DEBT INSTRUMENTS 4 8 4 ,953 2 9 1 , 9 96\nDANAHER CORP 2.600% 10/01/2050 DD 10/06/20 CORPORATE DEBT INSTRUMENTS 8 8 , 7 23 5 9 , 5 9 1\nDANAHER CORP 2.800% 12/10/2051 DD 12/10/21 CORPORATE DEBT INSTRUMENTS 7 7 5 ,541 4 8 0 , 594\nDEERE & CO 2.875% 09/07/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 6 3 4 ,746 4 1 5 , 3 53\nDEUTSCHE BANK AG/NEW YORK NY VAR RT 09/11/2035 DD 09/11/24 CORPORATE DEBT INSTRUMENTS 3 4 0 ,000 3 2 2 , 5 41\nDEUTSCHE TELEKOM INTERNAT 144A 4.875% 03/06/2042 DD 03/06/12 CORPORATE DEBT INSTRUMENTS 5 6 6 ,973 5 1 8 , 4 26\nDEVON ENERGY CORP 5.750% 09/15/2054 DD 08/28/24 CORPORATE DEBT INSTRUMENTS 8 9 3 ,944 8 1 3 , 7 07\nDH EUROPE FINANCE II SARL 3.250% 11/15/2039 DD 11/07/19 CORPORATE DEBT INSTRUMENTS 4 1 9 ,221 3 2 7 , 646\nDH EUROPE FINANCE II SARL 3.400% 11/15/2049 DD 11/07/19 CORPORATE DEBT INSTRUMENTS 8 9 , 7 80 6 3 , 7 7 8\nDIAMONDBACK ENERGY INC 4.250% 03/15/2052 DD 03/17/22 CORPORATE DEBT INSTRUMENTS 9 2 9 ,818 9 2 2 , 088\nDIAMONDBACK ENERGY INC 5.750% 04/18/2054 DD 04/18/24 CORPORATE DEBT INSTRUMENTS 5 3 8 ,988 5 0 7 , 740\nDIAMONDBACK ENERGY INC 5.900% 04/18/2064 DD 04/18/24 CORPORATE DEBT INSTRUMENTS 3 1 9 ,853 3 0 0 , 486\nDISCOVERY COMMUNICATIONS LLC 5.000% 09/20/2037 DD 09/21/17 CORPORATE DEBT INSTRUMENTS 1 , 2 79,486 1 , 0 6 1,608\nDOMINION ENERGY INC 3.300% 04/15/2041 DD 04/05/21 CORPORATE DEBT INSTRUMENTS 9 3 0 ,789 6 7 0 , 743\nDOMINION ENERGY INC 4.850% 08/15/2052 DD 08/19/22 CORPORATE DEBT INSTRUMENTS 1 2 8 ,441 1 1 1 , 7 93\nDOMINION ENERGY INC 4.900% 08/01/2041 DD 08/05/11 CORPORATE DEBT INSTRUMENTS 1 , 4 61,840 1 , 2 4 0,725\nDOMINION ENERGY INC VAR RT 06/01/2054 DD 05/20/24 CORPORATE DEBT INSTRUMENTS 6 4 4 ,000 6 8 0 , 0 51\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nDOW CHEMICAL CO/THE 3.600% 11/15/2050 DD 08/26/20 CORPORATE DEBT INSTRUMENTS 8 9 3 ,340 6 1 8 , 9 75\nDOW CHEMICAL CO/THE 4.375% 11/15/2042 DD 11/14/12 CORPORATE DEBT INSTRUMENTS 1 , 4 77,399 1 , 2 3 5,379\nDOW CHEMICAL CO/THE 4.800% 05/15/2049 DD 11/15/19 CORPORATE DEBT INSTRUMENTS 9 9 , 4 03 8 4 , 1 9 2\nDTE ELECTRIC CO 2.950% 03/01/2050 DD 02/26/20 CORPORATE DEBT INSTRUMENTS 9 5 9 ,616 6 2 4 , 672\nDTE ELECTRIC CO 4.050% 05/15/2048 DD 05/07/18 CORPORATE DEBT INSTRUMENTS 7 6 1 ,565 6 1 2 , 7 88\nDUKE ENERGY CAROLINAS LLC 4.000% 09/30/2042 DD 09/21/12 CORPORATE DEBT INSTRUMENTS 3 6 3 ,444 3 0 0 , 795\nDUKE ENERGY CAROLINAS LLC 4.000% 09/30/2042 DD 09/21/12 CORPORATE DEBT INSTRUMENTS 8 4 6 ,428 7 3 5 , 729\nDUKE ENERGY CAROLINAS LLC 5.300% 02/15/2040 DD 11/19/09 CORPORATE DEBT INSTRUMENTS 5 , 0 75,383 4 , 7 4 8,150\nDUKE ENERGY CAROLINAS LLC 5.400% 01/15/2054 DD 06/15/23 CORPORATE DEBT INSTRUMENTS 1 9 1 ,544 1 8 0 , 9 29\nDUKE ENERGY CORP 5.000% 08/15/2052 DD 08/11/22 CORPORATE DEBT INSTRUMENTS 8 , 5 5 5 8 , 7 4 1\nDUKE ENERGY FLORIDA LLC 3.400% 10/01/2046 DD 09/09/16 CORPORATE DEBT INSTRUMENTS 3 , 4 30,611 2 , 4 4 6,291\nDUKE ENERGY FLORIDA LLC 4.200% 07/15/2048 DD 06/21/18 CORPORATE DEBT INSTRUMENTS 3 1 9 ,555 2 5 6 , 608\nDUKE ENERGY FLORIDA LLC 6.200% 11/15/2053 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 2 3 3 ,571 2 4 8 , 0 17\nDUKE ENERGY FLORIDA LLC 6.350% 09/15/2037 DD 09/18/07 CORPORATE DEBT INSTRUMENTS 1 , 5 60,845 1 , 3 0 8,068\nDUKE ENERGY INDIANA LLC 2.750% 04/01/2050 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 2 5 9 ,680 1 5 7 , 2 58\nDUKE ENERGY INDIANA LLC 2.750% 04/01/2050 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 5 6 7 ,301 3 4 3 , 549\nDUKE ENERGY INDIANA LLC 3.250% 10/01/2049 DD 09/27/19 CORPORATE DEBT INSTRUMENTS 1 , 2 41,590 8 5 4 , 875\nDUKE ENERGY INDIANA LLC 6.350% 08/15/2038 DD 08/21/08 CORPORATE DEBT INSTRUMENTS 2 9 6 ,312 2 5 2 , 1 71\nDUKE ENERGY OHIO INC 2.125% 06/01/2030 DD 05/21/20 CORPORATE DEBT INSTRUMENTS 1 , 9 22,641 1 , 6 1 6,708\nDUKE ENERGY OHIO INC 4.300% 02/01/2049 DD 01/08/19 CORPORATE DEBT INSTRUMENTS 6 7 9 ,897 4 7 0 , 439\nDUKE ENERGY OHIO INC 5.550% 03/15/2054 DD 03/14/24 CORPORATE DEBT INSTRUMENTS 4 2 3 ,891 4 1 0 , 8 18\nDUKE ENERGY OHIO INC 5.650% 04/01/2053 DD 03/22/23 CORPORATE DEBT INSTRUMENTS 1 7 5 ,479 1 6 6 , 6 31\nDUPONT DE NEMOURS INC 5.319% 11/15/2038 DD 11/28/18 CORPORATE DEBT INSTRUMENTS 7 8 8 ,550 7 4 9 , 473\nDUPONT DE NEMOURS INC 5.419% 11/15/2048 DD 11/28/18 CORPORATE DEBT INSTRUMENTS 4 2 5 ,000 4 2 3 , 687\nEASTERN ENERGY GAS HOLDINGS LL 5.650% 10/15/2054 DD 10/09/24 CORPORATE DEBT INSTRUMENTS 8 6 8 ,366 8 2 0 , 875\nEASTERN ENERGY GAS HOLDINGS LL 5.650% 10/15/2054 DD 10/09/24 CORPORATE DEBT INSTRUMENTS 1 6 4 ,880 1 5 5 , 8 62\nEATON CORP 4.150% 03/15/2033 DD 08/23/22 CORPORATE DEBT INSTRUMENTS 4 6 8 ,945 4 7 0 , 1 45\nECOLAB INC 2.700% 11/01/2026 DD 10/18/16 CORPORATE DEBT INSTRUMENTS 1 , 5 36,133 1 , 3 3 6,378\nELECTRICITE DE FRANCE SA 144A 5.000% 09/21/2048 DD 09/21/18 CORPORATE DEBT INSTRUMENTS 3 6 8 ,798 3 3 1 , 0 83\nELECTRONIC ARTS INC 2.950% 02/15/2051 DD 02/11/21 CORPORATE DEBT INSTRUMENTS 1 , 2 40,295 1 , 1 6 4,254\nELEVANCE HEALTH INC 3.600% 03/15/2051 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 4 2 5 ,150 2 8 9 , 388\nELEVANCE HEALTH INC 3.700% 09/15/2049 DD 09/09/19 CORPORATE DEBT INSTRUMENTS 7 8 0 ,204 5 5 9 , 956\nELEVANCE HEALTH INC 3.700% 09/15/2049 DD 09/09/19 CORPORATE DEBT INSTRUMENTS 9 8 , 4 29 8 9 , 1 6 5\nELEVANCE HEALTH INC 4.375% 12/01/2047 DD 11/21/17 CORPORATE DEBT INSTRUMENTS 3 5 4 ,996 2 8 6 , 7 51\nELEVANCE HEALTH INC 4.375% 12/01/2047 DD 11/21/17 CORPORATE DEBT INSTRUMENTS 1 , 7 45,324 1 , 4 2 8,102\nELEVANCE HEALTH INC 4.550% 03/01/2048 DD 03/02/18 CORPORATE DEBT INSTRUMENTS 3 9 3 ,653 3 2 4 , 824\nELEVANCE HEALTH INC 4.650% 01/15/2043 DD 09/10/12 CORPORATE DEBT INSTRUMENTS 1 , 8 74,343 1 , 6 6 4,020\nELEVANCE HEALTH INC 5.100% 01/15/2044 DD 08/06/13 CORPORATE DEBT INSTRUMENTS 8 7 , 1 35 6 8 , 2 3 4\nELEVANCE HEALTH INC 5.650% 06/15/2054 DD 05/30/24 CORPORATE DEBT INSTRUMENTS 2 9 9 ,781 2 8 8 , 870\nELEVANCE HEALTH INC 5.700% 02/15/2055 DD 10/31/24 CORPORATE DEBT INSTRUMENTS 4 4 7 ,539 4 3 4 , 290\nELI LILLY & CO 4.150% 03/15/2059 DD 02/22/19 CORPORATE DEBT INSTRUMENTS 7 4 , 8 67 6 6 , 6 3 5\nELI LILLY & CO 4.600% 08/14/2034 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 3 0 6 ,930 2 8 8 , 060\nELI LILLY & CO 4.700% 02/27/2033 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 6 9 6 ,028 6 8 6 , 259\nELI LILLY & CO 4.875% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 4 0 4 ,745 3 6 7 , 392\nELI LILLY & CO 4.875% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 5 7 3 ,923 5 2 3 , 420\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nELI LILLY & CO 4.950% 02/27/2063 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 5 5 4 ,020 5 0 3 , 278\nELI LILLY & CO 5.000% 02/09/2054 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 8 2 9 ,094 7 7 2 , 4 81\nELI LILLY & CO 5.000% 02/09/2054 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 3 8 2 ,809 3 5 4 , 054\nELI LILLY & CO 5.050% 08/14/2054 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 2 7 3 ,653 2 5 5 , 1 83\nELI LILLY & CO 5.100% 02/09/2064 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 1 , 6 74,006 1 , 5 3 4,613\nELI LILLY & CO 5.100% 02/09/2064 DD 02/09/24 CORPORATE DEBT INSTRUMENTS 9 1 2 ,779 8 3 7 , 8 11\nELI LILLY & CO 5.200% 08/14/2064 DD 08/14/24 CORPORATE DEBT INSTRUMENTS 3 3 1 ,954 3 0 7 , 609\nEMERSON ELECTRIC CO 2.750% 10/15/2050 DD 04/29/20 CORPORATE DEBT INSTRUMENTS 4 0 9 ,500 2 5 5 , 709\nEMERSON ELECTRIC CO 2.800% 12/21/2051 DD 12/21/21 CORPORATE DEBT INSTRUMENTS 5 8 3 ,701 3 6 2 , 1 56\nEMERSON ELECTRIC CO 2.800% 12/21/2051 DD 12/21/21 CORPORATE DEBT INSTRUMENTS 1 , 3 11,083 8 1 3 , 4 58\nEMPOWER FINANCE 2020 LP 144A 1.776% 03/17/2031 DD 09/17/20 CORPORATE DEBT INSTRUMENTS 5 6 7 ,127 4 6 2 , 385\nENBRIDGE INC 6.700% 11/15/2053 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 5 7 2 ,255 6 2 2 , 7 19\nENBRIDGE INC 6.700% 11/15/2053 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 4 0 9 ,467 4 4 5 , 576\nENERGY TRANSFER LP 5.000% 05/15/2050 DD 01/22/20 CORPORATE DEBT INSTRUMENTS 2 , 4 00,513 2 , 3 4 4,758\nENERGY TRANSFER LP 5.150% 02/01/2043 DD 01/22/13 CORPORATE DEBT INSTRUMENTS 1 3 3 ,787 1 2 7 , 9 91\nENERGY TRANSFER LP 5.300% 04/15/2047 DD 01/17/17 CORPORATE DEBT INSTRUMENTS 8 9 4 ,885 8 0 1 , 5 49\nENERGY TRANSFER LP 5.350% 05/15/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 6 3 0 ,752 5 7 2 , 262\nENERGY TRANSFER LP 5.350% 05/15/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 5 08,838 1 , 3 6 8,923\nENERGY TRANSFER LP 5.350% 05/15/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 2 7 , 2 22 2 7 , 0 3 6\nENERGY TRANSFER LP 5.400% 10/01/2047 DD 09/21/17 CORPORATE DEBT INSTRUMENTS 9 8 3 ,862 8 8 1 , 0 79\nENERGY TRANSFER LP 5.800% 06/15/2038 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 6 2 , 5 92 5 8 , 9 7 2\nENERGY TRANSFER LP 5.950% 10/01/2043 DD 09/19/13 CORPORATE DEBT INSTRUMENTS 1 , 9 59,367 1 , 8 3 5,549\nENERGY TRANSFER LP 6.500% 02/01/2042 DD 01/17/12 CORPORATE DEBT INSTRUMENTS 7 7 , 2 14 7 2 , 5 5 1\nENERGY TRANSFER LP 6.550% 12/01/2033 DD 10/13/23 CORPORATE DEBT INSTRUMENTS 5 8 4 ,333 6 2 2 , 7 91\nENI SPA 144A 5.700% 10/01/2040 DD 10/01/10 CORPORATE DEBT INSTRUMENTS 3 0 8 ,199 2 6 8 , 040\nENI SPA 144A 5.950% 05/15/2054 DD 05/15/24 CORPORATE DEBT INSTRUMENTS 4 0 5 ,195 3 9 4 , 609\nENTERGY ARKANSAS LLC 5.750% 06/01/2054 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 1 , 1 92,611 1 , 1 7 3,707\nENTERGY ARKANSAS LLC 5.750% 06/01/2054 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 4 9 4 ,788 4 9 2 , 264\nENTERGY CORP 3.750% 06/15/2050 DD 05/19/20 CORPORATE DEBT INSTRUMENTS 6 9 3 ,261 4 4 3 , 675\nENTERGY LOUISIANA LLC 2.900% 03/15/2051 DD 03/06/20 CORPORATE DEBT INSTRUMENTS 1 6 8 ,702 1 0 7 , 7 70\nENTERGY LOUISIANA LLC 3.100% 06/15/2041 DD 03/10/21 CORPORATE DEBT INSTRUMENTS 7 3 0 ,325 5 2 7 , 9 21\nENTERGY LOUISIANA LLC 4.750% 09/15/2052 DD 08/24/22 CORPORATE DEBT INSTRUMENTS 1 5 4 ,158 1 3 3 , 7 32\nENTERGY LOUISIANA LLC 5.700% 03/15/2054 DD 03/08/24 CORPORATE DEBT INSTRUMENTS 3 9 4 ,431 3 9 0 , 659\nENTERGY MISSISSIPPI LLC 2.850% 06/01/2028 DD 05/13/16 CORPORATE DEBT INSTRUMENTS 1 , 5 68,074 1 , 3 6 0,419\nENTERGY MISSISSIPPI LLC 5.850% 06/01/2054 DD 05/16/24 CORPORATE DEBT INSTRUMENTS 4 6 4 ,786 4 6 9 , 357\nENTERGY TEXAS INC 5.000% 09/15/2052 DD 08/25/22 CORPORATE DEBT INSTRUMENTS 2 3 3 ,651 2 1 0 , 3 60\nENTERGY TEXAS INC 5.550% 09/15/2054 DD 08/15/24 CORPORATE DEBT INSTRUMENTS 3 3 7 ,566 3 3 0 , 1 03\nENTERPRISE PRODUCTS OPERATING 3.200% 02/15/2052 DD 08/07/20 CORPORATE DEBT INSTRUMENTS 5 0 7 ,024 4 6 5 , 200\nENTERPRISE PRODUCTS OPERATING 3.700% 01/31/2051 DD 01/15/20 CORPORATE DEBT INSTRUMENTS 3 0 3 ,681 2 0 8 , 336\nENTERPRISE PRODUCTS OPERATING 4.250% 02/15/2048 DD 02/15/18 CORPORATE DEBT INSTRUMENTS 4 9 4 ,031 3 9 3 , 6 71\nENTERPRISE PRODUCTS OPERATING 4.450% 02/15/2043 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 1 1 8 ,426 1 1 5 , 2 28\nENTERPRISE PRODUCTS OPERATING 4.800% 02/01/2049 DD 10/11/18 CORPORATE DEBT INSTRUMENTS 4 3 2 ,347 3 7 4 , 896\nENTERPRISE PRODUCTS OPERATING 4.850% 01/31/2034 DD 01/11/24 CORPORATE DEBT INSTRUMENTS 9 5 7 ,168 9 2 8 , 8 19\nENTERPRISE PRODUCTS OPERATING 4.850% 03/15/2044 DD 03/18/13 CORPORATE DEBT INSTRUMENTS 4 1 3 ,428 3 6 6 , 979\nENTERPRISE PRODUCTS OPERATING 4.900% 05/15/2046 DD 05/07/15 CORPORATE DEBT INSTRUMENTS 3 6 8 ,650 3 3 0 , 1 73\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nENTERPRISE PRODUCTS OPERATING 4.900% 05/15/2046 DD 05/07/15 CORPORATE DEBT INSTRUMENTS 4 0 4 ,745 3 7 0 , 329\nENTERPRISE PRODUCTS OPERATING 4.950% 10/15/2054 DD 10/14/14 CORPORATE DEBT INSTRUMENTS 1 , 0 37,656 9 2 2 , 787\nENTERPRISE PRODUCTS OPERATING 5.100% 02/15/2045 DD 02/12/14 CORPORATE DEBT INSTRUMENTS 2 8 9 ,551 2 6 7 , 537\nENTERPRISE PRODUCTS OPERATING 5.100% 02/15/2045 DD 02/12/14 CORPORATE DEBT INSTRUMENTS 3 0 , 7 70 3 2 , 2 8 9\nENTERPRISE PRODUCTS OPERATING 5.550% 02/16/2055 DD 08/08/24 CORPORATE DEBT INSTRUMENTS 1 1 4 ,612 1 1 0 , 8 13\nENTERPRISE PRODUCTS OPERATING 5.700% 02/15/2042 DD 08/24/11 CORPORATE DEBT INSTRUMENTS 7 7 0 ,318 7 5 5 , 955\nENTERPRISE PRODUCTS OPERATING 5.700% 02/15/2042 DD 08/24/11 CORPORATE DEBT INSTRUMENTS 2 8 1 ,047 2 9 4 , 982\nENTERPRISE PRODUCTS OPERATING 6.450% 09/01/2040 DD 05/20/10 CORPORATE DEBT INSTRUMENTS 2 , 9 17,473 2 , 6 4 5,456\nENTERPRISE PRODUCTS OPERATING 6.450% 09/01/2040 DD 05/20/10 CORPORATE DEBT INSTRUMENTS 9 7 , 3 94 9 6 , 9 4 3\nEOG RESOURCES INC 5.650% 12/01/2054 DD 11/21/24 CORPORATE DEBT INSTRUMENTS 8 8 1 ,776 8 6 9 , 8 01\nEQUINIX INC 2.950% 09/15/2051 DD 10/07/20 CORPORATE DEBT INSTRUMENTS 8 6 0 ,139 5 3 1 , 5 17\nEQUINOR ASA 3.700% 04/06/2050 DD 04/06/20 CORPORATE DEBT INSTRUMENTS 1 , 2 25,923 9 1 6 , 1 60\nEQUITABLE HOLDINGS INC 5.000% 04/20/2048 DD 10/20/18 CORPORATE DEBT INSTRUMENTS 7 2 1 ,442 6 3 5 , 1 32\nERP OPERATING LP 3.375% 06/01/2025 DD 05/14/15 CORPORATE DEBT INSTRUMENTS 1 , 9 25,827 1 , 7 5 0,091\nERP OPERATING LP 4.500% 07/01/2044 DD 06/19/14 CORPORATE DEBT INSTRUMENTS 1 0 2 ,953 1 0 3 , 6 90\nESSEX PORTFOLIO LP 4.500% 03/15/2048 DD 03/08/18 CORPORATE DEBT INSTRUMENTS 9 4 3 ,018 7 8 1 , 4 45\nEXELON CORP 4.100% 03/15/2052 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 1 6 9 ,881 1 2 9 , 4 35\nEXELON CORP 4.950% 06/15/2035 DD 12/15/15 CORPORATE DEBT INSTRUMENTS 2 , 1 19,093 2 , 0 1 3,140\nEXELON CORP 4.950% 06/15/2035 DD 12/15/15 CORPORATE DEBT INSTRUMENTS 5 5 3 ,457 5 2 5 , 785\nEXELON CORP 5.600% 03/15/2053 DD 02/21/23 CORPORATE DEBT INSTRUMENTS 5 4 4 ,313 5 2 6 , 306\nEXELON CORP 5.625% 06/15/2035 DD 06/09/05 CORPORATE DEBT INSTRUMENTS 1 , 0 20,546 8 4 5 , 427\nEXTRA SPACE STORAGE LP 5.400% 02/01/2034 DD 01/19/24 CORPORATE DEBT INSTRUMENTS 3 4 9 ,314 3 4 6 , 5 91\nEXXON MOBIL CORP 3.095% 08/16/2049 DD 08/16/19 CORPORATE DEBT INSTRUMENTS 2 3 5 ,409 1 6 0 , 1 54\nEXXON MOBIL CORP 3.452% 04/15/2051 DD 04/15/20 CORPORATE DEBT INSTRUMENTS 9 2 , 1 99 8 7 , 7 5 7\nEXXON MOBIL CORP 3.452% 04/15/2051 DD 04/15/20 CORPORATE DEBT INSTRUMENTS 1 , 7 12,163 1 , 0 7 5,556\nEXXON MOBIL CORP 3.452% 04/15/2051 DD 04/15/20 CORPORATE DEBT INSTRUMENTS 6 0 1 ,978 4 2 8 , 257\nEXXON MOBIL CORP 4.227% 03/19/2040 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 7 80,000 1 , 5 6 3,071\nEXXON MOBIL CORP 4.227% 03/19/2040 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 9 0 1 ,834 7 4 6 , 4 10\nEXXON MOBIL CORP 4.327% 03/19/2050 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 6 76,703 1 , 3 2 9,936\nEXXON MOBIL CORP 4.327% 03/19/2050 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 5 87,000 1 , 3 0 6,879\nFEDEX CORP 4.050% 02/15/2048 DD 01/31/18 CORPORATE DEBT INSTRUMENTS 6 2 3 ,159 6 2 0 , 646\nFIRST REPUBLIC BANK/CA 4.625% 02/13/2047 DD 02/13/17 CORPORATE DEBT INSTRUMENTS 7 7 5 ,609 1 8 6\nFIRSTENERGY PENNSYLVANIA ELECT 6.150% 10/01/2038 DD 09/30/09 CORPORATE DEBT INSTRUMENTS 2 , 2 22,314 2 , 1 5 5,037\nFIRSTENERGY TRANSMISSION 144A 5.450% 07/15/2044 DD 05/19/14 CORPORATE DEBT INSTRUMENTS 2 8 5 ,685 2 6 8 , 335\nFLORIDA POWER & LIGHT CO 2.850% 04/01/2025 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 2 , 3 01,310 2 , 1 0 4,848\nFLORIDA POWER & LIGHT CO 3.150% 10/01/2049 DD 09/13/19 CORPORATE DEBT INSTRUMENTS 5 4 1 ,528 3 6 8 , 044\nFLORIDA POWER & LIGHT CO 3.800% 12/15/2042 DD 12/20/12 CORPORATE DEBT INSTRUMENTS 1 , 4 51,360 1 , 2 6 8,832\nFLORIDA POWER & LIGHT CO 3.990% 03/01/2049 DD 02/26/19 CORPORATE DEBT INSTRUMENTS 5 0 4 ,732 3 9 5 , 425\nFLORIDA POWER & LIGHT CO 5.690% 03/01/2040 DD 02/09/10 CORPORATE DEBT INSTRUMENTS 1 , 2 86,997 1 , 2 6 1,021\nFLORIDA POWER & LIGHT CO 5.960% 04/01/2039 DD 03/17/09 CORPORATE DEBT INSTRUMENTS 8 1 4 ,398 6 7 9 , 8 15\nFOUNDRY JV HOLDCO LLC 144A 6.400% 01/25/2038 DD 05/07/24 CORPORATE DEBT INSTRUMENTS 7 0 3 ,224 7 1 0 , 5 43\nFOX CORP 5.476% 01/25/2039 DD 01/25/20 CORPORATE DEBT INSTRUMENTS 1 8 6 ,060 1 9 0 , 0 62\nGA GLOBAL FUNDING TRUST 144A 2.900% 01/06/2032 DD 01/06/22 CORPORATE DEBT INSTRUMENTS 7 4 3 ,778 6 2 4 , 1 31\nGATX CORP 3.100% 06/01/2051 DD 02/03/21 CORPORATE DEBT INSTRUMENTS 1 , 5 23,839 9 8 0 , 979\nGENERAL DYNAMICS CORP 2.850% 06/01/2041 DD 05/10/21 CORPORATE DEBT INSTRUMENTS 2 2 5 ,271 1 5 6 , 9 77\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nGENERAL DYNAMICS CORP 3.625% 04/01/2030 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 , 8 99,827 1 , 5 5 3,653\nGENERAL DYNAMICS CORP 4.250% 04/01/2040 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 7 4 1 ,482 6 0 2 , 798\nGENERAL DYNAMICS CORP 4.250% 04/01/2040 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 1 3 ,129 9 6 , 0 9 8\nGENERAL DYNAMICS CORP 4.250% 04/01/2050 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 6 0 , 2 69 5 7 , 8 8 2\nGENERAL MOTORS CO 5.150% 04/01/2038 DD 08/07/17 CORPORATE DEBT INSTRUMENTS 2 4 3 ,663 2 0 2 , 633\nGENERAL MOTORS CO 5.600% 10/15/2032 DD 08/02/22 CORPORATE DEBT INSTRUMENTS 6 7 8 ,341 6 8 6 , 208\nGENERAL MOTORS CO 6.250% 10/02/2043 DD 04/02/14 CORPORATE DEBT INSTRUMENTS 5 9 0 ,815 4 5 6 , 3 61\nGENERAL MOTORS CO 6.600% 04/01/2036 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 8 4 6 ,322 8 8 9 , 3 16\nGENERAL MOTORS CO 6.600% 04/01/2036 DD 02/23/16 CORPORATE DEBT INSTRUMENTS 3 2 7 ,651 3 1 4 , 9 88\nGENERAL MOTORS FINANCIAL CO IN 6.400% 01/09/2033 DD 01/09/23 CORPORATE DEBT INSTRUMENTS 3 7 5 ,065 3 6 8 , 0 11\nGEORGIA POWER CO 2.650% 09/15/2029 DD 09/10/19 CORPORATE DEBT INSTRUMENTS 1 , 5 25,204 1 , 3 1 9,539\nGEORGIA POWER CO 3.700% 01/30/2050 DD 01/10/20 CORPORATE DEBT INSTRUMENTS 7 6 6 ,112 5 2 9 , 459\nGEORGIA POWER CO 4.300% 03/15/2042 DD 03/06/12 CORPORATE DEBT INSTRUMENTS 2 , 0 38,960 1 , 7 3 6,285\nGEORGIA POWER CO 4.300% 03/15/2042 DD 03/06/12 CORPORATE DEBT INSTRUMENTS 7 8 0 ,021 7 0 2 , 1 74\nGILEAD SCIENCES INC 4.150% 03/01/2047 DD 09/20/16 CORPORATE DEBT INSTRUMENTS 1 6 7 ,395 1 0 4 , 3 28\nGILEAD SCIENCES INC 4.150% 03/01/2047 DD 09/20/16 CORPORATE DEBT INSTRUMENTS 7 2 , 0 98 6 4 , 2 0 2\nGILEAD SCIENCES INC 4.500% 02/01/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 7 44,698 1 , 5 0 5,808\nGILEAD SCIENCES INC 4.500% 02/01/2045 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 1 6 ,812 9 4 , 3 8 1\nGILEAD SCIENCES INC 4.750% 03/01/2046 DD 09/14/15 CORPORATE DEBT INSTRUMENTS 2 2 1 ,054 1 9 8 , 4 36\nGILEAD SCIENCES INC 4.800% 04/01/2044 DD 03/07/14 CORPORATE DEBT INSTRUMENTS 3 7 6 ,510 3 3 1 , 4 61\nGILEAD SCIENCES INC 5.500% 11/15/2054 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 3 3 6 ,320 3 2 6 , 454\nGILEAD SCIENCES INC 5.500% 11/15/2054 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 1 , 3 30,503 1 , 2 6 1,965\nGILEAD SCIENCES INC 5.600% 11/15/2064 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 1 7 4 ,474 1 6 4 , 3 37\nGLENCORE FINANCE CANADA L 144A 6.000% 11/15/2041 DD 11/10/11 CORPORATE DEBT INSTRUMENTS 1 , 5 16,153 1 , 5 0 2,523\nGLOBAL ATLANTIC FIN CO 144A 6.750% 03/15/2054 DD 03/15/24 CORPORATE DEBT INSTRUMENTS 4 4 2 ,001 4 5 2 , 298\nGLOBAL ATLANTIC FIN CO 144A 6.750% 03/15/2054 DD 03/15/24 CORPORATE DEBT INSTRUMENTS 5 9 2 ,347 5 8 9 , 5 12\nGLOBAL PAYMENTS INC 5.950% 08/15/2052 DD 08/22/22 CORPORATE DEBT INSTRUMENTS 7 1 1 ,840 6 9 4 , 086\nGOLDMAN SACHS GROUP INC/THE 2.600% 02/07/2030 DD 02/07/20 CORPORATE DEBT INSTRUMENTS 1 , 5 16,008 1 , 3 1 0,806\nGOLDMAN SACHS GROUP INC/THE 4.800% 07/08/2044 DD 07/08/14 CORPORATE DEBT INSTRUMENTS 1 1 4 ,484 9 7 , 3 2 1\nGOLDMAN SACHS GROUP INC/THE 5.150% 05/22/2045 DD 05/22/15 CORPORATE DEBT INSTRUMENTS 5 7 9 ,467 5 3 5 , 050\nGOLDMAN SACHS GROUP INC/THE 6.250% 02/01/2041 DD 01/28/11 CORPORATE DEBT INSTRUMENTS 2 8 9 ,840 2 8 4 , 386\nGOLDMAN SACHS GROUP INC/THE 6.250% 02/01/2041 DD 01/28/11 CORPORATE DEBT INSTRUMENTS 2 , 9 86,034 2 , 6 8 2,704\nGOLDMAN SACHS GROUP INC/THE 6.750% 10/01/2037 DD 10/03/07 CORPORATE DEBT INSTRUMENTS 1 , 7 94,865 1 , 9 4 0,086\nGOLDMAN SACHS GROUP INC/THE VAR RT 02/24/2043 DD 01/24/22 CORPORATE DEBT INSTRUMENTS 5 2 0 ,299 4 1 7 , 1 38\nGOLDMAN SACHS GROUP INC/THE VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 7 4 6 ,681 7 4 2 , 054\nGOLDMAN SACHS GROUP INC/THE VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 3 6 5 ,000 2 6 6 , 322\nGOLDMAN SACHS GROUP INC/THE VAR RT 04/23/2039 DD 04/23/18 CORPORATE DEBT INSTRUMENTS 5 6 2 ,001 5 0 7 , 368\nGOLDMAN SACHS GROUP INC/THE VAR RT 07/23/2035 DD 07/23/24 CORPORATE DEBT INSTRUMENTS 1 , 0 05,000 9 8 7 , 523\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/23/2035 DD 10/23/24 CORPORATE DEBT INSTRUMENTS 3 9 0 ,000 3 7 3 , 487\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/31/2038 DD 10/31/17 CORPORATE DEBT INSTRUMENTS 5 7 0 ,000 4 8 2 , 847\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/31/2038 DD 10/31/17 CORPORATE DEBT INSTRUMENTS 9 9 5 ,969 9 8 0 , 095\nGOLDMAN SACHS GROUP INC/THE VAR RT 10/31/2038 DD 10/31/17 CORPORATE DEBT INSTRUMENTS 5 9 , 0 33 4 6 , 5 9 0\nGOLDMAN SACHS GROUP INC/THE VAR RT 11/19/2045 DD 11/19/24 CORPORATE DEBT INSTRUMENTS 1 , 9 22,453 1 , 8 5 1,077\nGUARDIAN LIFE INSURANCE C 144A 4.875% 06/19/2064 DD 06/19/14 CORPORATE DEBT INSTRUMENTS 7 4 2 ,504 6 3 0 , 009\nHCA INC 4.375% 03/15/2042 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 1 8 ,111 9 8 , 0 3 0\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nHCA INC 4.625% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 2 3 7 ,853 2 2 2 , 0 61\nHCA INC 5.125% 06/15/2039 DD 06/12/19 CORPORATE DEBT INSTRUMENTS 6 4 5 ,050 5 9 3 , 250\nHCA INC 5.500% 06/15/2047 DD 06/22/17 CORPORATE DEBT INSTRUMENTS 7 9 , 2 94 7 7 , 4 2 1\nHCA INC 5.950% 09/15/2054 DD 08/12/24 CORPORATE DEBT INSTRUMENTS 1 , 0 90,067 1 , 0 1 4,530\nHCA INC 5.950% 09/15/2054 DD 08/12/24 CORPORATE DEBT INSTRUMENTS 6 1 7 ,737 5 7 1 , 5 66\nHCA INC 6.000% 04/01/2054 DD 02/23/24 CORPORATE DEBT INSTRUMENTS 4 3 3 ,385 4 0 5 , 463\nHCA INC 6.100% 04/01/2064 DD 02/23/24 CORPORATE DEBT INSTRUMENTS 7 8 , 7 34 7 1 , 6 4 7\nHEALTH CARE SERVICE CORP 144A 5.875% 06/15/2054 DD 06/10/24 CORPORATE DEBT INSTRUMENTS 9 2 6 ,588 8 7 3 , 6 10\nHERSHEY CO/THE 2.450% 11/15/2029 DD 10/31/19 CORPORATE DEBT INSTRUMENTS 1 , 9 31,761 1 , 6 1 8,498\nHESS CORP 5.800% 04/01/2047 DD 09/28/16 CORPORATE DEBT INSTRUMENTS 6 0 2 ,332 5 1 6 , 1 48\nHESS CORP 6.000% 01/15/2040 DD 12/14/09 CORPORATE DEBT INSTRUMENTS 8 1 , 6 56 8 3 , 3 5 4\nHOME DEPOT INC/THE 2.375% 03/15/2051 DD 01/07/21 CORPORATE DEBT INSTRUMENTS 7 3 , 8 35 6 8 , 0 3 5\nHOME DEPOT INC/THE 2.500% 04/15/2027 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 1 , 9 16,992 1 , 6 8 4,003\nHOME DEPOT INC/THE 3.125% 12/15/2049 DD 01/13/20 CORPORATE DEBT INSTRUMENTS 4 3 8 ,858 3 7 4 , 1 78\nHOME DEPOT INC/THE 3.125% 12/15/2049 DD 01/13/20 CORPORATE DEBT INSTRUMENTS 1 4 4 ,433 8 7 , 1 7 4\nHOME DEPOT INC/THE 3.300% 04/15/2040 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 3 0 4 ,315 2 3 7 , 845\nHOME DEPOT INC/THE 3.350% 04/15/2050 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 9 5 3 ,980 6 7 3 , 879\nHOME DEPOT INC/THE 3.350% 04/15/2050 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 3 1 8 ,213 2 6 1 , 8 70\nHOME DEPOT INC/THE 3.625% 04/15/2052 DD 03/28/22 CORPORATE DEBT INSTRUMENTS 8 1 9 ,172 6 7 6 , 343\nHOME DEPOT INC/THE 3.900% 06/15/2047 DD 06/05/17 CORPORATE DEBT INSTRUMENTS 7 2 8 ,615 4 7 5 , 997\nHOME DEPOT INC/THE 3.900% 06/15/2047 DD 06/05/17 CORPORATE DEBT INSTRUMENTS 1 , 0 61,539 8 3 7 , 692\nHOME DEPOT INC/THE 4.200% 04/01/2043 DD 04/05/13 CORPORATE DEBT INSTRUMENTS 5 5 2 ,658 4 6 9 , 7 41\nHOME DEPOT INC/THE 4.250% 04/01/2046 DD 06/02/15 CORPORATE DEBT INSTRUMENTS 6 4 , 2 30 6 2 , 6 1 0\nHOME DEPOT INC/THE 4.500% 12/06/2048 DD 12/06/18 CORPORATE DEBT INSTRUMENTS 5 5 0 ,491 4 7 8 , 934\nHOME DEPOT INC/THE 4.500% 12/06/2048 DD 12/06/18 CORPORATE DEBT INSTRUMENTS 6 0 1 ,113 5 1 3 , 1 44\nHOME DEPOT INC/THE 4.875% 02/15/2044 DD 09/10/13 CORPORATE DEBT INSTRUMENTS 7 4 5 ,037 6 8 2 , 062\nHOME DEPOT INC/THE 5.300% 06/25/2054 DD 06/25/24 CORPORATE DEBT INSTRUMENTS 9 5 3 ,655 9 2 5 , 6 18\nHOME DEPOT INC/THE 5.300% 06/25/2054 DD 06/25/24 CORPORATE DEBT INSTRUMENTS 2 8 4 ,286 2 6 8 , 573\nHOME DEPOT INC/THE 5.400% 06/25/2064 DD 06/25/24 CORPORATE DEBT INSTRUMENTS 1 5 8 ,359 1 5 3 , 6 11\nHONEYWELL INTERNATIONAL INC 1.950% 06/01/2030 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 1 , 5 34,819 1 , 2 8 6,198\nHONEYWELL INTERNATIONAL INC 5.250% 03/01/2054 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 1 , 1 42,424 1 , 0 7 4,159\nHONEYWELL INTERNATIONAL INC 5.250% 03/01/2054 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 1 , 7 99,941 1 , 6 9 2,387\nHONEYWELL INTERNATIONAL INC 5.250% 03/01/2054 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 3 6 8 ,994 3 4 7 , 1 08\nHONEYWELL INTERNATIONAL INC 5.350% 03/01/2064 DD 03/01/24 CORPORATE DEBT INSTRUMENTS 3 0 9 ,237 2 9 1 , 2 08\nHORMEL FOODS CORP 1.700% 06/03/2028 DD 06/03/21 CORPORATE DEBT INSTRUMENTS 5 5 7 ,751 5 4 3 , 684\nHSBC BANK USA NA 7.000% 01/15/2039 DD 06/18/08 CORPORATE DEBT INSTRUMENTS 3 , 5 06,939 3 , 1 5 9,579\nHSBC BANK USA NA 7.000% 01/15/2039 DD 06/18/08 CORPORATE DEBT INSTRUMENTS 8 3 0 ,667 7 1 3 , 2 74\nHSBC HOLDINGS PLC 6.800% 06/01/2038 DD 06/01/22 CORPORATE DEBT INSTRUMENTS 1 , 8 00,006 1 , 4 0 5,486\nHSBC HOLDINGS PLC VAR RT 03/09/2044 DD 03/09/23 CORPORATE DEBT INSTRUMENTS 4 7 6 ,294 4 7 5 , 447\nHUMANA INC 4.950% 10/01/2044 DD 09/19/14 CORPORATE DEBT INSTRUMENTS 3 5 3 ,289 3 0 1 , 8 56\nHUMANA INC 5.500% 03/15/2053 DD 03/13/23 CORPORATE DEBT INSTRUMENTS 4 8 3 ,312 4 5 5 , 9 14\nHUMANA INC 5.750% 04/15/2054 DD 03/13/24 CORPORATE DEBT INSTRUMENTS 1 , 0 28,654 9 6 5 , 297\nHUNTINGTON BANCSHARES INC/OH VAR RT 11/18/2039 DD 11/18/24 CORPORATE DEBT INSTRUMENTS 2 5 5 ,000 2 5 4 , 850\nIBM INTERNATIONAL CAPITAL PTE 5.250% 02/05/2044 DD 02/05/24 CORPORATE DEBT INSTRUMENTS 4 8 , 9 53 4 7 , 4 1 5\nIBM INTERNATIONAL CAPITAL PTE 5.300% 02/05/2054 DD 02/05/24 CORPORATE DEBT INSTRUMENTS 6 5 6 ,271 6 0 9 , 886\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nIDAHO POWER CO 4.200% 03/01/2048 DD 03/16/18 CORPORATE DEBT INSTRUMENTS 7 7 2 ,380 5 8 8 , 0 71\nINDIANA MICHIGAN POWER CO 4.250% 08/15/2048 DD 08/08/18 CORPORATE DEBT INSTRUMENTS 3 5 2 ,969 2 8 0 , 248\nINDIANA MICHIGAN POWER CO 5.625% 04/01/2053 DD 03/23/23 CORPORATE DEBT INSTRUMENTS 4 3 8 ,935 4 1 9 , 5 90\nINTEL CORP 3.250% 11/15/2049 DD 11/21/19 CORPORATE DEBT INSTRUMENTS 1 , 1 58,706 1 , 0 2 8,336\nINTEL CORP 3.734% 12/08/2047 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 3 8 2 ,505 2 6 6 , 069\nINTEL CORP 3.734% 12/08/2047 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 6 8 8 ,073 4 9 5 , 1 65\nINTEL CORP 3.734% 12/08/2047 DD 06/08/18 CORPORATE DEBT INSTRUMENTS 5 6 0 ,326 3 8 6 , 229\nINTEL CORP 4.750% 03/25/2050 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 7 4 ,654 1 6 2 , 4 75\nINTEL CORP 4.900% 08/05/2052 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 4 8 9 ,005 3 8 7 , 458\nINTEL CORP 4.900% 08/05/2052 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 2 6 1 ,967 2 1 3 , 4 97\nINTEL CORP 5.050% 08/05/2062 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 2 7 9 ,378 2 1 8 , 7 30\nINTEL CORP 5.600% 02/21/2054 DD 02/21/24 CORPORATE DEBT INSTRUMENTS 3 9 6 ,097 3 6 7 , 238\nINTEL CORP 5.625% 02/10/2043 DD 02/10/23 CORPORATE DEBT INSTRUMENTS 1 0 9 ,934 1 0 1 , 0 41\nINTEL CORP 5.700% 02/10/2053 DD 02/10/23 CORPORATE DEBT INSTRUMENTS 7 9 1 ,659 7 0 1 , 4 59\nINTERCONTINENTAL EXCHANGE INC 3.000% 06/15/2050 DD 05/26/20 CORPORATE DEBT INSTRUMENTS 4 9 9 ,813 3 1 7 , 2 68\nINTERCONTINENTAL EXCHANGE INC 4.950% 06/15/2052 DD 05/23/22 CORPORATE DEBT INSTRUMENTS 4 4 6 ,703 4 0 4 , 0 18\nINTERNATIONAL BUSINESS MACHINE 4.900% 07/27/2052 DD 07/27/22 CORPORATE DEBT INSTRUMENTS 2 0 4 ,936 2 0 9 , 392\nINTERNATIONAL FLAVORS & F 144A 3.268% 11/15/2040 DD 09/16/20 CORPORATE DEBT INSTRUMENTS 1 , 1 07,025 8 8 5 , 5 71\nINTERNATIONAL FLAVORS & F 144A 3.468% 12/01/2050 DD 09/16/20 CORPORATE DEBT INSTRUMENTS 1 , 3 67,576 1 , 0 6 7,186\nINTERNATIONAL FLAVORS & FRAGRA 5.000% 09/26/2048 DD 09/26/18 CORPORATE DEBT INSTRUMENTS 2 3 6 ,448 1 8 4 , 7 28\nINTUIT INC 5.500% 09/15/2053 DD 09/15/23 CORPORATE DEBT INSTRUMENTS 1 9 5 ,286 1 9 1 , 2 42\nJBS USA HOLDING LUX SARL/ JBS 4.375% 02/02/2052 DD 08/02/23 CORPORATE DEBT INSTRUMENTS 6 1 5 ,584 4 6 3 , 495\nJBS USA HOLDING LUX SARL/ JBS 6.500% 12/01/2052 DD 06/01/23 CORPORATE DEBT INSTRUMENTS 1 , 3 08,777 1 , 3 5 2,903\nJBS USA HOLDING LUX SARL/ JBS 7.250% 11/15/2053 DD 11/15/24 CORPORATE DEBT INSTRUMENTS 7 9 2 ,581 8 4 8 , 394\nJOHN DEERE CAPITAL CORP 2.800% 07/18/2029 DD 07/18/19 CORPORATE DEBT INSTRUMENTS 1 , 5 37,764 1 , 2 8 5,799\nJOHNSON & JOHNSON 2.950% 03/03/2027 DD 03/03/17 CORPORATE DEBT INSTRUMENTS 2 , 3 05,841 2 , 0 0 2,905\nJOHNSON & JOHNSON 3.700% 03/01/2046 DD 03/01/16 CORPORATE DEBT INSTRUMENTS 6 1 , 8 25 5 9 , 3 2 7\nJPMORGAN CHASE & CO 5.400% 01/06/2042 DD 12/22/11 CORPORATE DEBT INSTRUMENTS 9 8 9 ,455 9 1 8 , 5 24\nJPMORGAN CHASE & CO 5.400% 01/06/2042 DD 12/22/11 CORPORATE DEBT INSTRUMENTS 1 5 7 ,285 1 2 9 , 3 83\nJPMORGAN CHASE & CO 5.500% 10/15/2040 DD 10/21/10 CORPORATE DEBT INSTRUMENTS 3 6 , 3 17 2 9 , 8 7 2\nJPMORGAN CHASE & CO 5.600% 07/15/2041 DD 07/21/11 CORPORATE DEBT INSTRUMENTS 3 , 0 47,693 3 , 0 4 4,034\nJPMORGAN CHASE & CO 5.600% 07/15/2041 DD 07/21/11 CORPORATE DEBT INSTRUMENTS 1 , 5 45,546 1 , 3 0 2,423\nJPMORGAN CHASE & CO 5.600% 07/15/2041 DD 07/21/11 CORPORATE DEBT INSTRUMENTS 5 7 7 ,143 5 2 5 , 008\nJPMORGAN CHASE & CO 6.400% 05/15/2038 DD 05/22/08 CORPORATE DEBT INSTRUMENTS 1 , 1 43,390 9 6 0 , 8 10\nJPMORGAN CHASE & CO VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 1 5 0 ,208 1 4 9 , 3 13\nJPMORGAN CHASE & CO VAR RT 04/22/2035 DD 04/22/24 CORPORATE DEBT INSTRUMENTS 5 1 5 ,000 5 2 6 , 938\nJPMORGAN CHASE & CO VAR RT 04/22/2041 DD 04/22/20 CORPORATE DEBT INSTRUMENTS 6 6 6 ,081 4 9 7 , 1 47\nJPMORGAN CHASE & CO VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 2 0 4 ,908 2 0 2 , 1 17\nJPMORGAN CHASE & CO VAR RT 04/22/2051 DD 04/22/20 CORPORATE DEBT INSTRUMENTS 7 4 , 9 45 4 3 , 1 2 2\nJPMORGAN CHASE & CO VAR RT 04/22/2052 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 3 5 8 ,795 2 5 7 , 340\nJPMORGAN CHASE & CO VAR RT 05/06/2030 DD 05/06/19 CORPORATE DEBT INSTRUMENTS 1 , 9 08,347 1 , 5 9 5,442\nJPMORGAN CHASE & CO VAR RT 07/22/2035 DD 07/22/24 CORPORATE DEBT INSTRUMENTS 9 0 0 ,163 8 8 0 , 504\nJPMORGAN CHASE & CO VAR RT 07/24/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 1 9 0 ,029 1 7 9 , 3 11\nJPMORGAN CHASE & CO VAR RT 07/24/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 1 , 7 90,843 1 , 2 8 4,205\nJPMORGAN CHASE & CO VAR RT 07/24/2048 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 7 7 3 ,035 6 1 5 , 8 33\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nJPMORGAN CHASE & CO VAR RT 07/24/2048 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 4 6 9 ,069 3 6 7 , 1 31\nJPMORGAN CHASE & CO VAR RT 10/22/2035 DD 10/22/24 CORPORATE DEBT INSTRUMENTS 6 4 6 ,180 6 2 6 , 1 58\nJPMORGAN CHASE & CO VAR RT 11/15/2048 DD 11/10/17 CORPORATE DEBT INSTRUMENTS 9 3 5 ,905 8 9 9 , 9 10\nJPMORGAN CHASE & CO VAR RT 11/15/2048 DD 11/10/17 CORPORATE DEBT INSTRUMENTS 5 0 9 ,055 4 0 6 , 9 16\nJPMORGAN CHASE & CO VAR RT 11/19/2041 DD 11/19/20 CORPORATE DEBT INSTRUMENTS 5 6 , 3 33 5 4 , 2 4 9\nJPMORGAN CHASE & CO VAR RT 11/29/2045 DD 11/29/24 CORPORATE DEBT INSTRUMENTS 3 1 0 ,000 3 0 2 , 858\nKAISER FOUNDATION HOSPITALS 2.810% 06/01/2041 DD 06/15/21 CORPORATE DEBT INSTRUMENTS 5 7 7 ,540 4 0 7 , 347\nKAISER FOUNDATION HOSPITALS 3.002% 06/01/2051 DD 06/15/21 CORPORATE DEBT INSTRUMENTS 7 7 8 ,794 5 0 4 , 076\nKAISER FOUNDATION HOSPITALS 3.266% 11/01/2049 DD 10/31/19 CORPORATE DEBT INSTRUMENTS 7 2 0 ,000 4 9 9 , 802\nKAISER FOUNDATION HOSPITALS 3.266% 11/01/2049 DD 10/31/19 CORPORATE DEBT INSTRUMENTS 3 6 0 ,000 2 4 9 , 9 01\nKAISER FOUNDATION HOSPITALS 4.150% 05/01/2047 DD 05/03/17 CORPORATE DEBT INSTRUMENTS 1 8 8 ,197 1 5 5 , 1 31\nKENTUCKY UTILITIES CO 5.125% 11/01/2040 DD 05/01/11 CORPORATE DEBT INSTRUMENTS 3 6 0 ,731 3 0 7 , 895\nKENVUE INC 5.000% 03/22/2030 DD 09/22/23 CORPORATE DEBT INSTRUMENTS 6 9 3 ,256 7 0 0 , 727\nKENVUE INC 5.100% 03/22/2043 DD 09/22/23 CORPORATE DEBT INSTRUMENTS 1 4 3 ,500 1 3 9 , 2 28\nKEURIG DR PEPPER INC 4.500% 04/15/2052 DD 04/22/22 CORPORATE DEBT INSTRUMENTS 7 1 8 ,519 5 9 6 , 965\nKILROY REALTY LP 2.650% 11/15/2033 DD 10/07/21 CORPORATE DEBT INSTRUMENTS 3 4 , 8 03 3 4 , 4 3 2\nKILROY REALTY LP 6.250% 01/15/2036 DD 01/12/24 CORPORATE DEBT INSTRUMENTS 5 0 , 5 56 4 9 , 6 1 9\nKIMBERLY-CLARK CORP 3.100% 03/26/2030 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 1 , 5 33,233 1 , 2 4 3,385\nKINDER MORGAN ENERGY PARTNERS 4.700% 11/01/2042 DD 11/08/12 CORPORATE DEBT INSTRUMENTS 1 6 2 ,198 1 1 7 , 7 46\nKINDER MORGAN ENERGY PARTNERS 5.400% 09/01/2044 DD 09/11/14 CORPORATE DEBT INSTRUMENTS 1 1 1 ,514 1 1 8 , 7 23\nKINDER MORGAN ENERGY PARTNERS 5.500% 03/01/2044 DD 02/24/14 CORPORATE DEBT INSTRUMENTS 1 , 0 79,263 9 8 7 , 436\nKINDER MORGAN ENERGY PARTNERS 5.500% 03/01/2044 DD 02/24/14 CORPORATE DEBT INSTRUMENTS 2 1 5 ,742 2 1 3 , 2 49\nKINDER MORGAN ENERGY PARTNERS 5.625% 09/01/2041 DD 08/17/11 CORPORATE DEBT INSTRUMENTS 1 , 4 05,540 1 , 3 0 6,761\nKINDER MORGAN ENERGY PARTNERS 6.375% 03/01/2041 DD 03/04/11 CORPORATE DEBT INSTRUMENTS 3 0 3 ,266 3 1 1 , 8 75\nKINDER MORGAN ENERGY PARTNERS 6.950% 01/15/2038 DD 06/21/07 CORPORATE DEBT INSTRUMENTS 2 1 9 ,704 1 9 5 , 2 05\nKINDER MORGAN INC 5.050% 02/15/2046 DD 02/26/15 CORPORATE DEBT INSTRUMENTS 3 , 1 00,659 2 , 6 7 9,777\nKINDER MORGAN INC 5.050% 02/15/2046 DD 02/26/15 CORPORATE DEBT INSTRUMENTS 6 1 1 ,981 4 7 4 , 335\nKINDER MORGAN INC 5.200% 03/01/2048 DD 03/01/18 CORPORATE DEBT INSTRUMENTS 5 7 7 ,939 5 6 5 , 920\nKINDER MORGAN INC 5.200% 03/01/2048 DD 03/01/18 CORPORATE DEBT INSTRUMENTS 1 2 9 ,516 1 1 4 , 9 53\nKINDER MORGAN INC 5.550% 06/01/2045 DD 11/26/14 CORPORATE DEBT INSTRUMENTS 5 6 5 ,936 4 5 3 , 1 65\nKINDER MORGAN INC 5.550% 06/01/2045 DD 11/26/14 CORPORATE DEBT INSTRUMENTS 3 5 , 6 59 3 2 , 7 0 3\nKKR GROUP FINANCE CO II L 144A 5.500% 02/01/2043 DD 02/01/13 CORPORATE DEBT INSTRUMENTS 9 7 2 ,060 9 3 8 , 988\nKKR GROUP FINANCE CO III 144A 5.125% 06/01/2044 DD 05/29/14 CORPORATE DEBT INSTRUMENTS 4 3 5 ,232 3 2 0 , 037\nKLA CORP 4.700% 02/01/2034 DD 02/01/24 CORPORATE DEBT INSTRUMENTS 4 8 9 ,900 4 8 5 , 405\nKLA CORP 4.950% 07/15/2052 DD 06/23/22 CORPORATE DEBT INSTRUMENTS 1 7 7 ,553 1 6 2 , 0 23\nKLA CORP 4.950% 07/15/2052 DD 06/23/22 CORPORATE DEBT INSTRUMENTS 3 6 2 ,639 3 2 7 , 686\nKLA CORP 5.000% 03/15/2049 DD 03/20/19 CORPORATE DEBT INSTRUMENTS 6 6 9 ,134 6 1 9 , 7 23\nKRAFT HEINZ FOODS CO 4.375% 06/01/2046 DD 05/24/16 CORPORATE DEBT INSTRUMENTS 1 , 2 15,026 1 , 1 6 1,225\nKRAFT HEINZ FOODS CO 4.875% 10/01/2049 DD 10/01/20 CORPORATE DEBT INSTRUMENTS 2 6 5 ,398 2 4 4 , 836\nKRAFT HEINZ FOODS CO 5.200% 07/15/2045 DD 07/15/16 CORPORATE DEBT INSTRUMENTS 6 0 0 ,870 5 6 5 , 288\nKRAFT HEINZ FOODS CO 5.500% 06/01/2050 DD 12/01/20 CORPORATE DEBT INSTRUMENTS 2 3 4 ,504 2 3 0 , 1 70\nKROGER CO/THE 4.450% 02/01/2047 DD 01/24/17 CORPORATE DEBT INSTRUMENTS 1 , 2 49,153 1 , 0 1 7,294\nKROGER CO/THE 4.450% 02/01/2047 DD 01/24/17 CORPORATE DEBT INSTRUMENTS 1 , 7 86,424 1 , 4 8 3,520\nKROGER CO/THE 5.500% 09/15/2054 DD 08/27/24 CORPORATE DEBT INSTRUMENTS 3 2 7 ,645 3 1 0 , 2 67\nKROGER CO/THE 5.650% 09/15/2064 DD 08/27/24 CORPORATE DEBT INSTRUMENTS 2 9 3 ,687 2 7 7 , 858\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nL3HARRIS TECHNOLOGIES INC 5.500% 08/15/2054 DD 08/02/24 CORPORATE DEBT INSTRUMENTS 1 , 3 46,586 1 , 3 1 3,198\nL3HARRIS TECHNOLOGIES INC 5.600% 07/31/2053 DD 07/31/23 CORPORATE DEBT INSTRUMENTS 3 0 5 ,517 2 9 6 , 900\nLELAND STANFORD JUNIOR UNIVERS 1.289% 06/01/2027 DD 06/04/20 CORPORATE DEBT INSTRUMENTS 2 , 1 00,987 1 , 9 0 8,768\nLOCKHEED MARTIN CORP 1.850% 06/15/2030 DD 05/20/20 CORPORATE DEBT INSTRUMENTS 1 , 9 19,606 1 , 6 0 7,438\nLOCKHEED MARTIN CORP 4.090% 09/15/2052 DD 09/07/17 CORPORATE DEBT INSTRUMENTS 8 1 8 ,599 7 5 4 , 795\nLOCKHEED MARTIN CORP 4.090% 09/15/2052 DD 09/07/17 CORPORATE DEBT INSTRUMENTS 8 4 , 3 66 7 5 , 2 4 2\nLOCKHEED MARTIN CORP 4.700% 05/15/2046 DD 11/23/15 CORPORATE DEBT INSTRUMENTS 1 , 9 58,167 1 , 6 3 1,767\nLOCKHEED MARTIN CORP 5.200% 02/15/2055 DD 05/25/23 CORPORATE DEBT INSTRUMENTS 1 3 3 ,974 1 2 7 , 2 40\nLOCKHEED MARTIN CORP 5.200% 02/15/2064 DD 01/29/24 CORPORATE DEBT INSTRUMENTS 6 6 2 ,865 6 1 8 , 4 23\nLOCKHEED MARTIN CORP 5.200% 02/15/2064 DD 01/29/24 CORPORATE DEBT INSTRUMENTS 6 9 4 ,763 6 4 8 , 1 82\nLOCKHEED MARTIN CORP 5.700% 11/15/2054 DD 10/24/22 CORPORATE DEBT INSTRUMENTS 9 2 2 ,374 9 4 7 , 828\nLOUISVILLE GAS AND ELECTRIC CO 3.300% 10/01/2025 DD 09/28/15 CORPORATE DEBT INSTRUMENTS 1 , 9 69,069 1 , 7 4 7,350\nLOUISVILLE GAS AND ELECTRIC CO 4.650% 11/15/2043 DD 11/14/13 CORPORATE DEBT INSTRUMENTS 7 6 9 ,620 6 3 9 , 4 13\nLOWE'S COS INC 3.000% 10/15/2050 DD 10/22/20 CORPORATE DEBT INSTRUMENTS 9 8 5 ,967 6 0 0 , 539\nLOWE'S COS INC 3.700% 04/15/2046 DD 04/20/16 CORPORATE DEBT INSTRUMENTS 8 7 8 ,895 6 6 6 , 846\nLOWE'S COS INC 4.050% 05/03/2047 DD 05/03/17 CORPORATE DEBT INSTRUMENTS 3 1 2 ,997 2 4 4 , 774\nLOWE'S COS INC 4.050% 05/03/2047 DD 05/03/17 CORPORATE DEBT INSTRUMENTS 1 , 1 18,839 8 7 4 , 970\nLOWE'S COS INC 4.250% 04/01/2052 DD 03/24/22 CORPORATE DEBT INSTRUMENTS 4 9 6 ,553 4 4 1 , 8 07\nLOWE'S COS INC 4.450% 04/01/2062 DD 03/24/22 CORPORATE DEBT INSTRUMENTS 1 0 9 ,918 8 5 , 3 4 9\nLOWE'S COS INC 4.550% 04/05/2049 DD 04/05/19 CORPORATE DEBT INSTRUMENTS 1 5 5 ,198 1 0 3 , 3 39\nLOWE'S COS INC 5.800% 09/15/2062 DD 09/08/22 CORPORATE DEBT INSTRUMENTS 1 , 2 04,822 1 , 1 7 5,407\nLOWE'S COS INC 5.800% 09/15/2062 DD 09/08/22 CORPORATE DEBT INSTRUMENTS 7 4 , 8 55 7 2 , 6 1 6\nLSEG US FIN CORP 144A 5.297% 03/28/2034 DD 03/28/24 CORPORATE DEBT INSTRUMENTS 5 0 7 ,765 4 9 7 , 985\nLYB INTERNATIONAL FINANCE III 4.200% 05/01/2050 DD 04/20/20 CORPORATE DEBT INSTRUMENTS 1 , 5 20,407 1 , 1 4 1,824\nM&T BANK CORP VAR RT 01/16/2036 DD 12/17/24 CORPORATE DEBT INSTRUMENTS 5 2 0 ,000 5 0 4 , 1 97\nMARATHON PETROLEUM CORP 4.750% 09/15/2044 DD 09/05/14 CORPORATE DEBT INSTRUMENTS 1 9 5 ,809 1 4 1 , 2 21\nMARATHON PETROLEUM CORP 6.500% 03/01/2041 DD 09/01/11 CORPORATE DEBT INSTRUMENTS 8 8 9 ,982 8 3 7 , 686\nMARATHON PETROLEUM CORP 6.500% 03/01/2041 DD 09/01/11 CORPORATE DEBT INSTRUMENTS 1 6 9 ,911 1 3 4 , 7 76\nMARKEL GROUP INC 5.000% 05/20/2049 DD 05/20/19 CORPORATE DEBT INSTRUMENTS 1 , 2 92,966 1 , 1 2 5,410\nMARSH & MCLENNAN COS INC 2.250% 11/15/2030 DD 05/07/20 CORPORATE DEBT INSTRUMENTS 1 , 5 31,522 1 , 2 7 3,338\nMARSH & MCLENNAN COS INC 4.200% 03/01/2048 DD 03/01/18 CORPORATE DEBT INSTRUMENTS 7 2 7 ,036 5 9 2 , 6 14\nMARSH & MCLENNAN COS INC 4.350% 01/30/2047 DD 01/12/17 CORPORATE DEBT INSTRUMENTS 3 0 3 ,603 3 2 5 , 8 61\nMARSH & MCLENNAN COS INC 4.750% 03/15/2039 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 7 5 6 ,440 7 4 0 , 880\nMARSH & MCLENNAN COS INC 4.900% 03/15/2049 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 9 5 3 ,978 8 5 5 , 986\nMARSH & MCLENNAN COS INC 4.900% 03/15/2049 DD 01/15/19 CORPORATE DEBT INSTRUMENTS 9 2 , 6 48 9 4 , 1 1 4\nMARSH & MCLENNAN COS INC 5.400% 03/15/2055 DD 11/08/24 CORPORATE DEBT INSTRUMENTS 2 3 0 ,884 2 2 2 , 657\nMARSH & MCLENNAN COS INC 5.450% 03/15/2054 DD 02/20/24 CORPORATE DEBT INSTRUMENTS 5 9 , 4 76 5 8 , 0 1 9\nMARSH & MCLENNAN COS INC 5.700% 09/15/2053 DD 09/11/23 CORPORATE DEBT INSTRUMENTS 8 4 9 ,444 8 5 5 , 2 21\nMARTIN MARIETTA MATERIALS INC 5.500% 12/01/2054 DD 11/04/24 CORPORATE DEBT INSTRUMENTS 7 6 4 ,447 7 3 6 , 9 21\nMASS GENERAL BRIGHAM INC 3.192% 07/01/2049 DD 01/29/20 CORPORATE DEBT INSTRUMENTS 1 , 0 96,103 7 4 0 , 1 32\nMASSACHUSETTS INSTITUTE OF TEC 3.067% 04/01/2052 DD 03/08/22 CORPORATE DEBT INSTRUMENTS 1 , 0 00,000 6 7 2 , 1 90\nMASSACHUSETTS INSTITUTE OF TEC 5.600% 07/01/2111 DD 05/18/11 CORPORATE DEBT INSTRUMENTS 7 4 3 ,740 5 8 4 , 408\nMASSACHUSETTS MUTUAL LIFE 144A 3.375% 04/15/2050 DD 04/16/20 CORPORATE DEBT INSTRUMENTS 2 0 4 ,155 1 3 7 , 0 65\nMASSACHUSETTS MUTUAL LIFE 144A 3.729% 10/15/2070 DD 10/11/19 CORPORATE DEBT INSTRUMENTS 2 8 2 ,471 1 9 4 , 0 16\nMASTERCARD INC 3.300% 03/26/2027 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 1 , 9 17,164 1 , 6 5 2,828\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nMASTERCARD INC 3.650% 06/01/2049 DD 05/31/19 CORPORATE DEBT INSTRUMENTS 4 6 1 ,561 3 2 8 , 673\nMCDONALD'S CORP 3.625% 09/01/2049 DD 08/12/19 CORPORATE DEBT INSTRUMENTS 5 1 2 ,198 3 7 1 , 8 04\nMCDONALD'S CORP 3.625% 09/01/2049 DD 08/12/19 CORPORATE DEBT INSTRUMENTS 6 7 4 ,195 4 5 0 , 497\nMCDONALD'S CORP 4.450% 03/01/2047 DD 03/09/17 CORPORATE DEBT INSTRUMENTS 1 , 1 29,427 9 5 3 , 627\nMCDONALD'S CORP 4.450% 03/01/2047 DD 03/09/17 CORPORATE DEBT INSTRUMENTS 1 , 3 33,263 1 , 1 3 2,590\nMCDONALD'S CORP 4.600% 05/26/2045 DD 05/26/15 CORPORATE DEBT INSTRUMENTS 3 2 9 ,699 2 8 6 , 440\nMCDONALD'S CORP 5.150% 09/09/2052 DD 09/09/22 CORPORATE DEBT INSTRUMENTS 4 7 9 ,103 4 7 6 , 450\nMEDTRONIC INC 4.375% 03/15/2035 DD 03/15/15 CORPORATE DEBT INSTRUMENTS 4 5 4 ,020 4 4 1 , 6 31\nMEMORIAL HEALTH SERVICES 3.447% 11/01/2049 DD 12/12/19 CORPORATE DEBT INSTRUMENTS 4 0 5 ,000 2 8 8 , 1 53\nMERCEDES-BENZ FINANCE NOR 144A 5.000% 01/11/2034 DD 01/11/24 CORPORATE DEBT INSTRUMENTS 5 8 8 ,042 5 8 0 , 452\nMERCK & CO INC 2.350% 06/24/2040 DD 06/24/20 CORPORATE DEBT INSTRUMENTS 1 0 6 ,961 8 1 , 3 1 3\nMERCK & CO INC 2.750% 02/10/2025 DD 02/10/15 CORPORATE DEBT INSTRUMENTS 1 , 5 30,860 1 , 4 1 2,312\nMERCK & CO INC 2.750% 12/10/2051 DD 12/10/21 CORPORATE DEBT INSTRUMENTS 1 7 8 ,263 1 6 0 , 8 92\nMERCK & CO INC 2.900% 12/10/2061 DD 12/10/21 CORPORATE DEBT INSTRUMENTS 8 2 2 ,674 4 7 4 , 062\nMERCK & CO INC 3.700% 02/10/2045 DD 02/10/15 CORPORATE DEBT INSTRUMENTS 5 5 1 ,809 4 3 0 , 264\nMERCK & CO INC 4.150% 05/18/2043 DD 05/20/13 CORPORATE DEBT INSTRUMENTS 5 9 3 ,179 4 9 8 , 860\nMERCK & CO INC 4.900% 05/17/2044 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 1 , 1 24,103 1 , 0 4 4,425\nMERCK & CO INC 5.000% 05/17/2053 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 4 4 8 ,196 4 1 0 , 1 75\nMERCK & CO INC 5.150% 05/17/2063 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 3 4 3 ,492 3 1 6 , 1 17\nMETA PLATFORMS INC 3.850% 08/15/2032 DD 08/09/22 CORPORATE DEBT INSTRUMENTS 5 5 7 ,358 5 5 7 , 796\nMETA PLATFORMS INC 4.450% 08/15/2052 DD 08/09/22 CORPORATE DEBT INSTRUMENTS 1 2 9 ,085 1 2 2 , 4 15\nMETA PLATFORMS INC 4.450% 08/15/2052 DD 08/09/22 CORPORATE DEBT INSTRUMENTS 5 4 1 ,931 4 7 6 , 1 51\nMETA PLATFORMS INC 4.750% 08/15/2034 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 0 3 ,851 5 8 9 , 270\nMETA PLATFORMS INC 5.400% 08/15/2054 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 8 2 ,267 6 6 3 , 786\nMETA PLATFORMS INC 5.400% 08/15/2054 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 1 6 ,530 5 9 9 , 830\nMETA PLATFORMS INC 5.400% 08/15/2054 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 4 3 3 ,264 4 2 1 , 5 28\nMETA PLATFORMS INC 5.550% 08/15/2064 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 6 2 2 ,300 6 1 1 , 8 88\nMETA PLATFORMS INC 5.550% 08/15/2064 DD 08/09/24 CORPORATE DEBT INSTRUMENTS 8 5 6 ,285 8 4 1 , 9 57\nMETA PLATFORMS INC 5.600% 05/15/2053 DD 05/03/23 CORPORATE DEBT INSTRUMENTS 2 , 3 61,095 2 , 3 7 4,100\nMETA PLATFORMS INC 5.750% 05/15/2063 DD 05/03/23 CORPORATE DEBT INSTRUMENTS 1 3 9 ,583 1 4 1 , 6 09\nMETLIFE INC 4.050% 03/01/2045 DD 03/05/15 CORPORATE DEBT INSTRUMENTS 2 , 6 17,989 2 , 1 6 0,601\nMETLIFE INC 4.050% 03/01/2045 DD 03/05/15 CORPORATE DEBT INSTRUMENTS 1 2 6 ,075 1 0 0 , 1 76\nMETLIFE INC 4.125% 08/13/2042 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 3 2 8 ,960 2 4 9 , 078\nMETLIFE INC 4.875% 11/13/2043 DD 11/13/13 CORPORATE DEBT INSTRUMENTS 8 7 8 ,448 7 9 5 , 1 83\nMETLIFE INC 5.000% 07/15/2052 DD 07/11/22 CORPORATE DEBT INSTRUMENTS 8 8 , 9 44 8 6 , 1 1 5\nMETLIFE INC 5.250% 01/15/2054 DD 01/06/23 CORPORATE DEBT INSTRUMENTS 1 , 0 81,182 1 , 0 3 1,415\nMETLIFE INC 5.700% 06/15/2035 DD 06/23/05 CORPORATE DEBT INSTRUMENTS 2 8 0 ,405 2 5 1 , 8 89\nMETLIFE INC 5.875% 02/06/2041 DD 08/06/10 CORPORATE DEBT INSTRUMENTS 5 1 5 ,779 4 6 9 , 982\nMETLIFE INC 5.875% 02/06/2041 DD 08/06/10 CORPORATE DEBT INSTRUMENTS 3 2 2 ,467 3 2 6 , 944\nMETLIFE INC VAR RT 12/15/2044 DD 09/15/14 CORPORATE DEBT INSTRUMENTS 1 9 6 ,790 1 7 2 , 3 31\nMETLIFE INC VAR RT 12/15/2044 DD 09/15/14 CORPORATE DEBT INSTRUMENTS 1 8 2 ,948 1 2 8 , 1 44\nMETROPOLITAN LIFE GLOBAL 144A 4.300% 08/25/2029 DD 08/25/22 CORPORATE DEBT INSTRUMENTS 5 9 9 ,424 5 8 3 , 1 64\nMICROSOFT CORP 2.525% 06/01/2050 DD 06/01/20 CORPORATE DEBT INSTRUMENTS 7 3 3 ,205 7 2 8 , 367\nMICROSOFT CORP 2.525% 06/01/2050 DD 06/01/20 CORPORATE DEBT INSTRUMENTS 1 , 0 93,314 7 4 9 , 9 71\nMICROSOFT CORP 2.675% 06/01/2060 DD 06/01/20 CORPORATE DEBT INSTRUMENTS 1 , 5 81,126 9 6 5 , 480\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nMICROSOFT CORP 2.921% 03/17/2052 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 1 , 9 82,256 1 , 3 6 5,574\nMICROSOFT CORP 2.921% 03/17/2052 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 5 5 2 ,910 3 8 1 , 1 68\nMICROSOFT CORP 3.041% 03/17/2062 DD 03/17/21 CORPORATE DEBT INSTRUMENTS 2 , 0 85,308 1 , 3 5 6,965\nMICROSOFT CORP 3.300% 02/06/2027 DD 02/06/17 CORPORATE DEBT INSTRUMENTS 2 , 2 93,620 1 , 9 6 2,975\nMICROSOFT CORP 3.700% 08/08/2046 DD 08/08/16 CORPORATE DEBT INSTRUMENTS 1 , 3 81,635 1 , 2 0 9,767\nMIDAMERICAN ENERGY CO 3.150% 04/15/2050 DD 10/15/19 CORPORATE DEBT INSTRUMENTS 6 0 1 ,588 4 0 6 , 608\nMIDAMERICAN ENERGY CO 5.300% 02/01/2055 DD 01/24/24 CORPORATE DEBT INSTRUMENTS 5 7 5 ,549 5 4 6 , 886\nMIDAMERICAN ENERGY CO 5.800% 10/15/2036 DD 10/06/06 CORPORATE DEBT INSTRUMENTS 6 6 6 ,394 5 7 3 , 7 31\nMIDAMERICAN ENERGY CO 5.850% 09/15/2054 DD 09/07/23 CORPORATE DEBT INSTRUMENTS 2 9 6 ,655 3 0 2 , 503\nMINERA MEXICO SA DE CV 144A 4.500% 01/26/2050 DD 09/26/19 CORPORATE DEBT INSTRUMENTS 7 6 8 ,707 6 0 7 , 232\nMONONGAHELA POWER CO 144A 5.400% 12/15/2043 DD 11/27/13 CORPORATE DEBT INSTRUMENTS 3 2 4 ,378 2 8 3 , 602\nMOODY'S CORP 4.875% 12/17/2048 DD 12/17/18 CORPORATE DEBT INSTRUMENTS 5 2 8 ,021 4 7 8 , 080\nMOODY'S CORP 5.250% 07/15/2044 DD 07/16/14 CORPORATE DEBT INSTRUMENTS 8 7 6 ,959 8 2 4 , 377\nMORGAN STANLEY 4.300% 01/27/2045 DD 01/27/15 CORPORATE DEBT INSTRUMENTS 1 , 0 81,795 9 0 7 , 489\nMORGAN STANLEY 4.300% 01/27/2045 DD 01/27/15 CORPORATE DEBT INSTRUMENTS 7 4 1 ,802 6 1 4 , 6 18\nMORGAN STANLEY 4.375% 01/22/2047 DD 01/20/17 CORPORATE DEBT INSTRUMENTS 4 1 , 9 11 4 5 , 9 8 2\nMORGAN STANLEY 6.375% 07/24/2042 DD 07/24/12 CORPORATE DEBT INSTRUMENTS 1 , 2 92,104 1 , 1 4 1,278\nMORGAN STANLEY VAR RT 01/23/2030 DD 01/23/19 CORPORATE DEBT INSTRUMENTS 1 , 5 27,528 1 , 2 5 5,880\nMORGAN STANLEY VAR RT 01/25/2052 DD 01/25/21 CORPORATE DEBT INSTRUMENTS 9 1 4 ,000 5 5 9 , 1 76\nMORGAN STANLEY VAR RT 04/19/2035 DD 04/19/24 CORPORATE DEBT INSTRUMENTS 1 4 6 ,247 1 4 8 , 0 26\nMORGAN STANLEY VAR RT 04/22/2039 DD 04/24/18 CORPORATE DEBT INSTRUMENTS 3 6 3 ,120 3 0 9 , 9 61\nMORGAN STANLEY VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 7 9 5 ,000 5 8 9 , 0 31\nMORGAN STANLEY VAR RT 04/22/2042 DD 04/22/21 CORPORATE DEBT INSTRUMENTS 1 , 3 03,000 9 6 5 , 4 19\nMORGAN STANLEY VAR RT 07/19/2035 DD 07/19/24 CORPORATE DEBT INSTRUMENTS 3 8 5 ,000 3 7 8 , 828\nMORGAN STANLEY VAR RT 07/21/2032 DD 07/20/21 CORPORATE DEBT INSTRUMENTS 3 0 1 ,063 3 2 7 , 392\nMORGAN STANLEY VAR RT 07/22/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 3 9 5 ,515 3 5 3 , 090\nMORGAN STANLEY VAR RT 07/22/2038 DD 07/24/17 CORPORATE DEBT INSTRUMENTS 4 1 5 ,000 3 5 3 , 090\nMORGAN STANLEY VAR RT 11/19/2055 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 8 0 0 ,000 7 7 2 , 672\nMPLX LP 4.500% 04/15/2038 DD 02/08/18 CORPORATE DEBT INSTRUMENTS 6 7 6 ,401 5 9 2 , 8 51\nMPLX LP 5.500% 02/15/2049 DD 11/15/18 CORPORATE DEBT INSTRUMENTS 1 , 0 96,967 1 , 0 2 8,809\nMULTICARE HEALTH SYSTEM 2.803% 08/15/2050 DD 07/22/20 CORPORATE DEBT INSTRUMENTS 6 1 0 ,000 3 5 8 , 7 41\nNASDAQ INC 5.950% 08/15/2053 DD 06/28/23 CORPORATE DEBT INSTRUMENTS 4 5 , 9 39 4 5 , 4 4 5\nNASDAQ INC 6.100% 06/28/2063 DD 06/28/23 CORPORATE DEBT INSTRUMENTS 2 3 1 ,211 2 3 9 , 496\nNATIONAL RURAL UTILITIES COOPE 3.250% 11/01/2025 DD 10/27/15 CORPORATE DEBT INSTRUMENTS 1 , 9 21,446 1 , 6 9 9,085\nNATIONAL RURAL UTILITIES COOPE 4.300% 03/15/2049 DD 01/31/19 CORPORATE DEBT INSTRUMENTS 6 3 7 ,811 5 1 7 , 9 90\nNATIONWIDE CHILDREN'S HOSPITAL 4.556% 11/01/2052 DD 05/12/22 CORPORATE DEBT INSTRUMENTS 3 7 5 ,000 3 2 8 , 076\nNATIONWIDE MUTUAL INSURAN 144A 4.350% 04/30/2050 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 7 4 5 ,259 5 5 9 , 398\nNESTLE CAPITAL CORP 144A 5.100% 03/12/2054 DD 03/12/24 CORPORATE DEBT INSTRUMENTS 6 6 6 ,868 6 3 6 , 633\nNESTLE HOLDINGS INC 144A 3.625% 09/24/2028 DD 09/24/18 CORPORATE DEBT INSTRUMENTS 1 , 7 47,665 1 , 4 4 3,975\nNESTLE HOLDINGS INC 144A 3.900% 09/24/2038 DD 09/24/18 CORPORATE DEBT INSTRUMENTS 6 3 3 ,158 5 5 1 , 5 33\nNETFLIX INC 5.400% 08/15/2054 DD 08/01/24 CORPORATE DEBT INSTRUMENTS 6 0 9 ,717 5 9 7 , 448\nNEVADA POWER CO 6.000% 03/15/2054 DD 09/13/23 CORPORATE DEBT INSTRUMENTS 4 0 8 ,176 4 5 5 , 1 10\nNEW ENGLAND POWER CO 144A 3.800% 12/05/2047 DD 12/05/17 CORPORATE DEBT INSTRUMENTS 9 3 8 ,631 7 0 1 , 2 75\nNEW YORK AND PRESBYTERIAN HOSP 4.763% 08/01/2116 DD 06/28/16 CORPORATE DEBT INSTRUMENTS 8 7 4 ,302 6 3 1 , 3 63\nNEW YORK LIFE INSURANCE C 144A 3.750% 05/15/2050 DD 04/14/20 CORPORATE DEBT INSTRUMENTS 2 2 3 ,625 1 6 3 , 8 32\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nNEW YORK LIFE INSURANCE C 144A 5.875% 05/15/2033 DD 05/08/03 CORPORATE DEBT INSTRUMENTS 9 2 5 ,669 7 9 1 , 2 29\nNEW YORK LIFE INSURANCE C 144A 6.750% 11/15/2039 DD 10/08/09 CORPORATE DEBT INSTRUMENTS 1 , 5 74,732 1 , 3 9 7,403\nNIAGARA MOHAWK POWER CORP 144A 4.119% 11/28/2042 DD 11/28/12 CORPORATE DEBT INSTRUMENTS 1 , 9 29,348 1 , 5 1 8,917\nNIKE INC 2.850% 03/27/2030 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 1 , 9 08,294 1 , 5 7 5,684\nNIKE INC 3.250% 03/27/2040 DD 03/27/20 CORPORATE DEBT INSTRUMENTS 1 , 0 75,090 9 4 5 , 602\nNISOURCE INC 3.950% 03/30/2048 DD 09/14/17 CORPORATE DEBT INSTRUMENTS 6 7 8 ,267 5 1 8 , 2 67\nNISOURCE INC 4.375% 05/15/2047 DD 05/22/17 CORPORATE DEBT INSTRUMENTS 4 7 4 ,611 3 8 8 , 764\nNNN REIT INC 3.500% 04/15/2051 DD 03/10/21 CORPORATE DEBT INSTRUMENTS 1 , 2 28,613 8 4 7 , 779\nNORFOLK SOUTHERN CORP 3.155% 05/15/2055 DD 05/15/20 CORPORATE DEBT INSTRUMENTS 7 1 4 ,059 6 9 0 , 297\nNORFOLK SOUTHERN CORP 3.942% 11/01/2047 DD 05/01/18 CORPORATE DEBT INSTRUMENTS 2 0 3 ,012 1 5 3 , 9 28\nNORFOLK SOUTHERN CORP 4.150% 02/28/2048 DD 02/28/18 CORPORATE DEBT INSTRUMENTS 8 0 3 ,296 6 4 2 , 888\nNORFOLK SOUTHERN CORP 4.837% 10/01/2041 DD 04/01/12 CORPORATE DEBT INSTRUMENTS 7 3 5 ,066 5 9 3 , 502\nNORFOLK SOUTHERN CORP 5.100% 08/01/2118 DD 08/02/18 CORPORATE DEBT INSTRUMENTS 1 , 3 03,466 1 , 1 1 1,302\nNORFOLK SOUTHERN CORP 5.950% 03/15/2064 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 4 8 3 ,647 4 9 8 , 604\nNORFOLK SOUTHERN CORP 5.950% 03/15/2064 DD 11/22/23 CORPORATE DEBT INSTRUMENTS 1 4 9 ,582 1 5 4 , 2 08\nNORTHERN NATURAL GAS CO 144A 4.300% 01/15/2049 DD 07/17/18 CORPORATE DEBT INSTRUMENTS 8 7 4 ,016 6 7 0 , 8 71\nNORTHERN STATES POWER CO/MN 2.900% 03/01/2050 DD 09/10/19 CORPORATE DEBT INSTRUMENTS 2 7 4 ,599 1 7 9 , 4 41\nNORTHERN STATES POWER CO/MN 3.400% 08/15/2042 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 1 , 0 15,464 8 1 7 , 7 49\nNORTHERN STATES POWER CO/MN 3.400% 08/15/2042 DD 08/13/12 CORPORATE DEBT INSTRUMENTS 3 3 2 ,353 3 0 0 , 1 96\nNORTHERN STATES POWER CO/MN 5.100% 05/15/2053 DD 05/08/23 CORPORATE DEBT INSTRUMENTS 4 2 6 ,792 3 9 8 , 429\nNORTHERN STATES POWER CO/MN 5.100% 05/15/2053 DD 05/08/23 CORPORATE DEBT INSTRUMENTS 3 3 2 ,501 3 1 0 , 4 04\nNORTHERN STATES POWER CO/MN 6.200% 07/01/2037 DD 06/26/07 CORPORATE DEBT INSTRUMENTS 2 , 5 30,246 2 , 3 8 1,237\nNORTHROP GRUMMAN CORP 3.850% 04/15/2045 DD 02/06/15 CORPORATE DEBT INSTRUMENTS 1 , 4 63,745 1 , 2 0 1,199\nNORTHROP GRUMMAN CORP 4.030% 10/15/2047 DD 10/13/17 CORPORATE DEBT INSTRUMENTS 7 1 6 ,520 5 5 3 , 876\nNORTHROP GRUMMAN CORP 4.030% 10/15/2047 DD 10/13/17 CORPORATE DEBT INSTRUMENTS 7 7 7 ,786 6 2 0 , 656\nNORTHROP GRUMMAN CORP 4.750% 06/01/2043 DD 05/31/13 CORPORATE DEBT INSTRUMENTS 1 , 2 93,757 1 , 1 6 1,576\nNORTHROP GRUMMAN CORP 4.750% 06/01/2043 DD 05/31/13 CORPORATE DEBT INSTRUMENTS 5 5 4 ,491 5 0 6 , 788\nNORTHROP GRUMMAN CORP 4.950% 03/15/2053 DD 02/08/23 CORPORATE DEBT INSTRUMENTS 6 2 1 ,005 5 8 1 , 9 55\nNORTHROP GRUMMAN CORP 5.150% 05/01/2040 DD 03/23/20 CORPORATE DEBT INSTRUMENTS 3 1 8 ,802 3 1 1 , 2 04\nNORTHROP GRUMMAN CORP 5.200% 06/01/2054 DD 01/31/24 CORPORATE DEBT INSTRUMENTS 4 6 3 ,205 4 3 2 , 529\nNORTHROP GRUMMAN CORP 5.200% 06/01/2054 DD 01/31/24 CORPORATE DEBT INSTRUMENTS 9 , 7 7 7 9 , 3 0 2\nNORTHWELL HEALTHCARE INC 4.260% 11/01/2047 DD 09/26/17 CORPORATE DEBT INSTRUMENTS 2 3 5 ,000 1 8 8 , 0 80\nNORTHWESTERN MUTUAL LIFE 144A 3.625% 09/30/2059 DD 09/20/19 CORPORATE DEBT INSTRUMENTS 1 , 8 90,526 1 , 2 5 8,823\nNOVANT HEALTH INC 3.168% 11/01/2051 DD 04/15/21 CORPORATE DEBT INSTRUMENTS 1 , 0 65,000 7 0 4 , 700\nNOVARTIS CAPITAL CORP 2.200% 08/14/2030 DD 02/14/20 CORPORATE DEBT INSTRUMENTS 1 , 5 33,781 1 , 2 6 9,765\nNOVARTIS CAPITAL CORP 4.400% 05/06/2044 DD 02/21/14 CORPORATE DEBT INSTRUMENTS 7 6 9 ,223 6 8 9 , 2 14\nNSTAR ELECTRIC CO 3.950% 04/01/2030 DD 03/26/20 CORPORATE DEBT INSTRUMENTS 8 5 2 ,040 6 6 9 , 256\nNSTAR ELECTRIC CO 4.400% 03/01/2044 DD 03/07/14 CORPORATE DEBT INSTRUMENTS 1 , 9 11,698 1 , 6 2 6,644\nNVIDIA CORP 2.000% 06/15/2031 DD 06/16/21 CORPORATE DEBT INSTRUMENTS 4 8 1 ,844 4 6 7 , 4 12\nNVIDIA CORP 3.500% 04/01/2040 DD 03/31/20 CORPORATE DEBT INSTRUMENTS 3 7 0 ,524 3 0 6 , 1 97\nNVIDIA CORP 3.500% 04/01/2050 DD 03/31/20 CORPORATE DEBT INSTRUMENTS 7 5 6 ,773 5 3 5 , 838\nNXP BV / NXP FUNDING LLC / NXP 3.250% 05/11/2041 DD 05/11/22 CORPORATE DEBT INSTRUMENTS 1 , 1 70,252 8 6 1 , 9 20\nOCCIDENTAL PETROLEUM CORP 4.400% 04/15/2046 DD 04/04/16 CORPORATE DEBT INSTRUMENTS 1 1 9 ,075 1 2 2 , 4 33\nOCCIDENTAL PETROLEUM CORP 6.050% 10/01/2054 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 6 1 3 ,625 5 8 3 , 506\nOCCIDENTAL PETROLEUM CORP 6.050% 10/01/2054 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 8 1 6 ,449 7 7 8 , 957\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nOCCIDENTAL PETROLEUM CORP 6.050% 10/01/2054 DD 07/26/24 CORPORATE DEBT INSTRUMENTS 2 0 3 ,542 1 8 9 , 7 58\nOCCIDENTAL PETROLEUM CORP 6.200% 03/15/2040 DD 09/15/19 CORPORATE DEBT INSTRUMENTS 2 3 9 ,477 2 4 1 , 4 87\nOCCIDENTAL PETROLEUM CORP 6.600% 03/15/2046 DD 09/15/19 CORPORATE DEBT INSTRUMENTS 3 0 , 7 02 3 0 , 3 0 8\nOCCIDENTAL PETROLEUM CORP 7.950% 06/15/2039 DD 06/15/19 CORPORATE DEBT INSTRUMENTS 3 2 , 0 94 3 4 , 2 1 8\nOGLETHORPE POWER CORP 3.750% 08/01/2050 DD 02/01/21 CORPORATE DEBT INSTRUMENTS 3 3 9 ,935 2 4 5 , 864\nOGLETHORPE POWER CORP 4.500% 04/01/2047 DD 04/01/23 CORPORATE DEBT INSTRUMENTS 3 9 3 ,246 3 2 3 , 975\nOGLETHORPE POWER CORP 5.050% 10/01/2048 DD 04/01/19 CORPORATE DEBT INSTRUMENTS 1 4 8 ,843 1 2 7 , 8 13\nOGLETHORPE POWER CORP 5.375% 11/01/2040 DD 11/09/10 CORPORATE DEBT INSTRUMENTS 1 , 0 26,663 9 0 3 , 974\nOGLETHORPE POWER CORP 6.200% 12/01/2053 DD 12/05/23 CORPORATE DEBT INSTRUMENTS 1 8 2 ,277 1 9 0 , 8 16\nOHIOHEALTH CORP 2.297% 11/15/2031 DD 10/26/21 CORPORATE DEBT INSTRUMENTS 6 2 5 ,000 5 2 3 , 9 31\nONCOR ELECTRIC DELIVERY CO LLC 2.700% 11/15/2051 DD 11/16/21 CORPORATE DEBT INSTRUMENTS 3 9 7 ,220 2 3 9 , 1 69\nONCOR ELECTRIC DELIVERY CO LLC 2.750% 05/15/2030 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 1 , 5 31,068 1 , 2 5 2,236\nONCOR ELECTRIC DELIVERY CO LLC 3.750% 04/01/2045 DD 10/01/15 CORPORATE DEBT INSTRUMENTS 4 2 1 ,664 3 2 6 , 880\nONCOR ELECTRIC DELIVERY CO LLC 3.800% 09/30/2047 DD 03/30/18 CORPORATE DEBT INSTRUMENTS 9 7 8 ,599 7 4 3 , 869\nONCOR ELECTRIC DELIVERY CO LLC 4.550% 12/01/2041 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 3 6 5 ,194 3 2 9 , 336\nONCOR ELECTRIC DELIVERY CO LLC 4.950% 09/15/2052 DD 09/08/22 CORPORATE DEBT INSTRUMENTS 6 8 7 ,449 6 6 8 , 348\nONCOR ELECTRIC DELIVERY CO LLC 5.300% 06/01/2042 DD 05/18/12 CORPORATE DEBT INSTRUMENTS 6 4 6 ,689 6 0 8 , 368\nONCOR ELECTRIC DELIVERY CO LLC 5.300% 06/01/2042 DD 05/18/12 CORPORATE DEBT INSTRUMENTS 4 0 3 ,676 3 5 6 , 398\nONCOR ELECTRIC DELIVERY CO LLC 5.350% 10/01/2052 DD 04/01/21 CORPORATE DEBT INSTRUMENTS 1 , 7 81,866 1 , 0 4 0,203\nONCOR ELECTRIC DELIVERY CO LLC 5.350% 10/01/2052 DD 04/01/21 CORPORATE DEBT INSTRUMENTS 5 5 7 ,646 3 2 5 , 538\nONEOK INC 4.250% 09/15/2046 DD 09/13/16 CORPORATE DEBT INSTRUMENTS 3 4 0 ,729 2 6 5 , 295\nONTARIO TEACHERS' CADILLA 144A 2.500% 10/15/2031 DD 10/15/21 CORPORATE DEBT INSTRUMENTS 3 7 1 ,033 3 1 1 , 6 89\nORACLE CORP 3.600% 04/01/2040 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 3 , 1 50,101 2 , 1 2 4,252\nORACLE CORP 3.600% 04/01/2050 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 1 , 9 85,983 1 , 3 3 2,318\nORACLE CORP 3.600% 04/01/2050 DD 04/01/20 CORPORATE DEBT INSTRUMENTS 6 8 9 ,165 6 2 7 , 592\nORACLE CORP 3.650% 03/25/2041 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 6 4 3 ,116 5 9 7 , 1 36\nORACLE CORP 3.800% 11/15/2037 DD 11/09/17 CORPORATE DEBT INSTRUMENTS 2 6 8 ,985 2 2 5 , 620\nORACLE CORP 3.850% 07/15/2036 DD 07/07/16 CORPORATE DEBT INSTRUMENTS 1 4 3 ,569 1 1 1 , 4 11\nORACLE CORP 3.900% 05/15/2035 DD 05/05/15 CORPORATE DEBT INSTRUMENTS 1 , 0 42,913 9 2 0 , 1 47\nORACLE CORP 3.950% 03/25/2051 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 1 , 2 87,578 9 5 9 , 996\nORACLE CORP 3.950% 03/25/2051 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 3 , 6 91,426 2 , 8 4 3,665\nORACLE CORP 3.950% 03/25/2051 DD 03/24/21 CORPORATE DEBT INSTRUMENTS 4 2 2 ,800 4 0 7 , 7 21\nORACLE CORP 4.000% 07/15/2046 DD 07/07/16 CORPORATE DEBT INSTRUMENTS 4 7 9 ,502 3 6 9 , 792\nORACLE CORP 4.000% 11/15/2047 DD 11/09/17 CORPORATE DEBT INSTRUMENTS 6 7 1 ,966 7 6 0 , 6 11\nORACLE CORP 4.000% 11/15/2047 DD 11/09/17 CORPORATE DEBT INSTRUMENTS 1 4 1 ,851 1 4 1 , 1 37\nORACLE CORP 4.125% 05/15/2045 DD 05/05/15 CORPORATE DEBT INSTRUMENTS 8 7 , 4 84 7 1 , 0 5 8\nORACLE CORP 4.375% 05/15/2055 DD 05/05/15 CORPORATE DEBT INSTRUMENTS 1 , 6 92,333 1 , 3 3 2,562\nORACLE CORP 5.375% 09/27/2054 DD 09/27/24 CORPORATE DEBT INSTRUMENTS 1 , 0 18,136 9 7 6 , 885\nORACLE CORP 5.500% 09/27/2064 DD 09/27/24 CORPORATE DEBT INSTRUMENTS 2 3 1 ,406 2 1 5 , 4 15\nORACLE CORP 6.900% 11/09/2052 DD 11/09/22 CORPORATE DEBT INSTRUMENTS 7 5 9 ,930 8 2 4 , 824\nOTIS WORLDWIDE CORP 3.112% 02/15/2040 DD 08/15/20 CORPORATE DEBT INSTRUMENTS 4 0 0 ,027 3 1 0 , 7 06\nOTIS WORLDWIDE CORP 3.362% 02/15/2050 DD 08/15/20 CORPORATE DEBT INSTRUMENTS 4 5 2 ,273 3 1 0 , 1 63\nOWENS CORNING 5.950% 06/15/2054 DD 05/31/24 CORPORATE DEBT INSTRUMENTS 1 , 1 75,492 1 , 1 5 7,891\nPACIFIC GAS AND ELECTRIC CO 3.300% 08/01/2040 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 3 9 5 ,457 3 1 8 , 4 02\nPACIFIC GAS AND ELECTRIC CO 3.500% 08/01/2050 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 2 3 6 ,576 2 9 1 , 7 07\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nPACIFIC GAS AND ELECTRIC CO 3.500% 08/01/2050 DD 06/19/20 CORPORATE DEBT INSTRUMENTS 5 6 0 ,440 4 0 4 , 958\nPACIFIC GAS AND ELECTRIC CO 4.200% 06/01/2041 DD 03/11/21 CORPORATE DEBT INSTRUMENTS 4 7 5 ,278 3 9 5 , 7 12\nPACIFIC GAS AND ELECTRIC CO 4.500% 07/01/2040 DD 07/02/20 CORPORATE DEBT INSTRUMENTS 5 1 0 ,255 5 4 2 , 649\nPACIFIC GAS AND ELECTRIC CO 4.950% 07/01/2050 DD 07/02/20 CORPORATE DEBT INSTRUMENTS 7 4 0 ,897 7 6 7 , 304\nPACIFIC GAS AND ELECTRIC CO 5.250% 03/01/2052 DD 02/18/22 CORPORATE DEBT INSTRUMENTS 1 , 1 27,526 1 , 0 2 2,854\nPACIFIC GAS AND ELECTRIC CO 5.250% 03/01/2052 DD 02/18/22 CORPORATE DEBT INSTRUMENTS 2 6 , 9 46 2 6 , 9 1 7\nPACIFIC GAS AND ELECTRIC CO 5.900% 10/01/2054 DD 09/05/24 CORPORATE DEBT INSTRUMENTS 3 1 3 ,485 3 1 1 , 4 41\nPACIFIC GAS AND ELECTRIC CO 5.900% 10/01/2054 DD 09/05/24 CORPORATE DEBT INSTRUMENTS 2 9 8 ,557 2 9 6 , 6 10\nPACIFIC GAS AND ELECTRIC CO 6.700% 04/01/2053 DD 03/30/23 CORPORATE DEBT INSTRUMENTS 2 7 4 ,013 2 9 8 , 034\nPACIFIC GAS AND ELECTRIC CO 6.750% 01/15/2053 DD 01/06/23 CORPORATE DEBT INSTRUMENTS 1 , 7 77,085 1 , 8 6 4,128\nPACIFIC LIFECORP 144A 3.350% 09/15/2050 DD 09/15/20 CORPORATE DEBT INSTRUMENTS 8 4 3 ,472 5 6 5 , 3 10\nPACIFICORP 5.500% 05/15/2054 DD 05/17/23 CORPORATE DEBT INSTRUMENTS 3 9 4 ,349 3 8 8 , 037\nPACIFICORP 5.750% 04/01/2037 DD 03/14/07 CORPORATE DEBT INSTRUMENTS 2 , 0 72,041 2 , 0 0 1,014\nPACIFICORP 5.800% 01/15/2055 DD 01/05/24 CORPORATE DEBT INSTRUMENTS 1 8 0 ,412 1 7 7 , 2 10\nPACIFICORP 6.000% 01/15/2039 DD 01/08/09 CORPORATE DEBT INSTRUMENTS 7 8 0 ,813 6 5 3 , 062\nPACIFICORP 6.350% 07/15/2038 DD 07/17/08 CORPORATE DEBT INSTRUMENTS 1 , 6 52,750 1 , 4 5 4,482\nPARKER-HANNIFIN CORP 4.000% 06/14/2049 DD 06/14/19 CORPORATE DEBT INSTRUMENTS 2 8 4 ,200 1 8 3 , 7 30\nPARKER-HANNIFIN CORP 4.450% 11/21/2044 DD 11/21/14 CORPORATE DEBT INSTRUMENTS 6 6 9 ,116 5 7 4 , 525\nPAYPAL HOLDINGS INC 3.250% 06/01/2050 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 6 8 7 ,364 4 6 7 , 834\nPECO ENERGY CO 3.000% 09/15/2049 DD 09/10/19 CORPORATE DEBT INSTRUMENTS 8 6 2 ,840 5 6 8 , 223\nPECO ENERGY CO 3.700% 09/15/2047 DD 09/18/17 CORPORATE DEBT INSTRUMENTS 2 9 8 ,869 2 2 5 , 009\nPECO ENERGY CO 4.375% 08/15/2052 DD 08/23/22 CORPORATE DEBT INSTRUMENTS 2 6 3 ,906 2 1 9 , 1 13\nPECO ENERGY CO 5.250% 09/15/2054 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 8 4 2 ,964 8 0 0 , 849\nPEPSICO INC 2.625% 10/21/2041 DD 10/21/21 CORPORATE DEBT INSTRUMENTS 6 1 , 6 23 4 3 , 7 6 5\nPEPSICO INC 2.750% 03/19/2030 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 1 , 9 28,978 1 , 5 9 9,066\nPEPSICO INC 2.875% 10/15/2049 DD 10/09/19 CORPORATE DEBT INSTRUMENTS 1 4 7 ,216 8 4 , 9 9 9\nPEPSICO INC 3.625% 03/19/2050 DD 03/19/20 CORPORATE DEBT INSTRUMENTS 7 3 6 ,108 5 5 1 , 7 74\nPEPSICO INC 5.250% 07/17/2054 DD 07/17/24 CORPORATE DEBT INSTRUMENTS 6 2 3 ,406 6 0 5 , 588\nPEPSICO INC 5.250% 07/17/2054 DD 07/17/24 CORPORATE DEBT INSTRUMENTS 6 7 0 ,313 6 4 9 , 1 90\nPFIZER INC 2.550% 05/28/2040 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 2 2 2 ,629 1 6 6 , 3 70\nPFIZER INC 3.900% 03/15/2039 DD 03/11/19 CORPORATE DEBT INSTRUMENTS 4 4 0 ,015 4 2 2 , 1 55\nPFIZER INC 4.100% 09/15/2038 DD 09/07/18 CORPORATE DEBT INSTRUMENTS 3 7 9 ,880 3 4 9 , 464\nPFIZER INC 4.400% 05/15/2044 DD 05/15/14 CORPORATE DEBT INSTRUMENTS 3 9 3 ,496 3 4 6 , 508\nPFIZER INC 7.200% 03/15/2039 DD 03/24/09 CORPORATE DEBT INSTRUMENTS 9 3 7 ,115 7 7 9 , 956\nPFIZER INVESTMENT ENTERPRISES 5.110% 05/19/2043 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 1 , 7 87,286 1 , 7 1 5,646\nPFIZER INVESTMENT ENTERPRISES 5.300% 05/19/2053 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 2 , 3 31,928 2 , 1 8 5,074\nPFIZER INVESTMENT ENTERPRISES 5.340% 05/19/2063 DD 05/19/23 CORPORATE DEBT INSTRUMENTS 3 0 7 ,500 2 8 6 , 865\nPG&E RECOVERY FUNDING LLC 5.529% 06/01/2051 DD 08/01/24 CORPORATE DEBT INSTRUMENTS 2 , 2 04,917 2 , 1 9 0,447\nPG&E WILDFIRE RECOVERY FUNDING 4.451% 12/01/2049 DD 05/10/22 CORPORATE DEBT INSTRUMENTS 8 6 9 ,118 8 8 4 , 475\nPHILIP MORRIS INTERNATIONAL IN 1.500% 05/01/2025 DD 05/01/20 CORPORATE DEBT INSTRUMENTS 1 , 9 24,209 1 , 8 6 9,720\nPHILIP MORRIS INTERNATIONAL IN 3.875% 08/21/2042 DD 08/21/12 CORPORATE DEBT INSTRUMENTS 6 6 3 ,149 6 6 1 , 0 53\nPHILIP MORRIS INTERNATIONAL IN 3.875% 08/21/2042 DD 08/21/12 CORPORATE DEBT INSTRUMENTS 1 3 4 ,159 1 2 2 , 7 10\nPHILIP MORRIS INTERNATIONAL IN 4.125% 03/04/2043 DD 03/04/13 CORPORATE DEBT INSTRUMENTS 8 0 , 6 68 7 3 , 1 9 7\nPHILIP MORRIS INTERNATIONAL IN 4.500% 03/20/2042 DD 03/20/12 CORPORATE DEBT INSTRUMENTS 9 9 5 ,047 8 9 3 , 607\nPHILIP MORRIS INTERNATIONAL IN 4.500% 03/20/2042 DD 03/20/12 CORPORATE DEBT INSTRUMENTS 1 4 8 ,566 1 3 4 , 4 75\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nPHILLIPS 66 3.300% 03/15/2052 DD 11/15/21 CORPORATE DEBT INSTRUMENTS 1 3 8 ,968 9 0 , 3 3 1\nPHILLIPS 66 4.650% 11/15/2034 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 5 0 7 ,863 4 8 4 , 905\nPHILLIPS 66 4.875% 11/15/2044 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 1 96,808 1 , 0 5 5,019\nPHILLIPS 66 4.875% 11/15/2044 DD 11/17/14 CORPORATE DEBT INSTRUMENTS 1 , 3 98,775 1 , 0 2 8,212\nPHILLIPS 66 CO 4.680% 02/15/2045 DD 02/15/23 CORPORATE DEBT INSTRUMENTS 1 , 6 40,741 1 , 4 3 4,735\nPNC BANK NA 3.250% 06/01/2025 DD 06/01/15 CORPORATE DEBT INSTRUMENTS 1 , 9 28,028 1 , 7 3 8,730\nPNC FINANCIAL SERVICES GROUP I VAR RT 07/23/2035 DD 07/23/24 CORPORATE DEBT INSTRUMENTS 4 8 4 ,989 4 8 1 , 7 70\nPOTOMAC ELECTRIC POWER CO 5.500% 03/15/2054 DD 03/04/24 CORPORATE DEBT INSTRUMENTS 6 5 3 ,124 6 3 4 , 707\nPPL ELECTRIC UTILITIES CORP 3.000% 10/01/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 8 0 6 ,232 5 3 9 , 2 16\nPPL ELECTRIC UTILITIES CORP 3.950% 06/01/2047 DD 05/11/17 CORPORATE DEBT INSTRUMENTS 4 7 0 ,203 3 7 3 , 265\nPPL ELECTRIC UTILITIES CORP 6.250% 05/15/2039 DD 05/22/09 CORPORATE DEBT INSTRUMENTS 1 , 1 05,348 8 6 7 , 885\nPRESIDENT AND FELLOWS OF HARVA 3.745% 11/15/2052 DD 04/19/22 CORPORATE DEBT INSTRUMENTS 4 5 0 ,000 3 4 5 , 497\nPRESIDENT AND FELLOWS OF HARVA 4.609% 02/15/2035 DD 03/12/24 CORPORATE DEBT INSTRUMENTS 7 0 0 ,000 6 7 9 , 700\nPROCTER & GAMBLE CO/THE 3.000% 03/25/2030 DD 03/25/20 CORPORATE DEBT INSTRUMENTS 1 , 9 13,554 1 , 5 4 6,608\nPROLOGIS LP 2.250% 04/15/2030 DD 02/18/20 CORPORATE DEBT INSTRUMENTS 1 , 5 76,718 1 , 3 0 3,303\nPROLOGIS LP 3.000% 04/15/2050 DD 02/18/20 CORPORATE DEBT INSTRUMENTS 9 2 6 ,042 6 0 3 , 273\nPROLOGIS LP 5.250% 03/15/2054 DD 01/25/24 CORPORATE DEBT INSTRUMENTS 1 2 8 ,523 1 2 1 , 4 46\nPROLOGIS LP 5.250% 03/15/2054 DD 01/25/24 CORPORATE DEBT INSTRUMENTS 6 1 9 ,893 5 9 7 , 888\nPROLOGIS LP 5.250% 06/15/2053 DD 03/30/23 CORPORATE DEBT INSTRUMENTS 2 5 7 ,972 2 4 7 , 688\nPROLOGIS TARGETED US LOGI 144A 5.500% 04/01/2034 DD 03/07/24 CORPORATE DEBT INSTRUMENTS 7 8 9 ,260 7 9 6 , 1 13\nPRUDENTIAL FINANCIAL INC 3.905% 12/07/2047 DD 12/07/17 CORPORATE DEBT INSTRUMENTS 2 5 2 ,999 1 6 7 , 8 47\nPRUDENTIAL FINANCIAL INC 3.935% 12/07/2049 DD 12/07/17 CORPORATE DEBT INSTRUMENTS 2 7 9 ,570 1 8 8 , 7 50\nPRUDENTIAL FINANCIAL INC 5.700% 12/14/2036 DD 12/14/06 CORPORATE DEBT INSTRUMENTS 2 , 4 77,024 2 , 4 8 2,017\nPUBLIC SERVICE CO OF COLORADO 1.900% 01/15/2031 DD 05/15/20 CORPORATE DEBT INSTRUMENTS 1 , 9 29,898 1 , 5 9 0,370\nPUBLIC SERVICE CO OF COLORADO 3.800% 06/15/2047 DD 06/19/17 CORPORATE DEBT INSTRUMENTS 7 9 6 ,736 5 9 4 , 488\nPUBLIC SERVICE CO OF COLORADO 3.950% 03/15/2043 DD 03/26/13 CORPORATE DEBT INSTRUMENTS 1 , 6 63,283 1 , 3 9 7,192\nPUBLIC SERVICE CO OF COLORADO 4.500% 06/01/2052 DD 05/17/22 CORPORATE DEBT INSTRUMENTS 2 2 7 ,491 1 9 0 , 4 26\nPUBLIC SERVICE CO OF COLORADO 6.250% 09/01/2037 DD 08/15/07 CORPORATE DEBT INSTRUMENTS 1 , 4 03,534 1 , 1 6 2,348\nPUBLIC SERVICE ELECTRIC AND GA 2.250% 09/15/2026 DD 09/13/16 CORPORATE DEBT INSTRUMENTS 1 , 9 22,706 1 , 7 3 1,708\nPUBLIC SERVICE ELECTRIC AND GA 3.200% 08/01/2049 DD 08/12/19 CORPORATE DEBT INSTRUMENTS 7 3 4 ,635 5 0 5 , 1 91\nPUBLIC SERVICE ELECTRIC AND GA 3.600% 12/01/2047 DD 12/06/17 CORPORATE DEBT INSTRUMENTS 5 2 4 ,617 3 8 7 , 660\nPUBLIC SERVICE ELECTRIC AND GA 5.300% 08/01/2054 DD 08/05/24 CORPORATE DEBT INSTRUMENTS 6 8 1 ,842 6 5 3 , 1 13\nPUBLIC STORAGE OPERATING CO 3.094% 09/15/2027 DD 09/18/17 CORPORATE DEBT INSTRUMENTS 1 , 9 18,994 1 , 6 5 8,553\nPUBLIC STORAGE OPERATING CO 5.350% 08/01/2053 DD 07/26/23 CORPORATE DEBT INSTRUMENTS 1 7 1 ,936 1 6 6 , 6 35\nPUGET SOUND ENERGY INC 2.893% 09/15/2051 DD 09/15/21 CORPORATE DEBT INSTRUMENTS 7 3 0 ,000 4 4 6 , 424\nPUGET SOUND ENERGY INC 5.685% 06/15/2054 DD 06/11/24 CORPORATE DEBT INSTRUMENTS 1 6 9 ,998 1 6 6 , 8 50\nRAYMOND JAMES FINANCIAL INC 4.950% 07/15/2046 DD 07/12/16 CORPORATE DEBT INSTRUMENTS 1 , 2 59,305 8 6 5 , 256\nREALTY INCOME CORP 0.750% 03/15/2026 DD 12/14/20 CORPORATE DEBT INSTRUMENTS 7 8 3 ,617 7 5 3 , 399\nREALTY INCOME CORP 5.125% 02/15/2034 DD 01/16/24 CORPORATE DEBT INSTRUMENTS 2 0 5 ,618 1 9 6 , 0 12\nREALTY INCOME CORP 5.375% 09/01/2054 DD 08/26/24 CORPORATE DEBT INSTRUMENTS 3 2 9 ,553 3 1 8 , 5 11\nREALTY INCOME CORP 5.375% 09/01/2054 DD 08/26/24 CORPORATE DEBT INSTRUMENTS 3 1 4 ,797 3 0 4 , 250\nREGENCY CENTERS LP 4.400% 02/01/2047 DD 01/26/17 CORPORATE DEBT INSTRUMENTS 1 2 5 ,952 1 0 7 , 1 21\nREGENCY CENTERS LP 4.650% 03/15/2049 DD 03/06/19 CORPORATE DEBT INSTRUMENTS 5 4 2 ,657 4 4 4 , 560\nREYNOLDS AMERICAN INC 5.850% 08/15/2045 DD 06/12/15 CORPORATE DEBT INSTRUMENTS 1 , 1 13,799 8 9 1 , 6 25\nREYNOLDS AMERICAN INC 6.150% 09/15/2043 DD 09/17/13 CORPORATE DEBT INSTRUMENTS 3 6 5 ,241 2 9 6 , 982\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nRIO TINTO FINANCE USA LTD 2.750% 11/02/2051 DD 11/02/21 CORPORATE DEBT INSTRUMENTS 9 2 1 ,850 6 2 3 , 200\nRIO TINTO FINANCE USA LTD 5.200% 11/02/2040 DD 11/02/10 CORPORATE DEBT INSTRUMENTS 1 , 1 24,188 9 1 2 , 9 94\nRIO TINTO FINANCE USA PLC 5.125% 03/09/2053 DD 03/09/23 CORPORATE DEBT INSTRUMENTS 5 7 , 6 64 5 5 , 6 0 4\nROCHE HOLDINGS INC 144A 1.930% 12/13/2028 DD 12/13/21 CORPORATE DEBT INSTRUMENTS 7 8 0 ,000 7 0 2 , 086\nROCHE HOLDINGS INC 144A 2.607% 12/13/2051 DD 12/13/21 CORPORATE DEBT INSTRUMENTS 3 6 9 ,273 2 2 0 , 527\nROCHE HOLDINGS INC 144A 4.592% 09/09/2034 DD 09/09/24 CORPORATE DEBT INSTRUMENTS 5 0 0 ,000 4 7 9 , 425\nROGERS COMMUNICATIONS INC 4.550% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 6 8 6 ,484 5 5 6 , 005\nROGERS COMMUNICATIONS INC 5.000% 03/15/2044 DD 03/10/14 CORPORATE DEBT INSTRUMENTS 2 , 2 17,813 1 , 9 8 1,260\nROYAL BANK OF CANADA 2.300% 11/03/2031 DD 10/29/21 CORPORATE DEBT INSTRUMENTS 5 4 4 ,368 4 5 7 , 7 13\nRTX CORP 3.030% 03/15/2052 DD 11/16/21 CORPORATE DEBT INSTRUMENTS 9 1 , 3 69 6 0 , 1 9 6\nRTX CORP 3.125% 07/01/2050 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 7 6 , 2 98 6 8 , 8 9 1\nRTX CORP 4.350% 04/15/2047 DD 10/15/20 CORPORATE DEBT INSTRUMENTS 2 , 6 49,861 1 , 6 8 9,662\nRTX CORP 4.450% 11/16/2038 DD 08/16/18 CORPORATE DEBT INSTRUMENTS 2 6 4 ,545 2 3 5 , 879\nRTX CORP 4.500% 06/01/2042 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 2 , 4 73,959 2 , 0 1 8,782\nRTX CORP 4.500% 06/01/2042 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 1 , 0 11,044 8 0 2 , 3 14\nRTX CORP 4.500% 06/01/2042 DD 06/01/12 CORPORATE DEBT INSTRUMENTS 2 , 1 32,662 1 , 7 3 2,860\nRTX CORP 5.375% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 4 7 9 ,597 5 0 4 , 0 51\nRTX CORP 5.375% 02/27/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 7 9 , 4 34 8 0 , 8 3 8\nRTX CORP 6.400% 03/15/2054 DD 11/08/23 CORPORATE DEBT INSTRUMENTS 3 9 1 ,526 4 2 8 , 1 26\nRTX CORP 6.400% 03/15/2054 DD 11/08/23 CORPORATE DEBT INSTRUMENTS 2 0 0 ,588 2 1 6 , 7 87\nS&P GLOBAL INC 3.700% 03/01/2052 DD 03/01/23 CORPORATE DEBT INSTRUMENTS 8 6 0 ,983 6 5 4 , 1 85\nS&P GLOBAL INC 5.250% 09/15/2033 DD 03/15/24 CORPORATE DEBT INSTRUMENTS 8 2 5 ,809 8 0 8 , 432\nSABAL TRAIL TRANSMISSION 144A 4.682% 05/01/2038 DD 04/30/18 CORPORATE DEBT INSTRUMENTS 4 0 5 ,391 3 5 7 , 1 49\nSABAL TRAIL TRANSMISSION 144A 4.832% 05/01/2048 DD 04/30/18 CORPORATE DEBT INSTRUMENTS 1 3 8 ,330 1 1 3 , 4 00\nSALESFORCE INC 2.700% 07/15/2041 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 8 1 4 ,821 6 0 7 , 4 01\nSALESFORCE INC 2.900% 07/15/2051 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 1 5 4 ,113 1 5 0 , 4 61\nSALESFORCE INC 2.900% 07/15/2051 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 4 2 7 ,598 2 7 8 , 5 13\nSALESFORCE INC 3.050% 07/15/2061 DD 07/12/21 CORPORATE DEBT INSTRUMENTS 2 9 9 ,034 1 8 5 , 4 18\nSAN DIEGO GAS & ELECTRIC CO 3.000% 03/15/2032 DD 03/11/22 CORPORATE DEBT INSTRUMENTS 5 2 0 ,296 5 2 2 , 702\nSAN DIEGO GAS & ELECTRIC CO 3.320% 04/15/2050 DD 04/07/20 CORPORATE DEBT INSTRUMENTS 1 0 4 ,860 7 1 , 0 1 7\nSCENTRE GROUP TRUST 1 / S 144A 3.625% 01/28/2026 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 1 , 0 81,680 9 8 5 , 340\nSCENTRE GROUP TRUST 1 / S 144A 4.375% 05/28/2030 DD 05/28/20 CORPORATE DEBT INSTRUMENTS 5 8 7 ,208 4 9 5 , 554\nSEMPRA 3.800% 02/01/2038 DD 01/12/18 CORPORATE DEBT INSTRUMENTS 7 7 6 ,506 6 4 9 , 093\nSEMPRA 3.800% 02/01/2038 DD 01/12/18 CORPORATE DEBT INSTRUMENTS 5 1 4 ,374 4 2 9 , 972\nSEMPRA 4.000% 02/01/2048 DD 01/12/18 CORPORATE DEBT INSTRUMENTS 2 2 , 6 90 1 7 , 4 1 5\nSEMPRA 6.000% 10/15/2039 DD 10/08/09 CORPORATE DEBT INSTRUMENTS 2 , 1 09,388 1 , 8 7 1,241\nSHELL FINANCE US INC 2.375% 11/07/2029 DD 05/07/24 CORPORATE DEBT INSTRUMENTS 1 , 3 43,536 1 , 3 0 9,386\nSHELL FINANCE US INC 3.250% 04/06/2050 DD 10/06/24 CORPORATE DEBT INSTRUMENTS 8 1 , 6 22 7 4 , 1 1 0\nSHELL FINANCE US INC 3.750% 09/12/2046 DD 09/12/24 CORPORATE DEBT INSTRUMENTS 3 0 1 ,216 2 7 4 , 520\nSHELL FINANCE US INC 4.000% 05/10/2046 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 5 0 2 ,713 4 7 4 , 332\nSHELL FINANCE US INC 4.000% 05/10/2046 DD 05/10/24 CORPORATE DEBT INSTRUMENTS 5 5 7 ,312 5 0 5 , 693\nSHELL FINANCE US INC 4.375% 05/11/2045 DD 05/11/24 CORPORATE DEBT INSTRUMENTS 2 , 8 52,186 2 , 5 9 5,010\nSHELL INTERNATIONAL FINANCE BV 3.000% 11/26/2051 DD 11/26/21 CORPORATE DEBT INSTRUMENTS 6 9 3 ,360 4 4 0 , 6 51\nSHELL INTERNATIONAL FINANCE BV 5.500% 03/25/2040 DD 03/25/10 CORPORATE DEBT INSTRUMENTS 2 , 0 54,059 2 , 0 0 0,012\nSHERWIN-WILLIAMS CO/THE 2.900% 03/15/2052 DD 11/10/21 CORPORATE DEBT INSTRUMENTS 1 7 5 ,476 1 7 6 , 6 80\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nSHERWIN-WILLIAMS CO/THE 3.300% 05/15/2050 DD 03/17/20 CORPORATE DEBT INSTRUMENTS 8 0 6 ,570 5 3 6 , 698\nSIEMENS FINANCIERINGSMAAT 144A 2.150% 03/11/2031 DD 03/11/21 CORPORATE DEBT INSTRUMENTS 4 8 0 ,755 4 6 8 , 6 17\nSIEMENS FINANCIERINGSMAAT 144A 2.875% 03/11/2041 DD 03/11/21 CORPORATE DEBT INSTRUMENTS 9 4 7 ,343 7 1 1 , 8 00\nSIEMENS FINANCIERINGSMAAT 144A 4.400% 05/27/2045 DD 05/27/15 CORPORATE DEBT INSTRUMENTS 5 9 2 ,570 5 1 9 , 2 23\nSIMON PROPERTY GROUP LP 3.250% 09/13/2049 DD 09/13/19 CORPORATE DEBT INSTRUMENTS 6 5 2 ,387 4 4 0 , 6 91\nSIMON PROPERTY GROUP LP 3.250% 09/13/2049 DD 09/13/19 CORPORATE DEBT INSTRUMENTS 2 0 1 ,015 2 1 1 , 9 35\nSIMON PROPERTY GROUP LP 3.800% 07/15/2050 DD 07/09/20 CORPORATE DEBT INSTRUMENTS 6 4 , 3 37 7 3 , 7 2 1\nSIMON PROPERTY GROUP LP 4.250% 11/30/2046 DD 11/23/16 CORPORATE DEBT INSTRUMENTS 1 , 3 59,562 1 , 0 6 4,043\nSIMON PROPERTY GROUP LP 4.250% 11/30/2046 DD 11/23/16 CORPORATE DEBT INSTRUMENTS 8 1 , 4 75 6 1 , 2 4 6\nSIMON PROPERTY GROUP LP 5.850% 03/08/2053 DD 03/08/23 CORPORATE DEBT INSTRUMENTS 1 , 1 42,692 1 , 1 6 3,446\nSIMON PROPERTY GROUP LP 5.850% 03/08/2053 DD 03/08/23 CORPORATE DEBT INSTRUMENTS 4 1 8 ,421 4 3 3 , 896\nSIMON PROPERTY GROUP LP 6.250% 01/15/2034 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 1 , 1 12,600 1 , 0 6 0,710\nSIMON PROPERTY GROUP LP 6.650% 01/15/2054 DD 11/09/23 CORPORATE DEBT INSTRUMENTS 2 6 8 ,012 2 9 5 , 372\nSNAP-ON INC 3.100% 05/01/2050 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 1 , 2 26,159 8 1 8 , 6 20\nSOLVENTUM CORP 144A 5.900% 04/30/2054 DD 02/27/24 CORPORATE DEBT INSTRUMENTS 1 , 3 63,844 1 , 2 8 5,944\nSOLVENTUM CORP 144A 6.000% 05/15/2064 DD 02/27/24 CORPORATE DEBT INSTRUMENTS 6 1 9 ,357 6 0 5 , 752\nSOUTHERN CALIFORNIA EDISON CO 3.900% 03/15/2043 DD 03/07/13 CORPORATE DEBT INSTRUMENTS 4 5 3 ,909 3 3 5 , 368\nSOUTHERN CALIFORNIA EDISON CO 4.000% 04/01/2047 DD 03/24/17 CORPORATE DEBT INSTRUMENTS 1 5 0 ,783 1 1 1 , 7 17\nSOUTHERN CALIFORNIA EDISON CO 4.125% 03/01/2048 DD 03/05/18 CORPORATE DEBT INSTRUMENTS 7 3 3 ,663 5 9 2 , 329\nSOUTHERN CALIFORNIA EDISON CO 4.500% 09/01/2040 DD 08/30/10 CORPORATE DEBT INSTRUMENTS 8 4 2 ,793 7 0 4 , 359\nSOUTHERN CALIFORNIA EDISON CO 4.650% 10/01/2043 DD 10/02/13 CORPORATE DEBT INSTRUMENTS 7 5 9 ,737 6 6 3 , 706\nSOUTHERN CALIFORNIA GAS CO 3.750% 09/15/2042 DD 09/21/12 CORPORATE DEBT INSTRUMENTS 4 2 2 ,718 3 6 8 , 574\nSOUTHERN CALIFORNIA GAS CO 5.600% 04/01/2054 DD 03/18/24 CORPORATE DEBT INSTRUMENTS 4 2 0 ,750 4 1 6 , 6 57\nSOUTHERN CALIFORNIA GAS CO 5.750% 06/01/2053 DD 05/23/23 CORPORATE DEBT INSTRUMENTS 4 5 2 ,128 4 5 0 , 7 71\nSOUTHERN NATURAL GAS CO L 144A 4.800% 03/15/2047 DD 03/14/17 CORPORATE DEBT INSTRUMENTS 4 1 6 ,885 3 4 8 , 6 71\nSOUTHWESTERN ELECTRIC POWER CO 6.200% 03/15/2040 DD 03/08/10 CORPORATE DEBT INSTRUMENTS 1 , 7 93,885 1 , 5 5 0,225\nSOUTHWESTERN PUBLIC SERVICE CO 4.400% 11/15/2048 DD 11/05/18 CORPORATE DEBT INSTRUMENTS 3 9 7 ,420 3 2 4 , 576\nSOUTHWESTERN PUBLIC SERVICE CO 6.000% 06/01/2054 DD 06/06/24 CORPORATE DEBT INSTRUMENTS 3 9 7 ,032 4 0 4 , 808\nSTARBUCKS CORP 3.350% 03/12/2050 DD 03/12/20 CORPORATE DEBT INSTRUMENTS 1 9 4 ,244 1 3 7 , 1 25\nSTARBUCKS CORP 3.500% 11/15/2050 DD 05/07/20 CORPORATE DEBT INSTRUMENTS 8 1 4 ,506 5 6 7 , 760\nSTARBUCKS CORP 4.450% 08/15/2049 DD 05/13/19 CORPORATE DEBT INSTRUMENTS 3 5 9 ,366 2 9 5 , 096\nSTRYKER CORP 4.100% 04/01/2043 DD 03/25/13 CORPORATE DEBT INSTRUMENTS 8 8 2 ,299 7 3 4 , 3 21\nSUN COMMUNITIES OPERATING LP 4.200% 04/15/2032 DD 04/12/22 CORPORATE DEBT INSTRUMENTS 5 9 5 ,013 5 5 2 , 1 11\nSUNCOR ENERGY INC 6.800% 05/15/2038 DD 05/15/08 CORPORATE DEBT INSTRUMENTS 5 5 5 ,346 4 9 1 , 9 79\nSUNCOR ENERGY INC 6.800% 05/15/2038 DD 05/15/08 CORPORATE DEBT INSTRUMENTS 2 3 , 7 31 1 8 , 1 0 3\nSUTTER HEALTH 3.361% 08/15/2050 DD 10/29/20 CORPORATE DEBT INSTRUMENTS 2 8 0 ,000 1 9 7 , 1 20\nSUTTER HEALTH 5.547% 08/15/2053 DD 06/08/23 CORPORATE DEBT INSTRUMENTS 5 2 0 ,000 5 1 9 , 6 83\nTAKEDA PHARMACEUTICAL CO LTD 3.025% 07/09/2040 DD 07/09/20 CORPORATE DEBT INSTRUMENTS 1 , 0 10,000 7 3 5 , 3 91\nTARGET CORP 1.950% 01/15/2027 DD 01/24/22 CORPORATE DEBT INSTRUMENTS 6 8 3 ,836 6 5 1 , 6 20\nTARGET CORP 2.950% 01/15/2052 DD 01/24/22 CORPORATE DEBT INSTRUMENTS 2 1 9 ,581 1 5 3 , 1 70\nTARGET CORP 4.500% 09/15/2034 DD 09/06/24 CORPORATE DEBT INSTRUMENTS 4 9 7 ,125 4 7 5 , 7 10\nTEXAS EASTERN TRANSMISSIO 144A 4.150% 01/15/2048 DD 01/09/18 CORPORATE DEBT INSTRUMENTS 3 9 6 ,468 3 0 8 , 320\nTEXAS INSTRUMENTS INC 3.875% 03/15/2039 DD 03/11/19 CORPORATE DEBT INSTRUMENTS 5 3 0 ,420 4 9 4 , 1 61\nTEXAS INSTRUMENTS INC 5.000% 03/14/2053 DD 03/14/23 CORPORATE DEBT INSTRUMENTS 9 7 2 ,275 8 8 9 , 956\nTEXAS INSTRUMENTS INC 5.050% 05/18/2063 DD 05/18/23 CORPORATE DEBT INSTRUMENTS 5 5 0 ,377 5 0 0 , 993\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nTEXAS INSTRUMENTS INC 5.050% 05/18/2063 DD 05/18/23 CORPORATE DEBT INSTRUMENTS 6 8 7 ,653 6 4 4 , 5 21\nTHERMO FISHER SCIENTIFIC INC 2.800% 10/15/2041 DD 08/23/21 CORPORATE DEBT INSTRUMENTS 4 1 3 ,189 2 9 2 , 206\nTHERMO FISHER SCIENTIFIC INC 4.100% 08/15/2047 DD 08/14/17 CORPORATE DEBT INSTRUMENTS 4 7 9 ,301 3 9 4 , 1 06\nTIME WARNER CABLE LLC 4.500% 09/15/2042 DD 08/10/12 CORPORATE DEBT INSTRUMENTS 4 0 4 ,715 3 3 6 , 9 51\nTIME WARNER CABLE LLC 5.875% 11/15/2040 DD 11/15/10 CORPORATE DEBT INSTRUMENTS 7 8 9 ,743 7 5 6 , 250\nTIME WARNER CABLE LLC 5.875% 11/15/2040 DD 11/15/10 CORPORATE DEBT INSTRUMENTS 5 1 8 ,103 4 3 4 , 060\nTIME WARNER CABLE LLC 6.550% 05/01/2037 DD 04/09/07 CORPORATE DEBT INSTRUMENTS 1 , 5 15,025 1 , 0 9 2,168\nTIME WARNER CABLE LLC 6.550% 05/01/2037 DD 04/09/07 CORPORATE DEBT INSTRUMENTS 1 6 4 ,105 1 3 0 , 4 80\nTIME WARNER CABLE LLC 6.750% 06/15/2039 DD 06/29/09 CORPORATE DEBT INSTRUMENTS 4 4 6 ,374 3 6 7 , 785\nTIME WARNER CABLE LLC 7.300% 07/01/2038 DD 06/19/08 CORPORATE DEBT INSTRUMENTS 5 4 0 ,016 4 3 8 , 007\nT-MOBILE USA INC 3.000% 02/15/2041 DD 02/15/21 CORPORATE DEBT INSTRUMENTS 5 7 3 ,219 4 4 2 , 7 61\nT-MOBILE USA INC 3.300% 02/15/2051 DD 02/15/21 CORPORATE DEBT INSTRUMENTS 1 , 9 87,653 1 , 3 5 1,029\nT-MOBILE USA INC 3.400% 10/15/2052 DD 04/15/22 CORPORATE DEBT INSTRUMENTS 1 , 3 76,525 9 5 2 , 670\nT-MOBILE USA INC 3.600% 11/15/2060 DD 05/15/21 CORPORATE DEBT INSTRUMENTS 1 , 0 43,204 7 6 8 , 245\nT-MOBILE USA INC 5.500% 01/15/2055 DD 01/12/24 CORPORATE DEBT INSTRUMENTS 1 3 9 ,854 1 3 1 , 8 93\nT-MOBILE USA INC 5.650% 01/15/2053 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 9 2 5 ,545 9 1 6 , 6 88\nT-MOBILE USA INC 5.650% 01/15/2053 DD 09/15/22 CORPORATE DEBT INSTRUMENTS 5 5 7 ,720 5 4 2 , 252\nT-MOBILE USA INC 5.750% 01/15/2054 DD 05/11/23 CORPORATE DEBT INSTRUMENTS 7 0 9 ,116 6 9 7 , 1 62\nT-MOBILE USA INC 6.000% 06/15/2054 DD 09/14/23 CORPORATE DEBT INSTRUMENTS 3 0 8 ,986 3 1 9 , 9 27\nTOTALENERGIES CAPITAL INTERNAT 2.434% 01/10/2025 DD 07/10/19 CORPORATE DEBT INSTRUMENTS 1 , 5 25,622 1 , 4 3 9,194\nTOTALENERGIES CAPITAL INTERNAT 2.986% 06/29/2041 DD 06/29/20 CORPORATE DEBT INSTRUMENTS 4 3 9 ,123 3 1 6 , 2 10\nTOTALENERGIES CAPITAL INTERNAT 3.127% 05/29/2050 DD 05/29/20 CORPORATE DEBT INSTRUMENTS 9 0 5 ,000 5 9 3 , 780\nTOTALENERGIES CAPITAL INTERNAT 3.127% 05/29/2050 DD 05/29/20 CORPORATE DEBT INSTRUMENTS 1 , 1 74,051 7 6 4 , 368\nTOTALENERGIES CAPITAL SA 5.275% 09/10/2054 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 1 9 9 ,544 1 8 5 , 2 04\nTOTALENERGIES CAPITAL SA 5.425% 09/10/2064 DD 09/10/24 CORPORATE DEBT INSTRUMENTS 4 8 8 ,099 4 5 0 , 3 13\nTOTALENERGIES CAPITAL SA 5.488% 04/05/2054 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 3 5 0 ,551 3 3 6 , 028\nTOTALENERGIES CAPITAL SA 5.638% 04/05/2064 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 9 5 0 ,000 9 1 0 , 1 86\nTOTALENERGIES CAPITAL SA 5.638% 04/05/2064 DD 04/05/24 CORPORATE DEBT INSTRUMENTS 9 0 8 ,507 8 7 1 , 8 62\nTOYOTA MOTOR CREDIT CORP 4.450% 06/29/2029 DD 06/30/22 CORPORATE DEBT INSTRUMENTS 6 2 4 ,925 6 1 5 , 0 63\nTOYOTA MOTOR CREDIT CORP 4.800% 01/05/2034 DD 01/05/24 CORPORATE DEBT INSTRUMENTS 3 0 7 ,920 2 9 1 , 5 82\nTRANSCANADA PIPELINES LTD 6.100% 06/01/2040 DD 06/01/10 CORPORATE DEBT INSTRUMENTS 1 , 5 50,514 1 , 5 1 7,215\nTRANSCANADA PIPELINES LTD 6.200% 10/15/2037 DD 10/05/07 CORPORATE DEBT INSTRUMENTS 1 , 1 01,020 9 1 2 , 3 64\nTRANSCONTINENTAL GAS PIPE LINE 4.600% 03/15/2048 DD 09/15/18 CORPORATE DEBT INSTRUMENTS 1 , 0 01,695 8 3 9 , 488\nTRANSCONTINENTAL GAS PIPE LINE 5.400% 08/15/2041 DD 02/15/12 CORPORATE DEBT INSTRUMENTS 7 7 9 ,645 6 9 6 , 606\nTRAVELERS COS INC/THE 5.450% 05/25/2053 DD 05/25/23 CORPORATE DEBT INSTRUMENTS 5 9 4 ,122 5 6 5 , 1 75\nTRUIST FINANCIAL CORP VAR RT 01/24/2035 DD 01/24/24 CORPORATE DEBT INSTRUMENTS 1 , 1 13,253 1 , 1 1 3,685\nTRUIST FINANCIAL CORP VAR RT 01/26/2034 DD 01/26/23 CORPORATE DEBT INSTRUMENTS 3 2 4 ,396 3 2 5 , 587\nTRUIST FINANCIAL CORP VAR RT 01/26/2034 DD 01/26/23 CORPORATE DEBT INSTRUMENTS 2 6 7 ,429 2 6 2 , 4 13\nTRUIST FINANCIAL CORP VAR RT 06/08/2034 DD 06/08/23 CORPORATE DEBT INSTRUMENTS 4 8 5 ,000 4 9 3 , 900\nTRUIST FINANCIAL CORP VAR RT 06/08/2034 DD 06/08/23 CORPORATE DEBT INSTRUMENTS 5 1 3 ,519 5 2 4 , 450\nTRUSTEES OF COLUMBIA UNIVERSIT 4.355% 10/01/2035 DD 10/09/24 CORPORATE DEBT INSTRUMENTS 7 7 5 ,000 7 3 1 , 7 24\nTTX CO 144A 4.600% 02/01/2049 DD 01/18/19 CORPORATE DEBT INSTRUMENTS 8 9 7 ,964 7 6 4 , 862\nUBER TECHNOLOGIES INC 5.350% 09/15/2054 DD 09/09/24 CORPORATE DEBT INSTRUMENTS 9 7 9 ,745 9 1 2 , 2 42\nUBS GROUP AG 144A 4.253% 03/23/2028 DD 03/23/17 CORPORATE DEBT INSTRUMENTS 1 , 1 35,490 9 7 1 , 8 40\nUBS GROUP AG 144A VAR RT 02/08/2035 DD 01/08/24 CORPORATE DEBT INSTRUMENTS 5 7 9 ,954 5 8 3 , 944\nUBS GROUP AG 144A VAR RT 08/05/2033 DD 08/05/22 CORPORATE DEBT INSTRUMENTS 1 5 5 ,000 1 5 0 , 3 33\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nUDR INC 3.100% 11/01/2034 DD 10/11/19 CORPORATE DEBT INSTRUMENTS 6 1 0 ,284 4 9 9 , 368\nUNILEVER CAPITAL CORP 2.125% 09/06/2029 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 1 , 9 18,116 1 , 6 1 9,836\nUNION ELECTRIC CO 4.000% 04/01/2048 DD 04/06/18 CORPORATE DEBT INSTRUMENTS 2 7 3 ,809 2 1 3 , 8 40\nUNION ELECTRIC CO 5.125% 03/15/2055 DD 10/07/24 CORPORATE DEBT INSTRUMENTS 1 0 4 ,875 9 6 , 3 5 3\nUNION ELECTRIC CO 5.125% 03/15/2055 DD 10/07/24 CORPORATE DEBT INSTRUMENTS 1 5 4 ,816 1 4 2 , 2 36\nUNION PACIFIC CORP 2.375% 05/20/2031 DD 05/20/21 CORPORATE DEBT INSTRUMENTS 6 7 0 ,995 5 6 1 , 2 49\nUNION PACIFIC CORP 2.950% 03/10/2052 DD 09/10/21 CORPORATE DEBT INSTRUMENTS 3 3 6 ,118 2 0 5 , 585\nUNION PACIFIC CORP 2.973% 09/16/2062 DD 03/16/21 CORPORATE DEBT INSTRUMENTS 5 5 2 ,622 3 1 9 , 9 52\nUNION PACIFIC CORP 3.250% 02/05/2050 DD 01/31/20 CORPORATE DEBT INSTRUMENTS 6 5 4 ,439 4 2 3 , 235\nUNION PACIFIC CORP 3.375% 02/14/2042 DD 02/14/22 CORPORATE DEBT INSTRUMENTS 1 2 4 ,838 9 5 , 1 6 0\nUNION PACIFIC CORP 3.500% 02/14/2053 DD 02/14/22 CORPORATE DEBT INSTRUMENTS 3 7 1 ,608 2 8 9 , 358\nUNION PACIFIC CORP 3.550% 08/15/2039 DD 08/05/19 CORPORATE DEBT INSTRUMENTS 1 4 6 ,199 1 1 7 , 7 27\nUNION PACIFIC CORP 3.799% 10/01/2051 DD 10/04/16 CORPORATE DEBT INSTRUMENTS 4 3 6 ,558 3 3 2 , 468\nUNION PACIFIC CORP 3.839% 03/20/2060 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 1 , 1 82,375 7 8 6 , 5 11\nUNION PACIFIC CORP 3.839% 03/20/2060 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 9 9 3 ,966 7 5 7 , 1 96\nUNION PACIFIC CORP 3.839% 03/20/2060 DD 03/20/20 CORPORATE DEBT INSTRUMENTS 2 4 0 ,384 1 7 1 , 6 02\nUNION PACIFIC CORP 3.950% 08/15/2059 DD 08/05/19 CORPORATE DEBT INSTRUMENTS 5 9 5 ,218 4 3 6 , 950\nUNION PACIFIC CORP 4.000% 04/15/2047 DD 04/05/17 CORPORATE DEBT INSTRUMENTS 3 , 1 37,229 2 , 5 1 6,398\nUNION PACIFIC CORP 4.950% 05/15/2053 DD 02/21/23 CORPORATE DEBT INSTRUMENTS 5 7 , 0 70 5 4 , 8 9 9\nUNITED PARCEL SERVICE INC 5.050% 03/03/2053 DD 02/27/23 CORPORATE DEBT INSTRUMENTS 8 0 4 ,509 7 4 3 , 758\nUNITED PARCEL SERVICE INC 5.200% 04/01/2040 DD 03/24/20 CORPORATE DEBT INSTRUMENTS 3 8 8 ,124 3 8 0 , 2 19\nUNITED PARCEL SERVICE INC 5.500% 05/22/2054 DD 05/22/24 CORPORATE DEBT INSTRUMENTS 8 0 8 ,506 7 8 1 , 0 72\nUNITED PARCEL SERVICE INC 6.200% 01/15/2038 DD 01/15/08 CORPORATE DEBT INSTRUMENTS 6 6 2 ,388 6 4 2 , 384\nUNITEDHEALTH GROUP INC 2.900% 05/15/2050 DD 05/18/20 CORPORATE DEBT INSTRUMENTS 2 8 8 ,410 1 8 0 , 3 13\nUNITEDHEALTH GROUP INC 2.950% 10/15/2027 DD 10/25/17 CORPORATE DEBT INSTRUMENTS 1 , 5 44,026 1 , 3 2 5,708\nUNITEDHEALTH GROUP INC 3.050% 05/15/2041 DD 05/19/21 CORPORATE DEBT INSTRUMENTS 5 0 0 ,551 3 8 3 , 466\nUNITEDHEALTH GROUP INC 3.250% 05/15/2051 DD 05/19/21 CORPORATE DEBT INSTRUMENTS 5 3 5 ,033 3 4 2 , 5 12\nUNITEDHEALTH GROUP INC 3.700% 08/15/2049 DD 07/25/19 CORPORATE DEBT INSTRUMENTS 1 , 0 41,970 7 5 0 , 386\nUNITEDHEALTH GROUP INC 3.750% 10/15/2047 DD 10/25/17 CORPORATE DEBT INSTRUMENTS 3 2 6 ,951 2 4 6 , 256\nUNITEDHEALTH GROUP INC 4.200% 01/15/2047 DD 12/20/16 CORPORATE DEBT INSTRUMENTS 4 8 6 ,340 3 9 6 , 337\nUNITEDHEALTH GROUP INC 4.250% 06/15/2048 DD 06/19/18 CORPORATE DEBT INSTRUMENTS 5 3 8 ,271 4 3 5 , 486\nUNITEDHEALTH GROUP INC 4.450% 12/15/2048 DD 12/17/18 CORPORATE DEBT INSTRUMENTS 1 , 1 62,215 9 6 2 , 227\nUNITEDHEALTH GROUP INC 4.750% 05/15/2052 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 8 7 8 ,543 7 8 1 , 0 44\nUNITEDHEALTH GROUP INC 4.750% 05/15/2052 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 2 , 0 05,722 1 , 8 7 8,797\nUNITEDHEALTH GROUP INC 4.750% 05/15/2052 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 4 4 9 ,156 3 9 9 , 1 05\nUNITEDHEALTH GROUP INC 4.750% 07/15/2045 DD 07/23/15 CORPORATE DEBT INSTRUMENTS 2 1 4 ,116 1 8 9 , 5 93\nUNITEDHEALTH GROUP INC 4.750% 07/15/2045 DD 07/23/15 CORPORATE DEBT INSTRUMENTS 6 4 , 9 26 6 1 , 7 2 8\nUNITEDHEALTH GROUP INC 4.950% 05/15/2062 DD 05/20/22 CORPORATE DEBT INSTRUMENTS 1 7 8 ,236 1 5 5 , 3 78\nUNITEDHEALTH GROUP INC 5.050% 04/15/2053 DD 03/28/23 CORPORATE DEBT INSTRUMENTS 1 6 4 ,767 1 4 8 , 8 18\nUNITEDHEALTH GROUP INC 5.200% 04/15/2063 DD 03/28/23 CORPORATE DEBT INSTRUMENTS 2 4 9 ,204 2 2 9 , 783\nUNITEDHEALTH GROUP INC 5.500% 04/15/2064 DD 03/21/24 CORPORATE DEBT INSTRUMENTS 5 3 3 ,764 5 0 0 , 744\nUNITEDHEALTH GROUP INC 5.500% 07/15/2044 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 8 9 6 ,683 8 7 9 , 506\nUNITEDHEALTH GROUP INC 5.625% 07/15/2054 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 9 8 2 ,777 9 5 7 , 932\nUNITEDHEALTH GROUP INC 5.750% 07/15/2064 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 1 3 6 ,341 1 2 6 , 7 71\nUNITEDHEALTH GROUP INC 5.750% 07/15/2064 DD 07/25/24 CORPORATE DEBT INSTRUMENTS 2 2 8 ,613 2 2 4 , 287\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nUNITEDHEALTH GROUP INC 5.800% 03/15/2036 DD 03/02/06 CORPORATE DEBT INSTRUMENTS 3 8 8 ,839 3 9 2 , 1 52\nUNITEDHEALTH GROUP INC 5.875% 02/15/2053 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 3 0 6 ,255 2 6 9 , 1 01\nUNITEDHEALTH GROUP INC 5.875% 02/15/2053 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 3 3 2 ,175 3 3 1 , 3 56\nUNITEDHEALTH GROUP INC 5.950% 02/15/2041 DD 02/17/11 CORPORATE DEBT INSTRUMENTS 4 8 , 6 88 4 6 , 1 4 0\nUNITEDHEALTH GROUP INC 6.050% 02/15/2063 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 7 4 1 ,150 7 6 6 , 853\nUNITEDHEALTH GROUP INC 6.050% 02/15/2063 DD 10/28/22 CORPORATE DEBT INSTRUMENTS 2 8 1 ,637 2 9 1 , 4 04\nUNITEDHEALTH GROUP INC 6.625% 11/15/2037 DD 11/19/07 CORPORATE DEBT INSTRUMENTS 1 , 0 37,824 1 , 2 3 8,018\nUNIVERSITY OF NOTRE DAME DU LA 1.637% 02/15/2030 DD 06/10/20 CORPORATE DEBT INSTRUMENTS 2 , 3 36,202 1 , 9 4 4,075\nUNIVERSITY OF SOUTHERN CALIFOR 3.028% 10/01/2039 DD 08/22/16 CORPORATE DEBT INSTRUMENTS 4 8 4 ,980 4 7 4 , 648\nUS BANCORP 1.375% 07/22/2030 DD 07/20/20 CORPORATE DEBT INSTRUMENTS 3 6 7 ,628 3 0 5 , 505\nUS BANCORP VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 7 5 1 ,673 7 5 6 , 848\nUS BANCORP VAR RT 02/01/2034 DD 02/01/23 CORPORATE DEBT INSTRUMENTS 8 7 0 ,000 8 3 2 , 990\nVERISK ANALYTICS INC 3.625% 05/15/2050 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 1 , 3 83,601 9 8 1 , 6 62\nVERIZON COMMUNICATIONS INC 2.650% 11/20/2040 DD 11/20/20 CORPORATE DEBT INSTRUMENTS 1 , 3 26,594 9 3 1 , 0 02\nVERIZON COMMUNICATIONS INC 2.987% 10/30/2056 DD 04/30/21 CORPORATE DEBT INSTRUMENTS 5 4 0 ,919 3 8 6 , 896\nVERIZON COMMUNICATIONS INC 2.987% 10/30/2056 DD 04/30/21 CORPORATE DEBT INSTRUMENTS 1 , 0 65,123 7 6 9 , 037\nVERIZON COMMUNICATIONS INC 3.400% 03/22/2041 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 7 2 0 ,929 5 6 0 , 269\nVERIZON COMMUNICATIONS INC 3.550% 03/22/2051 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 4 , 3 91,414 2 , 9 0 8,391\nVERIZON COMMUNICATIONS INC 3.550% 03/22/2051 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 4 8 3 ,403 3 5 0 , 366\nVERIZON COMMUNICATIONS INC 3.700% 03/22/2061 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 4 , 5 30,582 3 , 0 8 3,523\nVERIZON COMMUNICATIONS INC 3.700% 03/22/2061 DD 03/22/21 CORPORATE DEBT INSTRUMENTS 2 , 5 44,441 1 , 7 1 2,238\nVERIZON COMMUNICATIONS INC 4.272% 01/15/2036 DD 07/15/15 CORPORATE DEBT INSTRUMENTS 3 8 8 ,423 3 8 2 , 343\nVERIZON COMMUNICATIONS INC 4.272% 01/15/2036 DD 07/15/15 CORPORATE DEBT INSTRUMENTS 3 , 3 23,683 3 , 0 3 1,753\nVERIZON COMMUNICATIONS INC 4.400% 11/01/2034 DD 10/29/14 CORPORATE DEBT INSTRUMENTS 4 1 6 ,959 3 8 9 , 227\nVIATRIS INC 4.000% 06/22/2050 DD 06/22/21 CORPORATE DEBT INSTRUMENTS 7 2 8 ,102 4 9 8 , 1 23\nVICI PROPERTIES LP 5.625% 05/15/2052 DD 04/29/22 CORPORATE DEBT INSTRUMENTS 4 1 9 ,062 4 1 8 , 6 80\nVIRGINIA ELECTRIC AND POWER CO 2.450% 12/15/2050 DD 12/15/20 CORPORATE DEBT INSTRUMENTS 2 7 7 ,511 1 5 8 , 8 82\nVIRGINIA ELECTRIC AND POWER CO 2.875% 07/15/2029 DD 07/10/19 CORPORATE DEBT INSTRUMENTS 1 , 5 26,035 1 , 2 7 5,987\nVIRGINIA ELECTRIC AND POWER CO 3.750% 05/15/2027 DD 05/31/22 CORPORATE DEBT INSTRUMENTS 1 7 9 ,438 1 7 6 , 2 51\nVIRGINIA ELECTRIC AND POWER CO 4.650% 08/15/2043 DD 08/15/13 CORPORATE DEBT INSTRUMENTS 1 , 1 59,443 1 , 0 1 8,225\nVIRGINIA ELECTRIC AND POWER CO 5.350% 01/15/2054 DD 01/08/24 CORPORATE DEBT INSTRUMENTS 8 3 7 ,866 7 9 3 , 565\nVIRGINIA ELECTRIC AND POWER CO 5.450% 04/01/2053 DD 03/30/23 CORPORATE DEBT INSTRUMENTS 4 8 1 ,628 4 6 1 , 3 10\nVIRGINIA ELECTRIC AND POWER CO 5.550% 08/15/2054 DD 08/12/24 CORPORATE DEBT INSTRUMENTS 1 1 9 ,478 1 1 6 , 1 73\nVIRGINIA ELECTRIC AND POWER CO 8.875% 11/15/2038 DD 11/06/08 CORPORATE DEBT INSTRUMENTS 3 , 2 54,394 2 , 7 8 4,060\nVISA INC 2.050% 04/15/2030 DD 04/02/20 CORPORATE DEBT INSTRUMENTS 1 , 5 33,284 1 , 2 8 1,450\nVISA INC 2.700% 04/15/2040 DD 04/02/20 CORPORATE DEBT INSTRUMENTS 3 1 6 ,685 2 2 9 , 783\nVISA INC 4.300% 12/14/2045 DD 12/14/15 CORPORATE DEBT INSTRUMENTS 1 , 1 45,919 9 5 0 , 582\nVISA INC 4.300% 12/14/2045 DD 12/14/15 CORPORATE DEBT INSTRUMENTS 4 0 1 ,382 2 7 8 , 324\nVODAFONE GROUP PLC 4.250% 09/17/2050 DD 09/17/19 CORPORATE DEBT INSTRUMENTS 4 5 3 ,447 3 4 9 , 956\nVODAFONE GROUP PLC 5.625% 02/10/2053 DD 02/10/23 CORPORATE DEBT INSTRUMENTS 2 4 8 ,958 2 3 8 , 095\nVODAFONE GROUP PLC 5.750% 06/28/2054 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 4 2 7 ,566 4 1 5 , 1 31\nVODAFONE GROUP PLC 5.750% 06/28/2054 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 2 , 2 35,103 2 , 1 5 7,714\nVODAFONE GROUP PLC 5.875% 06/28/2064 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 4 0 6 ,074 3 8 3 , 004\nVODAFONE GROUP PLC 5.875% 06/28/2064 DD 06/28/24 CORPORATE DEBT INSTRUMENTS 4 5 0 ,942 4 3 6 , 334\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nVULCAN MATERIALS CO 5.700% 12/01/2054 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 6 0 3 ,566 5 6 6 , 405\nWALMART INC 1.800% 09/22/2031 DD 09/22/21 CORPORATE DEBT INSTRUMENTS 1 , 8 68,194 1 , 5 6 4,988\nWALMART INC 2.375% 09/24/2029 DD 09/24/19 CORPORATE DEBT INSTRUMENTS 2 2 4 ,717 1 8 8 , 4 26\nWALMART INC 2.500% 09/22/2041 DD 09/22/21 CORPORATE DEBT INSTRUMENTS 7 9 6 ,780 5 7 0 , 409\nWALMART INC 2.650% 09/22/2051 DD 09/22/21 CORPORATE DEBT INSTRUMENTS 8 3 1 ,911 5 1 7 , 2 91\nWALT DISNEY CO/THE 2.750% 09/01/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 8 5 0 ,147 5 1 1 , 1 85\nWALT DISNEY CO/THE 2.750% 09/01/2049 DD 09/06/19 CORPORATE DEBT INSTRUMENTS 8 5 6 ,459 5 5 3 , 054\nWALT DISNEY CO/THE 3.350% 03/24/2025 DD 03/23/20 CORPORATE DEBT INSTRUMENTS 1 , 5 32,059 1 , 3 9 1,094\nWALT DISNEY CO/THE 3.500% 05/13/2040 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 6 2 2 ,189 6 1 7 , 9 64\nWALT DISNEY CO/THE 3.500% 05/13/2040 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 7 2 5 ,408 6 3 8 , 027\nWALT DISNEY CO/THE 3.600% 01/13/2051 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 1 , 8 13,319 1 , 3 9 5,971\nWALT DISNEY CO/THE 3.600% 01/13/2051 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 6 4 3 ,124 4 7 4 , 409\nWALT DISNEY CO/THE 3.600% 01/13/2051 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 3 3 1 ,356 2 3 5 , 7 31\nWALT DISNEY CO/THE 3.800% 05/13/2060 DD 05/13/20 CORPORATE DEBT INSTRUMENTS 1 , 1 86,301 8 6 4 , 496\nWARNERMEDIA HOLDINGS INC 5.050% 03/15/2042 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 3 4 0 ,000 2 7 3 , 863\nWARNERMEDIA HOLDINGS INC 5.050% 03/15/2042 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 , 4 06,482 1 , 2 4 8,494\nWARNERMEDIA HOLDINGS INC 5.141% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 , 0 54,002 8 3 6 , 1 25\nWARNERMEDIA HOLDINGS INC 5.141% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 6 1 4 ,071 5 4 4 , 228\nWARNERMEDIA HOLDINGS INC 5.141% 03/15/2052 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 2 , 1 5 1,111 2 , 0 3 4,322\nWARNERMEDIA HOLDINGS INC 5.391% 03/15/2062 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 1 , 2 77,894 9 7 5 , 374\nWARNERMEDIA HOLDINGS INC 5.391% 03/15/2062 DD 03/15/23 CORPORATE DEBT INSTRUMENTS 2 4 6 ,183 2 2 8 , 892\nWASTE MANAGEMENT INC 3.900% 03/01/2035 DD 02/26/15 CORPORATE DEBT INSTRUMENTS 9 2 4 ,142 8 3 5 , 923\nWASTE MANAGEMENT INC 5.350% 10/15/2054 DD 11/04/24 CORPORATE DEBT INSTRUMENTS 8 6 6 ,645 8 3 4 , 1 58\nWELLS FARGO & CO 3.900% 05/01/2045 DD 04/30/15 CORPORATE DEBT INSTRUMENTS 2 , 4 50,354 1 , 8 7 9,757\nWELLS FARGO & CO 4.650% 11/04/2044 DD 11/04/14 CORPORATE DEBT INSTRUMENTS 1 , 0 16,171 8 5 7 , 2 18\nWELLS FARGO & CO 4.750% 12/07/2046 DD 12/08/16 CORPORATE DEBT INSTRUMENTS 1 , 0 97,258 9 2 9 , 062\nWELLS FARGO & CO 4.750% 12/07/2046 DD 12/08/16 CORPORATE DEBT INSTRUMENTS 4 8 6 ,578 4 0 1 , 5 51\nWELLS FARGO & CO 4.900% 11/17/2045 DD 11/17/15 CORPORATE DEBT INSTRUMENTS 5 8 3 ,970 4 9 0 , 2 51\nWELLS FARGO & CO 5.606% 01/15/2044 DD 11/26/13 CORPORATE DEBT INSTRUMENTS 2 3 8 ,786 2 0 5 , 9 16\nWELLS FARGO & CO VAR RT 01/23/2035 DD 01/23/24 CORPORATE DEBT INSTRUMENTS 3 4 1 ,172 3 3 4 , 045\nWELLS FARGO & CO VAR RT 02/11/2031 DD 02/11/20 CORPORATE DEBT INSTRUMENTS 1 , 8 92,619 1 , 6 2 7,179\nWELLS FARGO & CO VAR RT 04/04/2051 DD 03/30/20 CORPORATE DEBT INSTRUMENTS 1 0 8 ,700 9 7 , 7 8 1\nWELLS FARGO & CO VAR RT 04/25/2053 DD 04/25/22 CORPORATE DEBT INSTRUMENTS 1 , 6 35,210 1 , 4 1 1,036\nWELLS FARGO & CO VAR RT 04/30/2041 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 3 9 0 ,000 2 8 4 , 1 35\nWELLS FARGO & CO VAR RT 04/30/2041 DD 04/30/20 CORPORATE DEBT INSTRUMENTS 1 2 9 ,845 1 2 7 , 4 96\nWELLS FARGO BANK NA 5.850% 02/01/2037 DD 01/29/07 CORPORATE DEBT INSTRUMENTS 2 , 9 46,345 2 , 6 0 7,173\nWELLS FARGO BANK NA 6.600% 01/15/2038 DD 12/07/07 CORPORATE DEBT INSTRUMENTS 2 , 1 51,329 2 , 1 6 0,002\nWESTPAC BANKING CORP 3.133% 11/18/2041 DD 11/18/21 CORPORATE DEBT INSTRUMENTS 3 6 0 ,000 2 5 8 , 448\nWESTPAC BANKING CORP VAR RT 11/20/2035 DD 11/20/24 CORPORATE DEBT INSTRUMENTS 4 1 5 ,000 4 0 7 , 974\nWILLIAMS COS INC/THE 5.750% 06/24/2044 DD 06/24/14 CORPORATE DEBT INSTRUMENTS 1 4 4 ,491 1 3 0 , 9 19\nWILLIAMS COS INC/THE 5.800% 11/15/2043 DD 11/15/13 CORPORATE DEBT INSTRUMENTS 1 4 3 ,382 1 4 1 , 6 85\nWILLIAMS COS INC/THE 6.300% 04/15/2040 DD 02/09/10 CORPORATE DEBT INSTRUMENTS 4 1 8 ,949 3 2 8 , 302\nWW GRAINGER INC 4.600% 06/15/2045 DD 06/11/15 CORPORATE DEBT INSTRUMENTS 3 3 9 ,725 3 0 3 , 773\nWYETH LLC 5.950% 04/01/2037 DD 03/27/07 CORPORATE DEBT INSTRUMENTS 3 7 2 ,643 3 5 5 , 055\nWYETH LLC 6.000% 02/15/2036 DD 11/14/05 CORPORATE DEBT INSTRUMENTS 1 , 2 80,888 1 , 2 0 6,326\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nXL GROUP LTD 5.250% 12/15/2043 DD 11/21/13 CORPORATE DEBT INSTRUMENTS 1 , 7 33,238 1 , 2 7 9,243\nYALE UNIVERSITY 1.482% 04/15/2030 DD 06/09/20 CORPORATE DEBT INSTRUMENTS 1 , 5 52,760 1 , 3 0 5,364\nZOETIS INC 3.000% 05/15/2050 DD 05/12/20 CORPORATE DEBT INSTRUMENTS 3 7 5 ,839 2 4 4 , 2 41\n$ 1 ,083,138,462 $ 9 2 5,674,665\nADIDAS AG CORPORATE STOCK - COMMON $ 3 0 2 ,773 $ 8 0 4 , 277\nAIA GROUP LTD HK/01299 CORPORATE STOCK - COMMON 8 3 8 ,526 1 , 1 0 8,903\nAIR LIQUIDE SA CORPORATE STOCK - COMMON 7 8 6 ,696 1 , 5 8 1,846\nALIMENTATION COUCHE-TARD INC CORPORATE STOCK - COMMON 8 4 1 ,131 1 , 8 9 4,611\nAMADEUS IT GROUP SA CORPORATE STOCK - COMMON 8 8 0 ,558 1 , 0 2 0,475\nASML HOLDING NV CORPORATE STOCK - COMMON 7 6 0 ,854 1 , 6 8 6,705\nATLAS COPCO AB CORPORATE STOCK - COMMON 6 6 4 ,268 7 7 5 , 299\nCANADIAN NATIONAL RAILWAY CO CORPORATE STOCK - COMMON 1 , 0 18,536 9 6 5 , 2 17\nCAPITALAND ASCENDAS REIT CORPORATE STOCK - COMMON 9 6 6 ,143 8 7 4 , 4 18\nCLP HOLDINGS LTD HK/00002 CORPORATE STOCK - COMMON 4 9 5 ,229 5 5 4 , 8 18\nCOCHLEAR LTD CORPORATE STOCK - COMMON 2 1 0 ,524 5 3 4 , 848\nCOLOPLAST A/S CORPORATE STOCK - COMMON 5 6 6 ,600 8 8 3 , 1 87\nCOMPASS GROUP PLC CORPORATE STOCK - COMMON 7 2 5 ,563 1 , 4 7 6,579\nCSL LTD CORPORATE STOCK - COMMON 1 7 9 ,134 9 3 6 , 207\nDAIKIN INDUSTRIES LTD CORPORATE STOCK - COMMON 1 5 0 ,651 7 2 4 , 268\nDASSAULT SYSTEMES SE CORPORATE STOCK - COMMON 8 2 5 ,522 7 4 9 , 288\nDIAGEO PLC CORPORATE STOCK - COMMON 9 6 6 ,589 8 8 6 , 652\nEXPERIAN PLC CORPORATE STOCK - COMMON 3 8 6 ,242 1 , 0 3 4,621\nFANUC CORP CORPORATE STOCK - COMMON 2 8 1 ,522 5 4 4 , 588\nFERRARI NV CORPORATE STOCK - COMMON 4 8 1 ,715 7 0 4 , 6 16\nHERMES INTERNATIONAL SCA CORPORATE STOCK - COMMON 4 3 5 ,395 7 6 9 , 4 18\nHOYA CORP CORPORATE STOCK - COMMON 7 8 7 ,327 8 1 9 , 5 31\nINDUSTRIA DE DISENO TEXTIL SA CORPORATE STOCK - COMMON 3 2 1 ,414 1 , 4 4 4,402\nINFINEON TECHNOLOGIES AG CORPORATE STOCK - COMMON 1 , 1 66,788 1 , 0 9 8,997\nJARDINE MATHESON HOLDINGS LTD CORPORATE STOCK - COMMON 8 8 7 ,469 5 8 1 , 7 74\nKAP RESOURCES LTD CORPORATE STOCK - COMMON 8 5 , 1 97 -\nKEYENCE CORP CORPORATE STOCK - COMMON 1 4 1 ,556 1 , 4 0 4,785\nKONE OYJ CORPORATE STOCK - COMMON 6 9 1 ,077 9 1 0 , 1 01\nKUEHNE + NAGEL INTERNATIONAL A CORPORATE STOCK - COMMON 5 1 2 ,280 8 0 4 , 8 31\nLONZA GROUP AG CORPORATE STOCK - COMMON 1 , 0 76,641 9 2 2 , 3 15\nL'OREAL SA CORPORATE STOCK - COMMON 2 0 9 ,159 1 , 0 7 2,577\nLVMH MOET HENNESSY LOUIS VUITT CORPORATE STOCK - COMMON 3 4 7 ,844 1 , 2 4 3,734\nMERCK KGAA CORPORATE STOCK - COMMON 1 , 0 68,579 8 3 1 , 5 33\nMISUMI GROUP INC CORPORATE STOCK - COMMON 6 5 4 ,741 3 6 3 , 970\nMURATA MANUFACTURING CO LTD CORPORATE STOCK - COMMON 3 6 8 ,076 4 7 0 , 664\nNOVARTIS AG CORPORATE STOCK - COMMON 3 9 3 ,534 9 8 4 , 6 31\nNOVO NORDISK A/S CORPORATE STOCK - COMMON 1 7 9 ,772 1 , 4 6 6,544\nOBIC CO LTD CORPORATE STOCK - COMMON 8 7 1 ,843 9 2 5 , 700\nRECORDATI INDUSTRIA CHIMICA E CORPORATE STOCK - COMMON 6 6 0 ,891 5 2 9 , 203\nROCHE HOLDING AG CORPORATE STOCK - COMMON 1 , 0 01,982 1 , 2 4 0,497\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nSAGE GROUP PLC/THE CORPORATE STOCK - COMMON 5 7 4 ,129 6 6 6 , 420\nSAP SE CORPORATE STOCK - COMMON 1 9 7 ,958 1 , 3 0 9,084\nSGS SA CORPORATE STOCK - COMMON 4 9 9 ,747 1 , 0 2 2,068\nSHIMADZU CORP CORPORATE STOCK - COMMON 5 3 7 ,824 4 7 4 , 0 31\nSHIN-ETSU CHEMICAL CO LTD CORPORATE STOCK - COMMON 3 8 4 ,615 1 , 0 5 8,122\nSMC CORP CORPORATE STOCK - COMMON 6 0 8 ,025 9 4 9 , 555\nSYSMEX CORP CORPORATE STOCK - COMMON 1 , 0 94,652 1 , 0 3 7,365\nTAIWAN SEMICONDUCTOR MANUFACTU ADR CORPORATE STOCK - COMMON 1 5 8 ,625 2 , 4 1 1,353\nTERUMO CORP CORPORATE STOCK - COMMON 7 6 4 ,713 8 7 0 , 905\nTOTALENERGIES SE CORPORATE STOCK - COMMON 7 1 9 ,496 8 0 2 , 442\nUNIVERSAL MUSIC GROUP NV CORPORATE STOCK - COMMON 1 , 2 02,453 1 , 1 0 6,762\nVAT GROUP AG CORPORATE STOCK - COMMON 1 6 4 ,178 5 1 6 , 3 28\nWOLTERS KLUWER NV CORPORATE STOCK - COMMON 1 , 0 02,174 1 , 0 9 4,561\n$ 3 2 ,098,930 $ 5 0 , 945,626\nEQUITABLE REAL ESTATE PARTNERSHIP/JOINT VENTURE $ 6 7 ,606,999 $ 1 2 3 ,671,905\n$ 6 7 ,606,999 $ 1 2 3 ,671,905\nBLACKROCK LIQ T FUND INSTL REGISTERED INVESTMENT COMPANY $ 1 2 1,769,713 $ 1 2 1 ,769,713\n$ 1 2 1,769,713 $ 1 2 1 ,769,713\nRESOLUTION FDG CORP PRIN STRIP 0.000% 04/15/2030 DD 04/15/90 U. S. GOVERNMENT SECURITIES $ 1 4 ,619,531 $ 2 1 ,5 49,933\nU S TREASURY BD CPN STRIP 0.000% 02/15/2035 DD 02/15/06 U. S. GOVERNMENT SECURITIES 4 , 0 41,650 3 , 0 8 7,700\nU S TREASURY BD CPN STRIP 0.000% 02/15/2036 DD 02/15/06 U. S. GOVERNMENT SECURITIES 9 , 3 28,480 8 , 2 2 2,620\nU S TREASURY BD CPN STRIP 0.000% 02/15/2039 DD 02/17/09 U. S. GOVERNMENT SECURITIES 6 , 7 39,980 6 , 4 5 7,100\nU S TREASURY BD CPN STRIP 0.000% 05/15/2034 DD 08/15/07 U. S. GOVERNMENT SECURITIES 2 5 ,228,531 2 2 , 199,383\nU S TREASURY BD CPN STRIP 0.000% 05/15/2039 DD 05/15/09 U. S. GOVERNMENT SECURITIES 6 , 6 37,410 6 , 3 5 5,440\nU S TREASURY BD CPN STRIP 0.000% 08/15/2034 DD 02/15/06 U. S. GOVERNMENT SECURITIES 2 0 ,596,196 1 7 , 689,280\nU S TREASURY BD CPN STRIP 0.000% 08/15/2039 DD 08/17/09 U. S. GOVERNMENT SECURITIES 6 , 5 46,020 6 , 2 5 2,220\nU S TREASURY BD CPN STRIP 0.000% 11/15/2039 DD 11/16/09 U. S. GOVERNMENT SECURITIES 6 , 4 52,030 6 , 1 7 8,120\nU S TREASURY BD PRIN STRIP 0.000% 05/15/2043 DD 05/15/13 U. S. GOVERNMENT SECURITIES 1 5 ,481,200 1 4 , 431,550\nU S TREASURY BD PRIN STRIP 0.000% 08/15/2043 DD 08/15/13 U. S. GOVERNMENT SECURITIES 2 4 ,168,925 2 2 , 451,000\nU S TREASURY BD PRIN STRIP 0.000% 11/15/2043 DD 11/15/13 U. S. GOVERNMENT SECURITIES 3 0 ,572,800 2 8 , 235,200\nU S TREASURY BOND 1.375% 11/15/2040 DD 11/15/20 U. S. GOVERNMENT SECURITIES 4 , 7 73,242 3 , 0 9 8,450\nU S TREASURY BOND 2.250% 08/15/2046 DD 08/15/16 U. S. GOVERNMENT SECURITIES 1 , 6 70,787 1 , 5 0 6,782\nU S TREASURY BOND 2.375% 02/15/2042 DD 02/15/22 U. S. GOVERNMENT SECURITIES 1 4 ,044,703 1 0 , 690,500\nU S TREASURY BOND 2.875% 05/15/2043 DD 05/15/13 U. S. GOVERNMENT SECURITIES 6 , 1 56,047 5 , 5 5 0,610\nU S TREASURY BOND 3.375% 05/15/2044 DD 05/15/14 U. S. GOVERNMENT SECURITIES 4 , 9 58,284 4 , 5 8 0,184\nU S TREASURY BOND 3.375% 08/15/2042 DD 08/15/22 U. S. GOVERNMENT SECURITIES 3 , 7 40,124 3 , 4 0 3,818\nU S TREASURY BOND 3.375% 08/15/2042 DD 08/15/22 U. S. GOVERNMENT SECURITIES 1 3 ,583,528 1 2 , 395,550\nU S TREASURY BOND 3.500% 02/15/2039 DD 02/15/09 U. S. GOVERNMENT SECURITIES 5 , 0 69,380 4 , 3 8 6,550\nU S TREASURY BOND 3.625% 08/15/2043 DD 08/15/13 U. S. GOVERNMENT SECURITIES 8 , 4 79,835 8 , 1 1 5,456\nU S TREASURY BOND 3.875% 02/15/2043 DD 02/15/23 U. S. GOVERNMENT SECURITIES 9 , 5 32,028 8 , 8 3 2,800\nU S TREASURY BOND 3.875% 05/15/2043 DD 05/15/23 U. S. GOVERNMENT SECURITIES 8 , 5 67,831 8 , 1 2 7,778\nU S TREASURY BOND 3.875% 05/15/2043 DD 05/15/23 U. S. GOVERNMENT SECURITIES 3 , 1 64,995 2 , 9 3 8,335\nU S TREASURY BOND 3.875% 08/15/2040 DD 08/15/10 U. S. GOVERNMENT SECURITIES 2 9 ,069,118 2 7 , 023,400\nU S TREASURY BOND 4.000% 11/15/2042 DD 11/15/22 U. S. GOVERNMENT SECURITIES 1 4 ,634,679 1 3 , 5 11,100\nU S TREASURY BOND 4.250% 08/15/2054 DD 08/15/24 U. S. GOVERNMENT SECURITIES 1 , 0 37,011 9 8 8 , 027\nU S TREASURY BOND 4.250% 08/15/2054 DD 08/15/24 U. S. GOVERNMENT SECURITIES 1 2 ,934,793 1 2 , 400,656\n\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nPlan Sponsor: GlaxoSmithKline LLC\nEIN: 23-1099050 PN: 003\nSchedule H, Line 4(i) Schedule of Assets (Held at End of Year) As of\nDecember 31, 2024\nU S TREASURY BOND 4.250% 11/15/2040 DD 11/15/10 U. S. GOVERNMENT SECURITIES 2 7 ,390,814 2 3 , 520,500\nU S TREASURY BOND 4.375% 08/15/2043 DD 08/15/23 U. S. GOVERNMENT SECURITIES 2 , 2 98,144 2 , 2 1 8,198\nU S TREASURY BOND 4.375% 11/15/2039 DD 11/15/09 U. S. GOVERNMENT SECURITIES 4 1 ,695,866 4 1 , 251,620\nU S TREASURY BOND 4.500% 02/15/2044 DD 02/15/24 U. S. GOVERNMENT SECURITIES 2 , 3 79,132 2 , 2 8 0,707\nU S TREASURY BOND 4.500% 08/15/2039 DD 08/15/09 U. S. GOVERNMENT SECURITIES 4 4 ,520,634 4 3 , 841,700\nU S TREASURY BOND 4.625% 05/15/2044 DD 05/15/24 U. S. GOVERNMENT SECURITIES 2 , 8 27,444 2 , 7 0 2,759\nU S TREASURY BOND 4.625% 05/15/2044 DD 05/15/24 U. S. GOVERNMENT SECURITIES 1 2 3 ,225 1 1 6 , 4 56\nU S TREASURY BOND 4.625% 11/15/2044 DD 11/15/24 U. S. GOVERNMENT SECURITIES 2 0 ,727,233 1 9 , 970,712\nU S TREASURY BOND 4.625% 11/15/2044 DD 11/15/24 U. S. GOVERNMENT SECURITIES 1 , 4 32,775 1 , 4 0 2,560\nU S TREASURY BOND 4.750% 02/15/2041 DD 02/15/11 U. S. GOVERNMENT SECURITIES 2 6 ,747,900 2 2 , 914,670\nU S TREASURY NOTE 0.625% 03/31/2027 DD 03/31/20 U. S. GOVERNMENT SECURITIES 1 5 ,134,180 1 3 , 847,400\nU S TREASURY NOTE 2.375% 04/30/2026 DD 04/30/19 U. S. GOVERNMENT SECURITIES 1 5 ,739,493 1 4 , 636,100\nU S TREASURY NOTE 2.625% 02/15/2029 DD 02/15/19 U. S. GOVERNMENT SECURITIES 2 1 ,616,581 1 8 , 696,200\nU S TREASURY NOTE 3.500% 09/30/2029 DD 09/30/24 U. S. GOVERNMENT SECURITIES 4 , 9 33,825 4 , 7 5 2,626\nU S TREASURY NOTE 3.750% 08/31/2031 DD 08/31/24 U. S. GOVERNMENT SECURITIES 3 7 ,343,974 3 5 , 446,370\nU S TREASURY NOTE 3.875% 08/15/2034 DD 08/15/24 U. S. GOVERNMENT SECURITIES 2 , 5 25,222 2 , 4 4 4,841\nU S TREASURY NOTE 4.000% 01/31/2029 DD 01/31/24 U. S. GOVERNMENT SECURITIES 3 , 6 95,667 3 , 6 9 8,138\nU S TREASURY NOTE 4.000% 01/31/2031 DD 01/31/24 U. S. GOVERNMENT SECURITIES 1 6 ,658,740 1 6 , 584,350\nU S TREASURY NOTE 4.000% 02/28/2030 DD 02/28/23 U. S. GOVERNMENT SECURITIES 2 5 ,333,660 2 4 , 534,250\nU S TREASURY NOTE 4.000% 07/31/2029 DD 07/31/24 U. S. GOVERNMENT SECURITIES 5 0 ,589,844 4 9 , 201,000\nU S TREASURY NOTE 4.125% 07/31/2031 DD 07/31/24 U. S. GOVERNMENT SECURITIES 4 2 ,872,227 4 1 , 160,000\nU S TREASURY NOTE 4.250% 01/31/2026 DD 01/31/24 U. S. GOVERNMENT SECURITIES 2 3 ,793,830 2 4 , 000,000\nU S TREASURY NOTE 4.250% 02/28/2029 DD 02/29/24 U. S. GOVERNMENT SECURITIES 2 0 ,139,130 1 9 , 904,000\nU S TREASURY NOTE 4.250% 02/28/2031 DD 02/29/24 U. S. GOVERNMENT SECURITIES 3 0 ,260,276 2 9 , 656,800\nU S TREASURY NOTE 4.250% 11/15/2034 DD 11/15/24 U. S. GOVERNMENT SECURITIES 1 1 1,573,822 1 0 9 ,624,106\nU S TREASURY NOTE 4.250% 11/15/2034 DD 11/15/24 U. S. GOVERNMENT SECURITIES 1 2 0 ,235 1 1 6 , 9 06\nU S TREASURY NOTE 4.375% 05/15/2034 DD 05/15/24 U. S. GOVERNMENT SECURITIES 5 6 ,618,788 5 3 , 476,812\nU S TREASURY NOTE 4.375% 08/31/2028 DD 08/31/23 U. S. GOVERNMENT SECURITIES 1 0 ,094,565 1 0 , 006,600\nU S TREASURY NOTE 4.500% 11/15/2033 DD 11/15/23 U. S. GOVERNMENT SECURITIES 1 9 ,676,801 1 9 , 1 16,096\nU S TREASURY NOTE 4.625% 06/30/2026 DD 06/30/24 U. S. GOVERNMENT SECURITIES 2 5 ,296,875 2 5 , 132,750\n$ 1 ,015,990,040 $ 9 6 6 ,914,769\nJOHN HANCOCK GROUP ANNUITY 0.000% 12/31/2049 DD 01/01/96 UNALLOCATED INSURANCE CONTRACT $ 1 0 ,659,514 $ 1 0 , 6 59,514\nCHICAGO IL MET WTR RECLAMATION 5.720% 12/01/2038 DD 08/26/09 MUNICIPAL BONDS $ 4 0 9 ,749 $ 3 0 1 , 203\nMUNI ELEC AUTH OF GEORGIA 6.637% 04/01/2057 DD 03/11/10 MUNICIPAL BONDS 4 9 2 ,353 3 5 6 , 3 71\nRUTGERS NJ ST UNIV 3.915% 05/01/2119 DD 09/16/19 MUNICIPAL BONDS 4 2 9 ,000 2 9 1 , 0 64\nTEXAS TRANSPRTN COMMISSION ST 5.178% 04/01/2030 DD 08/05/10 MUNICIPAL BONDS 1 , 9 43,970 1 , 5 1 4,130\nUNIV OF CALIFORNIA REVENUES 4.767% 05/15/2115 DD 04/08/15 MUNICIPAL BONDS 7 3 6 ,807 4 5 2 , 580\n$ 4 , 0 11,879 $ 2 , 9 1 5,348\nTOTAL INVESTMENTS: $ 2 , 743,533,620\nVariation Margin on Futures $ 2 , 6 8 6,827\n$ 2 , 6 8 6,827\nTOTAL ASSETS: $ 2 , 746,220,447\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB, Line 32\nSchedule of Amortization Bases\nas of January 1, 2024\nRemaining\nDate Amortization Outstanding Amortization\nType of Base Established Initial Amount Period (Years) Balance Payment\n1.Shortfall 01/01/2024 496,247,097 15.00000 496,247,097 45,148,712\nTotal 496,247,097 45,148,712\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024\n\nSCHEDULE SB ATTACHMENTS\nSchedule SB, Line 24\nChange in Actuarial Assumptions\n\u2022 The mortality projection scale for cash balance annuity conversions was updated from MP-2020 to\nMP-2021.\n\u2022 The cash balance annuity conversion rates for married participants were changed from segment rates\nof 4.75% for the first 5 years, 5.00% for the next 15 years, and 5.74% thereafter to 4.75% for the first\n5 years, 4.87% for the next 15 years, and 5.59% thereafter.\n\u2022 The cash balance interest crediting rate assumption was changed to be based on the 30-year\ntreasury bond yield as of the last day of the prior plan year, rounded to the nearest 10 basis points.\nThe change in the approach did not change the 2024 assumption of 4.00% and increased from the\n2.75% used for 2023 valuations.\n\u2022 The retirement and termination assumptions were updated to reflect the results of the experience\nstudy completed during 2023.\n\u2022 The commencement rates for current terminated vested participants were updated to reflect the\nresults of the experience study completed during 2023.\n\u2022 The spouse age assumption was updated from 3 years to 2 years to reflect the results of the\nexperience study completed in 2023.\n\u2022 The form of payment assumption was updated to reflect the results of the experience study\ncompleted in 2023.\n\u2022 The expected administrative expenses were updated from $20,000,000 to $13,100,000 to account for\nlower expected expenses to be paid from the trust.\nPlan Name: GlaxoSmithKline Cash Balance Pension Plan\nEIN / PN: 23-1099050/003\nPlan Sponsor: GlaxoSmithKline, LLC\nValuation Date: January 1, 2024",
    "char_count": 195494
  }
]